<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinform Adv</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinform Adv</journal-id>
    <journal-id journal-id-type="publisher-id">bioadv</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics Advances</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2635-0041</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10948285</article-id>
    <article-id pub-id-type="doi">10.1093/bioadv/vbae034</article-id>
    <article-id pub-id-type="publisher-id">vbae034</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Original Article</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Gene Regulation</subject>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Inference of differential gene regulatory networks using boosted differential trees</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3980-938X</contrib-id>
        <name>
          <surname>Galindez</surname>
          <given-names>Gihanna</given-names>
        </name>
        <aff><institution>Division Data Science in Biomedicine, Peter L. Reichertz Institute for Medical Informatics of Technische Universität Braunschweig and Hannover Medical School</institution>, Braunschweig, 38106, <country country="DE">Germany</country></aff>
        <aff><institution>Braunschweig Integrated Centre of Systems Biology (BRICS), TU Braunschweig</institution>, Braunschweig, 38106, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0941-4168</contrib-id>
        <name>
          <surname>List</surname>
          <given-names>Markus</given-names>
        </name>
        <aff><institution>Experimental Bioinformatics, TUM School of Life Sciences, Technical University of Munich</institution>, Munich, 85354, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0282-0462</contrib-id>
        <name>
          <surname>Baumbach</surname>
          <given-names>Jan</given-names>
        </name>
        <aff><institution>Institute for Computational Systems Biology, University of Hamburg</institution>, Hamburg, 22607, <country country="DE">Germany</country></aff>
        <aff><institution>Computational Biomedicine Lab, Department of Mathematics and Computer Science, University of Southern Denmark</institution>, Odense, 5230, <country country="DK">Denmark</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5689-3448</contrib-id>
        <name>
          <surname>Völker</surname>
          <given-names>Uwe</given-names>
        </name>
        <aff><institution>Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald</institution>, Greifswald, 17475, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Mäder</surname>
          <given-names>Ulrike</given-names>
        </name>
        <aff><institution>Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald</institution>, Greifswald, 17475, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8651-750X</contrib-id>
        <name>
          <surname>Blumenthal</surname>
          <given-names>David B</given-names>
        </name>
        <aff><institution>Biomedical Network Science Lab, Department of Artificial Intelligence in Biomedical Engineering, Friedrich-Alexander-Universität Erlangen-Nürnberg</institution>, Erlangen, 91052, <country country="DE">Germany</country></aff>
        <xref rid="vbae034-FM1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5393-2413</contrib-id>
        <name>
          <surname>Kacprowski</surname>
          <given-names>Tim</given-names>
        </name>
        <aff><institution>Division Data Science in Biomedicine, Peter L. Reichertz Institute for Medical Informatics of Technische Universität Braunschweig and Hannover Medical School</institution>, Braunschweig, 38106, <country country="DE">Germany</country></aff>
        <aff><institution>Braunschweig Integrated Centre of Systems Biology (BRICS), TU Braunschweig</institution>, Braunschweig, 38106, <country country="DE">Germany</country></aff>
        <xref rid="vbae034-FM1" ref-type="author-notes"/>
        <xref rid="vbae034-cor1" ref-type="corresp"/>
        <!--t.kacprowski@tu-braunschweig.de-->
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Yamanishi</surname>
          <given-names>Yoshihiro</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="vbae034-cor1">Corresponding author. Division Data Science in Biomedicine, Peter L. Reichertz Institute for Medical Informatics of Technische Universität Braunschweig and Hannover Medical School, Braunschweig, 38106, Germany. E-mail: <email>t.kacprowski@tu-braunschweig.de</email></corresp>
      <fn id="vbae034-FM1">
        <p>David B Blumenthal and Tim Kacprowski Equal contribution.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="collection">
      <year>2024</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2024-02-29">
      <day>29</day>
      <month>2</month>
      <year>2024</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>29</day>
      <month>2</month>
      <year>2024</year>
    </pub-date>
    <volume>4</volume>
    <issue>1</issue>
    <elocation-id>vbae034</elocation-id>
    <history>
      <date date-type="received">
        <day>29</day>
        <month>8</month>
        <year>2023</year>
      </date>
      <date date-type="rev-recd">
        <day>24</day>
        <month>1</month>
        <year>2024</year>
      </date>
      <date date-type="editorial-decision">
        <day>19</day>
        <month>2</month>
        <year>2024</year>
      </date>
      <date date-type="accepted">
        <day>27</day>
        <month>2</month>
        <year>2024</year>
      </date>
      <date date-type="corrected-typeset">
        <day>18</day>
        <month>3</month>
        <year>2024</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2024. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2024</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="vbae034.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Summary</title>
        <p>Diseases can be caused by molecular perturbations that induce specific changes in regulatory interactions and their coordinated expression, also referred to as network rewiring. However, the detection of complex changes in regulatory connections remains a challenging task and would benefit from the development of novel nonparametric approaches. We develop a new ensemble method called BoostDiff (boosted differential regression trees) to infer a differential network discriminating between two conditions. BoostDiff builds an adaptively boosted (AdaBoost) ensemble of differential trees with respect to a target condition. To build the differential trees, we propose differential variance improvement as a novel splitting criterion. Variable importance measures derived from the resulting models are used to reflect changes in gene expression predictability and to build the output differential networks. BoostDiff outperforms existing differential network methods on simulated data evaluated in four different complexity settings. We then demonstrate the power of our approach when applied to real transcriptomics data in COVID-19, Crohn’s disease, breast cancer, prostate adenocarcinoma, and stress response in <italic toggle="yes">Bacillus subtilis</italic>. BoostDiff identifies context-specific networks that are enriched with genes of known disease-relevant pathways and complements standard differential expression analyses.</p>
      </sec>
      <sec id="s2">
        <title>Availability and implementation</title>
        <p>BoostDiff is available at <ext-link xlink:href="https://github.com/scibiome/boostdiff_inference" ext-link-type="uri">https://github.com/scibiome/boostdiff_inference</ext-link>.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>German Federal Ministry of Education and Research</institution>
          </institution-wrap>
        </funding-source>
        <award-id>031L0309A</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="20"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>Gene regulation is a fundamental biological process that underlies various cellular functions, including developmental, environmental, and disease contexts. The regulatory relationships in a biological sample can be represented by gene regulatory networks (GRNs), where two gene nodes with a regulatory relationship are connected by an edge (<xref rid="vbae034-B38" ref-type="bibr">Karlebach and Shamir 2008</xref>). GRN inference remains a challenging task because of the inherent complexity of transcriptional regulation, as well as the high dimensionality and noise in biological datasets. Furthermore, GRNs are dynamic and context-specific (<xref rid="vbae034-B35" ref-type="bibr">Ideker and Krogan 2012</xref>, <xref rid="vbae034-B61" ref-type="bibr">Nagy-Staron <italic toggle="yes">et al.</italic> 2021</xref>), i.e. some regulatory processes are active only in certain cell types, tissues, conditions, or in response to specific stimuli. Changes in these pairwise dependencies have been associated with the development of complex diseases (<xref rid="vbae034-B19" ref-type="bibr">de la Fuente 2010</xref>). Differential network analysis, which aims to detect altered connectivity between different conditions or disease states, has recently emerged as a powerful complement to standard differential expression (DE) analysis and is more suitable for detecting context-specific GRNs (<xref rid="vbae034-B19" ref-type="bibr">de la Fuente 2010</xref>, <xref rid="vbae034-B51" ref-type="bibr">Marbach <italic toggle="yes">et al.</italic> 2012</xref>). Exploring how GRN structures are rewired between two different states can reveal molecular mechanisms that drive disease development and progression and identify more relevant therapeutic targets.</p>
    <p>Various approaches for deriving differential networks have been the focus of recent studies (<xref rid="vbae034-B7" ref-type="bibr">Bhuva <italic toggle="yes">et al.</italic> 2019</xref>, <xref rid="vbae034-B4" ref-type="bibr">Basha <italic toggle="yes">et al.</italic> 2020</xref>, <xref rid="vbae034-B5" ref-type="bibr">Baur <italic toggle="yes">et al.</italic> 2020</xref>). Representative methods are shown in <xref rid="vbae034-T1" ref-type="table">Table 1</xref>. The <italic toggle="yes">z</italic>-score method performs Fisher transformation of Pearson’s correlation coefficients between two conditions. The resulting <italic toggle="yes">z</italic>-scores are modeled as a normal distribution, followed by a <italic toggle="yes">z</italic>-test to detect significant pairwise edges (<xref rid="vbae034-B90" ref-type="bibr">Zhang <italic toggle="yes">et al.</italic> 2007</xref>). Diffcoex, a framework based on weighted gene co-expression analysis (WGGNA), first builds a correlation matrix for each condition being compared and then calculates their difference. From the difference matrix, a dissimilarity matrix is calculated based on a topological overlap measure and hierarchical clustering is applied to find the differentially co-expressed gene clusters (<xref rid="vbae034-B80" ref-type="bibr">Tesson <italic toggle="yes">et al.</italic> 2010</xref>). Another approach, a Gaussian graphical model (GGM)-based method, learns the differential network from conditional associations (<xref rid="vbae034-B14" ref-type="bibr">Chu <italic toggle="yes">et al.</italic> 2011</xref>). EBcoexpress relies on empirical Bayes’ estimation to calculate the posterior probability that an edge is differentially co-expressed (<xref rid="vbae034-B16" ref-type="bibr">Dawson and Kendziorski 2012</xref>, <xref rid="vbae034-B17" ref-type="bibr">Dawson <italic toggle="yes">et al.</italic> 2012</xref>).</p>
    <table-wrap position="float" id="vbae034-T1">
      <label>Table 1.</label>
      <caption>
        <p>Overview of methods used to derive differential networks and patient-specific networks.<xref rid="tblfn1" ref-type="table-fn"><sup>a</sup></xref></p>
      </caption>
      <table frame="hsides" rules="groups">
        <colgroup span="1">
          <col valign="top" align="left" span="1"/>
          <col valign="top" align="left" span="1"/>
          <col valign="top" align="left" span="1"/>
          <col valign="top" align="left" span="1"/>
          <col valign="top" align="left" span="1"/>
          <col valign="top" align="left" span="1"/>
          <col valign="top" align="left" span="1"/>
        </colgroup>
        <thead>
          <tr>
            <th rowspan="1" colspan="1">Method</th>
            <th rowspan="1" colspan="1">Algorithmic approach</th>
            <th rowspan="1" colspan="1">Test</th>
            <th rowspan="1" colspan="1">Directionality</th>
            <th rowspan="1" colspan="1">No. of conditions</th>
            <th rowspan="1" colspan="1">Network type</th>
            <th rowspan="1" colspan="1">Reference</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td rowspan="1" colspan="1">BoostDiff</td>
            <td rowspan="1" colspan="1">Tree-based</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">Two</td>
            <td rowspan="1" colspan="1">Differential network</td>
            <td rowspan="1" colspan="1">This paper</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"><italic toggle="yes">z</italic>-score</td>
            <td rowspan="1" colspan="1">Correlation-based</td>
            <td rowspan="1" colspan="1"><italic toggle="yes">z</italic>-test</td>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1">Two</td>
            <td rowspan="1" colspan="1">Differential network</td>
            <td rowspan="1" colspan="1">
              <xref rid="vbae034-B90" ref-type="bibr">Zhang <italic toggle="yes">et al</italic>. (2007)</xref>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">EBcoexpress</td>
            <td rowspan="1" colspan="1">Empirical Bayes; correlation</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1">Multiple</td>
            <td rowspan="1" colspan="1">Differential network</td>
            <td rowspan="1" colspan="1">
              <xref rid="vbae034-B16" ref-type="bibr">Dawson and Kendziorski, (2012)</xref>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Diffcoex</td>
            <td rowspan="1" colspan="1">Correlation-based</td>
            <td rowspan="1" colspan="1">Permutation test</td>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1">Multiple</td>
            <td rowspan="1" colspan="1">Differential network</td>
            <td rowspan="1" colspan="1">
              <xref rid="vbae034-B80" ref-type="bibr">Tesson <italic toggle="yes">et al</italic>. (2010)</xref>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">GGM-based</td>
            <td rowspan="1" colspan="1">GGM; posterior odds</td>
            <td rowspan="1" colspan="1">Permutation test</td>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1">Two</td>
            <td rowspan="1" colspan="1">Differential network</td>
            <td rowspan="1" colspan="1">
              <xref rid="vbae034-B14" ref-type="bibr">Chu <italic toggle="yes">et al</italic>. (2011)</xref>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">chNet</td>
            <td rowspan="1" colspan="1">GGM; differential expression</td>
            <td rowspan="1" colspan="1">t-test</td>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1">Two</td>
            <td rowspan="1" colspan="1">Differential network</td>
            <td rowspan="1" colspan="1">
              <xref rid="vbae034-B81" ref-type="bibr">Tu <italic toggle="yes">et al</italic>. (2021)</xref>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">LIONESS</td>
            <td rowspan="1" colspan="1">Linear interpolation</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Patient-specific</td>
            <td rowspan="1" colspan="1">
              <xref rid="vbae034-B41" ref-type="bibr">Kuijjer <italic toggle="yes">et al</italic>. (2019)</xref>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <xref rid="vbae034-B78" ref-type="bibr">Tanaka <italic toggle="yes">et al.</italic> (2020)</xref>
            </td>
            <td rowspan="1" colspan="1">Nonparametric Bayesian network; <inline-formula id="IE1"><mml:math id="IM1" display="inline" overflow="scroll"><mml:mo>Δ</mml:mo></mml:math></inline-formula> Edge contribution value</td>
            <td rowspan="1" colspan="1"><italic toggle="yes">t</italic>-test</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Patient-specific</td>
            <td rowspan="1" colspan="1">
              <xref rid="vbae034-B78" ref-type="bibr">Tanaka <italic toggle="yes">et al</italic>. (2020)</xref>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">DEVC-net</td>
            <td rowspan="1" colspan="1">Differential expression variance covariance (DEVC)</td>
            <td rowspan="1" colspan="1"><italic toggle="yes">t</italic>-test; Wilcoxon rank sum test</td>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1">Two</td>
            <td rowspan="1" colspan="1">Differential network; patient-specific</td>
            <td rowspan="1" colspan="1">
              <xref rid="vbae034-B87" ref-type="bibr">Yu <italic toggle="yes">et al.</italic> (2015)</xref>
            </td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tblfn1">
          <label>a</label>
          <p>Adapted from <xref rid="vbae034-B7" ref-type="bibr">Bhuva <italic toggle="yes">et al</italic>. (2019)</xref>.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <p>The differential network methods described above measure linear relationships or rely on joint normality assumptions, which may not hold in practice (<xref rid="vbae034-B73" ref-type="bibr">Shojaie 2021</xref>). Nonlinear regulatory dependencies are common mechanisms that occur in biology (<xref rid="vbae034-B10" ref-type="bibr">Brunel <italic toggle="yes">et al.</italic> 2010</xref>, <xref rid="vbae034-B15" ref-type="bibr">Costello <italic toggle="yes">et al.</italic> 2014</xref>) and these complex relationships from real datasets may be difficult to detect using correlation- or GGM-based methods. As discussed in a recent review, new methods for differential network analysis for non-Gaussian data are needed (<xref rid="vbae034-B73" ref-type="bibr">Shojaie 2021</xref>). Some methods for inferring patient-specific networks have also been developed. To measure the sample-specific edge contributions, DEVC-net (<xref rid="vbae034-B87" ref-type="bibr">Yu <italic toggle="yes">et al.</italic> 2015</xref>) uses a method that calculates an integrated score called DEVC that considers the differential expression of a gene, differential expression variance of a gene, and covariance of gene pairs. This method uses a template network to identify differential network features from gene expression data and can be used to obtain sample-specific networks. Linear Interpolation to Obtain Network Estimates for Single Samples (LIONESS) reverse engineers sample-specific networks from an aggregate network by applying linear interpolation on the edge weights from the aggregate networks (<xref rid="vbae034-B41" ref-type="bibr">Kuijjer <italic toggle="yes">et al.</italic> 2019</xref>). This approach can be used in combination with existing network inference methods to also capture nonlinear dependencies. <xref rid="vbae034-B78" ref-type="bibr">Tanaka <italic toggle="yes">et al.</italic> (2020)</xref> infer nonparametric Bayesian networks using B-spline regression. From the model parameters, the method derives a value representing the contribution of each edge to the expression in a particular sample, called the edge contribution value (ECv). The absolute differences in ECvs (<inline-formula id="IE2"><mml:math id="IM2" display="inline" overflow="scroll"><mml:mo>Δ</mml:mo></mml:math></inline-formula>ECv) between certain samples are then used to build sample-specific networks. An alternative to the abovementioned approaches are tree-based strategies, which offer the advantage of more relaxed model assumptions. While examples such as GENIE3 and derived tools continue to be successfully applied in various biological settings (<xref rid="vbae034-B34" ref-type="bibr">Huynh-Thu <italic toggle="yes">et al.</italic> 2010</xref>, <xref rid="vbae034-B59" ref-type="bibr">Moerman <italic toggle="yes">et al.</italic> 2019</xref>, <xref rid="vbae034-B82" ref-type="bibr">Van de Sande <italic toggle="yes">et al.</italic> 2020</xref>), they cannot be used to directly compare two different biological conditions.</p>
    <p>We introduce BoostDiff, a nonparametric tree-based approach for reconstructing directed differential networks (<xref rid="vbae034-F1" ref-type="fig">Fig. 1</xref>). The main component of BoostDiff is the differential tree, a modified version of the standard regression tree that can be used to identify gene pairs exhibiting changes in regulatory dependencies between two biological conditions. To build the differential trees, we use a novel splitting criterion called the differential variance improvement (DVI), which measures the difference in predictive value of a feature on the gene expression levels between two conditions. We demonstrate that boosting the differential trees with respect to samples belonging to a specific target condition is an important step for promoting condition specificity of the output networks. Tree-based variable importance measures are then calculated to obtain a ranking of regulators and to derive the differential network. Using simulated gene expression data, we evaluate the performance of BoostDiff in comparison to baseline methods and existing differential network tools. We further apply BoostDiff to multiple transcriptomics datasets, including COVID-19, Crohn’s disease, prostate adenocarcinoma, and breast cancer data, as well as stress response data in the bacterium <italic toggle="yes">Bacillus subtilis</italic>.</p>
    <fig position="float" id="vbae034-F1">
      <label>Figure 1.</label>
      <caption>
        <p>Overview of the BoostDiff algorithm. As input, we require two gene expression matrices corresponding to a target condition (e.g. disease) and a baseline condition (e.g. control). For each of p total genes, a learning subsample (LS) is drawn from the two datasets, after which an AdaBoost ensemble of differential trees is built to identify the features that are more predictive of the gene expression levels in the target condition. By setting a target condition, BoostDiff can be used to identify regulatory relationships that are more pronounced in condition A (e.g. disease state) and condition B (e.g. control/healthy), thereby providing a differential network capturing context-specific regulatory changes. In the overall workflow, the BoostDiff algorithm is run twice, once with condition A as target condition and subsequently with B as target condition. The results are then combined to obtain the final differential network. Most notably, while existing approaches aim for the reconstruction of whole genome-scale GRNs, BoostDiff concentrates on maximizing the precision for those parts of the regulatory network that actually characterize the difference between the two phenotypes.</p>
      </caption>
      <graphic xlink:href="vbae034f1" position="float"/>
    </fig>
  </sec>
  <sec>
    <title>2 Methods</title>
    <sec>
      <title>2.1 Overview of the differential network inference approach</title>
      <p>The overall strategy of BoostDiff is inspired by the popular network inference tool GENIE3 (<xref rid="vbae034-B34" ref-type="bibr">Huynh-Thu <italic toggle="yes">et al.</italic> 2010</xref>). GENIE3 aims to reconstruct a network using as input a gene expression matrix derived from a single biological condition. For this, GENIE3 fits an ensemble of regression trees, using the expression levels of the target genes as the output variable and the expression levels of potential regulators as the features. The splitting criterion for a node in the regression tree is the reduction
<disp-formula id="E1"><mml:math id="M1" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mo>|</mml:mo><mml:mi>S</mml:mi><mml:mo>|</mml:mo><mml:mo>·</mml:mo><mml:mtext>Var</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mi>S</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo> </mml:mo><mml:mo>−</mml:mo><mml:mo> </mml:mo><mml:mo>|</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>L</mml:mi></mml:msub></mml:mrow><mml:mo>|</mml:mo><mml:mo>·</mml:mo><mml:mtext>Var</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>L</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo> </mml:mo><mml:mo>−</mml:mo><mml:mo> </mml:mo><mml:mo>|</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>R</mml:mi></mml:msub></mml:mrow><mml:mo>|</mml:mo><mml:mo>·</mml:mo><mml:mtext>Var</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>R</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula>
in variance (impurity) of the target gene’s expression caused by the split. Here, <italic toggle="yes">S</italic> denotes the set of samples that reach a node to be split, <inline-formula id="IE3"><mml:math id="IM3" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>L</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula id="IE4"><mml:math id="IM4" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>R</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> are the subsets of samples in the left and right branches of the split, respectively, and <inline-formula id="IE5"><mml:math id="IM5" display="inline" overflow="scroll"><mml:mrow><mml:mtext>Var</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> is the variance of the output variable in a set of samples <inline-formula id="IE6"><mml:math id="IM6" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>∈</mml:mo><mml:mo>{</mml:mo><mml:mi>S</mml:mi><mml:mo>,</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>L</mml:mi></mml:msub></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>R</mml:mi></mml:msub></mml:mrow><mml:mo>}</mml:mo></mml:mrow></mml:math></inline-formula>. The importance of one variable in a single regression tree is calculated by summing up the reductions in variance of all tree nodes where this variable is used as a splitting feature. The overall importance of a feature in the ensemble is then averaged across all trees. One ensemble model is learned for each target gene in the dataset. The tree-based feature importances based on variance reduction are interpreted as edge weights of candidate regulator-target gene links. A high edge weight indicates that a regulator has a large contribution in predicting the expression level of a target gene. The edges with the highest weights are returned as the inferred GRN. Biologically, the top-ranked edges inferred by GENIE3 represent the relationships that are dominant in the condition of interest.</p>
      <p>Similarly, the differential network inference problem can be decomposed into <italic toggle="yes">p</italic> independent regression subproblems, where <italic toggle="yes">p</italic> is the total number of genes in the expression data. Our strategy assumes that, in a given biological context, the expression level of a gene can be modeled as a function of the expression levels of other genes (<xref rid="vbae034-F1" ref-type="fig">Fig. 1</xref>). The crucial difference between BoostDiff and GENIE3 is that we simultaneously take into account two datasets for inferring a differential network. More precisely, our approach requires the availability of (1) gene expression data matrix
<disp-formula id="E2"><mml:math id="M2" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msub></mml:mrow><mml:mo>,</mml:mo><mml:mi>p</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula>
for <inline-formula id="IE7"><mml:math id="IM7" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> measurements from a disease condition and (2) the matrix
<disp-formula id="E3"><mml:math id="M3" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msub></mml:mrow><mml:mo>,</mml:mo><mml:mi>p</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula>
for <inline-formula id="IE8"><mml:math id="IM8" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> measurements from a control condition. Both matrices have <italic toggle="yes">p</italic> columns (total number of genes). That is, <inline-formula id="IE9"><mml:math id="IM9" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:math></inline-formula> contains the expression of gene <italic toggle="yes">g</italic> in measurement (patient) <italic toggle="yes">i</italic> from the disease condition.</p>
      <p>The inference task is modeled as a feature selection problem that aims to find features that are more predictive of expression levels in a target condition than in the baseline condition. For this, differential network analysis is performed by solving the regression problem while taking into account information from two distinct labels. We use the AdaBoost algorithm (<xref rid="vbae034-B21" ref-type="bibr">Drucker 1997</xref>) using differential trees as base learners to drive the improved prediction of expression levels in the target condition. The trained model provides a ranking of the edges by computing a feature importance weight for each regulator (see details below).</p>
      <p>For each target gene <inline-formula id="IE10"><mml:math id="IM10" display="inline" overflow="scroll"><mml:mrow><mml:mi>g</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>, we define regression problems <inline-formula id="IE11"><mml:math id="IM11" display="inline" overflow="scroll"><mml:mrow><mml:mi>L</mml:mi><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> and <inline-formula id="IE12"><mml:math id="IM12" display="inline" overflow="scroll"><mml:mrow><mml:mi>L</mml:mi><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msubsup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>. The design matrices <inline-formula id="IE13"><mml:math id="IM13" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula id="IE14"><mml:math id="IM14" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:math></inline-formula> are obtained by deleting the <italic toggle="yes">g</italic>th columns <inline-formula id="IE15"><mml:math id="IM15" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula id="IE16"><mml:math id="IM16" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:math></inline-formula> from <inline-formula id="IE17"><mml:math id="IM17" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula id="IE18"><mml:math id="IM18" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula>, respectively. The target variables are set to the deleted columns <inline-formula id="IE19"><mml:math id="IM19" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula id="IE20"><mml:math id="IM20" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:math></inline-formula>. The inference of our differential network is then performed as follows:</p>
      <list list-type="order">
        <list-item>
          <p>For each target gene <inline-formula id="IE21"><mml:math id="IM21" display="inline" overflow="scroll"><mml:mrow><mml:mi>g</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>:</p>
          <list list-type="alpha-lower">
            <list-item>
              <p>Generate the design matrices and target variable vectors for the regression problems <inline-formula id="IE22"><mml:math id="IM22" display="inline" overflow="scroll"><mml:mrow><mml:mi>L</mml:mi><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> and <inline-formula id="IE23"><mml:math id="IM23" display="inline" overflow="scroll"><mml:mrow><mml:mi>L</mml:mi><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> for gene <italic toggle="yes">g</italic> for the disease and the control conditions.</p>
            </list-item>
            <list-item>
              <p>Train an ensemble of differential regression trees with the disease selected as target condition, i.e. tree ensembles that yields a good fit for <inline-formula id="IE24"><mml:math id="IM24" display="inline" overflow="scroll"><mml:mrow><mml:mi>L</mml:mi><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> but not for <inline-formula id="IE25"><mml:math id="IM25" display="inline" overflow="scroll"><mml:mrow><mml:mi>L</mml:mi><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>.</p>
            </list-item>
            <list-item>
              <p>From the ensemble of differential trees, extract weights for all potential regulators of <italic toggle="yes">g</italic> which are large if the expression of the regulator is highly predictive of <italic toggle="yes">g</italic> in the disease condition but not in the control condition.</p>
            </list-item>
          </list>
        </list-item>
        <list-item>
          <p>Aggregate and sort the <italic toggle="yes">p</italic> gene rankings to obtain a global ranking of all differential regulatory edges.</p>
        </list-item>
        <list-item>
          <p>Repeat the steps 1 and 2 with reversed roles of <italic toggle="yes">D</italic> and <italic toggle="yes">C</italic> to identify regulatory links that are present in the control but not in the disease condition.</p>
        </list-item>
      </list>
      <p>In the following, we describe the details of the algorithm.</p>
    </sec>
    <sec>
      <title>2.2 Step 1a: Growing a differential tree</title>
      <p>We first explain how to build a single differential tree, the key ingredient of step 1a of the algorithm outlined above. We describe how to build the differential tree for the case where the disease has been selected as the target condition. The workflow with control as target condition is analogous.</p>
      <p>A differential tree is built through binary recursive partitioning. The key difference to standard regression trees is that, to determine the features (i.e. genes) used for splitting the samples at the inner nodes of our trees, we use a novel split criterion called differential variance improvement (DVI) instead of variance reduction. At each node of the differential tree, we maintain subsets <inline-formula id="IE26"><mml:math id="IM26" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo>⊆</mml:mo><mml:mo>{</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msub></mml:mrow><mml:mo>}</mml:mo></mml:mrow></mml:math></inline-formula> and <inline-formula id="IE27"><mml:math id="IM27" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo>⊆</mml:mo><mml:mo>{</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msub></mml:mrow><mml:mo>}</mml:mo></mml:mrow></mml:math></inline-formula> of the disease and control samples, respectively. Given a possible split feature (i.e. candidate predictor gene) <inline-formula id="IE28"><mml:math id="IM28" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula>, we define <inline-formula id="IE29"><mml:math id="IM29" display="inline" overflow="scroll"><mml:mrow><mml:mtext>DVI</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> as follows:
<disp-formula id="E4"><mml:math id="M4" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mtext>DVI</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mrow><mml:munder><mml:mrow><mml:mi>max</mml:mi></mml:mrow><mml:mo>τ</mml:mo></mml:munder></mml:mrow><mml:mtext>VarRed</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mo>−</mml:mo><mml:mrow><mml:munder><mml:mrow><mml:mi>max</mml:mi></mml:mrow><mml:mo>τ</mml:mo></mml:munder></mml:mrow><mml:mtext>VarRed</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p>
      <p>For a fixed <inline-formula id="IE30"><mml:math id="IM30" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> and splitting threshold <inline-formula id="IE31"><mml:math id="IM31" display="inline" overflow="scroll"><mml:mo>τ</mml:mo></mml:math></inline-formula>, the variance reduction for the disease samples is given by
<disp-formula id="E5"><mml:math id="M5" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mtext>VarRed</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mtext>MSE</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">]</mml:mo><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mo>−</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>L</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>|</mml:mo></mml:mrow><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo>|</mml:mo></mml:mrow></mml:mfrac></mml:mrow><mml:mo>·</mml:mo><mml:mtext>MSE</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>L</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">]</mml:mo><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mo>−</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>R</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>|</mml:mo></mml:mrow><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo>|</mml:mo></mml:mrow></mml:mfrac></mml:mrow><mml:mo>·</mml:mo><mml:mtext>MSE</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>R</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">]</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula>
where <inline-formula id="IE32"><mml:math id="IM32" display="inline" overflow="scroll"><mml:mrow><mml:mtext>MSE</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mo>·</mml:mo><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> is the mean squared error from the sample mean, <inline-formula id="IE33"><mml:math id="IM33" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mi>S</mml:mi><mml:mo stretchy="false">]</mml:mo><mml:mo>=</mml:mo><mml:mo>{</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo>|</mml:mo><mml:mi>i</mml:mi><mml:mo>∈</mml:mo><mml:mi>S</mml:mi><mml:mo>}</mml:mo></mml:mrow></mml:math></inline-formula> is the restriction of the target variable to the disease samples (rows) contained in a set of samples <italic toggle="yes">S</italic>, and <inline-formula id="IE34"><mml:math id="IM34" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>L</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo>{</mml:mo><mml:mi>i</mml:mi><mml:mo>∈</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo>≤</mml:mo><mml:mo>τ</mml:mo><mml:mo>}</mml:mo></mml:mrow></mml:math></inline-formula>, and <inline-formula id="IE35"><mml:math id="IM35" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>R</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo>{</mml:mo><mml:mi>i</mml:mi><mml:mo>∈</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo>&gt;</mml:mo><mml:mo>τ</mml:mo><mml:mo>}</mml:mo></mml:mrow></mml:math></inline-formula> are the subsets of disease samples <inline-formula id="IE36"><mml:math id="IM36" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> available at the current node whose split gene expression levels are, respectively, smaller or larger than the threshold <inline-formula id="IE37"><mml:math id="IM37" display="inline" overflow="scroll"><mml:mo>τ</mml:mo></mml:math></inline-formula>. Variance reduction for the control samples is defined analogously. A positive value of the <inline-formula id="IE38"><mml:math id="IM38" display="inline" overflow="scroll"><mml:mrow><mml:mtext>DVI</mml:mtext></mml:mrow></mml:math></inline-formula> hence means that the gene <inline-formula id="IE39"><mml:math id="IM39" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> is more predictive of <italic toggle="yes">g’</italic>s expression level in the disease condition than in the control condition, whereas a negative <inline-formula id="IE40"><mml:math id="IM40" display="inline" overflow="scroll"><mml:mrow><mml:mtext>DVI</mml:mtext></mml:mrow></mml:math></inline-formula> value indicates that the opposite is the case.</p>
      <p>When building our differential trees, we use genes <inline-formula id="IE41"><mml:math id="IM41" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> maximizing <inline-formula id="IE42"><mml:math id="IM42" display="inline" overflow="scroll"><mml:mrow><mml:mtext>DVI</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> as split features (see details below). If disease has been selected as the target condition, these genes correspond to regulators of <italic toggle="yes">g</italic> which are much more active in disease samples than in control samples. If control has been selected as the target condition, they correspond to regulators in healthy individuals that have lost their regulatory activity in the disease.</p>
      <p>Given the regression problems <inline-formula id="IE43"><mml:math id="IM43" display="inline" overflow="scroll"><mml:mrow><mml:mi>L</mml:mi><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> and <inline-formula id="IE44"><mml:math id="IM44" display="inline" overflow="scroll"><mml:mrow><mml:mi>L</mml:mi><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> for the disease and control conditions, respectively, we construct a differential regression tree whose nodes are 5-tuples
<disp-formula id="E6"><mml:math id="M6" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mi>v</mml:mi><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>D</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>C</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula>
where <inline-formula id="IE45"><mml:math id="IM45" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> is the split gene, <inline-formula id="IE46"><mml:math id="IM46" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>D</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow></mml:mrow></mml:math></inline-formula> is the split threshold for the disease samples, and <inline-formula id="IE47"><mml:math id="IM47" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>C</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow></mml:mrow></mml:math></inline-formula> is the split threshold for the control samples. Note that we use two different thresholds, since using a single threshold for both conditions while optimizing the <inline-formula id="IE48"><mml:math id="IM48" display="inline" overflow="scroll"><mml:mrow><mml:mtext>DVI</mml:mtext></mml:mrow></mml:math></inline-formula> leads to a skewed expression distribution in each side of the split, with one side favoring disease samples and the other side favoring control samples. The construction is done as follows:</p>
      <list list-type="order">
        <list-item>
          <p>Initialize root as
<disp-formula id="E7a"><mml:math id="M7a" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo>=</mml:mo><mml:mo>{</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msub></mml:mrow><mml:mo>}</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo>=</mml:mo><mml:mo>{</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msub></mml:mrow><mml:mo>}</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p>
          <p>where ‘<inline-formula id="IE50"><mml:math id="IM50" display="inline" overflow="scroll"><mml:mo>•</mml:mo></mml:math></inline-formula>’ is a placeholder for not yet defined split genes and thresholds.</p>
        </list-item>
        <list-item>
          <p>Starting at the root, recursively construct a differential tree via binary partitioning as follows:</p>
        </list-item>
        <list-item>
          <p>At the current node <inline-formula id="IE51"><mml:math id="IM51" display="inline" overflow="scroll"><mml:mrow><mml:mi>v</mml:mi><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> of the tree under construction, do the following:</p>
          <list list-type="alpha-lower">
            <list-item>
              <p>If a suitable termination criterion (the maximum depth of the tree has been reached or the number of target or baseline samples reaching in a node has been reached) has been satisfied or <inline-formula id="IE52"><mml:math id="IM52" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mrow><mml:mi>max</mml:mi></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:msub></mml:mrow><mml:mtext>DVI</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>≤</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></inline-formula>, label <italic toggle="yes">v</italic> as leaf and traceback.</p>
            </list-item>
            <list-item>
              <p>Otherwise, set the node <italic toggle="yes">v’</italic>s split gene to
<disp-formula id="E7"><mml:math id="M7" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msup></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:munder><mml:mrow><mml:mtext>argmax</mml:mtext></mml:mrow><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:munder></mml:mrow><mml:mtext>DVI</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p>
              <p>its disease threshold to
<disp-formula id="E8"><mml:math id="M8" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>D</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:munder><mml:mrow><mml:mtext>argmax</mml:mtext></mml:mrow><mml:mo>τ</mml:mo></mml:munder></mml:mrow><mml:mtext>VarRed</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p>
              <p>and its control threshold to
<disp-formula id="E9"><mml:math id="M9" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>C</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:munder><mml:mrow><mml:mtext>argmax</mml:mtext></mml:mrow><mml:mo>τ</mml:mo></mml:munder></mml:mrow><mml:mtext>VarRed</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p>
            </list-item>
            <list-item>
              <p>Initialize <italic toggle="yes">v’</italic>s left child as
<disp-formula id="E10"><mml:math id="M10" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mi>L</mml:mi></mml:msub></mml:mrow><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>L</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>D</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>L</mml:mi><mml:mi>C</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>C</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p>
              <p>its right child as
<disp-formula id="E11"><mml:math id="M11" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mi>R</mml:mi></mml:msub></mml:mrow><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>R</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>D</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>R</mml:mi><mml:mi>C</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>C</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p>
              <p>and continue with processing <inline-formula id="IE53"><mml:math id="IM53" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mi>L</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula id="IE54"><mml:math id="IM54" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mi>R</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>.</p>
            </list-item>
          </list>
        </list-item>
      </list>
      <p>In the regression trees described by (<xref rid="vbae034-B9" ref-type="bibr">Breiman <italic toggle="yes">et al.</italic> 1984</xref>), the prediction for a sample is determined by traversing the tree until a leaf node is reached. Here, we are more interested in predicting the expression values of the samples in the target condition; thus, prediction is performed only for target samples using the identified splitting thresholds <inline-formula id="IE55"><mml:math id="IM55" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>D</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow></mml:mrow></mml:math></inline-formula>. The final prediction is calculated as the expected value of the expression levels of the target samples assigned to the leaf nodes after fitting the differential tree.</p>
    </sec>
    <sec>
      <title>2.3 Step 1b: Boosting the differential trees</title>
      <p>Inspired by GRNBoost2 (<xref rid="vbae034-B59" ref-type="bibr">Moerman <italic toggle="yes">et al.</italic> 2019</xref>), we implement a boosting algorithm that derives a strong prediction model by sequentially training a pool of differential trees as the weak learners. AdaBoost for regression is typically used for solving problems where the output is a continuous variable (i.e. expression levels) without explicitly considering the class of the samples. Here, we adapted the AdaBoost.R2 algorithm (<xref rid="vbae034-B21" ref-type="bibr">Drucker 1997</xref>) to handle the regression problem, given labels from two classes (i.e. conditions). Using the differential trees as base learners, the modified algorithm performs the boosting with respect to samples belonging to the specified target condition. In this way, BoostDiff attempts to find a model that is more predictive of the target condition compared to the baseline condition. In each tree, only the target samples are re-weighted in subsequent boosting iterations, while samples from the baseline condition retain uniform weight. In particular, target samples that are more difficult to predict are selected with higher weights during the bootstrapping step and will always be compared to a uniform sample from the baseline condition. To avoid overfitting, we set a low number of trees and in practice find that 50–100 differential trees in the ensemble are sufficient for real transcriptomics datasets. The algorithm is described in detail in the <xref rid="sup1" ref-type="supplementary-material">Supplementary Methods section</xref>.</p>
    </sec>
    <sec>
      <title>2.4 Step 1c: Computing variable importances to rank the candidate predictors</title>
      <p>Tree-based methods allow for the calculation of a variable importance measure that can be used to rank the features according to their relevance for predicting the output. In GENIE3, the importance of a predictor gene <inline-formula id="IE56"><mml:math id="IM56" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> is calculated as the sum of the variance reduction across all nodes where <inline-formula id="IE57"><mml:math id="IM57" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> is used as the splitting feature, averaged over all trees in the ensemble. For BoostDiff, we derive a similar measure by considering the samples belonging to the target condition (step 1c in the high-level description of BoostDiff given above). If disease is selected as target condition, the importance <inline-formula id="IE58"><mml:math id="IM58" display="inline" overflow="scroll"><mml:mrow><mml:mtext>VIM</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> attributed to a candidate predictor gene <inline-formula id="IE59"><mml:math id="IM59" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> is calculated as the weighted variance reduction for the disease samples across all <italic toggle="yes">M</italic> trees in the ensemble:
<disp-formula id="E12"><mml:math id="M12" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mtext>VIM</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mrow><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>m</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>M</mml:mi></mml:munderover></mml:mrow><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mo>α</mml:mo></mml:mrow><mml:mi>m</mml:mi></mml:msup></mml:mrow></mml:mrow><mml:mo>·</mml:mo><mml:mrow><mml:munder><mml:mo>∑</mml:mo><mml:mrow><mml:mi>v</mml:mi><mml:mo>∈</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mi>m</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:munder></mml:mrow><mml:mrow><mml:mtext>VarRed</mml:mtext></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>v</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>v</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p>
      <p>Here, <italic toggle="yes">m</italic> is the boosting iteration, <inline-formula id="IE60"><mml:math id="IM60" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mo>α</mml:mo></mml:mrow><mml:mi>m</mml:mi></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> is the weight of the differential tree returned by AdaBoost, <inline-formula id="IE61"><mml:math id="IM61" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mi>m</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> is the set of nodes in tree <italic toggle="yes">m</italic> where <inline-formula id="IE62"><mml:math id="IM62" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> was used as the split feature, and <inline-formula id="IE63"><mml:math id="IM63" display="inline" overflow="scroll"><mml:mrow><mml:mtext>VarRed</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>v</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>v</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> is the variance reduction for the disease samples at a node <inline-formula id="IE64"><mml:math id="IM64" display="inline" overflow="scroll"><mml:mrow><mml:mi>v</mml:mi><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>v</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>∈</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mi>m</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>. Since each node in a differential tree has two independent thresholds, interpreting the tree becomes more abstract with increasing depth. Boosting using shallow differential trees (e.g. differential tree stumps) thus favors greater interpretability of the variable importance measure.</p>
    </sec>
    <sec>
      <title>2.5 Steps 2 and 3: Edge ranking and filtering from boosted differential trees</title>
      <p>Each modified AdaBoost model yields a separate ranking of the regulators. However, simply ordering the regulatory links according to the weights leads to a bias toward highly variable target genes. To avoid this, we first scale the expression levels of each target gene to unit variance, similarly implemented in GENIE3 (<xref rid="vbae034-B34" ref-type="bibr">Huynh-Thu <italic toggle="yes">et al.</italic> 2010</xref>).</p>
      <p>Boosting with respect to a target condition does not necessarily produce a model that predicts a gene’s expression in the target condition better than its expression in the baseline condition. To illustrate, sample plots of the training progression are shown in <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S1</xref>. To restrict the results to differential edges, we recommend examining the distributions of the mean difference in prediction error. Sample distributions of these values from the simulated and real transcriptomics data are shown in <xref rid="sup1" ref-type="supplementary-material">Supplementary Figs S2 and S3</xref>, respectively. Based on these generated plots, users can filter for target genes with lower mean prediction error in the target condition than the baseline condition by applying a threshold. Alternatively, users can select the top edges with the lowest mean difference in prediction error or input a user-defined percentile. After filtering, the edges are re-ranked based on the variable importance measure used as the edge weight. The procedure is performed for each of the two sub-analyses (disease or control as target condition). The top edges (user-specified parameter) from each sub-analysis are then merged to obtain the final network.</p>
      <p>Given the ensemble nature of BoostDiff where each differential tree is constructed differently from randomly selected predictors, deriving an explanation of the model’s predictions is challenging. To obtain more mechanistic and biologically meaningful results, we can rely on the topology of the differential network and use community detection algorithms that aim to find highly connected subnetworks that could be potentially associated with the disease of interest.</p>
    </sec>
    <sec>
      <title>2.6 Compared methods</title>
      <p>We evaluate the performance of BoostDiff against baseline methods and existing differential networks methods. To verify the condition specificity of the networks output by BoostDiff, we compare its performance to those of two GRN inference methods, GENIE3 and ARACNE (<xref rid="vbae034-B52" ref-type="bibr">Margolin <italic toggle="yes">et al.</italic> 2006</xref>). GENIE3 is run using the corresponding R package. ARACNE is run using the implementation provided in the R package <italic toggle="yes">minet</italic> (<xref rid="vbae034-B57" ref-type="bibr">Meyer <italic toggle="yes">et al.</italic> 2008</xref>). For both GENIE3 and ARACNE, only the gene expression matrix from the disease condition is used as input. We also compare BoostDiff to two additional baseline methods: (i) random forests of differential trees (‘RF Difftrees’) and (ii) a ‘Differential GENIE3’ approach, where we separately infer the networks from each condition using GENIE3 and subtract the calculated edge weights derived from the control condition from the weights derived from the disease condition and vice versa. For details, an AIMe report is available at <ext-link xlink:href="https://aime.report/656I3Z/2" ext-link-type="uri">https://aime.report/656I3Z/2</ext-link> (<xref rid="vbae034-B54" ref-type="bibr">Matschinske <italic toggle="yes">et al.</italic> 2021</xref>).</p>
      <p>Next, we compare the performance of BoostDiff to other differential network methods from the benchmarking study in <xref rid="vbae034-B7" ref-type="bibr">Bhuva <italic toggle="yes">et al.</italic> (2019)</xref>. These methods include <italic toggle="yes">z</italic>-score, EBcoexpress, Diffcoex, and a GGM-based method, which are implemented in the <italic toggle="yes">dcanr</italic> package in R. Additionally, we run the chNet algorithm (<xref rid="vbae034-B81" ref-type="bibr">Tu <italic toggle="yes">et al.</italic> 2021</xref>), which considers significant changes in both partial correlations of edges and differential expression. To facilitate comparability and given that only the tree-based methods provide directionality information among the methods examined here, we convert directed edges to undirected edges (<xref rid="vbae034-B7" ref-type="bibr">Bhuva <italic toggle="yes">et al.</italic> 2019</xref>).</p>
    </sec>
    <sec>
      <title>2.7 Evaluation using simulated datasets</title>
      <p>Gene expression data for disease and control conditions are simulated by adapting the SimulatorGRN approach (<xref rid="vbae034-B7" ref-type="bibr">Bhuva <italic toggle="yes">et al.</italic> 2019</xref>), a dynamical systems modeling tool to simulate differential co-expression patterns. SimulatorGRN induces differential co-expression by perturbing a reference network via gene knockdown to reduce their expression levels and models activation/repression of a gene by a set of regulators using normalized Hill equations. Knockdown leads to complex nonlinear differences between the generated disease and control samples (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S4</xref>). By default, known regulatory interactions in <italic toggle="yes">Saccharomyces cerevisiae</italic> are used to create a reference GRN. To obtain the ‘true’ differentially co-expressed edges and allow performance evaluation, genes in the network whose abundance are affected by the knockdown perturbation and thus exhibit regulatory dependency are determined via sensitivity analysis.</p>
      <p>In the original SimulatorGRN framework, a sample can have multiple genes knocked down, even though the evaluation considers each knockdown gene separately. To explicitly eliminate the confounding effect of additional knockdown genes in our experiments, we generate the expression data in the perturbed condition such that exactly one randomly selected input gene is knocked down. We evaluate the different tools across four scenarios: (i) 50 nodes; 500 simulations, (ii) 150 nodes; 500 simulations, (iii) 300 nodes; 500 simulations, and (iv) 500 nodes; 250 simulations. In each simulation, 100 samples are generated per condition. The final disease samples are those which have the gene knockdown, whereas the control samples are ‘wild type’ (<xref rid="vbae034-B7" ref-type="bibr">Bhuva <italic toggle="yes">et al.</italic> 2019</xref>). The edges from the ‘association network’ of each simulation are used as the ground truth edges for evaluating performance. The parameters for generating the simulated data are shown in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>.</p>
      <p>In the analyses on simulated data, all genes except the target gene are considered as potential regulators. The <italic toggle="yes">z</italic>-score method, chNet, Diffcoex, and the GGM-based method are run with the default parameters. The parameters used for the RF Difftrees and BoostDiff are provided in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S2</xref>. For each simulation, we filter for the target genes belonging to the 3rd percentile based on the mean difference in prediction errors. The parameters for the EBcoexpress runs are shown in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S3</xref>.</p>
      <p>The different tools have different statistical methods and cutoffs for determining the differentially coexpressed edges depending on how the algorithm works. To facilitate comparability, we show the top <italic toggle="yes">k</italic> predicted edges output by each method (except for chNet, wherein the number of predicted differential edges depends on the tuning parameter and is variable for each simulation; thus, extracting the top <italic toggle="yes">k</italic> edges cannot be consistently applied across simulations). For visualization, we show the results based on the top 100 predicted edges output by each method for the simulated data. We report the performance using precision, recall, and F1 score as the evaluation metrics.</p>
    </sec>
    <sec>
      <title>2.8 Evaluation using real datasets</title>
      <p>For evaluation on real datasets, BoostDiff, Diffcoex, EBcoexpress, the <italic toggle="yes">z</italic>-score method, and Differential GENIE3 are run on gene expression data for four human diseases (COVID-19, Crohn’s disease, breast cancer, and prostate adenocarcinoma) and for the stress response in <italic toggle="yes">B.subtilis</italic>. For the human diseases, we extract the top 1000 edges to generate the final network. For the <italic toggle="yes">B.subtilis</italic> data, we use the top 300 edges.</p>
      <p>For the COVID-19 RNA-Seq dataset, raw gene counts are downloaded from the Gene Expression Omnibus (GEO) database under the accession number GSE156063 (<xref rid="vbae034-B58" ref-type="bibr">Mick <italic toggle="yes">et al.</italic> 2020</xref>). We use data generated from nasal swab samples from COVID-19 (<inline-formula id="IE65"><mml:math id="IM65" display="inline" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>93</mml:mn></mml:mrow></mml:math></inline-formula>) and uninfected patients (<inline-formula id="IE66"><mml:math id="IM66" display="inline" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:math></inline-formula>). Count data are normalized using the <monospace>DESeq2</monospace> package in R with the variance stabilizing transformation (<monospace>vst}</monospace>) function. Differentially expressed genes (DEGs) are obtained using <monospace>DESeq2</monospace> (<xref rid="vbae034-B48" ref-type="bibr">Love <italic toggle="yes">et al.</italic> 2014</xref>).</p>
      <p>For the Crohn’s disease (CD) dataset, normalized microarray data are downloaded from the GEO database under the accession number GSE126124 (<xref rid="vbae034-B67" ref-type="bibr">Palmer <italic toggle="yes">et al.</italic> 2019</xref>), which were generated from colon biopsies of individuals with CD (<inline-formula id="IE67"><mml:math id="IM67" display="inline" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>37</mml:mn></mml:mrow></mml:math></inline-formula>) and healthy controls (<inline-formula id="IE68"><mml:math id="IM68" display="inline" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>19</mml:mn></mml:mrow></mml:math></inline-formula>). Differential expression analysis is performed using <monospace>limma</monospace> (<xref rid="vbae034-B68" ref-type="bibr">Ritchie <italic toggle="yes">et al.</italic> 2015</xref>).</p>
      <p>To evaluate BoostDiff on data from The Cancer Genome Atlas (TCGA), preprocessed RNA-Seq gene expression data and DEGs from primary tumors and normal solid tissues are obtained from <ext-link xlink:href="https://xenabrowser.net/" ext-link-type="uri">https://xenabrowser.net/</ext-link> (<xref rid="vbae034-B27" ref-type="bibr">Goldman <italic toggle="yes">et al.</italic> 2020</xref>). We use gene expression data for two cancer types, namely, prostate adenocarcinoma (PRAD) and breast cancer (BRCA), both of which contain at least 50 samples for the normal tissues.</p>
      <p>For the human datasets, Illumina IDs are converted to HGNC symbols using the R package <monospace>biomaRt</monospace> where applicable (<xref rid="vbae034-B22" ref-type="bibr">Durinck <italic toggle="yes">et al.</italic> 2009</xref>). Expression levels corresponding to probes mapped to the same gene symbol are averaged. The top 20% of genes with the lowest variance are filtered out. To generate the final GRN and facilitate comparability with BoostDiff, we filter the outputs for edges containing a TF, using the list of human transcription factors downloaded from <ext-link xlink:href="http://humantfs.ccbr.utoronto.ca/" ext-link-type="uri">http://humantfs.ccbr.utoronto.ca/</ext-link> (<xref rid="vbae034-B43" ref-type="bibr">Lambert <italic toggle="yes">et al.</italic> 2018</xref>). These TFs are also used as the candidate regulators for BoostDiff. Genes whose mean difference in prediction error of the models are more extreme than the threshold identified from the 3rd percentiles of the distributions are retained. For the CD dataset, a more stringent filtering step is performed because of the small sample size available for inference. All the outputs from the different methods are filtered for the top 1000 edges (except for chNet). For BoostDiff, the final network is thus comprised of the combined top 500 edges from the run where the disease condition is set as the target condition and the top 500 edges from the run where the control condition is set as the target condition. To identify more specific candidate network modules and facilitate the interpretability of the resulting networks, we apply the Louvain community detection algorithm using the python-louvain package (<ext-link xlink:href="https://github.com/taynaud/python-louvain" ext-link-type="uri">https://github.com/taynaud/python-louvain</ext-link>). The enrichr module of the gseapy v. 1.1.0 package is used to identify enriched KEGG pathways in the output networks (<xref rid="vbae034-B76" ref-type="bibr">Subramanian <italic toggle="yes">et al.</italic> 2005</xref>, <xref rid="vbae034-B42" ref-type="bibr">Kuleshov <italic toggle="yes">et al.</italic> 2016</xref>). KEGG terms are considered to be significantly enriched in a network if the overlap with the gene set is at least three genes.</p>
      <p>We further test the performance of BoostDiff using transcriptome data related to the well-characterized general stress response in <italic toggle="yes">B.subtilis</italic> (<xref rid="vbae034-B63" ref-type="bibr">Nicolas <italic toggle="yes">et al.</italic> 2012</xref>). We examine three contexts, namely, response to salt stress, response to heat stress, and response to ethanol stress, all of which are known to induce the SigB regulon. Expression data for all protein-coding genes and RNA features (S1 to S1583) of <italic toggle="yes">B.subtilis</italic> from the corresponding samples were downloaded from the GEO database (accession number GSE27219). Considering that bacterial adaptation is characterized by smaller variation across samples than in animal experiments or experiments with human specimens, gene expression datasets for bacterial adaptation generally have low number of replicates. Therefore, we generate additional synthetic samples using Synthetic Minority Over-sampling TEchnique (SMOTE) (<ext-link xlink:href="https://github.com/akazs/pySMOTE/" ext-link-type="uri">https://github.com/akazs/pySMOTE/</ext-link>) to obtain 48 samples per condition to be available for inference. We note that a large sample size from experimental data still remains ideal for using BoostDiff; SMOTE is used as a workaround in order to be able to run the compared network inference methods on the <italic toggle="yes">B.subtilis</italic> datasets. Genes with low variance are filtered out using a variance cutoff of 0.4. For the BoostDiff runs, the final network is obtained by filtering the differentially predicted target genes based on the 3rd percentile and combining the top 150 edges in the differential network for each of the two sub-analyses. The results of the compared methods are filtered for the top 300 edges to obtain the differential network. Enrichment analyses for the <italic toggle="yes">B.subtilis</italic> outputs is performed using the ShinyGO v. 0.77 (<xref rid="vbae034-B25" ref-type="bibr">Ge <italic toggle="yes">et al.</italic> 2020</xref>).</p>
    </sec>
  </sec>
  <sec>
    <title>3 Results and discussion</title>
    <sec>
      <title>3.1 BoostDiff outperforms existing methods on complex simulated settings</title>
      <p>As expected, BoostDiff better identifies the differential edges than GENIE3 and ARACNE, both of which infer a static network from the disease condition alone (<xref rid="vbae034-F2" ref-type="fig">Fig. 2</xref>). The Differential GENIE3 method shows similar performance to those of the baseline methods, despite using the expression data from both disease and control conditions. These findings indicate that the feature importances calculated from the trees built using <inline-formula id="IE69"><mml:math id="IM69" display="inline" overflow="scroll"><mml:mrow><mml:mtext>DVI</mml:mtext></mml:mrow></mml:math></inline-formula> as the splitting criterion are useful for identifying the differential edges. In addition, in all but the smallest simulation scenarios, the boosting scheme performs significantly better than the random forest of differential trees (see results for BoostDiff and RF Difftrees in <xref rid="vbae034-F2" ref-type="fig">Fig. 2</xref>): While RF Difftrees outperformed all the other methods in the 50-gene setting, BoostDiff is the best performing methods in the more complex 150-, 300-, and 500-gene settings. Results are similar for varying cutoffs of the number of top edges (<inline-formula id="IE70"><mml:math id="IM70" display="inline" overflow="scroll"><mml:mrow><mml:mi>k</mml:mi><mml:mo>∈</mml:mo><mml:mo>{</mml:mo><mml:mn>50</mml:mn><mml:mo>,</mml:mo><mml:mn>100</mml:mn><mml:mo>,</mml:mo><mml:mn>150</mml:mn><mml:mo>,</mml:mo><mml:mn>200</mml:mn><mml:mo>}</mml:mo></mml:mrow></mml:math></inline-formula>) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S5</xref>).</p>
      <fig position="float" id="vbae034-F2">
        <label>Figure 2.</label>
        <caption>
          <p>Performance of differential trees and BoostDiff compared to baseline methods and other differential network tools using simulated data comprising (a) 50 genes; (b) 150 genes; (c) 300 genes; (d) 500 genes. For all methods, the top 100 edges were considered (except for chNet). The one-sided Mann–Whitney U test is used to calculate the <italic toggle="yes">P</italic>-values.</p>
        </caption>
        <graphic xlink:href="vbae034f2" position="float"/>
      </fig>
      <p>We then determine the rank of each method in terms of the F1 score across all simulations in the four simulation settings. The results show that BoostDiff is the most frequently top-ranked method in the majority of simulations, more notably in the simulation settings with larger numbers of genes (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S6</xref>). In addition, except for when a high number of base learners is used in the ensemble, the performance of BoostDiff is consistent across different hyperparameter combinations (no. of features, maximum tree depth) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S7</xref>).</p>
    </sec>
    <sec>
      <title>3.2 Results on real datasets</title>
      <sec>
        <title>3.2.1 COVID-19</title>
        <p>The network inferred by BoostDiff shows stronger enrichment of COVID-19-related pathways compared to those of Diffcoex and the <italic toggle="yes">z</italic>-score method, whereas all edges in the EBcoexpress output are assigned zero posterior probabilities (<xref rid="vbae034-F3" ref-type="fig">Fig. 3</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S4–S7</xref>). In particular, the Diffcoex and <italic toggle="yes">z</italic>-score networks are enriched in less specific terms, such as ‘Influenza A,’ ‘Measles,’ and ‘Human T-cell leukemia virus 1 infection.’ Differential GENIE3 returned ‘Coronavirus disease,’ ‘Neutrophil extracellular trap formation,’ and ‘Phagosome.’ In addition to terms related to various pathogenic infections, the BoostDiff network is significantly enriched in COVID-19-relevant pathways, such as ‘Coronavirus disease,’ ‘TNF signaling pathway,’ ‘Th17 cell differentiation pathway,’ ‘NF-<inline-formula id="IE71"><mml:math id="IM71" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>B signaling pathway,’ ‘NOD-like receptor pathway,’ ‘Toll-like receptor signaling pathway,’ and ‘Viral protein interaction with cytokine and cytokine receptor’ (<xref rid="vbae034-F3" ref-type="fig">Fig. 3</xref>). However, similar to BoostDiff, ‘Herpes simplex I infection’ is a top enriched term in the networks output by both methods, which could indicate the presence of shared genes activated in response to viral infection. For the BoostDiff network, examining the differential edges when considering the two sub-analyses separately shows generally similar results, indicating the enrichment of infection-related pathways (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S8</xref>). We also compare the BoostDiff network to the list of DEGs. While the overlap between the differential network nodes and DEGs is significant, it is quite low (<inline-formula id="IE72"><mml:math id="IM72" display="inline" overflow="scroll"><mml:mrow><mml:mtext>Jaccard similarity</mml:mtext><mml:mo>=</mml:mo><mml:mn>0.129</mml:mn></mml:mrow></mml:math></inline-formula>). Further, removing the DEGs from the genes in the differential network retains the enrichment of COVID-19-related pathways (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S9</xref>), indicating that these dysregulated genes identified by BoostDiff are missed by standard DE analysis.</p>
        <fig position="float" id="vbae034-F3">
          <label>Figure 3.</label>
          <caption>
            <p>Enriched KEGG pathways in the networks inferred by BoostDiff for the COVID-19 dataset. The resulting differential networks were strongly enriched in inflammation-related and other relevant pathways, consistent with known disease pathophysiology.</p>
          </caption>
          <graphic xlink:href="vbae034f3" position="float"/>
        </fig>
        <p>To further examine the differential networks, we apply the Louvain community detection algorithm (<xref rid="vbae034-B8" ref-type="bibr">Blondel <italic toggle="yes">et al.</italic> 2008</xref>). BoostDiff, Diffcoex, <italic toggle="yes">z</italic>-score, and Differential GENIE3, identifies modules that are enriched in viral infection terms such as ‘Influenza A,’ ‘Coronavirus disease,’ ‘Hepatitis C,’ as well as signaling pathways ‘NOD-like receptor signaling pathway,’ ‘RIG-1-like receptor signaling pathway,’ and ‘Toll-like receptor signaling pathway’ (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figs S10–S12</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S8–S11</xref>). However, the BoostDiff module is additionally enriched in the terms ‘Cytosolic DNA-sensing pathway’ and ‘Chemokine signaling pathway’ (<xref rid="vbae034-F4" ref-type="fig">Fig. 4</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S10 and S11</xref>). Notable COVID-19-related genes in the BoostDiff module include <italic toggle="yes">CXCL10, DDX58, STAT1, STAT2, EIF2AK2</italic>, and <italic toggle="yes">ISG15.</italic> Other additionally known genes involved in pathogen response include <italic toggle="yes">IFIT1, IFIT2, IFIT3, CXCL11</italic>, and <italic toggle="yes">CXCL9</italic>. Chemokines are produced in response to a range of viral infections. In COVID-19, chemokine signaling has been linked to acute respiratory distress syndrome (<xref rid="vbae034-B92" ref-type="bibr">Zhou <italic toggle="yes">et al.</italic> 2020</xref>). <italic toggle="yes">DDX58</italic> (RIG-1) is involved in the production of interferons in response to COVID-19 (<xref rid="vbae034-B86" ref-type="bibr">Yamada <italic toggle="yes">et al.</italic> 2021</xref>). Interferon signaling mediated by STAT1 and STAT2 is a key antiviral defense mechanism, and SARS-CoV-2 was demonstrated to inhibit nuclear translocation of STAT1 and STAT2 (<xref rid="vbae034-B60" ref-type="bibr">Mu <italic toggle="yes">et al.</italic> 2020</xref>). OASL, OAS2, and OAS3 are members of the oligoadenylate synthetase family of proteins, which are involved in the antiviral activity of interferons and have been reported to exacerbate cardiac effects of COVID-19 (<xref rid="vbae034-B24" ref-type="bibr">Gao <italic toggle="yes">et al.</italic> 2023</xref>). JAK inhibitors have been explored for the treatment and management of COVID-19 (<xref rid="vbae034-B45" ref-type="bibr">Levy <italic toggle="yes">et al.</italic> 2022</xref>) and is known to regulate the release of pro-inflammatory cytokines and chemokines. For instance, the chemokines <italic toggle="yes">CXCL9, CXCL10</italic> and <italic toggle="yes">CXCL11</italic> are known to be upregulated in the COVID-19 response (<xref rid="vbae034-B11" ref-type="bibr">Callahan <italic toggle="yes">et al.</italic> 2021</xref>). IFIT1, IFIT2, and IFIT3 form a functional complex and participate in interferon-induced broad viral response (<xref rid="vbae034-B56" ref-type="bibr">Mears and Sweeney 2018</xref>, <xref rid="vbae034-B74" ref-type="bibr">Singh <italic toggle="yes">et al.</italic> 2022</xref>). <italic toggle="yes">ISG15</italic> encodes a ubiquitin-like protein whose activation triggers the release of various pro-inflammatory cytokines and chemokines (<xref rid="vbae034-B12" ref-type="bibr">Cao 2021</xref>).</p>
        <fig position="float" id="vbae034-F4">
          <label>Figure 4.</label>
          <caption>
            <p>Dysregulated module identified from the COVID-19 differential network inferred by BoostDiff using the Louvain algorithm. Some notable genes in the module include <italic toggle="yes">JAK2, CXCL9, CXCL10, CXCL11, DDX58, STAT1, STAT2, IFIT1, IFIT2, IFIT3, IFITM3, OASL, OAS2, OAS3</italic>, and <italic toggle="yes">ISG15</italic>.</p>
          </caption>
          <graphic xlink:href="vbae034f4" position="float"/>
        </fig>
        <p>In addition to the enrichment of COVID-19-related genes that are consistent with literature, BoostDiff also identified edges between <italic toggle="yes">TREX1</italic> and <italic toggle="yes">IFIT1, IFIT3, IFITM3, ISG15</italic>, and <italic toggle="yes">OAS3</italic>, all of which have been implicated with COVID-19. While <italic toggle="yes">TREX1</italic> has not been directly linked to COVID-19 pathogenesis, it encodes an exonuclease that is involved in host defense and has also been implicated in autoimmune diseases (<xref rid="vbae034-B75" ref-type="bibr">Stetson <italic toggle="yes">et al.</italic> 2008</xref>). In particular, <italic toggle="yes">TREX1</italic> regulates interferon-mediated signaling in antiviral response (<xref rid="vbae034-B31" ref-type="bibr">Hasan <italic toggle="yes">et al.</italic> 2013</xref>). Interestingly, a recent genome-wide screen identified TREX1 as a pro-viral factor in viral replication during influenza infection (<xref rid="vbae034-B40" ref-type="bibr">King <italic toggle="yes">et al.</italic> 2023</xref>). Given that nucleic acid detection is a key component of the immune response, <italic toggle="yes">TREX1</italic> could be a candidate player involved in immune response to viral pathogens, including SARS-CoV-2, that can be examined in future investigations.</p>
      </sec>
      <sec>
        <title>3.2.2 Crohn’s disease</title>
        <p>Notably, the BoostDiff network shows stronger enrichment of CD-related pathways than the networks inferred by the other methods (<xref rid="vbae034-F5" ref-type="fig">Fig. 5</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S12–S15</xref>). The network returned by Differential GENIE3 does not show any significant enrichment. In addition to infection pathways, the network output by BoostDiff for the CD dataset is enriched in CD-relevant pathways, including ‘TNF signaling pathway,’ ‘NOD-like receptor signaling pathway,’ ‘Th17 cell differentiation,’ ‘IL-17 signaling pathway,’ and ‘NF-<inline-formula id="IE73"><mml:math id="IM73" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>B signaling,’ as well as ‘Inflammatory bowel disease.’ NOD-like receptors play important roles in host defense and homeostasis by acting as sensors of microbial pathogens in the intestinal mucosa. IBD has been associated with abnormal gut microbiota composition, which promotes NF-<inline-formula id="IE74"><mml:math id="IM74" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>B signaling and downstream inflammatory responses (<xref rid="vbae034-B33" ref-type="bibr">Hug <italic toggle="yes">et al.</italic> 2018</xref>). The TF NF-<inline-formula id="IE75"><mml:math id="IM75" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>B functions in maintaining intestinal homeostasis, and dysregulation of the NF-<inline-formula id="IE76"><mml:math id="IM76" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>B pathway leads to sustained inflammatory state characteristic of IBD patients (<xref rid="vbae034-B88" ref-type="bibr">Zaidi and Wine 2018</xref>). NF-<inline-formula id="IE77"><mml:math id="IM77" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>B signaling activation has been associated with more severe clinical manifestations in CD patients (<xref rid="vbae034-B30" ref-type="bibr">Han <italic toggle="yes">et al.</italic> 2017</xref>, <xref rid="vbae034-B88" ref-type="bibr">Zaidi and Wine 2018</xref>). The Th17 subset of <inline-formula id="IE78"><mml:math id="IM78" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mrow><mml:mtext>CD</mml:mtext><mml:mn>4</mml:mn></mml:mrow></mml:mrow><mml:mo>+</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> T cells have well recognized roles in IBD pathogenesis. In CD, IL-17 signaling mediates the activation of Th17 cells, which further drive pro-inflammatory cascades via the production of IL-21, IL-22, IFN-<inline-formula id="IE79"><mml:math id="IM79" display="inline" overflow="scroll"><mml:mo>γ</mml:mo></mml:math></inline-formula>, and TNF (<xref rid="vbae034-B71" ref-type="bibr">Schmitt <italic toggle="yes">et al.</italic> 2021</xref>). The differential edges obtained from the two BoostDiff sub-analyses where the disease or control states are used as the target condition also show enrichment of CD-relevant pathways (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S13</xref>). The nodes in the BoostDiff network have a small overlap with the list of DEGs (<inline-formula id="IE80"><mml:math id="IM80" display="inline" overflow="scroll"><mml:mrow><mml:mtext>Jaccard similarity</mml:mtext><mml:mo>=</mml:mo><mml:mn>0.008</mml:mn></mml:mrow></mml:math></inline-formula>). Enrichment results after removal of DEGs are similar to those of the original network (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S14</xref>). The Diffcoex network is enriched in only the term ‘Herpes simplex virus 1 infection,’ while the <italic toggle="yes">z</italic>-score network is enriched in many cancer-related terms (<xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S12 and S13</xref>). The EBcoexpress network is also enriched in CD-related terms, such as ‘IL-17 signaling pathway,’ ‘NOD-like receptor signaling pathway,’ ‘TNF signaling pathway’ and ‘NF-<inline-formula id="IE81"><mml:math id="IM81" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>B signaling pathway.’ (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S15</xref>).</p>
        <fig position="float" id="vbae034-F5">
          <label>Figure 5.</label>
          <caption>
            <p>Enriched KEGG pathways in the networks inferred by BoostDiff for the CD dataset. The resulting differential networks are strongly enriched in inflammation-related and other relevant pathways, consistent with known disease pathophysiology.</p>
          </caption>
          <graphic xlink:href="vbae034f5" position="float"/>
        </fig>
        <p>The Louvain algorithm is then applied on the differential networks to refine the results. For Diffcoex and Differential GENIE3, none of the modules show significant CD-related enrichment. For <italic toggle="yes">z</italic>-score, one module is enriched in metabolism-related genes (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S15</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S16</xref>). The EBcoexpress network contains a module that is enriched in inflammation-related terms ‘Natural killer cell mediated cytotoxicity,’ ‘NF-<inline-formula id="IE82"><mml:math id="IM82" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>B signaling pathway,’ and ‘TNF signaling pathway’ (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S16</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S17</xref>). On the other hand, the BoostDiff network contains a module enriched in the terms ‘Necroptosis,’ ‘Apoptosis,’ and ‘TNF signaling pathway’ (<xref rid="vbae034-F6" ref-type="fig">Fig. 6</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S18</xref>). CD is characterized by inflammation in the intestinal mucosa leading to necroptosis, autophagy, and apoptosis. TLRs, such as TLR3, are central players in microbial defense in the gut that trigger downstream inflammatory signaling pathways, such as NF-<inline-formula id="IE83"><mml:math id="IM83" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>B (<xref rid="vbae034-B49" ref-type="bibr">Lu <italic toggle="yes">et al.</italic> 2018</xref>). The complex roles of caspases, including CASP1, CASP8, and CASP10, are also known to drive gut inflammation and tissue damage (<xref rid="vbae034-B50" ref-type="bibr">Mandal <italic toggle="yes">et al.</italic> 2018</xref>). <italic toggle="yes">CHUCK</italic> is a member of the NF-<inline-formula id="IE84"><mml:math id="IM84" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>B signaling pathway that functions in chemokine signaling (<xref rid="vbae034-B2" ref-type="bibr">Awane <italic toggle="yes">et al.</italic> 1999</xref>). Aberrant STAT1 and STAT3 signaling in IBD pathogenesis has been previously established (<xref rid="vbae034-B65" ref-type="bibr">Nieminen <italic toggle="yes">et al.</italic> 2013</xref>). The protective role of chemokine-like receptor 1 (CMKLR1) against microbiota-driven colitis has been reported (<xref rid="vbae034-B47" ref-type="bibr">Lin <italic toggle="yes">et al.</italic> 2022</xref>). <italic toggle="yes">TRIM40</italic> drives IBD pathogenesis by targeting cell-cell junctions in the mucosal epithelial barrier and promoting inflammation in the gut (<xref rid="vbae034-B66" ref-type="bibr">Noguchi <italic toggle="yes">et al.</italic> 2011</xref>, <xref rid="vbae034-B37" ref-type="bibr">Kang <italic toggle="yes">et al.</italic> 2023</xref>). Disturbances in the circadian rhythm are also linked to IBD manifestations (<xref rid="vbae034-B26" ref-type="bibr">Giebfried and Lorentz 2023</xref>); for instance, <italic toggle="yes">CLOCK</italic> expression is disrupted in IBD patients (<xref rid="vbae034-B85" ref-type="bibr">Weintraub <italic toggle="yes">et al.</italic> 2020</xref>, <xref rid="vbae034-B26" ref-type="bibr">Giebfried and Lorentz 2023</xref>). Interestingly, BoostDiff identifies an edge between <italic toggle="yes">CLOCK</italic> and <italic toggle="yes">STAT3</italic>, which could point to a candidate regulatory mechanism where the circadian clock influences <italic toggle="yes">STAT3</italic>, a known driver of the CD phenotype. Thus, this dependency could point to further research in this direction.</p>
        <fig position="float" id="vbae034-F6">
          <label>Figure 6.</label>
          <caption>
            <p>Dysregulated module identified from the CD differential network output by BoostDiff. Notable genes include <italic toggle="yes">CLOCK, TRIM40, IL7, TLR3, CASP1, STAT3, STAT1, CASP8, CASP10, CMKLR1</italic>, and <italic toggle="yes">CHUK</italic>.</p>
          </caption>
          <graphic xlink:href="vbae034f6" position="float"/>
        </fig>
      </sec>
      <sec>
        <title>3.2.3 Stress response in <italic toggle="yes">Bacillus subtilis</italic></title>
        <p>BoostDiff also outperforms its competitors on the <italic toggle="yes">B.subtilis</italic> data (<xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S19–S28</xref>). The networks inferred by BoostDiff are found to be enriched in stress-related pathways for all three conditions (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S17</xref>). On the other hand, only the Differential GENIE3 network in the salt stress condition is enriched in stress-related pathways. For Diffcoex, only one of the networks (heat treatment) is significantly enriched in stress-related pathways.</p>
        <p>Next, we examine the networks based on the top hub genes. For the salt stress experiment, all the top ten hub genes in the differential network (<italic toggle="yes">csbD, S536, ohrB, yuzA, ywjC, S1199, S1379, yfhK, yycD, ywmE</italic>, and <italic toggle="yes">ybyB</italic>) are part of the SigB regulon (<xref rid="vbae034-F7" ref-type="fig">Fig. 7</xref>). Similarly, for the heat stress experiment, BoostDiff identifies members of the SigB regulon, namely, <italic toggle="yes">csbD, ohrB, S536, yuzA, S1199, yycD, ywjC, yfhK, ywmE</italic>, and <italic toggle="yes">nhaX</italic>, as hub genes. For the ethanol stress experiment, BoostDiff idebtifies <italic toggle="yes">yuzA, ydaD, yycD, ydaE, yocK, yjgB, yhdF, S1477</italic>, and <italic toggle="yes">ytaB</italic> as the top ten hubs. Consistent with the applied stressors, the abovementioned genes encoding response proteins are part of the SigB regulon. The general stress response is controlled by the alternative sigma factor SigB, which induces the transcription of &gt;100 genes across a wide range of stress stimuli (<xref rid="vbae034-B62" ref-type="bibr">Nannapaneni <italic toggle="yes">et al.</italic> 2012</xref>). On the other hand, the other methods identify fewer relevant hub genes or do not produce meaningful outputs. EBcoexpress assigns a total of 68 532 edges and 1 080 620 edges with a posterior probability of 1.0 for the salt stress and heat stress experiments, respectively, thereby hindering biological interpretation. For the ethanol stress experiment, EBcoexpress did not run even after stringent filtering because of strong correlations in the dataset. The <italic toggle="yes">z</italic>-score method only identifies <italic toggle="yes">ctc</italic> as the relevant hub gene in the salt stress condition and no relevant genes in the heat stress condition; for the ethanol experiment, the <italic toggle="yes">z</italic>-score method identifies the ribosomal gene <italic toggle="yes">rplJ</italic> as a hub, which is not directly involved in the stress response (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S18</xref>). For Diffcoex, only three members of the SigB regulon (<italic toggle="yes">ydbD, yqjL</italic>, and <italic toggle="yes">yvgO</italic>) are identified as hubs in the heat stress condition and one relevant hub (<italic toggle="yes">S1290</italic>) is identified in the salt stress condition; no relevant hub gene is identified in the ethanol stress condition (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S19</xref>). Differential GENIE3 identifies only <italic toggle="yes">yflD</italic> as a hub in the salt stress condition (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S20</xref>).</p>
        <fig position="float" id="vbae034-F7">
          <label>Figure 7.</label>
          <caption>
            <p>The differential networks identified by BoostDiff for the stress response experiments in <italic toggle="yes">B.subtilis</italic>. (a) The differential network inferred with the salt stress versus Spizizen’s minimal medium control comparison. (b) The differential network inferred with the heat stress versus Belitsky Minimal Medium (BMM) control comparison (c). The differential network inferred with the ethanol stress versus BMM control comparison. In all three conditions, the top ten hub genes identified by BoostDiff are members of the SigB regulon, which is induced in diverse stresses in <italic toggle="yes">B.subtilis</italic>.</p>
          </caption>
          <graphic xlink:href="vbae034f7" position="float"/>
        </fig>
      </sec>
      <sec>
        <title>3.2.4 TCGA—breast cancer</title>
        <p>Again, the network inferred by BoostDiff shows stronger enrichment of disease-related pathways (including ‘Transcriptional misregulation in cancer,’ ‘Pathways in cancer,’ ‘Proteoglycans in cancer,’ and ‘Signaling pathways regulating pluripotency of stem cells’) than networks inferred using Diffcoex, EBcoexpress, Differential GENIE3, or the <italic toggle="yes">z</italic>-score method (<xref rid="vbae034-F8" ref-type="fig">Fig. 8</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S29–S32</xref>). Only the Diffcoex network is enriched in inflammatory and cancer-related pathways. Ebcoexpress assigns a posterior probability of 1 to 375 873 edges, while the <italic toggle="yes">z</italic>-score network is enriched in one term, ‘Tight junction’ (<xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S30 and S31</xref>). The network inferred by Differential GENIE3 is enriched in terms related to olfactory transduction and metabolism (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S32</xref>). For BoostDiff, the results of enrichment analysis when considering the two sub-analyses separately shows generally similar results (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S21</xref>). The nodes in the BoostDiff network have a small overlap with the list of DEGs (<inline-formula id="IE85"><mml:math id="IM85" display="inline" overflow="scroll"><mml:mrow><mml:mtext>Jaccard similarity</mml:mtext><mml:mo>=</mml:mo><mml:mn>0.126</mml:mn></mml:mrow></mml:math></inline-formula>). Enrichment results after removal of DEGs are similar to those of the original network (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S22</xref>).</p>
        <fig position="float" id="vbae034-F8">
          <label>Figure 8.</label>
          <caption>
            <p>Enriched KEGG pathways in the networks inferred by BoostDiff for the TCGA BRCA dataset.</p>
          </caption>
          <graphic xlink:href="vbae034f8" position="float"/>
        </fig>
        <p>No BRCA-related module is found in the Differential GENIE3 network. Module analysis for Diffcoex identifies a module that is primarily enriched in generic inflammation-related pathways, such as ‘IL-17 signaling pathway,’ ‘TNF signaling pathway,’ and ‘JAK-STAT signaling pathway.’ (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S23</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S33</xref>). BoostDiff results are more specific: Here, we identify a module that is enriched in the terms ‘PPAR signaling pathway,’ ‘Insulin resistance,’ ‘AMPK signaling pathway,’ ‘Adipocytokine signaling pathway,’ ‘Pyruvate metabolism,’ and ‘Regulation of lipolysis in adipocytes’ (<xref rid="vbae034-F9" ref-type="fig">Fig. 9</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S34</xref>). Adipose tissue plays an important role in tumor progression because it provides nutrients, metabolites, and adipokines to the tumor microenvironment of breast cancer cells (<xref rid="vbae034-B18" ref-type="bibr">DeBerardinis <italic toggle="yes">et al.</italic> 2008</xref>, <xref rid="vbae034-B28" ref-type="bibr">Guaita-Esteruelas <italic toggle="yes">et al.</italic> 2017</xref>). PPAR is a ligand-activated TF that is involved in fatty acid oxidation and lipid metabolism (<xref rid="vbae034-B44" ref-type="bibr">Lee <italic toggle="yes">et al.</italic> 2019</xref>). In the context of BRCA, PPAR signaling is known to contribute to metastasis and promote survival in harsh metabolic conditions (<xref rid="vbae034-B70" ref-type="bibr">Saez <italic toggle="yes">et al.</italic> 2004</xref>, <xref rid="vbae034-B84" ref-type="bibr">Wang <italic toggle="yes">et al.</italic> 2016</xref>).</p>
        <fig position="float" id="vbae034-F9">
          <label>Figure 9.</label>
          <caption>
            <p>Dysregulated Louvain module for the TCGA BRCA dataset. Notable genes include <italic toggle="yes">PPARG, PLIN1, PLIN4, CD36, ESR2, ADIPOQ, FABP4, PCK1, CEBPA, MEOX1</italic>, and <italic toggle="yes">MEOX2</italic>.</p>
          </caption>
          <graphic xlink:href="vbae034f9" position="float"/>
        </fig>
        <p>The BoostDiff results not only make sense in light of the enriched pathways, but also when zooming-in on the individual edges and hub nodes: For instance, BoostDiff identifies a relationship between <italic toggle="yes">PPARG</italic> and <italic toggle="yes">PLIN4</italic>, which are already known to be associated in the context of adipogenesis (<xref rid="vbae034-B64" ref-type="bibr">Nielsen <italic toggle="yes">et al.</italic> 2008</xref>). Perilipins comprise lipid droplet-associated proteins that modulate lipid homeostasis. In BRCA, <italic toggle="yes">PLIN4</italic> upregulation is associated with poor prognosis (<xref rid="vbae034-B39" ref-type="bibr">Kim <italic toggle="yes">et al.</italic> 2015</xref>, <xref rid="vbae034-B91" ref-type="bibr">Zhang <italic toggle="yes">et al.</italic> 2021</xref>). BoostDiff also predicts an edge between <italic toggle="yes">PPARG</italic> and <italic toggle="yes">PCK1</italic>, which is also part of the PPAR pathway. <italic toggle="yes">PCK1</italic> encodes a protein kinase that has multiple known metabolic roles, including lipogenesis and tumorigenesis (<xref rid="vbae034-B79" ref-type="bibr">Tang <italic toggle="yes">et al.</italic> 2021</xref>). BoostDiff identifies <italic toggle="yes">CD36</italic> as a hub gene in the module. In BRCA, <italic toggle="yes">CD36</italic> has been reported to be involved in metabolic rewiring and reprogramming favoring fatty acid oxidation and has been proposed as a therapeutic target in breast cancer (<xref rid="vbae034-B23" ref-type="bibr">Feng <italic toggle="yes">et al.</italic> 2019</xref>). BoostDiff further identified an edge between <italic toggle="yes">CD36</italic> and <italic toggle="yes">FABP4</italic>. In BRCA, CD36 was shown to directly interact with FABP4 to influence transport and metabolism of fatty acids (<xref rid="vbae034-B29" ref-type="bibr">Gyamfi <italic toggle="yes">et al.</italic> 2021</xref>). Further, <italic toggle="yes">CD36</italic> is upregulated along with other lipid metabolism genes <italic toggle="yes">PLIN1</italic> and <italic toggle="yes">ADIPOQ</italic> (adiponectin) in breast cancer (<xref rid="vbae034-B53" ref-type="bibr">Marino <italic toggle="yes">et al.</italic> 2020</xref>).</p>
        <p>The correlation between <italic toggle="yes">ESR2</italic> and <italic toggle="yes">ADIPOQ</italic> in adipose tissue is also established (<xref rid="vbae034-B1" ref-type="bibr">Ahmed <italic toggle="yes">et al.</italic> 2022</xref>). While this specific relationship has not been described in breast cancer, this could be investigated in future studies, given the established role of estrogens and adiposity in breast cancer (<xref rid="vbae034-B6" ref-type="bibr">Bhardwaj and Brown 2021</xref>). Along with <italic toggle="yes">PPARG, CEBPA</italic> is a known master regulator of adipogenesis that influences lipid accumulation (<xref rid="vbae034-B44" ref-type="bibr">Lee <italic toggle="yes">et al.</italic> 2019</xref>). Here, <italic toggle="yes">CEBPA</italic> is associated with <italic toggle="yes">ADIPOQ</italic>, another adipocyte marker (<xref rid="vbae034-B55" ref-type="bibr">Matulewicz <italic toggle="yes">et al.</italic> 2017</xref>). Other identified TFs include <italic toggle="yes">MEOX1</italic> and <italic toggle="yes">MEOX2</italic>, which are involved in angiogenesis and vascular development (<xref rid="vbae034-B72" ref-type="bibr">Schönrock <italic toggle="yes">et al.</italic> 2022</xref>, <xref rid="vbae034-B83" ref-type="bibr">Wang <italic toggle="yes">et al.</italic> 2022</xref>, <xref rid="vbae034-B89" ref-type="bibr">Zeng <italic toggle="yes">et al.</italic> 2023</xref>). For instance, <italic toggle="yes">MEOX1</italic> expression was found to be associated with tumor growth triple-negative BRCA (<xref rid="vbae034-B89" ref-type="bibr">Zeng <italic toggle="yes">et al.</italic> 2023</xref>). Based on their emerging roles in neoplastic diseases, MEOX1 and MEOX2 could be candidate targets in breast cancer. Overall, our results identify genes that can be further explored and reinforce the important role of adipogenesis in breast cancer.</p>
      </sec>
      <sec>
        <title>3.2.5 TCGA—prostate adenocarcinoma</title>
        <p>For PRAD, the EBcoexpress network is too large to analyze, as 375 873 edges are assigned with posterior probability of 1, while the <italic toggle="yes">z</italic>-score network is not significantly enriched in any terms. The Diffcoex network is enriched in infection- and cancer-related terms, while the Differential GENIE3 network is enriched in terms related to metabolism. On the other hand, the BoostDiff network shows overall stronger enrichment of cancer-related terms (<xref rid="vbae034-F10" ref-type="fig">Fig. 10</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S35–S37</xref>). The nodes in the BoostDiff network have a small overlap with the list of DEGs (<inline-formula id="IE86"><mml:math id="IM86" display="inline" overflow="scroll"><mml:mrow><mml:mtext>Jaccard similarity</mml:mtext><mml:mo>=</mml:mo><mml:mn>0.114</mml:mn></mml:mrow></mml:math></inline-formula>). The results of enrichment analysis when considering the two sub-analyses separately shows generally similar results (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S24</xref>). Enrichment results after removal of DEGs are similar to those of the original network (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S25</xref>).</p>
        <fig position="float" id="vbae034-F10">
          <label>Figure 10.</label>
          <caption>
            <p>Enriched KEGG pathways in the networks inferred by BoostDiff for the TCGA PRAD dataset.</p>
          </caption>
          <graphic xlink:href="vbae034f10" position="float"/>
        </fig>
        <p>For Diffcoex, we identify a cancer-associated module enriched in terms such as ‘Cell cycle,’ ‘Cellular senescence,’ and ‘Bladder cancer’ (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S26</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S38</xref>). None of the modules in the <italic toggle="yes">z</italic>-score and Differential GENIE3 networks show significant enrichment of cancer-related terms. For BoostDiff, we identify a module enriched in the terms ‘Transcriptional misregulation in cancer,’ ‘Adrenergic signaling in cardiomyocytes,’ ‘Dilated cardiomyopathy,’ ‘Thyroid hormone signaling pathway,’ ‘Cardiac muscle contraction,’ and ‘Pathways in cancer’ (<xref rid="vbae034-F11" ref-type="fig">Fig. 11</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S39</xref>). The module contains MEF2C, a TF known to be involved in oncogenesis and tumor proliferation in many types of cancers (<xref rid="vbae034-B3" ref-type="bibr">Bai <italic toggle="yes">et al.</italic> 2015</xref>, <xref rid="vbae034-B20" ref-type="bibr">Di Giorgio <italic toggle="yes">et al.</italic> 2017</xref>). <italic toggle="yes">TEAD4</italic> was found to be an important prognostic marker in PRAD and is a known effector of oncogenic pathways (<xref rid="vbae034-B13" ref-type="bibr">Chen <italic toggle="yes">et al.</italic> 2021</xref>). The potential involvement of <italic toggle="yes">MYH7</italic> in PRAD has been recently described; in particular (<xref rid="vbae034-B46" ref-type="bibr">Liang <italic toggle="yes">et al.</italic> 2022</xref>), found a higher frequency of <italic toggle="yes">MYH7</italic> variants in prostate cancer patients. <italic toggle="yes">CAMK2A</italic> is known to promote tumor progression in prostate cancer (<xref rid="vbae034-B69" ref-type="bibr">Rokhlin <italic toggle="yes">et al.</italic> 2007</xref>, <xref rid="vbae034-B32" ref-type="bibr">He and Li 2021</xref>). In an earlier study, protein-protein interaction network-based analyses similarly identified <italic toggle="yes">ACTN2, MYL1, MYL2</italic>, and <italic toggle="yes">MYH7</italic> as hub genes associated with <italic toggle="yes">PTEN</italic>-associated prostate cancer (<xref rid="vbae034-B77" ref-type="bibr">Sun <italic toggle="yes">et al.</italic> 2019</xref>). The dysregulation of <italic toggle="yes">ACTN2</italic> and <italic toggle="yes">MYH7</italic> has been described in the context of other cancers (<xref rid="vbae034-B36" ref-type="bibr">Ju <italic toggle="yes">et al.</italic> 2023</xref>). Our results suggest that candidate genes in the identified module can be further examined in the context of prostate cancer.</p>
        <fig position="float" id="vbae034-F11">
          <label>Figure 11.</label>
          <caption>
            <p>Dysregulated Louvain module for the TCGA PRAD dataset. Notable genes include <italic toggle="yes">MEF2C, MYL1, MYH6, MYH7, MYL2, ACTN2, CAMK2A</italic>, and <italic toggle="yes">TEAD4</italic>.</p>
          </caption>
          <graphic xlink:href="vbae034f11" position="float"/>
        </fig>
      </sec>
      <sec>
        <title>3.2.6 Expression distributions of top-ranked edges identified by BoostDiff reflect shifts in correlation distributions</title>
        <p>We additionally examine the Pearson correlations of the top edges from the differential networks identified by BoostDiff using the original expression data. This procedure is performed separately for the results of the two sub-analyses, namely, when the disease condition is used as the target condition, and when the control condition is used as the target condition. For the COVID-19 and CD datasets, for the same set of edges, we observe a unimodal distribution of correlation values in the nontarget condition and a bimodal distribution in the target condition, where strong positive correlation values suggest target-condition-specific activating regulator-target relationship, while negative values indicate target-condition-specific inhibitory relationships (<xref rid="vbae034-F12" ref-type="fig">Fig. 12</xref>). Similar observations can be derived for the <italic toggle="yes">B.subtilis</italic> stress adaptation and TCGA datasets (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S27</xref>). That is, expression levels of genes incident with differential edges returned by BoostDiff tend to exhibit highly condition-specific correlation patterns, indicating that BoostDiff can indeed uncover disease-specific gene dysregulation. Importantly, this striking observation does not hold for the set of all pairwise edges whose endpoints are DEGs or for randomly selected edges. For Differential GENIE3, similar patterns were observed for the salt stress and ethanol stress networks (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S28</xref>). However, no consistent patterns are observed when the same analysis is performed on the networks inferred from the human datasets (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S29</xref>).</p>
        <fig position="float" id="vbae034-F12">
          <label>Figure 12.</label>
          <caption>
            <p>Violin plots showing that the top 500 edges in the differential network predicted by BoostDiff for each sub-analysis tend to exhibit changes in correlation distributions between the disease and control expression data, indicating dysregulation in pairwise relationships. Correlations between predicted differential edges are compared to correlations between all pairwise combinations of DEGs, as well as randomly selected edges. Results are shown for (a) COVID-19, (b) CD, (c) TCGA—BRCA, and (d) TCGA—PRAD datasets.</p>
          </caption>
          <graphic xlink:href="vbae034f12" position="float"/>
        </fig>
      </sec>
    </sec>
  </sec>
  <sec>
    <title>4 Conclusions</title>
    <p>Gene regulation is a complex process that changes under different biological contexts. Differential network biology explores the rewiring of these regulatory interaction landscapes that are fundamentally distinct from the static networks that are inferred in most standard GRN inference methods (<xref rid="vbae034-B35" ref-type="bibr">Ideker and Krogan 2012</xref>). By additionally considering the regulatory dependencies from a baseline condition, we can uncover a more refined picture underlying the molecular processes that are perturbed in a condition of interest, such as disease.</p>
    <p>Inference of networks from biological expression data is a challenging task. The novelty of BoostDiff is 2-fold: (i) We use differential variance improvement as the splitting measure in a tree-based algorithm that can explicitly compare two datasets with a continuous output variable; (ii) BoostDiff adapts the AdaBoost algorithm to use differential trees as the base learner. Boosting the differential trees with respect to samples belonging to the target condition is a crucial step that significantly improves the detection of differential edges.</p>
    <p>BoostDiff outperforms existing differential network methods on simulated data in more complex settings with higher dimensionality. BoostDiff yields biologically meaningful results when evaluated on five real-world transcriptomics datasets. We show that BoostDiff infers differential networks that are consistent with the pathophysiology of COVID-19, Crohn’s disease, and two types of cancer, namely, breast cancer and prostate adenocarcinoma, using TCGA data. We further validate BoostDiff using three different stress conditions evaluating the response of <italic toggle="yes">B.subtilis</italic> to salt, heat, and ethanol stressors, where BoostDiff correctly identifies members of the SigB regulon as hub genes in the differential networks. On the other hand, the compared methods recover few stress-related response genes. BoostDiff is also scalable and has reasonable runtime since it builds one model for each gene and can hence easily be parallelized. To facilitate biological interpretation and further refine the results, various graph-based algorithms can be used to find highly connected subnetworks. In this study, we apply the Louvain community detection algorithm, although other graph-based tools can also be used to find perturbed modules.</p>
    <p>Nevertheless, our method has several limitations. First, BoostDiff can only compare two conditions at a time. Moreover, BoostDiff is similar to GENIE3 in that it does not perform statistical testing. Instead, scores are assigned to individual edges by calculating tree-based variable importance measures; thus, only the ranking of the edge weights is considered. Further, the AdaBoost algorithm can be prone to overfitting. In our experiments, BoostDiff performance decreased when setting the number of trees to 300. Thus, to avoid overfitting, we recommend users to set a low number of base differential trees (e.g. 50 trees).</p>
    <p>The application of BoostDiff is not limited to gene expression data; the proposed feature selection approach can be generalized to other omics datasets. For instance, BoostDiff can be applied to proteomics or metabolomics studies that aim to detect changes in dependencies of proteins or metabolites. Moreover, the simple but effective strategy implemented in BoostDiff is an algorithmic advancement that can be further extended to other problems that aim to extract differentially predictive features. Adapting BoostDiff for analyzing time-series datasets is also a promising research direction.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>vbae034_Supplementary_Data</label>
      <media xlink:href="vbae034_supplementary_data.zip"/>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ack1">
    <title>Acknowledgements</title>
    <p>We are grateful to Julian Beier for technical support. We thank the anonymous reviewers for their valuable suggestions.</p>
  </ack>
  <sec>
    <title>Author contributions</title>
    <p>G.G.: Conceptualization, Formal analysis, Methodology, Software, Writing—original draft. M.L.: Conceptualization, Writing—Review &amp; Editing. J.B.: Conceptualization, Writing—Review &amp; Editing. U.V.: Validation, Writing—Review &amp; Editing. U.M.: Validation, Writing—Review &amp; Editing. D.B.B.: Conceptualization, Methodology, Supervision, Writing—Review &amp; Editing. T.K.: Conceptualization, Methodology, Supervision, Writing—Review &amp; Editing.</p>
  </sec>
  <sec>
    <title>Supplementary data</title>
    <p><xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> are available at <italic toggle="yes">Bioinformatics Advances</italic> online.</p>
  </sec>
  <sec sec-type="COI-statement">
    <title>Conflict of interest</title>
    <p>None declared.</p>
  </sec>
  <sec>
    <title>Funding</title>
    <p>This work was supported by the German Federal Ministry of Education and Research (BMBF) [031L0309A to D.B.B.]; and the Open Access Publication Funds of Technische Universität Braunschweig.</p>
  </sec>
  <sec sec-type="data-availability">
    <title>Data availability</title>
    <p>The data used in this article are publicly available. Transcriptomics data used for analyzing the COVID-19, Crohn’s disease, and <italic toggle="yes">Bacillus subtilis</italic> stress response can be downloaded from Gene Expression Omnibus under the accession numbers GSE156063, GSE126124, and GSE27219, respecively. The TCGA datasets are available at <ext-link xlink:href="https://xenabrowser.net/datapages/" ext-link-type="uri">https://xenabrowser.net/datapages/</ext-link>. The simulated gene expression data are deposited at <ext-link xlink:href="https://zenodo.org/records/10214950" ext-link-type="uri">https://zenodo.org/records/10214950</ext-link>. Our BoostDiff implementation, as well as sample scripts and tutorials are available on GitHub: <ext-link xlink:href="https://github.com/scibiome/boostdiff_inference" ext-link-type="uri">https://github.com/scibiome/boostdiff_inference</ext-link>.</p>
  </sec>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="vbae034-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ahmed</surname><given-names>F</given-names></string-name>, <string-name><surname>Hetty</surname><given-names>S</given-names></string-name>, <string-name><surname>Vranic</surname><given-names>M</given-names></string-name></person-group><etal>et al</etal><article-title>ESR2 expression in subcutaneous adipose tissue is related to body fat distribution in women, and knockdown impairs preadipocyte differentiation</article-title>. <source>Adipocyte</source><year>2022</year>;<volume>11</volume>:<fpage>434</fpage>–<lpage>47</lpage>.<pub-id pub-id-type="pmid">35856485</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Awane</surname><given-names>M</given-names></string-name>, <string-name><surname>Andres</surname><given-names>PG</given-names></string-name>, <string-name><surname>Li</surname><given-names>DJ</given-names></string-name></person-group><etal>et al</etal><article-title>Nf-<inline-formula id="IE87"><mml:math id="IM87" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>b-inducing kinase is a common mediator of il-17-, tnf-<inline-formula id="IE88"><mml:math id="IM88" display="inline" overflow="scroll"><mml:mo>α</mml:mo></mml:math></inline-formula>-, and il-1<inline-formula id="IE89"><mml:math id="IM89" display="inline" overflow="scroll"><mml:mo>β</mml:mo></mml:math></inline-formula>-induced chemokine promoter activation in intestinal epithelial cells</article-title>. <source>J Immunol</source><year>1999</year>;<volume>162</volume>:<fpage>5337</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="pmid">10228009</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bai</surname><given-names>XL</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Q</given-names></string-name>, <string-name><surname>Ye</surname><given-names>LY</given-names></string-name></person-group><etal>et al</etal><article-title>Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth factor and Wnt/<inline-formula id="IE90"><mml:math id="IM90" display="inline" overflow="scroll"><mml:mo>β</mml:mo></mml:math></inline-formula>-catenin signaling</article-title>. <source>Oncogene</source><year>2015</year>;<volume>34</volume>:<fpage>4089</fpage>–<lpage>97</lpage>.<pub-id pub-id-type="pmid">25328135</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Basha</surname><given-names>O</given-names></string-name>, <string-name><surname>Argov</surname><given-names>CM</given-names></string-name>, <string-name><surname>Artzy</surname><given-names>R</given-names></string-name></person-group><etal>et al</etal><article-title>Differential network analysis of multiple human tissue interactomes highlights tissue-selective processes and genetic disorder genes</article-title>. <source>Bioinformatics</source><year>2020</year>;<volume>36</volume>:<fpage>2821</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">31960892</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Baur</surname><given-names>B</given-names></string-name>, <string-name><surname>Shin</surname><given-names>J</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>Data integration for inferring context-specific gene regulatory networks</article-title>. <source>Curr Opin Syst Biol</source><year>2020</year>;<volume>23</volume>:<fpage>38</fpage>–<lpage>46</lpage>.<pub-id pub-id-type="pmid">33225112</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bhardwaj</surname><given-names>P</given-names></string-name>, <string-name><surname>Brown</surname><given-names>KA.</given-names></string-name></person-group><article-title>Obese adipose tissue as a driver of breast cancer growth and development: update and emerging evidence</article-title>. <source>Front Oncol</source><year>2021</year>;<volume>11</volume>:<fpage>638918</fpage>.<pub-id pub-id-type="pmid">33859943</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bhuva</surname><given-names>DD</given-names></string-name>, <string-name><surname>Cursons</surname><given-names>J</given-names></string-name>, <string-name><surname>Smyth</surname><given-names>GK</given-names></string-name></person-group><etal>et al</etal><article-title>Differential co-expression-based detection of conditional relationships in transcriptional data: comparative analysis and application to breast cancer</article-title>. <source>Genome Biol</source><year>2019</year>;<volume>20</volume>:<fpage>236</fpage>.<pub-id pub-id-type="pmid">31727119</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Blondel</surname><given-names>VD</given-names></string-name>, <string-name><surname>Guillaume</surname><given-names>J-L</given-names></string-name>, <string-name><surname>Lambiotte</surname><given-names>R</given-names></string-name></person-group><etal>et al</etal> Fast unfolding of communities in large networks. <italic toggle="yes">J Stat Mech</italic><year>2008</year>;<volume>2008</volume>:P10008.</mixed-citation>
    </ref>
    <ref id="vbae034-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Breiman</surname><given-names>L</given-names></string-name>, <string-name><surname>Friedman</surname><given-names>J</given-names></string-name>, <string-name><surname>Olshen</surname><given-names>R</given-names></string-name></person-group><etal>et al</etal><article-title>Classification and regression trees</article-title>. <source>Wadsworth Int Group</source><year>1984</year>;<volume>37</volume>:<fpage>237</fpage>–<lpage>51</lpage>.</mixed-citation>
    </ref>
    <ref id="vbae034-B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brunel</surname><given-names>H</given-names></string-name>, <string-name><surname>Gallardo-Chacón</surname><given-names>J-J</given-names></string-name>, <string-name><surname>Buil</surname><given-names>A</given-names></string-name></person-group><etal>et al</etal><article-title>MISS: a non-linear methodology based on mutual information for genetic association studies in both population and sib-pairs analysis</article-title>. <source>Bioinformatics</source><year>2010</year>;<volume>26</volume>:<fpage>1811</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">20562420</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Callahan</surname><given-names>V</given-names></string-name>, <string-name><surname>Hawks</surname><given-names>S</given-names></string-name>, <string-name><surname>Crawford</surname><given-names>MA</given-names></string-name></person-group><etal>et al</etal> The pro-inflammatory chemokines CXCL9, CXCL10 and CXCL11 are upregulated following SARS-CoV-2 infection in an AKT-dependent manner. Viruses <year>2021</year>;<volume>13</volume>:<fpage>1062</fpage>.</mixed-citation>
    </ref>
    <ref id="vbae034-B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cao</surname><given-names>X.</given-names></string-name></person-group><article-title>ISG15 secretion exacerbates inflammation in SARS-CoV-2 infection</article-title>. <source>Nat Immunol</source><year>2021</year>;<volume>22</volume>:<fpage>1360</fpage>–<lpage>2</lpage>.<pub-id pub-id-type="pmid">34671145</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B13">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>C-L</given-names></string-name>, <string-name><surname>Hsu</surname><given-names>S-C</given-names></string-name>, <string-name><surname>Chung</surname><given-names>T-Y</given-names></string-name></person-group><etal>et al</etal><article-title>Arginine is an epigenetic regulator targeting tead4 to modulate oxphos in prostate cancer cells</article-title>. <source>Nat Commun</source><year>2021</year>;<volume>12</volume>:<fpage>2398</fpage>.<pub-id pub-id-type="pmid">33893278</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B14">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chu</surname><given-names>J-H</given-names></string-name>, <string-name><surname>Lazarus</surname><given-names>R</given-names></string-name>, <string-name><surname>Carey</surname><given-names>VJ</given-names></string-name></person-group><etal>et al</etal><article-title>Quantifying differential gene connectivity between disease states for objective identification of disease-relevant genes</article-title>. <source>BMC Syst Biol</source><year>2011</year>;<volume>5</volume>:<fpage>89</fpage>.<pub-id pub-id-type="pmid">21627793</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B15">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Costello</surname><given-names>JC</given-names></string-name>, <string-name><surname>Heiser</surname><given-names>LM</given-names></string-name>, <string-name><surname>Georgii</surname><given-names>E</given-names></string-name></person-group><etal>et al</etal>; <collab>NCI DREAM Community</collab>. <article-title>A community effort to assess and improve drug sensitivity prediction algorithms</article-title>. <source>Nat. Biotechnol</source><year>2014</year>;<volume>32</volume>:<fpage>1202</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="pmid">24880487</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B16">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dawson</surname><given-names>JA</given-names></string-name>, <string-name><surname>Kendziorski</surname><given-names>C.</given-names></string-name></person-group><article-title>An empirical Bayesian approach for identifying differential coexpression in high-throughput experiments</article-title>. <source>Biometrics</source><year>2012</year>;<volume>68</volume>:<fpage>455</fpage>–<lpage>65</lpage>.<pub-id pub-id-type="pmid">22004327</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B17">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dawson</surname><given-names>JA</given-names></string-name>, <string-name><surname>Ye</surname><given-names>S</given-names></string-name>, <string-name><surname>Kendziorski</surname><given-names>C.</given-names></string-name></person-group><article-title>R/EBcoexpress: an empirical Bayesian framework for discovering differential co-expression</article-title>. <source>Bioinformatics</source><year>2012</year>;<volume>28</volume>:<fpage>1939</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="pmid">22595207</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B18">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>DeBerardinis</surname><given-names>RJ</given-names></string-name>, <string-name><surname>Lum</surname><given-names>JJ</given-names></string-name>, <string-name><surname>Hatzivassiliou</surname><given-names>G</given-names></string-name></person-group><etal>et al</etal><article-title>The biology of cancer: metabolic reprogramming fuels cell growth and proliferation</article-title>. <source>Cell Metab</source><year>2008</year>;<volume>7</volume>:<fpage>11</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="pmid">18177721</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B19">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>de la Fuente</surname><given-names>A.</given-names></string-name></person-group><article-title>From ‘differential expression’ to ‘differential networking’ – identification of dysfunctional regulatory networks in diseases</article-title>. <source>Trends Genet</source><year>2010</year>;<volume>26</volume>:<fpage>326</fpage>–<lpage>33</lpage>.<pub-id pub-id-type="pmid">20570387</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B20">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Di Giorgio</surname><given-names>E</given-names></string-name>, <string-name><surname>Franforte</surname><given-names>E</given-names></string-name>, <string-name><surname>Cefalù</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>The co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressiveness</article-title>. <source>PLoS Genet</source><year>2017</year>;<volume>13</volume>:<fpage>e1006752</fpage>.<pub-id pub-id-type="pmid">28419090</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B21">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Drucker</surname><given-names>H.</given-names></string-name></person-group><article-title>Improving regressors using boosting techniques</article-title>. In: <source>ICML</source>, July 8–12, 1997; Nashville, Tennessee, USA: Morgan Kaufmann, Vol. <volume>97</volume>, <year>1997</year>, <fpage>107</fpage>–<lpage>15</lpage>.</mixed-citation>
    </ref>
    <ref id="vbae034-B22">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Durinck</surname><given-names>S</given-names></string-name>, <string-name><surname>Spellman</surname><given-names>PT</given-names></string-name>, <string-name><surname>Birney</surname><given-names>E</given-names></string-name></person-group><etal>et al</etal><article-title>Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomart</article-title>. <source>Nat Protoc</source><year>2009</year>;<volume>4</volume>:<fpage>1184</fpage>–<lpage>91</lpage>.<pub-id pub-id-type="pmid">19617889</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B23">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Feng</surname><given-names>WW</given-names></string-name>, <string-name><surname>Wilkins</surname><given-names>O</given-names></string-name>, <string-name><surname>Bang</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>CD36-Mediated metabolic rewiring of breast cancer cells promotes resistance to HER2-Targeted therapies</article-title>. <source>Cell Rep</source><year>2019</year>;<volume>29</volume>:<fpage>3405</fpage>–<lpage>20.e5</lpage>.<pub-id pub-id-type="pmid">31825825</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B24">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gao</surname><given-names>L-J</given-names></string-name>, <string-name><surname>He</surname><given-names>Z-M</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y-Y</given-names></string-name></person-group><etal>et al</etal><article-title>Role of OAS gene family in COVID-19 induced heart failure</article-title>. <source>J Transl Med</source><year>2023</year>;<volume>21</volume>:<fpage>212</fpage>.<pub-id pub-id-type="pmid">36949448</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B25">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ge</surname><given-names>SX</given-names></string-name>, <string-name><surname>Jung</surname><given-names>D</given-names></string-name>, <string-name><surname>Yao</surname><given-names>R.</given-names></string-name></person-group><article-title>ShinyGO: a graphical gene-set enrichment tool for animals and plants</article-title>. <source>Bioinformatics</source><year>2020</year>;<volume>36</volume>:<fpage>2628</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">31882993</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B26">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Giebfried</surname><given-names>J</given-names></string-name>, <string-name><surname>Lorentz</surname><given-names>A.</given-names></string-name></person-group><article-title>Relationship between the biological clock and inflammatory bowel disease</article-title>. <source>Clocks Sleep</source><year>2023</year>;<volume>5</volume>:<fpage>260</fpage>–<lpage>75</lpage>.<pub-id pub-id-type="pmid">37218867</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B27">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Goldman</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Craft</surname><given-names>B</given-names></string-name>, <string-name><surname>Hastie</surname><given-names>M</given-names></string-name></person-group><etal>et al</etal><article-title>Visualizing and interpreting cancer genomics data via the xena platform</article-title>. <source>Nat Biotechnol</source><year>2020</year>;<volume>38</volume>:<fpage>675</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">32444850</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B28">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guaita-Esteruelas</surname><given-names>S</given-names></string-name>, <string-name><surname>Bosquet</surname><given-names>A</given-names></string-name>, <string-name><surname>Saavedra</surname><given-names>P</given-names></string-name></person-group><etal>et al</etal><article-title>Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins</article-title>. <source>Mol Carcinog</source><year>2017</year>;<volume>56</volume>:<fpage>208</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="pmid">27061264</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B29">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gyamfi</surname><given-names>J</given-names></string-name>, <string-name><surname>Yeo</surname><given-names>JH</given-names></string-name>, <string-name><surname>Kwon</surname><given-names>D</given-names></string-name></person-group><etal>et al</etal><article-title>Interaction between CD36 and FABP4 modulates adipocyte-induced fatty acid import and metabolism in breast cancer</article-title>. <source>NPJ Breast Cancer</source><year>2021</year>;<volume>7</volume>:<fpage>129</fpage>.<pub-id pub-id-type="pmid">34561446</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B30">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Han</surname><given-names>YM</given-names></string-name>, <string-name><surname>Koh</surname><given-names>J</given-names></string-name>, <string-name><surname>Kim</surname><given-names>JW</given-names></string-name></person-group><etal>et al</etal><article-title>NF-kappa B activation correlates with disease phenotype in Crohn’s disease</article-title>. <source>PLoS One</source><year>2017</year>;<volume>12</volume>:<fpage>e0182071</fpage>.<pub-id pub-id-type="pmid">28753650</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B31">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hasan</surname><given-names>M</given-names></string-name>, <string-name><surname>Koch</surname><given-names>J</given-names></string-name>, <string-name><surname>Rakheja</surname><given-names>D</given-names></string-name></person-group><etal>et al</etal><article-title>Trex1 regulates lysosomal biogenesis and interferon-independent activation of antiviral genes</article-title>. <source>Nat Immunol</source><year>2013</year>;<volume>14</volume>:<fpage>61</fpage>–<lpage>71</lpage>.<pub-id pub-id-type="pmid">23160154</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B32">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>He</surname><given-names>Q</given-names></string-name>, <string-name><surname>Li</surname><given-names>Z.</given-names></string-name></person-group><article-title>The dysregulated expression and functional effect of CaMK2 in cancer</article-title>. <source>Cancer Cell Int</source><year>2021</year>;<volume>21</volume>:<fpage>326</fpage>.<pub-id pub-id-type="pmid">34193145</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B33">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hug</surname><given-names>H</given-names></string-name>, <string-name><surname>Mohajeri</surname><given-names>MH</given-names></string-name>, <string-name><surname>La Fata</surname><given-names>G.</given-names></string-name></person-group><article-title>Toll-Like receptors: regulators of the immune response in the human gut</article-title>. <source>Nutrients</source><year>2018</year>;<volume>10</volume>:<fpage>203</fpage>.<pub-id pub-id-type="pmid">29438282</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B34">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huynh-Thu</surname><given-names>VA</given-names></string-name>, <string-name><surname>Irrthum</surname><given-names>A</given-names></string-name>, <string-name><surname>Wehenkel</surname><given-names>L</given-names></string-name></person-group><etal>et al</etal><article-title>Inferring regulatory networks from expression data using tree-based methods</article-title>. <source>PLoS One</source><year>2010</year>;<volume>5</volume>:<fpage>203</fpage>.</mixed-citation>
    </ref>
    <ref id="vbae034-B35">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ideker</surname><given-names>T</given-names></string-name>, <string-name><surname>Krogan</surname><given-names>NJ.</given-names></string-name></person-group><article-title>Differential network biology</article-title>. <source>Mol Syst Biol</source><year>2012</year>;<volume>8</volume>:<fpage>565</fpage>.<pub-id pub-id-type="pmid">22252388</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B36">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ju</surname><given-names>G</given-names></string-name>, <string-name><surname>Yao</surname><given-names>Z</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>Y</given-names></string-name></person-group><etal>et al</etal><article-title>Data mining on identifying diagnosis and prognosis biomarkers in head and neck squamous carcinoma</article-title>. <source>Sci Rep</source><year>2023</year>;<volume>13</volume>:<fpage>10020</fpage>.<pub-id pub-id-type="pmid">37340028</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B37">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kang</surname><given-names>S</given-names></string-name>, <string-name><surname>Kim</surname><given-names>J</given-names></string-name>, <string-name><surname>Park</surname><given-names>A</given-names></string-name></person-group><etal>et al</etal><article-title>TRIM40 is a pathogenic driver of inflammatory bowel disease subverting intestinal barrier integrity</article-title>. <source>Nat Commun</source><year>2023</year>;<volume>14</volume>:<fpage>700</fpage>.<pub-id pub-id-type="pmid">36755029</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B38">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Karlebach</surname><given-names>G</given-names></string-name>, <string-name><surname>Shamir</surname><given-names>R.</given-names></string-name></person-group><article-title>Modelling and analysis of gene regulatory networks</article-title>. <source>Nat Rev Mol Cell Biol</source><year>2008</year>;<volume>9</volume>:<fpage>770</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">18797474</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B39">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kim</surname><given-names>S</given-names></string-name>, <string-name><surname>Lee</surname><given-names>Y</given-names></string-name>, <string-name><surname>Koo</surname><given-names>JS.</given-names></string-name></person-group><article-title>Differential expression of lipid metabolism-related proteins in different breast cancer subtypes</article-title>. <source>PLoS One</source><year>2015</year>;<volume>10</volume>:<fpage>e0119473</fpage>.<pub-id pub-id-type="pmid">25751270</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B40">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>King</surname><given-names>CR</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y</given-names></string-name>, <string-name><surname>Amato</surname><given-names>KA</given-names></string-name></person-group><etal>et al</etal><article-title>Pathogen-driven CRISPR screens identify TREX1 as a regulator of DNA self-sensing during influenza virus infection</article-title>. <source>Cell Host Microbe</source><year>2023</year>;<volume>31</volume>:<fpage>1552</fpage>–<lpage>67.e8</lpage>.<pub-id pub-id-type="pmid">37652009</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B41">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kuijjer</surname><given-names>ML</given-names></string-name>, <string-name><surname>Tung</surname><given-names>MG</given-names></string-name>, <string-name><surname>Yuan</surname><given-names>G</given-names></string-name></person-group><etal>et al</etal><article-title>Estimating Sample-Specific regulatory networks</article-title>. <source>iScience</source><year>2019</year>;<volume>14</volume>:<fpage>226</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="pmid">30981959</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B42">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kuleshov</surname><given-names>MV</given-names></string-name>, <string-name><surname>Jones</surname><given-names>MR</given-names></string-name>, <string-name><surname>Rouillard</surname><given-names>AD</given-names></string-name></person-group><etal>et al</etal><article-title>Enrichr: a comprehensive gene set enrichment analysis web server 2016 update</article-title>. <source>Nucleic Acids Res</source><year>2016</year>;<volume>44</volume>:<fpage>W90</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">27141961</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B43">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lambert</surname><given-names>SA</given-names></string-name>, <string-name><surname>Jolma</surname><given-names>A</given-names></string-name>, <string-name><surname>Campitelli</surname><given-names>LF</given-names></string-name></person-group><etal>et al</etal><article-title>The human transcription factors</article-title>. <source>Cell</source><year>2018</year>;<volume>175</volume>:<fpage>598</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">30290144</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B44">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname><given-names>J-E</given-names></string-name>, <string-name><surname>Schmidt</surname><given-names>H</given-names></string-name>, <string-name><surname>Lai</surname><given-names>B</given-names></string-name></person-group><etal>et al</etal><article-title>Transcriptional and epigenomic regulation of adipogenesis</article-title>. <source>Mol Cell Biol</source><year>2019</year>;<volume>39</volume>:<fpage>e00601-18</fpage>.<pub-id pub-id-type="pmid">30936246</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B45">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Levy</surname><given-names>G</given-names></string-name>, <string-name><surname>Guglielmelli</surname><given-names>P</given-names></string-name>, <string-name><surname>Langmuir</surname><given-names>P</given-names></string-name></person-group><etal>et al</etal><article-title>JAK inhibitors and COVID-19</article-title>. <source>J Immunother Cancer</source><year>2022</year>;<volume>10</volume>:<fpage>e002838</fpage>.<pub-id pub-id-type="pmid">35459733</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B46">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Chiu</surname><given-names>PK-F</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>Y</given-names></string-name></person-group><etal>et al</etal><article-title>Whole-exome sequencing reveals a comprehensive germline mutation landscape and identifies twelve novel predisposition genes in Chinese prostate cancer patients</article-title>. <source>PLoS Genet</source><year>2022</year>;<volume>18</volume>:<fpage>e1010373</fpage>.<pub-id pub-id-type="pmid">36095024</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B47">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lin</surname><given-names>Y</given-names></string-name>, <string-name><surname>Cai</surname><given-names>Q</given-names></string-name>, <string-name><surname>Luo</surname><given-names>Y</given-names></string-name></person-group><etal>et al</etal><article-title>Epithelial chemerin–CMKLR1 signaling restricts microbiota-driven colonic neutrophilia and tumorigenesis by up-regulating lactoperoxidase</article-title>. <source>Proc Natl Acad Sci USA</source><year>2022</year>;<volume>119</volume>:<fpage>e2205574119</fpage>.<pub-id pub-id-type="pmid">35858331</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B48">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Love</surname><given-names>MI</given-names></string-name>, <string-name><surname>Huber</surname><given-names>W</given-names></string-name>, <string-name><surname>Anders</surname><given-names>S.</given-names></string-name></person-group><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>. <source>Genome Biol</source><year>2014</year>;<volume>15</volume>:<fpage>550</fpage>.<pub-id pub-id-type="pmid">25516281</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B49">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lu</surname><given-names>Y</given-names></string-name>, <string-name><surname>Li</surname><given-names>X</given-names></string-name>, <string-name><surname>Liu</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>Toll-like receptors and inflammatory bowel disease</article-title>. <source>Front Immunol</source><year>2018</year>;<volume>9</volume>:<fpage>72</fpage>.<pub-id pub-id-type="pmid">29441063</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B50">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mandal</surname><given-names>P</given-names></string-name>, <string-name><surname>Feng</surname><given-names>Y</given-names></string-name>, <string-name><surname>Lyons</surname><given-names>JD</given-names></string-name></person-group><etal>et al</etal><article-title>Caspase-8 collaborates with caspase-11 to drive tissue damage and execution of endotoxic shock</article-title>. <source>Immunity</source><year>2018</year>;<volume>49</volume>:<fpage>42</fpage>–<lpage>55.e6</lpage>.<pub-id pub-id-type="pmid">30021146</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B51">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Marbach</surname><given-names>D</given-names></string-name>, <string-name><surname>Costello</surname><given-names>JC</given-names></string-name>, <string-name><surname>Küffner</surname><given-names>R</given-names></string-name></person-group><etal>et al</etal>; <collab>DREAM5 Consortium</collab>. <article-title>Wisdom of crowds for robust gene network inference</article-title>. <source>Nat. Methods</source><year>2012</year>;<volume>9</volume>:<fpage>796</fpage>–<lpage>804</lpage>.<pub-id pub-id-type="pmid">22796662</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B52">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Margolin</surname><given-names>AA</given-names></string-name>, <string-name><surname>Nemenman</surname><given-names>I</given-names></string-name>, <string-name><surname>Basso</surname><given-names>K</given-names></string-name></person-group><etal>et al</etal><article-title>ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context</article-title>. <source>BMC Bioinformatics</source><year>2006</year>;<volume>7</volume>:<fpage>S7</fpage>.</mixed-citation>
    </ref>
    <ref id="vbae034-B53">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Marino</surname><given-names>N</given-names></string-name>, <string-name><surname>German</surname><given-names>R</given-names></string-name>, <string-name><surname>Rao</surname><given-names>X</given-names></string-name></person-group><etal>et al</etal><article-title>Upregulation of lipid metabolism genes in the breast prior to cancer diagnosis</article-title>. <source>NPJ Breast Cancer</source><year>2020</year>;<volume>6</volume>:<fpage>50</fpage>.<pub-id pub-id-type="pmid">33083529</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B54">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Matschinske</surname><given-names>J</given-names></string-name>, <string-name><surname>Alcaraz</surname><given-names>N</given-names></string-name>, <string-name><surname>Benis</surname><given-names>A</given-names></string-name></person-group><etal>et al</etal><article-title>The AIMe registry for artificial intelligence in biomedical research</article-title>. <source>Nat Methods</source><year>2021</year>;<volume>18</volume>:<fpage>1128</fpage>–<lpage>31</lpage>.<pub-id pub-id-type="pmid">34433960</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B55">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Matulewicz</surname><given-names>N</given-names></string-name>, <string-name><surname>Stefanowicz</surname><given-names>M</given-names></string-name>, <string-name><surname>Nikolajuk</surname><given-names>A</given-names></string-name></person-group><etal>et al</etal><article-title>Markers of adipogenesis, but not inflammation, in adipose tissue are independently related to insulin sensitivity</article-title>. <source>J Clin Endocrinol Metab</source><year>2017</year>;<volume>102</volume>:<fpage>3040</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">28633482</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B56">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mears</surname><given-names>HV</given-names></string-name>, <string-name><surname>Sweeney</surname><given-names>TR.</given-names></string-name></person-group><article-title>Better together: the role of IFIT protein–protein interactions in the antiviral response</article-title>. <source>J Gen Virol</source><year>2018</year>;<volume>99</volume>:<fpage>1463</fpage>–<lpage>77</lpage>.<pub-id pub-id-type="pmid">30234477</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B57">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Meyer</surname><given-names>PE</given-names></string-name>, <string-name><surname>Lafitte</surname><given-names>F</given-names></string-name>, <string-name><surname>Bontempi</surname><given-names>G.</given-names></string-name></person-group><article-title>minet: a R/Bioconductor package for inferring large transcriptional networks using mutual information</article-title>. <source>BMC Bioinformatics</source><year>2008</year>;<volume>9</volume>:<fpage>461</fpage>.<pub-id pub-id-type="pmid">18959772</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B58">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mick</surname><given-names>E</given-names></string-name>, <string-name><surname>Kamm</surname><given-names>J</given-names></string-name>, <string-name><surname>Pisco</surname><given-names>AO</given-names></string-name></person-group><etal>et al</etal><article-title>Upper airway gene expression reveals suppressed immune responses to SARS-CoV-2 compared with other respiratory viruses</article-title>. <source>Nat Commun</source><year>2020</year>;<volume>11</volume>:<fpage>5854</fpage>.<pub-id pub-id-type="pmid">33203890</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B59">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Moerman</surname><given-names>T</given-names></string-name>, <string-name><surname>Aibar Santos</surname><given-names>S</given-names></string-name>, <string-name><surname>Bravo González-Blas</surname><given-names>C</given-names></string-name></person-group><etal>et al</etal><article-title>GRNBoost2 and arboreto: efficient and scalable inference of gene regulatory networks</article-title>. <source>Bioinformatics</source><year>2019</year>;<volume>35</volume>:<fpage>2159</fpage>–<lpage>61</lpage>.<pub-id pub-id-type="pmid">30445495</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B60">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mu</surname><given-names>J</given-names></string-name>, <string-name><surname>Fang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Yang</surname><given-names>Q</given-names></string-name></person-group><etal>et al</etal><article-title>SARS-CoV-2 N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2</article-title>. <source>Cell Discov</source><year>2020</year>;<volume>6</volume>:<fpage>65</fpage>.<pub-id pub-id-type="pmid">32953130</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B61">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nagy-Staron</surname><given-names>A</given-names></string-name>, <string-name><surname>Tomasek</surname><given-names>K</given-names></string-name>, <string-name><surname>Caruso Carter</surname><given-names>C</given-names></string-name></person-group><etal>et al</etal><article-title>Local genetic context shapes the function of a gene regulatory network</article-title>. <source>Elife</source><year>2021</year>;<volume>10</volume>:<fpage>e65993</fpage>.<pub-id pub-id-type="pmid">33683203</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B62">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nannapaneni</surname><given-names>P</given-names></string-name>, <string-name><surname>Hertwig</surname><given-names>F</given-names></string-name>, <string-name><surname>Depke</surname><given-names>M</given-names></string-name></person-group><etal>et al</etal><article-title>Defining the structure of the general stress regulon of <italic toggle="yes">Bacillus subtilis</italic> using targeted microarray analysis and random forest classification</article-title>. <source>Microbiology (Reading)</source><year>2012</year>;<volume>158</volume>:<fpage>696</fpage>–<lpage>707</lpage>.<pub-id pub-id-type="pmid">22174379</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B63">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nicolas</surname><given-names>P</given-names></string-name>, <string-name><surname>Mäder</surname><given-names>U</given-names></string-name>, <string-name><surname>Dervyn</surname><given-names>E</given-names></string-name></person-group><etal>et al</etal><article-title>Condition-dependent transcriptome reveals high-level regulatory architecture in <italic toggle="yes">Bacillus subtilis</italic></article-title>. <source>Science</source><year>2012</year>;<volume>335</volume>:<fpage>1103</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">22383849</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B64">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nielsen</surname><given-names>R</given-names></string-name>, <string-name><surname>Pedersen</surname><given-names>TA</given-names></string-name>, <string-name><surname>Hagenbeek</surname><given-names>D</given-names></string-name></person-group><etal>et al</etal><article-title>Genome-wide profiling of PPARgamma: RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis</article-title>. <source>Genes Dev</source><year>2008</year>;<volume>22</volume>:<fpage>2953</fpage>–<lpage>67</lpage>.<pub-id pub-id-type="pmid">18981474</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B65">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nieminen</surname><given-names>JK</given-names></string-name>, <string-name><surname>Niemi</surname><given-names>M</given-names></string-name>, <string-name><surname>Sipponen</surname><given-names>T</given-names></string-name></person-group><etal>et al</etal><article-title>Dendritic cells from Crohn’s disease patients show aberrant STAT1 and STAT3 signaling</article-title>. <source>PLoS One</source><year>2013</year>;<volume>8</volume>:<fpage>e70738</fpage>.<pub-id pub-id-type="pmid">23950992</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B66">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Noguchi</surname><given-names>K</given-names></string-name>, <string-name><surname>Okumura</surname><given-names>F</given-names></string-name>, <string-name><surname>Takahashi</surname><given-names>N</given-names></string-name></person-group><etal>et al</etal><article-title>TRIM40 promotes neddylation of IKK<inline-formula id="IE91"><mml:math id="IM91" display="inline" overflow="scroll"><mml:mo>γ</mml:mo></mml:math></inline-formula> and is downregulated in gastrointestinal cancers</article-title>. <source>Carcinogenesis</source><year>2011</year>;<volume>32</volume>:<fpage>995</fpage>–<lpage>1004</lpage>.<pub-id pub-id-type="pmid">21474709</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B67">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Palmer</surname><given-names>NP</given-names></string-name>, <string-name><surname>Silvester</surname><given-names>JA</given-names></string-name>, <string-name><surname>Lee</surname><given-names>JJ</given-names></string-name></person-group><etal>et al</etal><article-title>Concordance between gene expression in peripheral whole blood and colonic tissue in children with inflammatory bowel disease</article-title>. <source>PLoS One</source><year>2019</year>;<volume>14</volume>:<fpage>e0222952</fpage>.<pub-id pub-id-type="pmid">31618209</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B68">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ritchie</surname><given-names>ME</given-names></string-name>, <string-name><surname>Phipson</surname><given-names>B</given-names></string-name>, <string-name><surname>Wu</surname><given-names>D</given-names></string-name></person-group><etal>et al</etal><article-title>limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title>. <source>Nucleic Acids Res</source><year>2015</year>;<volume>43</volume>:<fpage>e47</fpage>.<pub-id pub-id-type="pmid">25605792</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B69">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rokhlin</surname><given-names>OW</given-names></string-name>, <string-name><surname>Taghiyev</surname><given-names>AF</given-names></string-name>, <string-name><surname>Bayer</surname><given-names>KU</given-names></string-name></person-group><etal>et al</etal><article-title>Calcium/calmodulin-dependent kinase II plays an important role in prostate cancer cell survival</article-title>. <source>Cancer Biol Ther</source><year>2007</year>;<volume>6</volume>:<fpage>732</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="pmid">17387273</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B70">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Saez</surname><given-names>E</given-names></string-name>, <string-name><surname>Rosenfeld</surname><given-names>J</given-names></string-name>, <string-name><surname>Livolsi</surname><given-names>A</given-names></string-name></person-group><etal>et al</etal><article-title>PPAR gamma signaling exacerbates mammary gland tumor development</article-title>. <source>Genes Dev</source><year>2004</year>;<volume>18</volume>:<fpage>528</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="pmid">15037548</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B71">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schmitt</surname><given-names>H</given-names></string-name>, <string-name><surname>Neurath</surname><given-names>MF</given-names></string-name>, <string-name><surname>Atreya</surname><given-names>R.</given-names></string-name></person-group><article-title>Role of the IL23/IL17 pathway in Crohn’s disease</article-title>. <source>Front Immunol</source><year>2021</year>;<volume>12</volume>:<fpage>622934</fpage>.<pub-id pub-id-type="pmid">33859636</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B72">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schönrock</surname><given-names>A</given-names></string-name>, <string-name><surname>Heinzelmann</surname><given-names>E</given-names></string-name>, <string-name><surname>Steffl</surname><given-names>B</given-names></string-name></person-group><etal>et al</etal><article-title>MEOX2 homeobox gene promotes growth of malignant gliomas</article-title>. <source>Neuro Oncol</source><year>2022</year>;<volume>24</volume>:<fpage>1911</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">35468210</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B73">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shojaie</surname><given-names>A.</given-names></string-name></person-group><article-title>Differential network analysis: a statistical perspective</article-title>. <source>Wiley Interdiscip Rev Comput Stat</source><year>2021</year>;<volume>13</volume>:<fpage>e1508</fpage>.<pub-id pub-id-type="pmid">37050915</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B74">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Singh</surname><given-names>DK</given-names></string-name>, <string-name><surname>Aladyeva</surname><given-names>E</given-names></string-name>, <string-name><surname>Das</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>Myeloid cell interferon responses correlate with clearance of SARS-CoV-2</article-title>. <source>Nat Commun</source><year>2022</year>;<volume>13</volume>:<fpage>679</fpage>.<pub-id pub-id-type="pmid">35115549</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B75">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stetson</surname><given-names>DB</given-names></string-name>, <string-name><surname>Ko</surname><given-names>JS</given-names></string-name>, <string-name><surname>Heidmann</surname><given-names>T</given-names></string-name></person-group><etal>et al</etal><article-title>Trex1 prevents cell-intrinsic initiation of autoimmunity</article-title>. <source>Cell</source><year>2008</year>;<volume>134</volume>:<fpage>587</fpage>–<lpage>98</lpage>.<pub-id pub-id-type="pmid">18724932</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B76">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Subramanian</surname><given-names>A</given-names></string-name>, <string-name><surname>Tamayo</surname><given-names>P</given-names></string-name>, <string-name><surname>Mootha</surname><given-names>VK</given-names></string-name></person-group><etal>et al</etal><article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title>. <source>Proc Natl Acad Sci USA</source><year>2005</year>;<volume>102</volume>:<fpage>15545</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">16199517</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B77">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sun</surname><given-names>J</given-names></string-name>, <string-name><surname>Li</surname><given-names>S</given-names></string-name>, <string-name><surname>Wang</surname><given-names>F</given-names></string-name></person-group><etal>et al</etal><article-title>Identification of key pathways and genes in PTEN mutation prostate cancer by bioinformatics analysis</article-title>. <source>BMC Med Genet</source><year>2019</year>;<volume>20</volume>:<fpage>191</fpage>.<pub-id pub-id-type="pmid">31791268</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B78">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tanaka</surname><given-names>Y</given-names></string-name>, <string-name><surname>Tamada</surname><given-names>Y</given-names></string-name>, <string-name><surname>Ikeguchi</surname><given-names>M</given-names></string-name></person-group><etal>et al</etal><article-title>System-based differential gene network analysis for characterizing a sample-specific subnetwork</article-title>. <source>Biomolecules</source><year>2020</year>;<volume>10</volume>:<fpage>306</fpage>.<pub-id pub-id-type="pmid">32075209</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B79">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tang</surname><given-names>K</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>L</given-names></string-name>, <string-name><surname>Chen</surname><given-names>J</given-names></string-name></person-group><etal>et al</etal><article-title>Hypoxia promotes breast cancer cell growth by activating a glycogen metabolic program</article-title>. <source>Cancer Res</source><year>2021</year>;<volume>81</volume>:<fpage>4949</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="pmid">34348966</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B80">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tesson</surname><given-names>BM</given-names></string-name>, <string-name><surname>Breitling</surname><given-names>R</given-names></string-name>, <string-name><surname>Jansen</surname><given-names>RC.</given-names></string-name></person-group><article-title>DiffCoEx: a simple and sensitive method to find differentially coexpressed gene modules</article-title>. <source>BMC Bioinformatics</source><year>2010</year>;<volume>11</volume>:<fpage>497</fpage>.<pub-id pub-id-type="pmid">20925918</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B81">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tu</surname><given-names>J-J</given-names></string-name>, <string-name><surname>Ou-Yang</surname><given-names>L</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>Y</given-names></string-name></person-group><etal>et al</etal><article-title>Differential network analysis by simultaneously considering changes in gene interactions and gene expression</article-title>. <source>Bioinformatics</source><year>2021</year>;<volume>37</volume>:<fpage>4414</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="pmid">34245246</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B82">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Van de Sande</surname><given-names>B</given-names></string-name>, <string-name><surname>Flerin</surname><given-names>C</given-names></string-name>, <string-name><surname>Davie</surname><given-names>K</given-names></string-name></person-group><etal>et al</etal><article-title>A scalable SCENIC workflow for single-cell gene regulatory network analysis</article-title>. <source>Nat Protoc</source><year>2020</year>;<volume>15</volume>:<fpage>2247</fpage>–<lpage>76</lpage>.<pub-id pub-id-type="pmid">32561888</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B83">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>H</given-names></string-name>, <string-name><surname>Tang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Yang</surname><given-names>X</given-names></string-name></person-group><etal>et al</etal><article-title>A crucial angiogenesis-associated gene meox2 could be a promising biomarker candidate for breast cancer</article-title>. <source>Front Oncol</source><year>2022</year>;<volume>12</volume>:<fpage>759300</fpage>.<pub-id pub-id-type="pmid">35615155</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B84">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>X</given-names></string-name>, <string-name><surname>Wang</surname><given-names>G</given-names></string-name>, <string-name><surname>Shi</surname><given-names>Y</given-names></string-name></person-group><etal>et al</etal><article-title>PPAR-Delta promotes survival of breast cancer cells in harsh metabolic conditions</article-title>. <source>Oncogenesis</source><year>2016</year>;<volume>5</volume>:<fpage>e232</fpage>.<pub-id pub-id-type="pmid">27270614</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B85">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Weintraub</surname><given-names>Y</given-names></string-name>, <string-name><surname>Cohen</surname><given-names>S</given-names></string-name>, <string-name><surname>Chapnik</surname><given-names>N</given-names></string-name></person-group><etal>et al</etal><article-title>Clock gene disruption is an initial manifestation of inflammatory bowel diseases</article-title>. <source>Clin Gastroenterol Hepatol</source><year>2020</year>;<volume>18</volume>:<fpage>115</fpage>–<lpage>22.e1</lpage>.<pub-id pub-id-type="pmid">30981000</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B86">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yamada</surname><given-names>T</given-names></string-name>, <string-name><surname>Sato</surname><given-names>S</given-names></string-name>, <string-name><surname>Sotoyama</surname><given-names>Y</given-names></string-name></person-group><etal>et al</etal><article-title>RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells</article-title>. <source>Nat Immunol</source><year>2021</year>;<volume>22</volume>:<fpage>820</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">33976430</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B87">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yu</surname><given-names>X</given-names></string-name>, <string-name><surname>Zeng</surname><given-names>T</given-names></string-name>, <string-name><surname>Wang</surname><given-names>X</given-names></string-name></person-group><etal>et al</etal><article-title>Unravelling personalized dysfunctional gene network of complex diseases based on differential network model</article-title>. <source>J Transl Med</source><year>2015</year>;<volume>13</volume>:<fpage>189</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="pmid">26070628</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B88">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zaidi</surname><given-names>D</given-names></string-name>, <string-name><surname>Wine</surname><given-names>E.</given-names></string-name></person-group><article-title>Regulation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-<inline-formula id="IE92"><mml:math id="IM92" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula><inline-formula id="IE93"><mml:math id="IM93" display="inline" overflow="scroll"><mml:mo>β</mml:mo></mml:math></inline-formula>) in inflammatory bowel diseases</article-title>. <source>Front Pediatrics</source><year>2018</year>;<volume>6</volume>:<fpage>317</fpage>.</mixed-citation>
    </ref>
    <ref id="vbae034-B89">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zeng</surname><given-names>G</given-names></string-name>, <string-name><surname>Liu</surname><given-names>X</given-names></string-name>, <string-name><surname>Su</surname><given-names>X</given-names></string-name></person-group><etal>et al</etal><article-title>The role of MEOX1 in non-neoplastic and neoplastic diseases</article-title>. <source>Biomed Pharmacother</source><year>2023</year>;<volume>158</volume>:<fpage>114068</fpage>.<pub-id pub-id-type="pmid">36495659</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B90">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>J</given-names></string-name>, <string-name><surname>Ji</surname><given-names>Y</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>L.</given-names></string-name></person-group><article-title>Extracting three-way gene interactions from microarray data</article-title>. <source>Bioinformatics</source><year>2007</year>;<volume>23</volume>:<fpage>2903</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">17921496</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B91">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>X</given-names></string-name>, <string-name><surname>Su</surname><given-names>L</given-names></string-name>, <string-name><surname>Sun</surname><given-names>K.</given-names></string-name></person-group><article-title>Expression status and prognostic value of the perilipin family of genes in breast cancer</article-title>. <source>Am J Transl Res</source><year>2021</year>;<volume>13</volume>:<fpage>4450</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="pmid">34150026</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B92">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhou</surname><given-names>Z</given-names></string-name>, <string-name><surname>Ren</surname><given-names>L</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>L</given-names></string-name></person-group><etal>et al</etal><article-title>Heightened innate immune responses in the respiratory tract of COVID-19 patients</article-title>. <source>Cell Host Microbe</source><year>2020</year>;<volume>27</volume>:<fpage>883</fpage>–<lpage>90.e2</lpage>.<pub-id pub-id-type="pmid">32407669</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinform Adv</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinform Adv</journal-id>
    <journal-id journal-id-type="publisher-id">bioadv</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics Advances</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2635-0041</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10948285</article-id>
    <article-id pub-id-type="doi">10.1093/bioadv/vbae034</article-id>
    <article-id pub-id-type="publisher-id">vbae034</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Original Article</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Gene Regulation</subject>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Inference of differential gene regulatory networks using boosted differential trees</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3980-938X</contrib-id>
        <name>
          <surname>Galindez</surname>
          <given-names>Gihanna</given-names>
        </name>
        <aff><institution>Division Data Science in Biomedicine, Peter L. Reichertz Institute for Medical Informatics of Technische Universität Braunschweig and Hannover Medical School</institution>, Braunschweig, 38106, <country country="DE">Germany</country></aff>
        <aff><institution>Braunschweig Integrated Centre of Systems Biology (BRICS), TU Braunschweig</institution>, Braunschweig, 38106, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0941-4168</contrib-id>
        <name>
          <surname>List</surname>
          <given-names>Markus</given-names>
        </name>
        <aff><institution>Experimental Bioinformatics, TUM School of Life Sciences, Technical University of Munich</institution>, Munich, 85354, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0282-0462</contrib-id>
        <name>
          <surname>Baumbach</surname>
          <given-names>Jan</given-names>
        </name>
        <aff><institution>Institute for Computational Systems Biology, University of Hamburg</institution>, Hamburg, 22607, <country country="DE">Germany</country></aff>
        <aff><institution>Computational Biomedicine Lab, Department of Mathematics and Computer Science, University of Southern Denmark</institution>, Odense, 5230, <country country="DK">Denmark</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5689-3448</contrib-id>
        <name>
          <surname>Völker</surname>
          <given-names>Uwe</given-names>
        </name>
        <aff><institution>Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald</institution>, Greifswald, 17475, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Mäder</surname>
          <given-names>Ulrike</given-names>
        </name>
        <aff><institution>Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald</institution>, Greifswald, 17475, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8651-750X</contrib-id>
        <name>
          <surname>Blumenthal</surname>
          <given-names>David B</given-names>
        </name>
        <aff><institution>Biomedical Network Science Lab, Department of Artificial Intelligence in Biomedical Engineering, Friedrich-Alexander-Universität Erlangen-Nürnberg</institution>, Erlangen, 91052, <country country="DE">Germany</country></aff>
        <xref rid="vbae034-FM1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5393-2413</contrib-id>
        <name>
          <surname>Kacprowski</surname>
          <given-names>Tim</given-names>
        </name>
        <aff><institution>Division Data Science in Biomedicine, Peter L. Reichertz Institute for Medical Informatics of Technische Universität Braunschweig and Hannover Medical School</institution>, Braunschweig, 38106, <country country="DE">Germany</country></aff>
        <aff><institution>Braunschweig Integrated Centre of Systems Biology (BRICS), TU Braunschweig</institution>, Braunschweig, 38106, <country country="DE">Germany</country></aff>
        <xref rid="vbae034-FM1" ref-type="author-notes"/>
        <xref rid="vbae034-cor1" ref-type="corresp"/>
        <!--t.kacprowski@tu-braunschweig.de-->
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Yamanishi</surname>
          <given-names>Yoshihiro</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="vbae034-cor1">Corresponding author. Division Data Science in Biomedicine, Peter L. Reichertz Institute for Medical Informatics of Technische Universität Braunschweig and Hannover Medical School, Braunschweig, 38106, Germany. E-mail: <email>t.kacprowski@tu-braunschweig.de</email></corresp>
      <fn id="vbae034-FM1">
        <p>David B Blumenthal and Tim Kacprowski Equal contribution.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="collection">
      <year>2024</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2024-02-29">
      <day>29</day>
      <month>2</month>
      <year>2024</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>29</day>
      <month>2</month>
      <year>2024</year>
    </pub-date>
    <volume>4</volume>
    <issue>1</issue>
    <elocation-id>vbae034</elocation-id>
    <history>
      <date date-type="received">
        <day>29</day>
        <month>8</month>
        <year>2023</year>
      </date>
      <date date-type="rev-recd">
        <day>24</day>
        <month>1</month>
        <year>2024</year>
      </date>
      <date date-type="editorial-decision">
        <day>19</day>
        <month>2</month>
        <year>2024</year>
      </date>
      <date date-type="accepted">
        <day>27</day>
        <month>2</month>
        <year>2024</year>
      </date>
      <date date-type="corrected-typeset">
        <day>18</day>
        <month>3</month>
        <year>2024</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2024. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2024</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="vbae034.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Summary</title>
        <p>Diseases can be caused by molecular perturbations that induce specific changes in regulatory interactions and their coordinated expression, also referred to as network rewiring. However, the detection of complex changes in regulatory connections remains a challenging task and would benefit from the development of novel nonparametric approaches. We develop a new ensemble method called BoostDiff (boosted differential regression trees) to infer a differential network discriminating between two conditions. BoostDiff builds an adaptively boosted (AdaBoost) ensemble of differential trees with respect to a target condition. To build the differential trees, we propose differential variance improvement as a novel splitting criterion. Variable importance measures derived from the resulting models are used to reflect changes in gene expression predictability and to build the output differential networks. BoostDiff outperforms existing differential network methods on simulated data evaluated in four different complexity settings. We then demonstrate the power of our approach when applied to real transcriptomics data in COVID-19, Crohn’s disease, breast cancer, prostate adenocarcinoma, and stress response in <italic toggle="yes">Bacillus subtilis</italic>. BoostDiff identifies context-specific networks that are enriched with genes of known disease-relevant pathways and complements standard differential expression analyses.</p>
      </sec>
      <sec id="s2">
        <title>Availability and implementation</title>
        <p>BoostDiff is available at <ext-link xlink:href="https://github.com/scibiome/boostdiff_inference" ext-link-type="uri">https://github.com/scibiome/boostdiff_inference</ext-link>.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>German Federal Ministry of Education and Research</institution>
          </institution-wrap>
        </funding-source>
        <award-id>031L0309A</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="20"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>Gene regulation is a fundamental biological process that underlies various cellular functions, including developmental, environmental, and disease contexts. The regulatory relationships in a biological sample can be represented by gene regulatory networks (GRNs), where two gene nodes with a regulatory relationship are connected by an edge (<xref rid="vbae034-B38" ref-type="bibr">Karlebach and Shamir 2008</xref>). GRN inference remains a challenging task because of the inherent complexity of transcriptional regulation, as well as the high dimensionality and noise in biological datasets. Furthermore, GRNs are dynamic and context-specific (<xref rid="vbae034-B35" ref-type="bibr">Ideker and Krogan 2012</xref>, <xref rid="vbae034-B61" ref-type="bibr">Nagy-Staron <italic toggle="yes">et al.</italic> 2021</xref>), i.e. some regulatory processes are active only in certain cell types, tissues, conditions, or in response to specific stimuli. Changes in these pairwise dependencies have been associated with the development of complex diseases (<xref rid="vbae034-B19" ref-type="bibr">de la Fuente 2010</xref>). Differential network analysis, which aims to detect altered connectivity between different conditions or disease states, has recently emerged as a powerful complement to standard differential expression (DE) analysis and is more suitable for detecting context-specific GRNs (<xref rid="vbae034-B19" ref-type="bibr">de la Fuente 2010</xref>, <xref rid="vbae034-B51" ref-type="bibr">Marbach <italic toggle="yes">et al.</italic> 2012</xref>). Exploring how GRN structures are rewired between two different states can reveal molecular mechanisms that drive disease development and progression and identify more relevant therapeutic targets.</p>
    <p>Various approaches for deriving differential networks have been the focus of recent studies (<xref rid="vbae034-B7" ref-type="bibr">Bhuva <italic toggle="yes">et al.</italic> 2019</xref>, <xref rid="vbae034-B4" ref-type="bibr">Basha <italic toggle="yes">et al.</italic> 2020</xref>, <xref rid="vbae034-B5" ref-type="bibr">Baur <italic toggle="yes">et al.</italic> 2020</xref>). Representative methods are shown in <xref rid="vbae034-T1" ref-type="table">Table 1</xref>. The <italic toggle="yes">z</italic>-score method performs Fisher transformation of Pearson’s correlation coefficients between two conditions. The resulting <italic toggle="yes">z</italic>-scores are modeled as a normal distribution, followed by a <italic toggle="yes">z</italic>-test to detect significant pairwise edges (<xref rid="vbae034-B90" ref-type="bibr">Zhang <italic toggle="yes">et al.</italic> 2007</xref>). Diffcoex, a framework based on weighted gene co-expression analysis (WGGNA), first builds a correlation matrix for each condition being compared and then calculates their difference. From the difference matrix, a dissimilarity matrix is calculated based on a topological overlap measure and hierarchical clustering is applied to find the differentially co-expressed gene clusters (<xref rid="vbae034-B80" ref-type="bibr">Tesson <italic toggle="yes">et al.</italic> 2010</xref>). Another approach, a Gaussian graphical model (GGM)-based method, learns the differential network from conditional associations (<xref rid="vbae034-B14" ref-type="bibr">Chu <italic toggle="yes">et al.</italic> 2011</xref>). EBcoexpress relies on empirical Bayes’ estimation to calculate the posterior probability that an edge is differentially co-expressed (<xref rid="vbae034-B16" ref-type="bibr">Dawson and Kendziorski 2012</xref>, <xref rid="vbae034-B17" ref-type="bibr">Dawson <italic toggle="yes">et al.</italic> 2012</xref>).</p>
    <table-wrap position="float" id="vbae034-T1">
      <label>Table 1.</label>
      <caption>
        <p>Overview of methods used to derive differential networks and patient-specific networks.<xref rid="tblfn1" ref-type="table-fn"><sup>a</sup></xref></p>
      </caption>
      <table frame="hsides" rules="groups">
        <colgroup span="1">
          <col valign="top" align="left" span="1"/>
          <col valign="top" align="left" span="1"/>
          <col valign="top" align="left" span="1"/>
          <col valign="top" align="left" span="1"/>
          <col valign="top" align="left" span="1"/>
          <col valign="top" align="left" span="1"/>
          <col valign="top" align="left" span="1"/>
        </colgroup>
        <thead>
          <tr>
            <th rowspan="1" colspan="1">Method</th>
            <th rowspan="1" colspan="1">Algorithmic approach</th>
            <th rowspan="1" colspan="1">Test</th>
            <th rowspan="1" colspan="1">Directionality</th>
            <th rowspan="1" colspan="1">No. of conditions</th>
            <th rowspan="1" colspan="1">Network type</th>
            <th rowspan="1" colspan="1">Reference</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td rowspan="1" colspan="1">BoostDiff</td>
            <td rowspan="1" colspan="1">Tree-based</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">Two</td>
            <td rowspan="1" colspan="1">Differential network</td>
            <td rowspan="1" colspan="1">This paper</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"><italic toggle="yes">z</italic>-score</td>
            <td rowspan="1" colspan="1">Correlation-based</td>
            <td rowspan="1" colspan="1"><italic toggle="yes">z</italic>-test</td>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1">Two</td>
            <td rowspan="1" colspan="1">Differential network</td>
            <td rowspan="1" colspan="1">
              <xref rid="vbae034-B90" ref-type="bibr">Zhang <italic toggle="yes">et al</italic>. (2007)</xref>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">EBcoexpress</td>
            <td rowspan="1" colspan="1">Empirical Bayes; correlation</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1">Multiple</td>
            <td rowspan="1" colspan="1">Differential network</td>
            <td rowspan="1" colspan="1">
              <xref rid="vbae034-B16" ref-type="bibr">Dawson and Kendziorski, (2012)</xref>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Diffcoex</td>
            <td rowspan="1" colspan="1">Correlation-based</td>
            <td rowspan="1" colspan="1">Permutation test</td>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1">Multiple</td>
            <td rowspan="1" colspan="1">Differential network</td>
            <td rowspan="1" colspan="1">
              <xref rid="vbae034-B80" ref-type="bibr">Tesson <italic toggle="yes">et al</italic>. (2010)</xref>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">GGM-based</td>
            <td rowspan="1" colspan="1">GGM; posterior odds</td>
            <td rowspan="1" colspan="1">Permutation test</td>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1">Two</td>
            <td rowspan="1" colspan="1">Differential network</td>
            <td rowspan="1" colspan="1">
              <xref rid="vbae034-B14" ref-type="bibr">Chu <italic toggle="yes">et al</italic>. (2011)</xref>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">chNet</td>
            <td rowspan="1" colspan="1">GGM; differential expression</td>
            <td rowspan="1" colspan="1">t-test</td>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1">Two</td>
            <td rowspan="1" colspan="1">Differential network</td>
            <td rowspan="1" colspan="1">
              <xref rid="vbae034-B81" ref-type="bibr">Tu <italic toggle="yes">et al</italic>. (2021)</xref>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">LIONESS</td>
            <td rowspan="1" colspan="1">Linear interpolation</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Patient-specific</td>
            <td rowspan="1" colspan="1">
              <xref rid="vbae034-B41" ref-type="bibr">Kuijjer <italic toggle="yes">et al</italic>. (2019)</xref>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <xref rid="vbae034-B78" ref-type="bibr">Tanaka <italic toggle="yes">et al.</italic> (2020)</xref>
            </td>
            <td rowspan="1" colspan="1">Nonparametric Bayesian network; <inline-formula id="IE1"><mml:math id="IM1" display="inline" overflow="scroll"><mml:mo>Δ</mml:mo></mml:math></inline-formula> Edge contribution value</td>
            <td rowspan="1" colspan="1"><italic toggle="yes">t</italic>-test</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Patient-specific</td>
            <td rowspan="1" colspan="1">
              <xref rid="vbae034-B78" ref-type="bibr">Tanaka <italic toggle="yes">et al</italic>. (2020)</xref>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">DEVC-net</td>
            <td rowspan="1" colspan="1">Differential expression variance covariance (DEVC)</td>
            <td rowspan="1" colspan="1"><italic toggle="yes">t</italic>-test; Wilcoxon rank sum test</td>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1">Two</td>
            <td rowspan="1" colspan="1">Differential network; patient-specific</td>
            <td rowspan="1" colspan="1">
              <xref rid="vbae034-B87" ref-type="bibr">Yu <italic toggle="yes">et al.</italic> (2015)</xref>
            </td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tblfn1">
          <label>a</label>
          <p>Adapted from <xref rid="vbae034-B7" ref-type="bibr">Bhuva <italic toggle="yes">et al</italic>. (2019)</xref>.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <p>The differential network methods described above measure linear relationships or rely on joint normality assumptions, which may not hold in practice (<xref rid="vbae034-B73" ref-type="bibr">Shojaie 2021</xref>). Nonlinear regulatory dependencies are common mechanisms that occur in biology (<xref rid="vbae034-B10" ref-type="bibr">Brunel <italic toggle="yes">et al.</italic> 2010</xref>, <xref rid="vbae034-B15" ref-type="bibr">Costello <italic toggle="yes">et al.</italic> 2014</xref>) and these complex relationships from real datasets may be difficult to detect using correlation- or GGM-based methods. As discussed in a recent review, new methods for differential network analysis for non-Gaussian data are needed (<xref rid="vbae034-B73" ref-type="bibr">Shojaie 2021</xref>). Some methods for inferring patient-specific networks have also been developed. To measure the sample-specific edge contributions, DEVC-net (<xref rid="vbae034-B87" ref-type="bibr">Yu <italic toggle="yes">et al.</italic> 2015</xref>) uses a method that calculates an integrated score called DEVC that considers the differential expression of a gene, differential expression variance of a gene, and covariance of gene pairs. This method uses a template network to identify differential network features from gene expression data and can be used to obtain sample-specific networks. Linear Interpolation to Obtain Network Estimates for Single Samples (LIONESS) reverse engineers sample-specific networks from an aggregate network by applying linear interpolation on the edge weights from the aggregate networks (<xref rid="vbae034-B41" ref-type="bibr">Kuijjer <italic toggle="yes">et al.</italic> 2019</xref>). This approach can be used in combination with existing network inference methods to also capture nonlinear dependencies. <xref rid="vbae034-B78" ref-type="bibr">Tanaka <italic toggle="yes">et al.</italic> (2020)</xref> infer nonparametric Bayesian networks using B-spline regression. From the model parameters, the method derives a value representing the contribution of each edge to the expression in a particular sample, called the edge contribution value (ECv). The absolute differences in ECvs (<inline-formula id="IE2"><mml:math id="IM2" display="inline" overflow="scroll"><mml:mo>Δ</mml:mo></mml:math></inline-formula>ECv) between certain samples are then used to build sample-specific networks. An alternative to the abovementioned approaches are tree-based strategies, which offer the advantage of more relaxed model assumptions. While examples such as GENIE3 and derived tools continue to be successfully applied in various biological settings (<xref rid="vbae034-B34" ref-type="bibr">Huynh-Thu <italic toggle="yes">et al.</italic> 2010</xref>, <xref rid="vbae034-B59" ref-type="bibr">Moerman <italic toggle="yes">et al.</italic> 2019</xref>, <xref rid="vbae034-B82" ref-type="bibr">Van de Sande <italic toggle="yes">et al.</italic> 2020</xref>), they cannot be used to directly compare two different biological conditions.</p>
    <p>We introduce BoostDiff, a nonparametric tree-based approach for reconstructing directed differential networks (<xref rid="vbae034-F1" ref-type="fig">Fig. 1</xref>). The main component of BoostDiff is the differential tree, a modified version of the standard regression tree that can be used to identify gene pairs exhibiting changes in regulatory dependencies between two biological conditions. To build the differential trees, we use a novel splitting criterion called the differential variance improvement (DVI), which measures the difference in predictive value of a feature on the gene expression levels between two conditions. We demonstrate that boosting the differential trees with respect to samples belonging to a specific target condition is an important step for promoting condition specificity of the output networks. Tree-based variable importance measures are then calculated to obtain a ranking of regulators and to derive the differential network. Using simulated gene expression data, we evaluate the performance of BoostDiff in comparison to baseline methods and existing differential network tools. We further apply BoostDiff to multiple transcriptomics datasets, including COVID-19, Crohn’s disease, prostate adenocarcinoma, and breast cancer data, as well as stress response data in the bacterium <italic toggle="yes">Bacillus subtilis</italic>.</p>
    <fig position="float" id="vbae034-F1">
      <label>Figure 1.</label>
      <caption>
        <p>Overview of the BoostDiff algorithm. As input, we require two gene expression matrices corresponding to a target condition (e.g. disease) and a baseline condition (e.g. control). For each of p total genes, a learning subsample (LS) is drawn from the two datasets, after which an AdaBoost ensemble of differential trees is built to identify the features that are more predictive of the gene expression levels in the target condition. By setting a target condition, BoostDiff can be used to identify regulatory relationships that are more pronounced in condition A (e.g. disease state) and condition B (e.g. control/healthy), thereby providing a differential network capturing context-specific regulatory changes. In the overall workflow, the BoostDiff algorithm is run twice, once with condition A as target condition and subsequently with B as target condition. The results are then combined to obtain the final differential network. Most notably, while existing approaches aim for the reconstruction of whole genome-scale GRNs, BoostDiff concentrates on maximizing the precision for those parts of the regulatory network that actually characterize the difference between the two phenotypes.</p>
      </caption>
      <graphic xlink:href="vbae034f1" position="float"/>
    </fig>
  </sec>
  <sec>
    <title>2 Methods</title>
    <sec>
      <title>2.1 Overview of the differential network inference approach</title>
      <p>The overall strategy of BoostDiff is inspired by the popular network inference tool GENIE3 (<xref rid="vbae034-B34" ref-type="bibr">Huynh-Thu <italic toggle="yes">et al.</italic> 2010</xref>). GENIE3 aims to reconstruct a network using as input a gene expression matrix derived from a single biological condition. For this, GENIE3 fits an ensemble of regression trees, using the expression levels of the target genes as the output variable and the expression levels of potential regulators as the features. The splitting criterion for a node in the regression tree is the reduction
<disp-formula id="E1"><mml:math id="M1" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mo>|</mml:mo><mml:mi>S</mml:mi><mml:mo>|</mml:mo><mml:mo>·</mml:mo><mml:mtext>Var</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mi>S</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo> </mml:mo><mml:mo>−</mml:mo><mml:mo> </mml:mo><mml:mo>|</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>L</mml:mi></mml:msub></mml:mrow><mml:mo>|</mml:mo><mml:mo>·</mml:mo><mml:mtext>Var</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>L</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo> </mml:mo><mml:mo>−</mml:mo><mml:mo> </mml:mo><mml:mo>|</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>R</mml:mi></mml:msub></mml:mrow><mml:mo>|</mml:mo><mml:mo>·</mml:mo><mml:mtext>Var</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>R</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula>
in variance (impurity) of the target gene’s expression caused by the split. Here, <italic toggle="yes">S</italic> denotes the set of samples that reach a node to be split, <inline-formula id="IE3"><mml:math id="IM3" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>L</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula id="IE4"><mml:math id="IM4" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>R</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> are the subsets of samples in the left and right branches of the split, respectively, and <inline-formula id="IE5"><mml:math id="IM5" display="inline" overflow="scroll"><mml:mrow><mml:mtext>Var</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> is the variance of the output variable in a set of samples <inline-formula id="IE6"><mml:math id="IM6" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>∈</mml:mo><mml:mo>{</mml:mo><mml:mi>S</mml:mi><mml:mo>,</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>L</mml:mi></mml:msub></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>R</mml:mi></mml:msub></mml:mrow><mml:mo>}</mml:mo></mml:mrow></mml:math></inline-formula>. The importance of one variable in a single regression tree is calculated by summing up the reductions in variance of all tree nodes where this variable is used as a splitting feature. The overall importance of a feature in the ensemble is then averaged across all trees. One ensemble model is learned for each target gene in the dataset. The tree-based feature importances based on variance reduction are interpreted as edge weights of candidate regulator-target gene links. A high edge weight indicates that a regulator has a large contribution in predicting the expression level of a target gene. The edges with the highest weights are returned as the inferred GRN. Biologically, the top-ranked edges inferred by GENIE3 represent the relationships that are dominant in the condition of interest.</p>
      <p>Similarly, the differential network inference problem can be decomposed into <italic toggle="yes">p</italic> independent regression subproblems, where <italic toggle="yes">p</italic> is the total number of genes in the expression data. Our strategy assumes that, in a given biological context, the expression level of a gene can be modeled as a function of the expression levels of other genes (<xref rid="vbae034-F1" ref-type="fig">Fig. 1</xref>). The crucial difference between BoostDiff and GENIE3 is that we simultaneously take into account two datasets for inferring a differential network. More precisely, our approach requires the availability of (1) gene expression data matrix
<disp-formula id="E2"><mml:math id="M2" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msub></mml:mrow><mml:mo>,</mml:mo><mml:mi>p</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula>
for <inline-formula id="IE7"><mml:math id="IM7" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> measurements from a disease condition and (2) the matrix
<disp-formula id="E3"><mml:math id="M3" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msub></mml:mrow><mml:mo>,</mml:mo><mml:mi>p</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula>
for <inline-formula id="IE8"><mml:math id="IM8" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> measurements from a control condition. Both matrices have <italic toggle="yes">p</italic> columns (total number of genes). That is, <inline-formula id="IE9"><mml:math id="IM9" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:math></inline-formula> contains the expression of gene <italic toggle="yes">g</italic> in measurement (patient) <italic toggle="yes">i</italic> from the disease condition.</p>
      <p>The inference task is modeled as a feature selection problem that aims to find features that are more predictive of expression levels in a target condition than in the baseline condition. For this, differential network analysis is performed by solving the regression problem while taking into account information from two distinct labels. We use the AdaBoost algorithm (<xref rid="vbae034-B21" ref-type="bibr">Drucker 1997</xref>) using differential trees as base learners to drive the improved prediction of expression levels in the target condition. The trained model provides a ranking of the edges by computing a feature importance weight for each regulator (see details below).</p>
      <p>For each target gene <inline-formula id="IE10"><mml:math id="IM10" display="inline" overflow="scroll"><mml:mrow><mml:mi>g</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>, we define regression problems <inline-formula id="IE11"><mml:math id="IM11" display="inline" overflow="scroll"><mml:mrow><mml:mi>L</mml:mi><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> and <inline-formula id="IE12"><mml:math id="IM12" display="inline" overflow="scroll"><mml:mrow><mml:mi>L</mml:mi><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msubsup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>. The design matrices <inline-formula id="IE13"><mml:math id="IM13" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula id="IE14"><mml:math id="IM14" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:math></inline-formula> are obtained by deleting the <italic toggle="yes">g</italic>th columns <inline-formula id="IE15"><mml:math id="IM15" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula id="IE16"><mml:math id="IM16" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:math></inline-formula> from <inline-formula id="IE17"><mml:math id="IM17" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula id="IE18"><mml:math id="IM18" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula>, respectively. The target variables are set to the deleted columns <inline-formula id="IE19"><mml:math id="IM19" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula id="IE20"><mml:math id="IM20" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:math></inline-formula>. The inference of our differential network is then performed as follows:</p>
      <list list-type="order">
        <list-item>
          <p>For each target gene <inline-formula id="IE21"><mml:math id="IM21" display="inline" overflow="scroll"><mml:mrow><mml:mi>g</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>:</p>
          <list list-type="alpha-lower">
            <list-item>
              <p>Generate the design matrices and target variable vectors for the regression problems <inline-formula id="IE22"><mml:math id="IM22" display="inline" overflow="scroll"><mml:mrow><mml:mi>L</mml:mi><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> and <inline-formula id="IE23"><mml:math id="IM23" display="inline" overflow="scroll"><mml:mrow><mml:mi>L</mml:mi><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> for gene <italic toggle="yes">g</italic> for the disease and the control conditions.</p>
            </list-item>
            <list-item>
              <p>Train an ensemble of differential regression trees with the disease selected as target condition, i.e. tree ensembles that yields a good fit for <inline-formula id="IE24"><mml:math id="IM24" display="inline" overflow="scroll"><mml:mrow><mml:mi>L</mml:mi><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> but not for <inline-formula id="IE25"><mml:math id="IM25" display="inline" overflow="scroll"><mml:mrow><mml:mi>L</mml:mi><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>.</p>
            </list-item>
            <list-item>
              <p>From the ensemble of differential trees, extract weights for all potential regulators of <italic toggle="yes">g</italic> which are large if the expression of the regulator is highly predictive of <italic toggle="yes">g</italic> in the disease condition but not in the control condition.</p>
            </list-item>
          </list>
        </list-item>
        <list-item>
          <p>Aggregate and sort the <italic toggle="yes">p</italic> gene rankings to obtain a global ranking of all differential regulatory edges.</p>
        </list-item>
        <list-item>
          <p>Repeat the steps 1 and 2 with reversed roles of <italic toggle="yes">D</italic> and <italic toggle="yes">C</italic> to identify regulatory links that are present in the control but not in the disease condition.</p>
        </list-item>
      </list>
      <p>In the following, we describe the details of the algorithm.</p>
    </sec>
    <sec>
      <title>2.2 Step 1a: Growing a differential tree</title>
      <p>We first explain how to build a single differential tree, the key ingredient of step 1a of the algorithm outlined above. We describe how to build the differential tree for the case where the disease has been selected as the target condition. The workflow with control as target condition is analogous.</p>
      <p>A differential tree is built through binary recursive partitioning. The key difference to standard regression trees is that, to determine the features (i.e. genes) used for splitting the samples at the inner nodes of our trees, we use a novel split criterion called differential variance improvement (DVI) instead of variance reduction. At each node of the differential tree, we maintain subsets <inline-formula id="IE26"><mml:math id="IM26" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo>⊆</mml:mo><mml:mo>{</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msub></mml:mrow><mml:mo>}</mml:mo></mml:mrow></mml:math></inline-formula> and <inline-formula id="IE27"><mml:math id="IM27" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo>⊆</mml:mo><mml:mo>{</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msub></mml:mrow><mml:mo>}</mml:mo></mml:mrow></mml:math></inline-formula> of the disease and control samples, respectively. Given a possible split feature (i.e. candidate predictor gene) <inline-formula id="IE28"><mml:math id="IM28" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula>, we define <inline-formula id="IE29"><mml:math id="IM29" display="inline" overflow="scroll"><mml:mrow><mml:mtext>DVI</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> as follows:
<disp-formula id="E4"><mml:math id="M4" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mtext>DVI</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mrow><mml:munder><mml:mrow><mml:mi>max</mml:mi></mml:mrow><mml:mo>τ</mml:mo></mml:munder></mml:mrow><mml:mtext>VarRed</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mo>−</mml:mo><mml:mrow><mml:munder><mml:mrow><mml:mi>max</mml:mi></mml:mrow><mml:mo>τ</mml:mo></mml:munder></mml:mrow><mml:mtext>VarRed</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p>
      <p>For a fixed <inline-formula id="IE30"><mml:math id="IM30" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> and splitting threshold <inline-formula id="IE31"><mml:math id="IM31" display="inline" overflow="scroll"><mml:mo>τ</mml:mo></mml:math></inline-formula>, the variance reduction for the disease samples is given by
<disp-formula id="E5"><mml:math id="M5" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mtext>VarRed</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mtext>MSE</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">]</mml:mo><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mo>−</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>L</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>|</mml:mo></mml:mrow><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo>|</mml:mo></mml:mrow></mml:mfrac></mml:mrow><mml:mo>·</mml:mo><mml:mtext>MSE</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>L</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">]</mml:mo><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mo>−</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>R</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>|</mml:mo></mml:mrow><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo>|</mml:mo></mml:mrow></mml:mfrac></mml:mrow><mml:mo>·</mml:mo><mml:mtext>MSE</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>R</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">]</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula>
where <inline-formula id="IE32"><mml:math id="IM32" display="inline" overflow="scroll"><mml:mrow><mml:mtext>MSE</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mo>·</mml:mo><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> is the mean squared error from the sample mean, <inline-formula id="IE33"><mml:math id="IM33" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mi>S</mml:mi><mml:mo stretchy="false">]</mml:mo><mml:mo>=</mml:mo><mml:mo>{</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo>|</mml:mo><mml:mi>i</mml:mi><mml:mo>∈</mml:mo><mml:mi>S</mml:mi><mml:mo>}</mml:mo></mml:mrow></mml:math></inline-formula> is the restriction of the target variable to the disease samples (rows) contained in a set of samples <italic toggle="yes">S</italic>, and <inline-formula id="IE34"><mml:math id="IM34" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>L</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo>{</mml:mo><mml:mi>i</mml:mi><mml:mo>∈</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo>≤</mml:mo><mml:mo>τ</mml:mo><mml:mo>}</mml:mo></mml:mrow></mml:math></inline-formula>, and <inline-formula id="IE35"><mml:math id="IM35" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>R</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo>{</mml:mo><mml:mi>i</mml:mi><mml:mo>∈</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo>&gt;</mml:mo><mml:mo>τ</mml:mo><mml:mo>}</mml:mo></mml:mrow></mml:math></inline-formula> are the subsets of disease samples <inline-formula id="IE36"><mml:math id="IM36" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> available at the current node whose split gene expression levels are, respectively, smaller or larger than the threshold <inline-formula id="IE37"><mml:math id="IM37" display="inline" overflow="scroll"><mml:mo>τ</mml:mo></mml:math></inline-formula>. Variance reduction for the control samples is defined analogously. A positive value of the <inline-formula id="IE38"><mml:math id="IM38" display="inline" overflow="scroll"><mml:mrow><mml:mtext>DVI</mml:mtext></mml:mrow></mml:math></inline-formula> hence means that the gene <inline-formula id="IE39"><mml:math id="IM39" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> is more predictive of <italic toggle="yes">g’</italic>s expression level in the disease condition than in the control condition, whereas a negative <inline-formula id="IE40"><mml:math id="IM40" display="inline" overflow="scroll"><mml:mrow><mml:mtext>DVI</mml:mtext></mml:mrow></mml:math></inline-formula> value indicates that the opposite is the case.</p>
      <p>When building our differential trees, we use genes <inline-formula id="IE41"><mml:math id="IM41" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> maximizing <inline-formula id="IE42"><mml:math id="IM42" display="inline" overflow="scroll"><mml:mrow><mml:mtext>DVI</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> as split features (see details below). If disease has been selected as the target condition, these genes correspond to regulators of <italic toggle="yes">g</italic> which are much more active in disease samples than in control samples. If control has been selected as the target condition, they correspond to regulators in healthy individuals that have lost their regulatory activity in the disease.</p>
      <p>Given the regression problems <inline-formula id="IE43"><mml:math id="IM43" display="inline" overflow="scroll"><mml:mrow><mml:mi>L</mml:mi><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> and <inline-formula id="IE44"><mml:math id="IM44" display="inline" overflow="scroll"><mml:mrow><mml:mi>L</mml:mi><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> for the disease and control conditions, respectively, we construct a differential regression tree whose nodes are 5-tuples
<disp-formula id="E6"><mml:math id="M6" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mi>v</mml:mi><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>D</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>C</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula>
where <inline-formula id="IE45"><mml:math id="IM45" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> is the split gene, <inline-formula id="IE46"><mml:math id="IM46" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>D</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow></mml:mrow></mml:math></inline-formula> is the split threshold for the disease samples, and <inline-formula id="IE47"><mml:math id="IM47" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>C</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow></mml:mrow></mml:math></inline-formula> is the split threshold for the control samples. Note that we use two different thresholds, since using a single threshold for both conditions while optimizing the <inline-formula id="IE48"><mml:math id="IM48" display="inline" overflow="scroll"><mml:mrow><mml:mtext>DVI</mml:mtext></mml:mrow></mml:math></inline-formula> leads to a skewed expression distribution in each side of the split, with one side favoring disease samples and the other side favoring control samples. The construction is done as follows:</p>
      <list list-type="order">
        <list-item>
          <p>Initialize root as
<disp-formula id="E7a"><mml:math id="M7a" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo>=</mml:mo><mml:mo>{</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msub></mml:mrow><mml:mo>}</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo>=</mml:mo><mml:mo>{</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msub></mml:mrow><mml:mo>}</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p>
          <p>where ‘<inline-formula id="IE50"><mml:math id="IM50" display="inline" overflow="scroll"><mml:mo>•</mml:mo></mml:math></inline-formula>’ is a placeholder for not yet defined split genes and thresholds.</p>
        </list-item>
        <list-item>
          <p>Starting at the root, recursively construct a differential tree via binary partitioning as follows:</p>
        </list-item>
        <list-item>
          <p>At the current node <inline-formula id="IE51"><mml:math id="IM51" display="inline" overflow="scroll"><mml:mrow><mml:mi>v</mml:mi><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> of the tree under construction, do the following:</p>
          <list list-type="alpha-lower">
            <list-item>
              <p>If a suitable termination criterion (the maximum depth of the tree has been reached or the number of target or baseline samples reaching in a node has been reached) has been satisfied or <inline-formula id="IE52"><mml:math id="IM52" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mrow><mml:mi>max</mml:mi></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:msub></mml:mrow><mml:mtext>DVI</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>≤</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></inline-formula>, label <italic toggle="yes">v</italic> as leaf and traceback.</p>
            </list-item>
            <list-item>
              <p>Otherwise, set the node <italic toggle="yes">v’</italic>s split gene to
<disp-formula id="E7"><mml:math id="M7" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msup></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:munder><mml:mrow><mml:mtext>argmax</mml:mtext></mml:mrow><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:munder></mml:mrow><mml:mtext>DVI</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p>
              <p>its disease threshold to
<disp-formula id="E8"><mml:math id="M8" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>D</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:munder><mml:mrow><mml:mtext>argmax</mml:mtext></mml:mrow><mml:mo>τ</mml:mo></mml:munder></mml:mrow><mml:mtext>VarRed</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p>
              <p>and its control threshold to
<disp-formula id="E9"><mml:math id="M9" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>C</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:munder><mml:mrow><mml:mtext>argmax</mml:mtext></mml:mrow><mml:mo>τ</mml:mo></mml:munder></mml:mrow><mml:mtext>VarRed</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p>
            </list-item>
            <list-item>
              <p>Initialize <italic toggle="yes">v’</italic>s left child as
<disp-formula id="E10"><mml:math id="M10" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mi>L</mml:mi></mml:msub></mml:mrow><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>L</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>D</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>L</mml:mi><mml:mi>C</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>C</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p>
              <p>its right child as
<disp-formula id="E11"><mml:math id="M11" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mi>R</mml:mi></mml:msub></mml:mrow><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>R</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>D</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>R</mml:mi><mml:mi>C</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>C</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p>
              <p>and continue with processing <inline-formula id="IE53"><mml:math id="IM53" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mi>L</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula id="IE54"><mml:math id="IM54" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mi>R</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>.</p>
            </list-item>
          </list>
        </list-item>
      </list>
      <p>In the regression trees described by (<xref rid="vbae034-B9" ref-type="bibr">Breiman <italic toggle="yes">et al.</italic> 1984</xref>), the prediction for a sample is determined by traversing the tree until a leaf node is reached. Here, we are more interested in predicting the expression values of the samples in the target condition; thus, prediction is performed only for target samples using the identified splitting thresholds <inline-formula id="IE55"><mml:math id="IM55" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>D</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow></mml:mrow></mml:math></inline-formula>. The final prediction is calculated as the expected value of the expression levels of the target samples assigned to the leaf nodes after fitting the differential tree.</p>
    </sec>
    <sec>
      <title>2.3 Step 1b: Boosting the differential trees</title>
      <p>Inspired by GRNBoost2 (<xref rid="vbae034-B59" ref-type="bibr">Moerman <italic toggle="yes">et al.</italic> 2019</xref>), we implement a boosting algorithm that derives a strong prediction model by sequentially training a pool of differential trees as the weak learners. AdaBoost for regression is typically used for solving problems where the output is a continuous variable (i.e. expression levels) without explicitly considering the class of the samples. Here, we adapted the AdaBoost.R2 algorithm (<xref rid="vbae034-B21" ref-type="bibr">Drucker 1997</xref>) to handle the regression problem, given labels from two classes (i.e. conditions). Using the differential trees as base learners, the modified algorithm performs the boosting with respect to samples belonging to the specified target condition. In this way, BoostDiff attempts to find a model that is more predictive of the target condition compared to the baseline condition. In each tree, only the target samples are re-weighted in subsequent boosting iterations, while samples from the baseline condition retain uniform weight. In particular, target samples that are more difficult to predict are selected with higher weights during the bootstrapping step and will always be compared to a uniform sample from the baseline condition. To avoid overfitting, we set a low number of trees and in practice find that 50–100 differential trees in the ensemble are sufficient for real transcriptomics datasets. The algorithm is described in detail in the <xref rid="sup1" ref-type="supplementary-material">Supplementary Methods section</xref>.</p>
    </sec>
    <sec>
      <title>2.4 Step 1c: Computing variable importances to rank the candidate predictors</title>
      <p>Tree-based methods allow for the calculation of a variable importance measure that can be used to rank the features according to their relevance for predicting the output. In GENIE3, the importance of a predictor gene <inline-formula id="IE56"><mml:math id="IM56" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> is calculated as the sum of the variance reduction across all nodes where <inline-formula id="IE57"><mml:math id="IM57" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> is used as the splitting feature, averaged over all trees in the ensemble. For BoostDiff, we derive a similar measure by considering the samples belonging to the target condition (step 1c in the high-level description of BoostDiff given above). If disease is selected as target condition, the importance <inline-formula id="IE58"><mml:math id="IM58" display="inline" overflow="scroll"><mml:mrow><mml:mtext>VIM</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> attributed to a candidate predictor gene <inline-formula id="IE59"><mml:math id="IM59" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> is calculated as the weighted variance reduction for the disease samples across all <italic toggle="yes">M</italic> trees in the ensemble:
<disp-formula id="E12"><mml:math id="M12" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mtext>VIM</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mrow><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>m</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>M</mml:mi></mml:munderover></mml:mrow><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mo>α</mml:mo></mml:mrow><mml:mi>m</mml:mi></mml:msup></mml:mrow></mml:mrow><mml:mo>·</mml:mo><mml:mrow><mml:munder><mml:mo>∑</mml:mo><mml:mrow><mml:mi>v</mml:mi><mml:mo>∈</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mi>m</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:munder></mml:mrow><mml:mrow><mml:mtext>VarRed</mml:mtext></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>v</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>v</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p>
      <p>Here, <italic toggle="yes">m</italic> is the boosting iteration, <inline-formula id="IE60"><mml:math id="IM60" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mo>α</mml:mo></mml:mrow><mml:mi>m</mml:mi></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> is the weight of the differential tree returned by AdaBoost, <inline-formula id="IE61"><mml:math id="IM61" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mi>m</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> is the set of nodes in tree <italic toggle="yes">m</italic> where <inline-formula id="IE62"><mml:math id="IM62" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> was used as the split feature, and <inline-formula id="IE63"><mml:math id="IM63" display="inline" overflow="scroll"><mml:mrow><mml:mtext>VarRed</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>v</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>v</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> is the variance reduction for the disease samples at a node <inline-formula id="IE64"><mml:math id="IM64" display="inline" overflow="scroll"><mml:mrow><mml:mi>v</mml:mi><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>v</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>∈</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mi>m</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>. Since each node in a differential tree has two independent thresholds, interpreting the tree becomes more abstract with increasing depth. Boosting using shallow differential trees (e.g. differential tree stumps) thus favors greater interpretability of the variable importance measure.</p>
    </sec>
    <sec>
      <title>2.5 Steps 2 and 3: Edge ranking and filtering from boosted differential trees</title>
      <p>Each modified AdaBoost model yields a separate ranking of the regulators. However, simply ordering the regulatory links according to the weights leads to a bias toward highly variable target genes. To avoid this, we first scale the expression levels of each target gene to unit variance, similarly implemented in GENIE3 (<xref rid="vbae034-B34" ref-type="bibr">Huynh-Thu <italic toggle="yes">et al.</italic> 2010</xref>).</p>
      <p>Boosting with respect to a target condition does not necessarily produce a model that predicts a gene’s expression in the target condition better than its expression in the baseline condition. To illustrate, sample plots of the training progression are shown in <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S1</xref>. To restrict the results to differential edges, we recommend examining the distributions of the mean difference in prediction error. Sample distributions of these values from the simulated and real transcriptomics data are shown in <xref rid="sup1" ref-type="supplementary-material">Supplementary Figs S2 and S3</xref>, respectively. Based on these generated plots, users can filter for target genes with lower mean prediction error in the target condition than the baseline condition by applying a threshold. Alternatively, users can select the top edges with the lowest mean difference in prediction error or input a user-defined percentile. After filtering, the edges are re-ranked based on the variable importance measure used as the edge weight. The procedure is performed for each of the two sub-analyses (disease or control as target condition). The top edges (user-specified parameter) from each sub-analysis are then merged to obtain the final network.</p>
      <p>Given the ensemble nature of BoostDiff where each differential tree is constructed differently from randomly selected predictors, deriving an explanation of the model’s predictions is challenging. To obtain more mechanistic and biologically meaningful results, we can rely on the topology of the differential network and use community detection algorithms that aim to find highly connected subnetworks that could be potentially associated with the disease of interest.</p>
    </sec>
    <sec>
      <title>2.6 Compared methods</title>
      <p>We evaluate the performance of BoostDiff against baseline methods and existing differential networks methods. To verify the condition specificity of the networks output by BoostDiff, we compare its performance to those of two GRN inference methods, GENIE3 and ARACNE (<xref rid="vbae034-B52" ref-type="bibr">Margolin <italic toggle="yes">et al.</italic> 2006</xref>). GENIE3 is run using the corresponding R package. ARACNE is run using the implementation provided in the R package <italic toggle="yes">minet</italic> (<xref rid="vbae034-B57" ref-type="bibr">Meyer <italic toggle="yes">et al.</italic> 2008</xref>). For both GENIE3 and ARACNE, only the gene expression matrix from the disease condition is used as input. We also compare BoostDiff to two additional baseline methods: (i) random forests of differential trees (‘RF Difftrees’) and (ii) a ‘Differential GENIE3’ approach, where we separately infer the networks from each condition using GENIE3 and subtract the calculated edge weights derived from the control condition from the weights derived from the disease condition and vice versa. For details, an AIMe report is available at <ext-link xlink:href="https://aime.report/656I3Z/2" ext-link-type="uri">https://aime.report/656I3Z/2</ext-link> (<xref rid="vbae034-B54" ref-type="bibr">Matschinske <italic toggle="yes">et al.</italic> 2021</xref>).</p>
      <p>Next, we compare the performance of BoostDiff to other differential network methods from the benchmarking study in <xref rid="vbae034-B7" ref-type="bibr">Bhuva <italic toggle="yes">et al.</italic> (2019)</xref>. These methods include <italic toggle="yes">z</italic>-score, EBcoexpress, Diffcoex, and a GGM-based method, which are implemented in the <italic toggle="yes">dcanr</italic> package in R. Additionally, we run the chNet algorithm (<xref rid="vbae034-B81" ref-type="bibr">Tu <italic toggle="yes">et al.</italic> 2021</xref>), which considers significant changes in both partial correlations of edges and differential expression. To facilitate comparability and given that only the tree-based methods provide directionality information among the methods examined here, we convert directed edges to undirected edges (<xref rid="vbae034-B7" ref-type="bibr">Bhuva <italic toggle="yes">et al.</italic> 2019</xref>).</p>
    </sec>
    <sec>
      <title>2.7 Evaluation using simulated datasets</title>
      <p>Gene expression data for disease and control conditions are simulated by adapting the SimulatorGRN approach (<xref rid="vbae034-B7" ref-type="bibr">Bhuva <italic toggle="yes">et al.</italic> 2019</xref>), a dynamical systems modeling tool to simulate differential co-expression patterns. SimulatorGRN induces differential co-expression by perturbing a reference network via gene knockdown to reduce their expression levels and models activation/repression of a gene by a set of regulators using normalized Hill equations. Knockdown leads to complex nonlinear differences between the generated disease and control samples (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S4</xref>). By default, known regulatory interactions in <italic toggle="yes">Saccharomyces cerevisiae</italic> are used to create a reference GRN. To obtain the ‘true’ differentially co-expressed edges and allow performance evaluation, genes in the network whose abundance are affected by the knockdown perturbation and thus exhibit regulatory dependency are determined via sensitivity analysis.</p>
      <p>In the original SimulatorGRN framework, a sample can have multiple genes knocked down, even though the evaluation considers each knockdown gene separately. To explicitly eliminate the confounding effect of additional knockdown genes in our experiments, we generate the expression data in the perturbed condition such that exactly one randomly selected input gene is knocked down. We evaluate the different tools across four scenarios: (i) 50 nodes; 500 simulations, (ii) 150 nodes; 500 simulations, (iii) 300 nodes; 500 simulations, and (iv) 500 nodes; 250 simulations. In each simulation, 100 samples are generated per condition. The final disease samples are those which have the gene knockdown, whereas the control samples are ‘wild type’ (<xref rid="vbae034-B7" ref-type="bibr">Bhuva <italic toggle="yes">et al.</italic> 2019</xref>). The edges from the ‘association network’ of each simulation are used as the ground truth edges for evaluating performance. The parameters for generating the simulated data are shown in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>.</p>
      <p>In the analyses on simulated data, all genes except the target gene are considered as potential regulators. The <italic toggle="yes">z</italic>-score method, chNet, Diffcoex, and the GGM-based method are run with the default parameters. The parameters used for the RF Difftrees and BoostDiff are provided in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S2</xref>. For each simulation, we filter for the target genes belonging to the 3rd percentile based on the mean difference in prediction errors. The parameters for the EBcoexpress runs are shown in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S3</xref>.</p>
      <p>The different tools have different statistical methods and cutoffs for determining the differentially coexpressed edges depending on how the algorithm works. To facilitate comparability, we show the top <italic toggle="yes">k</italic> predicted edges output by each method (except for chNet, wherein the number of predicted differential edges depends on the tuning parameter and is variable for each simulation; thus, extracting the top <italic toggle="yes">k</italic> edges cannot be consistently applied across simulations). For visualization, we show the results based on the top 100 predicted edges output by each method for the simulated data. We report the performance using precision, recall, and F1 score as the evaluation metrics.</p>
    </sec>
    <sec>
      <title>2.8 Evaluation using real datasets</title>
      <p>For evaluation on real datasets, BoostDiff, Diffcoex, EBcoexpress, the <italic toggle="yes">z</italic>-score method, and Differential GENIE3 are run on gene expression data for four human diseases (COVID-19, Crohn’s disease, breast cancer, and prostate adenocarcinoma) and for the stress response in <italic toggle="yes">B.subtilis</italic>. For the human diseases, we extract the top 1000 edges to generate the final network. For the <italic toggle="yes">B.subtilis</italic> data, we use the top 300 edges.</p>
      <p>For the COVID-19 RNA-Seq dataset, raw gene counts are downloaded from the Gene Expression Omnibus (GEO) database under the accession number GSE156063 (<xref rid="vbae034-B58" ref-type="bibr">Mick <italic toggle="yes">et al.</italic> 2020</xref>). We use data generated from nasal swab samples from COVID-19 (<inline-formula id="IE65"><mml:math id="IM65" display="inline" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>93</mml:mn></mml:mrow></mml:math></inline-formula>) and uninfected patients (<inline-formula id="IE66"><mml:math id="IM66" display="inline" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:math></inline-formula>). Count data are normalized using the <monospace>DESeq2</monospace> package in R with the variance stabilizing transformation (<monospace>vst}</monospace>) function. Differentially expressed genes (DEGs) are obtained using <monospace>DESeq2</monospace> (<xref rid="vbae034-B48" ref-type="bibr">Love <italic toggle="yes">et al.</italic> 2014</xref>).</p>
      <p>For the Crohn’s disease (CD) dataset, normalized microarray data are downloaded from the GEO database under the accession number GSE126124 (<xref rid="vbae034-B67" ref-type="bibr">Palmer <italic toggle="yes">et al.</italic> 2019</xref>), which were generated from colon biopsies of individuals with CD (<inline-formula id="IE67"><mml:math id="IM67" display="inline" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>37</mml:mn></mml:mrow></mml:math></inline-formula>) and healthy controls (<inline-formula id="IE68"><mml:math id="IM68" display="inline" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>19</mml:mn></mml:mrow></mml:math></inline-formula>). Differential expression analysis is performed using <monospace>limma</monospace> (<xref rid="vbae034-B68" ref-type="bibr">Ritchie <italic toggle="yes">et al.</italic> 2015</xref>).</p>
      <p>To evaluate BoostDiff on data from The Cancer Genome Atlas (TCGA), preprocessed RNA-Seq gene expression data and DEGs from primary tumors and normal solid tissues are obtained from <ext-link xlink:href="https://xenabrowser.net/" ext-link-type="uri">https://xenabrowser.net/</ext-link> (<xref rid="vbae034-B27" ref-type="bibr">Goldman <italic toggle="yes">et al.</italic> 2020</xref>). We use gene expression data for two cancer types, namely, prostate adenocarcinoma (PRAD) and breast cancer (BRCA), both of which contain at least 50 samples for the normal tissues.</p>
      <p>For the human datasets, Illumina IDs are converted to HGNC symbols using the R package <monospace>biomaRt</monospace> where applicable (<xref rid="vbae034-B22" ref-type="bibr">Durinck <italic toggle="yes">et al.</italic> 2009</xref>). Expression levels corresponding to probes mapped to the same gene symbol are averaged. The top 20% of genes with the lowest variance are filtered out. To generate the final GRN and facilitate comparability with BoostDiff, we filter the outputs for edges containing a TF, using the list of human transcription factors downloaded from <ext-link xlink:href="http://humantfs.ccbr.utoronto.ca/" ext-link-type="uri">http://humantfs.ccbr.utoronto.ca/</ext-link> (<xref rid="vbae034-B43" ref-type="bibr">Lambert <italic toggle="yes">et al.</italic> 2018</xref>). These TFs are also used as the candidate regulators for BoostDiff. Genes whose mean difference in prediction error of the models are more extreme than the threshold identified from the 3rd percentiles of the distributions are retained. For the CD dataset, a more stringent filtering step is performed because of the small sample size available for inference. All the outputs from the different methods are filtered for the top 1000 edges (except for chNet). For BoostDiff, the final network is thus comprised of the combined top 500 edges from the run where the disease condition is set as the target condition and the top 500 edges from the run where the control condition is set as the target condition. To identify more specific candidate network modules and facilitate the interpretability of the resulting networks, we apply the Louvain community detection algorithm using the python-louvain package (<ext-link xlink:href="https://github.com/taynaud/python-louvain" ext-link-type="uri">https://github.com/taynaud/python-louvain</ext-link>). The enrichr module of the gseapy v. 1.1.0 package is used to identify enriched KEGG pathways in the output networks (<xref rid="vbae034-B76" ref-type="bibr">Subramanian <italic toggle="yes">et al.</italic> 2005</xref>, <xref rid="vbae034-B42" ref-type="bibr">Kuleshov <italic toggle="yes">et al.</italic> 2016</xref>). KEGG terms are considered to be significantly enriched in a network if the overlap with the gene set is at least three genes.</p>
      <p>We further test the performance of BoostDiff using transcriptome data related to the well-characterized general stress response in <italic toggle="yes">B.subtilis</italic> (<xref rid="vbae034-B63" ref-type="bibr">Nicolas <italic toggle="yes">et al.</italic> 2012</xref>). We examine three contexts, namely, response to salt stress, response to heat stress, and response to ethanol stress, all of which are known to induce the SigB regulon. Expression data for all protein-coding genes and RNA features (S1 to S1583) of <italic toggle="yes">B.subtilis</italic> from the corresponding samples were downloaded from the GEO database (accession number GSE27219). Considering that bacterial adaptation is characterized by smaller variation across samples than in animal experiments or experiments with human specimens, gene expression datasets for bacterial adaptation generally have low number of replicates. Therefore, we generate additional synthetic samples using Synthetic Minority Over-sampling TEchnique (SMOTE) (<ext-link xlink:href="https://github.com/akazs/pySMOTE/" ext-link-type="uri">https://github.com/akazs/pySMOTE/</ext-link>) to obtain 48 samples per condition to be available for inference. We note that a large sample size from experimental data still remains ideal for using BoostDiff; SMOTE is used as a workaround in order to be able to run the compared network inference methods on the <italic toggle="yes">B.subtilis</italic> datasets. Genes with low variance are filtered out using a variance cutoff of 0.4. For the BoostDiff runs, the final network is obtained by filtering the differentially predicted target genes based on the 3rd percentile and combining the top 150 edges in the differential network for each of the two sub-analyses. The results of the compared methods are filtered for the top 300 edges to obtain the differential network. Enrichment analyses for the <italic toggle="yes">B.subtilis</italic> outputs is performed using the ShinyGO v. 0.77 (<xref rid="vbae034-B25" ref-type="bibr">Ge <italic toggle="yes">et al.</italic> 2020</xref>).</p>
    </sec>
  </sec>
  <sec>
    <title>3 Results and discussion</title>
    <sec>
      <title>3.1 BoostDiff outperforms existing methods on complex simulated settings</title>
      <p>As expected, BoostDiff better identifies the differential edges than GENIE3 and ARACNE, both of which infer a static network from the disease condition alone (<xref rid="vbae034-F2" ref-type="fig">Fig. 2</xref>). The Differential GENIE3 method shows similar performance to those of the baseline methods, despite using the expression data from both disease and control conditions. These findings indicate that the feature importances calculated from the trees built using <inline-formula id="IE69"><mml:math id="IM69" display="inline" overflow="scroll"><mml:mrow><mml:mtext>DVI</mml:mtext></mml:mrow></mml:math></inline-formula> as the splitting criterion are useful for identifying the differential edges. In addition, in all but the smallest simulation scenarios, the boosting scheme performs significantly better than the random forest of differential trees (see results for BoostDiff and RF Difftrees in <xref rid="vbae034-F2" ref-type="fig">Fig. 2</xref>): While RF Difftrees outperformed all the other methods in the 50-gene setting, BoostDiff is the best performing methods in the more complex 150-, 300-, and 500-gene settings. Results are similar for varying cutoffs of the number of top edges (<inline-formula id="IE70"><mml:math id="IM70" display="inline" overflow="scroll"><mml:mrow><mml:mi>k</mml:mi><mml:mo>∈</mml:mo><mml:mo>{</mml:mo><mml:mn>50</mml:mn><mml:mo>,</mml:mo><mml:mn>100</mml:mn><mml:mo>,</mml:mo><mml:mn>150</mml:mn><mml:mo>,</mml:mo><mml:mn>200</mml:mn><mml:mo>}</mml:mo></mml:mrow></mml:math></inline-formula>) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S5</xref>).</p>
      <fig position="float" id="vbae034-F2">
        <label>Figure 2.</label>
        <caption>
          <p>Performance of differential trees and BoostDiff compared to baseline methods and other differential network tools using simulated data comprising (a) 50 genes; (b) 150 genes; (c) 300 genes; (d) 500 genes. For all methods, the top 100 edges were considered (except for chNet). The one-sided Mann–Whitney U test is used to calculate the <italic toggle="yes">P</italic>-values.</p>
        </caption>
        <graphic xlink:href="vbae034f2" position="float"/>
      </fig>
      <p>We then determine the rank of each method in terms of the F1 score across all simulations in the four simulation settings. The results show that BoostDiff is the most frequently top-ranked method in the majority of simulations, more notably in the simulation settings with larger numbers of genes (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S6</xref>). In addition, except for when a high number of base learners is used in the ensemble, the performance of BoostDiff is consistent across different hyperparameter combinations (no. of features, maximum tree depth) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S7</xref>).</p>
    </sec>
    <sec>
      <title>3.2 Results on real datasets</title>
      <sec>
        <title>3.2.1 COVID-19</title>
        <p>The network inferred by BoostDiff shows stronger enrichment of COVID-19-related pathways compared to those of Diffcoex and the <italic toggle="yes">z</italic>-score method, whereas all edges in the EBcoexpress output are assigned zero posterior probabilities (<xref rid="vbae034-F3" ref-type="fig">Fig. 3</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S4–S7</xref>). In particular, the Diffcoex and <italic toggle="yes">z</italic>-score networks are enriched in less specific terms, such as ‘Influenza A,’ ‘Measles,’ and ‘Human T-cell leukemia virus 1 infection.’ Differential GENIE3 returned ‘Coronavirus disease,’ ‘Neutrophil extracellular trap formation,’ and ‘Phagosome.’ In addition to terms related to various pathogenic infections, the BoostDiff network is significantly enriched in COVID-19-relevant pathways, such as ‘Coronavirus disease,’ ‘TNF signaling pathway,’ ‘Th17 cell differentiation pathway,’ ‘NF-<inline-formula id="IE71"><mml:math id="IM71" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>B signaling pathway,’ ‘NOD-like receptor pathway,’ ‘Toll-like receptor signaling pathway,’ and ‘Viral protein interaction with cytokine and cytokine receptor’ (<xref rid="vbae034-F3" ref-type="fig">Fig. 3</xref>). However, similar to BoostDiff, ‘Herpes simplex I infection’ is a top enriched term in the networks output by both methods, which could indicate the presence of shared genes activated in response to viral infection. For the BoostDiff network, examining the differential edges when considering the two sub-analyses separately shows generally similar results, indicating the enrichment of infection-related pathways (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S8</xref>). We also compare the BoostDiff network to the list of DEGs. While the overlap between the differential network nodes and DEGs is significant, it is quite low (<inline-formula id="IE72"><mml:math id="IM72" display="inline" overflow="scroll"><mml:mrow><mml:mtext>Jaccard similarity</mml:mtext><mml:mo>=</mml:mo><mml:mn>0.129</mml:mn></mml:mrow></mml:math></inline-formula>). Further, removing the DEGs from the genes in the differential network retains the enrichment of COVID-19-related pathways (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S9</xref>), indicating that these dysregulated genes identified by BoostDiff are missed by standard DE analysis.</p>
        <fig position="float" id="vbae034-F3">
          <label>Figure 3.</label>
          <caption>
            <p>Enriched KEGG pathways in the networks inferred by BoostDiff for the COVID-19 dataset. The resulting differential networks were strongly enriched in inflammation-related and other relevant pathways, consistent with known disease pathophysiology.</p>
          </caption>
          <graphic xlink:href="vbae034f3" position="float"/>
        </fig>
        <p>To further examine the differential networks, we apply the Louvain community detection algorithm (<xref rid="vbae034-B8" ref-type="bibr">Blondel <italic toggle="yes">et al.</italic> 2008</xref>). BoostDiff, Diffcoex, <italic toggle="yes">z</italic>-score, and Differential GENIE3, identifies modules that are enriched in viral infection terms such as ‘Influenza A,’ ‘Coronavirus disease,’ ‘Hepatitis C,’ as well as signaling pathways ‘NOD-like receptor signaling pathway,’ ‘RIG-1-like receptor signaling pathway,’ and ‘Toll-like receptor signaling pathway’ (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figs S10–S12</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S8–S11</xref>). However, the BoostDiff module is additionally enriched in the terms ‘Cytosolic DNA-sensing pathway’ and ‘Chemokine signaling pathway’ (<xref rid="vbae034-F4" ref-type="fig">Fig. 4</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S10 and S11</xref>). Notable COVID-19-related genes in the BoostDiff module include <italic toggle="yes">CXCL10, DDX58, STAT1, STAT2, EIF2AK2</italic>, and <italic toggle="yes">ISG15.</italic> Other additionally known genes involved in pathogen response include <italic toggle="yes">IFIT1, IFIT2, IFIT3, CXCL11</italic>, and <italic toggle="yes">CXCL9</italic>. Chemokines are produced in response to a range of viral infections. In COVID-19, chemokine signaling has been linked to acute respiratory distress syndrome (<xref rid="vbae034-B92" ref-type="bibr">Zhou <italic toggle="yes">et al.</italic> 2020</xref>). <italic toggle="yes">DDX58</italic> (RIG-1) is involved in the production of interferons in response to COVID-19 (<xref rid="vbae034-B86" ref-type="bibr">Yamada <italic toggle="yes">et al.</italic> 2021</xref>). Interferon signaling mediated by STAT1 and STAT2 is a key antiviral defense mechanism, and SARS-CoV-2 was demonstrated to inhibit nuclear translocation of STAT1 and STAT2 (<xref rid="vbae034-B60" ref-type="bibr">Mu <italic toggle="yes">et al.</italic> 2020</xref>). OASL, OAS2, and OAS3 are members of the oligoadenylate synthetase family of proteins, which are involved in the antiviral activity of interferons and have been reported to exacerbate cardiac effects of COVID-19 (<xref rid="vbae034-B24" ref-type="bibr">Gao <italic toggle="yes">et al.</italic> 2023</xref>). JAK inhibitors have been explored for the treatment and management of COVID-19 (<xref rid="vbae034-B45" ref-type="bibr">Levy <italic toggle="yes">et al.</italic> 2022</xref>) and is known to regulate the release of pro-inflammatory cytokines and chemokines. For instance, the chemokines <italic toggle="yes">CXCL9, CXCL10</italic> and <italic toggle="yes">CXCL11</italic> are known to be upregulated in the COVID-19 response (<xref rid="vbae034-B11" ref-type="bibr">Callahan <italic toggle="yes">et al.</italic> 2021</xref>). IFIT1, IFIT2, and IFIT3 form a functional complex and participate in interferon-induced broad viral response (<xref rid="vbae034-B56" ref-type="bibr">Mears and Sweeney 2018</xref>, <xref rid="vbae034-B74" ref-type="bibr">Singh <italic toggle="yes">et al.</italic> 2022</xref>). <italic toggle="yes">ISG15</italic> encodes a ubiquitin-like protein whose activation triggers the release of various pro-inflammatory cytokines and chemokines (<xref rid="vbae034-B12" ref-type="bibr">Cao 2021</xref>).</p>
        <fig position="float" id="vbae034-F4">
          <label>Figure 4.</label>
          <caption>
            <p>Dysregulated module identified from the COVID-19 differential network inferred by BoostDiff using the Louvain algorithm. Some notable genes in the module include <italic toggle="yes">JAK2, CXCL9, CXCL10, CXCL11, DDX58, STAT1, STAT2, IFIT1, IFIT2, IFIT3, IFITM3, OASL, OAS2, OAS3</italic>, and <italic toggle="yes">ISG15</italic>.</p>
          </caption>
          <graphic xlink:href="vbae034f4" position="float"/>
        </fig>
        <p>In addition to the enrichment of COVID-19-related genes that are consistent with literature, BoostDiff also identified edges between <italic toggle="yes">TREX1</italic> and <italic toggle="yes">IFIT1, IFIT3, IFITM3, ISG15</italic>, and <italic toggle="yes">OAS3</italic>, all of which have been implicated with COVID-19. While <italic toggle="yes">TREX1</italic> has not been directly linked to COVID-19 pathogenesis, it encodes an exonuclease that is involved in host defense and has also been implicated in autoimmune diseases (<xref rid="vbae034-B75" ref-type="bibr">Stetson <italic toggle="yes">et al.</italic> 2008</xref>). In particular, <italic toggle="yes">TREX1</italic> regulates interferon-mediated signaling in antiviral response (<xref rid="vbae034-B31" ref-type="bibr">Hasan <italic toggle="yes">et al.</italic> 2013</xref>). Interestingly, a recent genome-wide screen identified TREX1 as a pro-viral factor in viral replication during influenza infection (<xref rid="vbae034-B40" ref-type="bibr">King <italic toggle="yes">et al.</italic> 2023</xref>). Given that nucleic acid detection is a key component of the immune response, <italic toggle="yes">TREX1</italic> could be a candidate player involved in immune response to viral pathogens, including SARS-CoV-2, that can be examined in future investigations.</p>
      </sec>
      <sec>
        <title>3.2.2 Crohn’s disease</title>
        <p>Notably, the BoostDiff network shows stronger enrichment of CD-related pathways than the networks inferred by the other methods (<xref rid="vbae034-F5" ref-type="fig">Fig. 5</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S12–S15</xref>). The network returned by Differential GENIE3 does not show any significant enrichment. In addition to infection pathways, the network output by BoostDiff for the CD dataset is enriched in CD-relevant pathways, including ‘TNF signaling pathway,’ ‘NOD-like receptor signaling pathway,’ ‘Th17 cell differentiation,’ ‘IL-17 signaling pathway,’ and ‘NF-<inline-formula id="IE73"><mml:math id="IM73" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>B signaling,’ as well as ‘Inflammatory bowel disease.’ NOD-like receptors play important roles in host defense and homeostasis by acting as sensors of microbial pathogens in the intestinal mucosa. IBD has been associated with abnormal gut microbiota composition, which promotes NF-<inline-formula id="IE74"><mml:math id="IM74" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>B signaling and downstream inflammatory responses (<xref rid="vbae034-B33" ref-type="bibr">Hug <italic toggle="yes">et al.</italic> 2018</xref>). The TF NF-<inline-formula id="IE75"><mml:math id="IM75" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>B functions in maintaining intestinal homeostasis, and dysregulation of the NF-<inline-formula id="IE76"><mml:math id="IM76" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>B pathway leads to sustained inflammatory state characteristic of IBD patients (<xref rid="vbae034-B88" ref-type="bibr">Zaidi and Wine 2018</xref>). NF-<inline-formula id="IE77"><mml:math id="IM77" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>B signaling activation has been associated with more severe clinical manifestations in CD patients (<xref rid="vbae034-B30" ref-type="bibr">Han <italic toggle="yes">et al.</italic> 2017</xref>, <xref rid="vbae034-B88" ref-type="bibr">Zaidi and Wine 2018</xref>). The Th17 subset of <inline-formula id="IE78"><mml:math id="IM78" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mrow><mml:mtext>CD</mml:mtext><mml:mn>4</mml:mn></mml:mrow></mml:mrow><mml:mo>+</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> T cells have well recognized roles in IBD pathogenesis. In CD, IL-17 signaling mediates the activation of Th17 cells, which further drive pro-inflammatory cascades via the production of IL-21, IL-22, IFN-<inline-formula id="IE79"><mml:math id="IM79" display="inline" overflow="scroll"><mml:mo>γ</mml:mo></mml:math></inline-formula>, and TNF (<xref rid="vbae034-B71" ref-type="bibr">Schmitt <italic toggle="yes">et al.</italic> 2021</xref>). The differential edges obtained from the two BoostDiff sub-analyses where the disease or control states are used as the target condition also show enrichment of CD-relevant pathways (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S13</xref>). The nodes in the BoostDiff network have a small overlap with the list of DEGs (<inline-formula id="IE80"><mml:math id="IM80" display="inline" overflow="scroll"><mml:mrow><mml:mtext>Jaccard similarity</mml:mtext><mml:mo>=</mml:mo><mml:mn>0.008</mml:mn></mml:mrow></mml:math></inline-formula>). Enrichment results after removal of DEGs are similar to those of the original network (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S14</xref>). The Diffcoex network is enriched in only the term ‘Herpes simplex virus 1 infection,’ while the <italic toggle="yes">z</italic>-score network is enriched in many cancer-related terms (<xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S12 and S13</xref>). The EBcoexpress network is also enriched in CD-related terms, such as ‘IL-17 signaling pathway,’ ‘NOD-like receptor signaling pathway,’ ‘TNF signaling pathway’ and ‘NF-<inline-formula id="IE81"><mml:math id="IM81" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>B signaling pathway.’ (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S15</xref>).</p>
        <fig position="float" id="vbae034-F5">
          <label>Figure 5.</label>
          <caption>
            <p>Enriched KEGG pathways in the networks inferred by BoostDiff for the CD dataset. The resulting differential networks are strongly enriched in inflammation-related and other relevant pathways, consistent with known disease pathophysiology.</p>
          </caption>
          <graphic xlink:href="vbae034f5" position="float"/>
        </fig>
        <p>The Louvain algorithm is then applied on the differential networks to refine the results. For Diffcoex and Differential GENIE3, none of the modules show significant CD-related enrichment. For <italic toggle="yes">z</italic>-score, one module is enriched in metabolism-related genes (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S15</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S16</xref>). The EBcoexpress network contains a module that is enriched in inflammation-related terms ‘Natural killer cell mediated cytotoxicity,’ ‘NF-<inline-formula id="IE82"><mml:math id="IM82" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>B signaling pathway,’ and ‘TNF signaling pathway’ (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S16</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S17</xref>). On the other hand, the BoostDiff network contains a module enriched in the terms ‘Necroptosis,’ ‘Apoptosis,’ and ‘TNF signaling pathway’ (<xref rid="vbae034-F6" ref-type="fig">Fig. 6</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S18</xref>). CD is characterized by inflammation in the intestinal mucosa leading to necroptosis, autophagy, and apoptosis. TLRs, such as TLR3, are central players in microbial defense in the gut that trigger downstream inflammatory signaling pathways, such as NF-<inline-formula id="IE83"><mml:math id="IM83" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>B (<xref rid="vbae034-B49" ref-type="bibr">Lu <italic toggle="yes">et al.</italic> 2018</xref>). The complex roles of caspases, including CASP1, CASP8, and CASP10, are also known to drive gut inflammation and tissue damage (<xref rid="vbae034-B50" ref-type="bibr">Mandal <italic toggle="yes">et al.</italic> 2018</xref>). <italic toggle="yes">CHUCK</italic> is a member of the NF-<inline-formula id="IE84"><mml:math id="IM84" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>B signaling pathway that functions in chemokine signaling (<xref rid="vbae034-B2" ref-type="bibr">Awane <italic toggle="yes">et al.</italic> 1999</xref>). Aberrant STAT1 and STAT3 signaling in IBD pathogenesis has been previously established (<xref rid="vbae034-B65" ref-type="bibr">Nieminen <italic toggle="yes">et al.</italic> 2013</xref>). The protective role of chemokine-like receptor 1 (CMKLR1) against microbiota-driven colitis has been reported (<xref rid="vbae034-B47" ref-type="bibr">Lin <italic toggle="yes">et al.</italic> 2022</xref>). <italic toggle="yes">TRIM40</italic> drives IBD pathogenesis by targeting cell-cell junctions in the mucosal epithelial barrier and promoting inflammation in the gut (<xref rid="vbae034-B66" ref-type="bibr">Noguchi <italic toggle="yes">et al.</italic> 2011</xref>, <xref rid="vbae034-B37" ref-type="bibr">Kang <italic toggle="yes">et al.</italic> 2023</xref>). Disturbances in the circadian rhythm are also linked to IBD manifestations (<xref rid="vbae034-B26" ref-type="bibr">Giebfried and Lorentz 2023</xref>); for instance, <italic toggle="yes">CLOCK</italic> expression is disrupted in IBD patients (<xref rid="vbae034-B85" ref-type="bibr">Weintraub <italic toggle="yes">et al.</italic> 2020</xref>, <xref rid="vbae034-B26" ref-type="bibr">Giebfried and Lorentz 2023</xref>). Interestingly, BoostDiff identifies an edge between <italic toggle="yes">CLOCK</italic> and <italic toggle="yes">STAT3</italic>, which could point to a candidate regulatory mechanism where the circadian clock influences <italic toggle="yes">STAT3</italic>, a known driver of the CD phenotype. Thus, this dependency could point to further research in this direction.</p>
        <fig position="float" id="vbae034-F6">
          <label>Figure 6.</label>
          <caption>
            <p>Dysregulated module identified from the CD differential network output by BoostDiff. Notable genes include <italic toggle="yes">CLOCK, TRIM40, IL7, TLR3, CASP1, STAT3, STAT1, CASP8, CASP10, CMKLR1</italic>, and <italic toggle="yes">CHUK</italic>.</p>
          </caption>
          <graphic xlink:href="vbae034f6" position="float"/>
        </fig>
      </sec>
      <sec>
        <title>3.2.3 Stress response in <italic toggle="yes">Bacillus subtilis</italic></title>
        <p>BoostDiff also outperforms its competitors on the <italic toggle="yes">B.subtilis</italic> data (<xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S19–S28</xref>). The networks inferred by BoostDiff are found to be enriched in stress-related pathways for all three conditions (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S17</xref>). On the other hand, only the Differential GENIE3 network in the salt stress condition is enriched in stress-related pathways. For Diffcoex, only one of the networks (heat treatment) is significantly enriched in stress-related pathways.</p>
        <p>Next, we examine the networks based on the top hub genes. For the salt stress experiment, all the top ten hub genes in the differential network (<italic toggle="yes">csbD, S536, ohrB, yuzA, ywjC, S1199, S1379, yfhK, yycD, ywmE</italic>, and <italic toggle="yes">ybyB</italic>) are part of the SigB regulon (<xref rid="vbae034-F7" ref-type="fig">Fig. 7</xref>). Similarly, for the heat stress experiment, BoostDiff identifies members of the SigB regulon, namely, <italic toggle="yes">csbD, ohrB, S536, yuzA, S1199, yycD, ywjC, yfhK, ywmE</italic>, and <italic toggle="yes">nhaX</italic>, as hub genes. For the ethanol stress experiment, BoostDiff idebtifies <italic toggle="yes">yuzA, ydaD, yycD, ydaE, yocK, yjgB, yhdF, S1477</italic>, and <italic toggle="yes">ytaB</italic> as the top ten hubs. Consistent with the applied stressors, the abovementioned genes encoding response proteins are part of the SigB regulon. The general stress response is controlled by the alternative sigma factor SigB, which induces the transcription of &gt;100 genes across a wide range of stress stimuli (<xref rid="vbae034-B62" ref-type="bibr">Nannapaneni <italic toggle="yes">et al.</italic> 2012</xref>). On the other hand, the other methods identify fewer relevant hub genes or do not produce meaningful outputs. EBcoexpress assigns a total of 68 532 edges and 1 080 620 edges with a posterior probability of 1.0 for the salt stress and heat stress experiments, respectively, thereby hindering biological interpretation. For the ethanol stress experiment, EBcoexpress did not run even after stringent filtering because of strong correlations in the dataset. The <italic toggle="yes">z</italic>-score method only identifies <italic toggle="yes">ctc</italic> as the relevant hub gene in the salt stress condition and no relevant genes in the heat stress condition; for the ethanol experiment, the <italic toggle="yes">z</italic>-score method identifies the ribosomal gene <italic toggle="yes">rplJ</italic> as a hub, which is not directly involved in the stress response (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S18</xref>). For Diffcoex, only three members of the SigB regulon (<italic toggle="yes">ydbD, yqjL</italic>, and <italic toggle="yes">yvgO</italic>) are identified as hubs in the heat stress condition and one relevant hub (<italic toggle="yes">S1290</italic>) is identified in the salt stress condition; no relevant hub gene is identified in the ethanol stress condition (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S19</xref>). Differential GENIE3 identifies only <italic toggle="yes">yflD</italic> as a hub in the salt stress condition (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S20</xref>).</p>
        <fig position="float" id="vbae034-F7">
          <label>Figure 7.</label>
          <caption>
            <p>The differential networks identified by BoostDiff for the stress response experiments in <italic toggle="yes">B.subtilis</italic>. (a) The differential network inferred with the salt stress versus Spizizen’s minimal medium control comparison. (b) The differential network inferred with the heat stress versus Belitsky Minimal Medium (BMM) control comparison (c). The differential network inferred with the ethanol stress versus BMM control comparison. In all three conditions, the top ten hub genes identified by BoostDiff are members of the SigB regulon, which is induced in diverse stresses in <italic toggle="yes">B.subtilis</italic>.</p>
          </caption>
          <graphic xlink:href="vbae034f7" position="float"/>
        </fig>
      </sec>
      <sec>
        <title>3.2.4 TCGA—breast cancer</title>
        <p>Again, the network inferred by BoostDiff shows stronger enrichment of disease-related pathways (including ‘Transcriptional misregulation in cancer,’ ‘Pathways in cancer,’ ‘Proteoglycans in cancer,’ and ‘Signaling pathways regulating pluripotency of stem cells’) than networks inferred using Diffcoex, EBcoexpress, Differential GENIE3, or the <italic toggle="yes">z</italic>-score method (<xref rid="vbae034-F8" ref-type="fig">Fig. 8</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S29–S32</xref>). Only the Diffcoex network is enriched in inflammatory and cancer-related pathways. Ebcoexpress assigns a posterior probability of 1 to 375 873 edges, while the <italic toggle="yes">z</italic>-score network is enriched in one term, ‘Tight junction’ (<xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S30 and S31</xref>). The network inferred by Differential GENIE3 is enriched in terms related to olfactory transduction and metabolism (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S32</xref>). For BoostDiff, the results of enrichment analysis when considering the two sub-analyses separately shows generally similar results (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S21</xref>). The nodes in the BoostDiff network have a small overlap with the list of DEGs (<inline-formula id="IE85"><mml:math id="IM85" display="inline" overflow="scroll"><mml:mrow><mml:mtext>Jaccard similarity</mml:mtext><mml:mo>=</mml:mo><mml:mn>0.126</mml:mn></mml:mrow></mml:math></inline-formula>). Enrichment results after removal of DEGs are similar to those of the original network (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S22</xref>).</p>
        <fig position="float" id="vbae034-F8">
          <label>Figure 8.</label>
          <caption>
            <p>Enriched KEGG pathways in the networks inferred by BoostDiff for the TCGA BRCA dataset.</p>
          </caption>
          <graphic xlink:href="vbae034f8" position="float"/>
        </fig>
        <p>No BRCA-related module is found in the Differential GENIE3 network. Module analysis for Diffcoex identifies a module that is primarily enriched in generic inflammation-related pathways, such as ‘IL-17 signaling pathway,’ ‘TNF signaling pathway,’ and ‘JAK-STAT signaling pathway.’ (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S23</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S33</xref>). BoostDiff results are more specific: Here, we identify a module that is enriched in the terms ‘PPAR signaling pathway,’ ‘Insulin resistance,’ ‘AMPK signaling pathway,’ ‘Adipocytokine signaling pathway,’ ‘Pyruvate metabolism,’ and ‘Regulation of lipolysis in adipocytes’ (<xref rid="vbae034-F9" ref-type="fig">Fig. 9</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S34</xref>). Adipose tissue plays an important role in tumor progression because it provides nutrients, metabolites, and adipokines to the tumor microenvironment of breast cancer cells (<xref rid="vbae034-B18" ref-type="bibr">DeBerardinis <italic toggle="yes">et al.</italic> 2008</xref>, <xref rid="vbae034-B28" ref-type="bibr">Guaita-Esteruelas <italic toggle="yes">et al.</italic> 2017</xref>). PPAR is a ligand-activated TF that is involved in fatty acid oxidation and lipid metabolism (<xref rid="vbae034-B44" ref-type="bibr">Lee <italic toggle="yes">et al.</italic> 2019</xref>). In the context of BRCA, PPAR signaling is known to contribute to metastasis and promote survival in harsh metabolic conditions (<xref rid="vbae034-B70" ref-type="bibr">Saez <italic toggle="yes">et al.</italic> 2004</xref>, <xref rid="vbae034-B84" ref-type="bibr">Wang <italic toggle="yes">et al.</italic> 2016</xref>).</p>
        <fig position="float" id="vbae034-F9">
          <label>Figure 9.</label>
          <caption>
            <p>Dysregulated Louvain module for the TCGA BRCA dataset. Notable genes include <italic toggle="yes">PPARG, PLIN1, PLIN4, CD36, ESR2, ADIPOQ, FABP4, PCK1, CEBPA, MEOX1</italic>, and <italic toggle="yes">MEOX2</italic>.</p>
          </caption>
          <graphic xlink:href="vbae034f9" position="float"/>
        </fig>
        <p>The BoostDiff results not only make sense in light of the enriched pathways, but also when zooming-in on the individual edges and hub nodes: For instance, BoostDiff identifies a relationship between <italic toggle="yes">PPARG</italic> and <italic toggle="yes">PLIN4</italic>, which are already known to be associated in the context of adipogenesis (<xref rid="vbae034-B64" ref-type="bibr">Nielsen <italic toggle="yes">et al.</italic> 2008</xref>). Perilipins comprise lipid droplet-associated proteins that modulate lipid homeostasis. In BRCA, <italic toggle="yes">PLIN4</italic> upregulation is associated with poor prognosis (<xref rid="vbae034-B39" ref-type="bibr">Kim <italic toggle="yes">et al.</italic> 2015</xref>, <xref rid="vbae034-B91" ref-type="bibr">Zhang <italic toggle="yes">et al.</italic> 2021</xref>). BoostDiff also predicts an edge between <italic toggle="yes">PPARG</italic> and <italic toggle="yes">PCK1</italic>, which is also part of the PPAR pathway. <italic toggle="yes">PCK1</italic> encodes a protein kinase that has multiple known metabolic roles, including lipogenesis and tumorigenesis (<xref rid="vbae034-B79" ref-type="bibr">Tang <italic toggle="yes">et al.</italic> 2021</xref>). BoostDiff identifies <italic toggle="yes">CD36</italic> as a hub gene in the module. In BRCA, <italic toggle="yes">CD36</italic> has been reported to be involved in metabolic rewiring and reprogramming favoring fatty acid oxidation and has been proposed as a therapeutic target in breast cancer (<xref rid="vbae034-B23" ref-type="bibr">Feng <italic toggle="yes">et al.</italic> 2019</xref>). BoostDiff further identified an edge between <italic toggle="yes">CD36</italic> and <italic toggle="yes">FABP4</italic>. In BRCA, CD36 was shown to directly interact with FABP4 to influence transport and metabolism of fatty acids (<xref rid="vbae034-B29" ref-type="bibr">Gyamfi <italic toggle="yes">et al.</italic> 2021</xref>). Further, <italic toggle="yes">CD36</italic> is upregulated along with other lipid metabolism genes <italic toggle="yes">PLIN1</italic> and <italic toggle="yes">ADIPOQ</italic> (adiponectin) in breast cancer (<xref rid="vbae034-B53" ref-type="bibr">Marino <italic toggle="yes">et al.</italic> 2020</xref>).</p>
        <p>The correlation between <italic toggle="yes">ESR2</italic> and <italic toggle="yes">ADIPOQ</italic> in adipose tissue is also established (<xref rid="vbae034-B1" ref-type="bibr">Ahmed <italic toggle="yes">et al.</italic> 2022</xref>). While this specific relationship has not been described in breast cancer, this could be investigated in future studies, given the established role of estrogens and adiposity in breast cancer (<xref rid="vbae034-B6" ref-type="bibr">Bhardwaj and Brown 2021</xref>). Along with <italic toggle="yes">PPARG, CEBPA</italic> is a known master regulator of adipogenesis that influences lipid accumulation (<xref rid="vbae034-B44" ref-type="bibr">Lee <italic toggle="yes">et al.</italic> 2019</xref>). Here, <italic toggle="yes">CEBPA</italic> is associated with <italic toggle="yes">ADIPOQ</italic>, another adipocyte marker (<xref rid="vbae034-B55" ref-type="bibr">Matulewicz <italic toggle="yes">et al.</italic> 2017</xref>). Other identified TFs include <italic toggle="yes">MEOX1</italic> and <italic toggle="yes">MEOX2</italic>, which are involved in angiogenesis and vascular development (<xref rid="vbae034-B72" ref-type="bibr">Schönrock <italic toggle="yes">et al.</italic> 2022</xref>, <xref rid="vbae034-B83" ref-type="bibr">Wang <italic toggle="yes">et al.</italic> 2022</xref>, <xref rid="vbae034-B89" ref-type="bibr">Zeng <italic toggle="yes">et al.</italic> 2023</xref>). For instance, <italic toggle="yes">MEOX1</italic> expression was found to be associated with tumor growth triple-negative BRCA (<xref rid="vbae034-B89" ref-type="bibr">Zeng <italic toggle="yes">et al.</italic> 2023</xref>). Based on their emerging roles in neoplastic diseases, MEOX1 and MEOX2 could be candidate targets in breast cancer. Overall, our results identify genes that can be further explored and reinforce the important role of adipogenesis in breast cancer.</p>
      </sec>
      <sec>
        <title>3.2.5 TCGA—prostate adenocarcinoma</title>
        <p>For PRAD, the EBcoexpress network is too large to analyze, as 375 873 edges are assigned with posterior probability of 1, while the <italic toggle="yes">z</italic>-score network is not significantly enriched in any terms. The Diffcoex network is enriched in infection- and cancer-related terms, while the Differential GENIE3 network is enriched in terms related to metabolism. On the other hand, the BoostDiff network shows overall stronger enrichment of cancer-related terms (<xref rid="vbae034-F10" ref-type="fig">Fig. 10</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S35–S37</xref>). The nodes in the BoostDiff network have a small overlap with the list of DEGs (<inline-formula id="IE86"><mml:math id="IM86" display="inline" overflow="scroll"><mml:mrow><mml:mtext>Jaccard similarity</mml:mtext><mml:mo>=</mml:mo><mml:mn>0.114</mml:mn></mml:mrow></mml:math></inline-formula>). The results of enrichment analysis when considering the two sub-analyses separately shows generally similar results (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S24</xref>). Enrichment results after removal of DEGs are similar to those of the original network (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S25</xref>).</p>
        <fig position="float" id="vbae034-F10">
          <label>Figure 10.</label>
          <caption>
            <p>Enriched KEGG pathways in the networks inferred by BoostDiff for the TCGA PRAD dataset.</p>
          </caption>
          <graphic xlink:href="vbae034f10" position="float"/>
        </fig>
        <p>For Diffcoex, we identify a cancer-associated module enriched in terms such as ‘Cell cycle,’ ‘Cellular senescence,’ and ‘Bladder cancer’ (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S26</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S38</xref>). None of the modules in the <italic toggle="yes">z</italic>-score and Differential GENIE3 networks show significant enrichment of cancer-related terms. For BoostDiff, we identify a module enriched in the terms ‘Transcriptional misregulation in cancer,’ ‘Adrenergic signaling in cardiomyocytes,’ ‘Dilated cardiomyopathy,’ ‘Thyroid hormone signaling pathway,’ ‘Cardiac muscle contraction,’ and ‘Pathways in cancer’ (<xref rid="vbae034-F11" ref-type="fig">Fig. 11</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S39</xref>). The module contains MEF2C, a TF known to be involved in oncogenesis and tumor proliferation in many types of cancers (<xref rid="vbae034-B3" ref-type="bibr">Bai <italic toggle="yes">et al.</italic> 2015</xref>, <xref rid="vbae034-B20" ref-type="bibr">Di Giorgio <italic toggle="yes">et al.</italic> 2017</xref>). <italic toggle="yes">TEAD4</italic> was found to be an important prognostic marker in PRAD and is a known effector of oncogenic pathways (<xref rid="vbae034-B13" ref-type="bibr">Chen <italic toggle="yes">et al.</italic> 2021</xref>). The potential involvement of <italic toggle="yes">MYH7</italic> in PRAD has been recently described; in particular (<xref rid="vbae034-B46" ref-type="bibr">Liang <italic toggle="yes">et al.</italic> 2022</xref>), found a higher frequency of <italic toggle="yes">MYH7</italic> variants in prostate cancer patients. <italic toggle="yes">CAMK2A</italic> is known to promote tumor progression in prostate cancer (<xref rid="vbae034-B69" ref-type="bibr">Rokhlin <italic toggle="yes">et al.</italic> 2007</xref>, <xref rid="vbae034-B32" ref-type="bibr">He and Li 2021</xref>). In an earlier study, protein-protein interaction network-based analyses similarly identified <italic toggle="yes">ACTN2, MYL1, MYL2</italic>, and <italic toggle="yes">MYH7</italic> as hub genes associated with <italic toggle="yes">PTEN</italic>-associated prostate cancer (<xref rid="vbae034-B77" ref-type="bibr">Sun <italic toggle="yes">et al.</italic> 2019</xref>). The dysregulation of <italic toggle="yes">ACTN2</italic> and <italic toggle="yes">MYH7</italic> has been described in the context of other cancers (<xref rid="vbae034-B36" ref-type="bibr">Ju <italic toggle="yes">et al.</italic> 2023</xref>). Our results suggest that candidate genes in the identified module can be further examined in the context of prostate cancer.</p>
        <fig position="float" id="vbae034-F11">
          <label>Figure 11.</label>
          <caption>
            <p>Dysregulated Louvain module for the TCGA PRAD dataset. Notable genes include <italic toggle="yes">MEF2C, MYL1, MYH6, MYH7, MYL2, ACTN2, CAMK2A</italic>, and <italic toggle="yes">TEAD4</italic>.</p>
          </caption>
          <graphic xlink:href="vbae034f11" position="float"/>
        </fig>
      </sec>
      <sec>
        <title>3.2.6 Expression distributions of top-ranked edges identified by BoostDiff reflect shifts in correlation distributions</title>
        <p>We additionally examine the Pearson correlations of the top edges from the differential networks identified by BoostDiff using the original expression data. This procedure is performed separately for the results of the two sub-analyses, namely, when the disease condition is used as the target condition, and when the control condition is used as the target condition. For the COVID-19 and CD datasets, for the same set of edges, we observe a unimodal distribution of correlation values in the nontarget condition and a bimodal distribution in the target condition, where strong positive correlation values suggest target-condition-specific activating regulator-target relationship, while negative values indicate target-condition-specific inhibitory relationships (<xref rid="vbae034-F12" ref-type="fig">Fig. 12</xref>). Similar observations can be derived for the <italic toggle="yes">B.subtilis</italic> stress adaptation and TCGA datasets (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S27</xref>). That is, expression levels of genes incident with differential edges returned by BoostDiff tend to exhibit highly condition-specific correlation patterns, indicating that BoostDiff can indeed uncover disease-specific gene dysregulation. Importantly, this striking observation does not hold for the set of all pairwise edges whose endpoints are DEGs or for randomly selected edges. For Differential GENIE3, similar patterns were observed for the salt stress and ethanol stress networks (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S28</xref>). However, no consistent patterns are observed when the same analysis is performed on the networks inferred from the human datasets (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S29</xref>).</p>
        <fig position="float" id="vbae034-F12">
          <label>Figure 12.</label>
          <caption>
            <p>Violin plots showing that the top 500 edges in the differential network predicted by BoostDiff for each sub-analysis tend to exhibit changes in correlation distributions between the disease and control expression data, indicating dysregulation in pairwise relationships. Correlations between predicted differential edges are compared to correlations between all pairwise combinations of DEGs, as well as randomly selected edges. Results are shown for (a) COVID-19, (b) CD, (c) TCGA—BRCA, and (d) TCGA—PRAD datasets.</p>
          </caption>
          <graphic xlink:href="vbae034f12" position="float"/>
        </fig>
      </sec>
    </sec>
  </sec>
  <sec>
    <title>4 Conclusions</title>
    <p>Gene regulation is a complex process that changes under different biological contexts. Differential network biology explores the rewiring of these regulatory interaction landscapes that are fundamentally distinct from the static networks that are inferred in most standard GRN inference methods (<xref rid="vbae034-B35" ref-type="bibr">Ideker and Krogan 2012</xref>). By additionally considering the regulatory dependencies from a baseline condition, we can uncover a more refined picture underlying the molecular processes that are perturbed in a condition of interest, such as disease.</p>
    <p>Inference of networks from biological expression data is a challenging task. The novelty of BoostDiff is 2-fold: (i) We use differential variance improvement as the splitting measure in a tree-based algorithm that can explicitly compare two datasets with a continuous output variable; (ii) BoostDiff adapts the AdaBoost algorithm to use differential trees as the base learner. Boosting the differential trees with respect to samples belonging to the target condition is a crucial step that significantly improves the detection of differential edges.</p>
    <p>BoostDiff outperforms existing differential network methods on simulated data in more complex settings with higher dimensionality. BoostDiff yields biologically meaningful results when evaluated on five real-world transcriptomics datasets. We show that BoostDiff infers differential networks that are consistent with the pathophysiology of COVID-19, Crohn’s disease, and two types of cancer, namely, breast cancer and prostate adenocarcinoma, using TCGA data. We further validate BoostDiff using three different stress conditions evaluating the response of <italic toggle="yes">B.subtilis</italic> to salt, heat, and ethanol stressors, where BoostDiff correctly identifies members of the SigB regulon as hub genes in the differential networks. On the other hand, the compared methods recover few stress-related response genes. BoostDiff is also scalable and has reasonable runtime since it builds one model for each gene and can hence easily be parallelized. To facilitate biological interpretation and further refine the results, various graph-based algorithms can be used to find highly connected subnetworks. In this study, we apply the Louvain community detection algorithm, although other graph-based tools can also be used to find perturbed modules.</p>
    <p>Nevertheless, our method has several limitations. First, BoostDiff can only compare two conditions at a time. Moreover, BoostDiff is similar to GENIE3 in that it does not perform statistical testing. Instead, scores are assigned to individual edges by calculating tree-based variable importance measures; thus, only the ranking of the edge weights is considered. Further, the AdaBoost algorithm can be prone to overfitting. In our experiments, BoostDiff performance decreased when setting the number of trees to 300. Thus, to avoid overfitting, we recommend users to set a low number of base differential trees (e.g. 50 trees).</p>
    <p>The application of BoostDiff is not limited to gene expression data; the proposed feature selection approach can be generalized to other omics datasets. For instance, BoostDiff can be applied to proteomics or metabolomics studies that aim to detect changes in dependencies of proteins or metabolites. Moreover, the simple but effective strategy implemented in BoostDiff is an algorithmic advancement that can be further extended to other problems that aim to extract differentially predictive features. Adapting BoostDiff for analyzing time-series datasets is also a promising research direction.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>vbae034_Supplementary_Data</label>
      <media xlink:href="vbae034_supplementary_data.zip"/>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ack1">
    <title>Acknowledgements</title>
    <p>We are grateful to Julian Beier for technical support. We thank the anonymous reviewers for their valuable suggestions.</p>
  </ack>
  <sec>
    <title>Author contributions</title>
    <p>G.G.: Conceptualization, Formal analysis, Methodology, Software, Writing—original draft. M.L.: Conceptualization, Writing—Review &amp; Editing. J.B.: Conceptualization, Writing—Review &amp; Editing. U.V.: Validation, Writing—Review &amp; Editing. U.M.: Validation, Writing—Review &amp; Editing. D.B.B.: Conceptualization, Methodology, Supervision, Writing—Review &amp; Editing. T.K.: Conceptualization, Methodology, Supervision, Writing—Review &amp; Editing.</p>
  </sec>
  <sec>
    <title>Supplementary data</title>
    <p><xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> are available at <italic toggle="yes">Bioinformatics Advances</italic> online.</p>
  </sec>
  <sec sec-type="COI-statement">
    <title>Conflict of interest</title>
    <p>None declared.</p>
  </sec>
  <sec>
    <title>Funding</title>
    <p>This work was supported by the German Federal Ministry of Education and Research (BMBF) [031L0309A to D.B.B.]; and the Open Access Publication Funds of Technische Universität Braunschweig.</p>
  </sec>
  <sec sec-type="data-availability">
    <title>Data availability</title>
    <p>The data used in this article are publicly available. Transcriptomics data used for analyzing the COVID-19, Crohn’s disease, and <italic toggle="yes">Bacillus subtilis</italic> stress response can be downloaded from Gene Expression Omnibus under the accession numbers GSE156063, GSE126124, and GSE27219, respecively. The TCGA datasets are available at <ext-link xlink:href="https://xenabrowser.net/datapages/" ext-link-type="uri">https://xenabrowser.net/datapages/</ext-link>. The simulated gene expression data are deposited at <ext-link xlink:href="https://zenodo.org/records/10214950" ext-link-type="uri">https://zenodo.org/records/10214950</ext-link>. Our BoostDiff implementation, as well as sample scripts and tutorials are available on GitHub: <ext-link xlink:href="https://github.com/scibiome/boostdiff_inference" ext-link-type="uri">https://github.com/scibiome/boostdiff_inference</ext-link>.</p>
  </sec>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="vbae034-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ahmed</surname><given-names>F</given-names></string-name>, <string-name><surname>Hetty</surname><given-names>S</given-names></string-name>, <string-name><surname>Vranic</surname><given-names>M</given-names></string-name></person-group><etal>et al</etal><article-title>ESR2 expression in subcutaneous adipose tissue is related to body fat distribution in women, and knockdown impairs preadipocyte differentiation</article-title>. <source>Adipocyte</source><year>2022</year>;<volume>11</volume>:<fpage>434</fpage>–<lpage>47</lpage>.<pub-id pub-id-type="pmid">35856485</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Awane</surname><given-names>M</given-names></string-name>, <string-name><surname>Andres</surname><given-names>PG</given-names></string-name>, <string-name><surname>Li</surname><given-names>DJ</given-names></string-name></person-group><etal>et al</etal><article-title>Nf-<inline-formula id="IE87"><mml:math id="IM87" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>b-inducing kinase is a common mediator of il-17-, tnf-<inline-formula id="IE88"><mml:math id="IM88" display="inline" overflow="scroll"><mml:mo>α</mml:mo></mml:math></inline-formula>-, and il-1<inline-formula id="IE89"><mml:math id="IM89" display="inline" overflow="scroll"><mml:mo>β</mml:mo></mml:math></inline-formula>-induced chemokine promoter activation in intestinal epithelial cells</article-title>. <source>J Immunol</source><year>1999</year>;<volume>162</volume>:<fpage>5337</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="pmid">10228009</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bai</surname><given-names>XL</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Q</given-names></string-name>, <string-name><surname>Ye</surname><given-names>LY</given-names></string-name></person-group><etal>et al</etal><article-title>Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth factor and Wnt/<inline-formula id="IE90"><mml:math id="IM90" display="inline" overflow="scroll"><mml:mo>β</mml:mo></mml:math></inline-formula>-catenin signaling</article-title>. <source>Oncogene</source><year>2015</year>;<volume>34</volume>:<fpage>4089</fpage>–<lpage>97</lpage>.<pub-id pub-id-type="pmid">25328135</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Basha</surname><given-names>O</given-names></string-name>, <string-name><surname>Argov</surname><given-names>CM</given-names></string-name>, <string-name><surname>Artzy</surname><given-names>R</given-names></string-name></person-group><etal>et al</etal><article-title>Differential network analysis of multiple human tissue interactomes highlights tissue-selective processes and genetic disorder genes</article-title>. <source>Bioinformatics</source><year>2020</year>;<volume>36</volume>:<fpage>2821</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">31960892</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Baur</surname><given-names>B</given-names></string-name>, <string-name><surname>Shin</surname><given-names>J</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>Data integration for inferring context-specific gene regulatory networks</article-title>. <source>Curr Opin Syst Biol</source><year>2020</year>;<volume>23</volume>:<fpage>38</fpage>–<lpage>46</lpage>.<pub-id pub-id-type="pmid">33225112</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bhardwaj</surname><given-names>P</given-names></string-name>, <string-name><surname>Brown</surname><given-names>KA.</given-names></string-name></person-group><article-title>Obese adipose tissue as a driver of breast cancer growth and development: update and emerging evidence</article-title>. <source>Front Oncol</source><year>2021</year>;<volume>11</volume>:<fpage>638918</fpage>.<pub-id pub-id-type="pmid">33859943</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bhuva</surname><given-names>DD</given-names></string-name>, <string-name><surname>Cursons</surname><given-names>J</given-names></string-name>, <string-name><surname>Smyth</surname><given-names>GK</given-names></string-name></person-group><etal>et al</etal><article-title>Differential co-expression-based detection of conditional relationships in transcriptional data: comparative analysis and application to breast cancer</article-title>. <source>Genome Biol</source><year>2019</year>;<volume>20</volume>:<fpage>236</fpage>.<pub-id pub-id-type="pmid">31727119</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Blondel</surname><given-names>VD</given-names></string-name>, <string-name><surname>Guillaume</surname><given-names>J-L</given-names></string-name>, <string-name><surname>Lambiotte</surname><given-names>R</given-names></string-name></person-group><etal>et al</etal> Fast unfolding of communities in large networks. <italic toggle="yes">J Stat Mech</italic><year>2008</year>;<volume>2008</volume>:P10008.</mixed-citation>
    </ref>
    <ref id="vbae034-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Breiman</surname><given-names>L</given-names></string-name>, <string-name><surname>Friedman</surname><given-names>J</given-names></string-name>, <string-name><surname>Olshen</surname><given-names>R</given-names></string-name></person-group><etal>et al</etal><article-title>Classification and regression trees</article-title>. <source>Wadsworth Int Group</source><year>1984</year>;<volume>37</volume>:<fpage>237</fpage>–<lpage>51</lpage>.</mixed-citation>
    </ref>
    <ref id="vbae034-B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brunel</surname><given-names>H</given-names></string-name>, <string-name><surname>Gallardo-Chacón</surname><given-names>J-J</given-names></string-name>, <string-name><surname>Buil</surname><given-names>A</given-names></string-name></person-group><etal>et al</etal><article-title>MISS: a non-linear methodology based on mutual information for genetic association studies in both population and sib-pairs analysis</article-title>. <source>Bioinformatics</source><year>2010</year>;<volume>26</volume>:<fpage>1811</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">20562420</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Callahan</surname><given-names>V</given-names></string-name>, <string-name><surname>Hawks</surname><given-names>S</given-names></string-name>, <string-name><surname>Crawford</surname><given-names>MA</given-names></string-name></person-group><etal>et al</etal> The pro-inflammatory chemokines CXCL9, CXCL10 and CXCL11 are upregulated following SARS-CoV-2 infection in an AKT-dependent manner. Viruses <year>2021</year>;<volume>13</volume>:<fpage>1062</fpage>.</mixed-citation>
    </ref>
    <ref id="vbae034-B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cao</surname><given-names>X.</given-names></string-name></person-group><article-title>ISG15 secretion exacerbates inflammation in SARS-CoV-2 infection</article-title>. <source>Nat Immunol</source><year>2021</year>;<volume>22</volume>:<fpage>1360</fpage>–<lpage>2</lpage>.<pub-id pub-id-type="pmid">34671145</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B13">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>C-L</given-names></string-name>, <string-name><surname>Hsu</surname><given-names>S-C</given-names></string-name>, <string-name><surname>Chung</surname><given-names>T-Y</given-names></string-name></person-group><etal>et al</etal><article-title>Arginine is an epigenetic regulator targeting tead4 to modulate oxphos in prostate cancer cells</article-title>. <source>Nat Commun</source><year>2021</year>;<volume>12</volume>:<fpage>2398</fpage>.<pub-id pub-id-type="pmid">33893278</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B14">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chu</surname><given-names>J-H</given-names></string-name>, <string-name><surname>Lazarus</surname><given-names>R</given-names></string-name>, <string-name><surname>Carey</surname><given-names>VJ</given-names></string-name></person-group><etal>et al</etal><article-title>Quantifying differential gene connectivity between disease states for objective identification of disease-relevant genes</article-title>. <source>BMC Syst Biol</source><year>2011</year>;<volume>5</volume>:<fpage>89</fpage>.<pub-id pub-id-type="pmid">21627793</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B15">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Costello</surname><given-names>JC</given-names></string-name>, <string-name><surname>Heiser</surname><given-names>LM</given-names></string-name>, <string-name><surname>Georgii</surname><given-names>E</given-names></string-name></person-group><etal>et al</etal>; <collab>NCI DREAM Community</collab>. <article-title>A community effort to assess and improve drug sensitivity prediction algorithms</article-title>. <source>Nat. Biotechnol</source><year>2014</year>;<volume>32</volume>:<fpage>1202</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="pmid">24880487</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B16">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dawson</surname><given-names>JA</given-names></string-name>, <string-name><surname>Kendziorski</surname><given-names>C.</given-names></string-name></person-group><article-title>An empirical Bayesian approach for identifying differential coexpression in high-throughput experiments</article-title>. <source>Biometrics</source><year>2012</year>;<volume>68</volume>:<fpage>455</fpage>–<lpage>65</lpage>.<pub-id pub-id-type="pmid">22004327</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B17">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dawson</surname><given-names>JA</given-names></string-name>, <string-name><surname>Ye</surname><given-names>S</given-names></string-name>, <string-name><surname>Kendziorski</surname><given-names>C.</given-names></string-name></person-group><article-title>R/EBcoexpress: an empirical Bayesian framework for discovering differential co-expression</article-title>. <source>Bioinformatics</source><year>2012</year>;<volume>28</volume>:<fpage>1939</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="pmid">22595207</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B18">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>DeBerardinis</surname><given-names>RJ</given-names></string-name>, <string-name><surname>Lum</surname><given-names>JJ</given-names></string-name>, <string-name><surname>Hatzivassiliou</surname><given-names>G</given-names></string-name></person-group><etal>et al</etal><article-title>The biology of cancer: metabolic reprogramming fuels cell growth and proliferation</article-title>. <source>Cell Metab</source><year>2008</year>;<volume>7</volume>:<fpage>11</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="pmid">18177721</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B19">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>de la Fuente</surname><given-names>A.</given-names></string-name></person-group><article-title>From ‘differential expression’ to ‘differential networking’ – identification of dysfunctional regulatory networks in diseases</article-title>. <source>Trends Genet</source><year>2010</year>;<volume>26</volume>:<fpage>326</fpage>–<lpage>33</lpage>.<pub-id pub-id-type="pmid">20570387</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B20">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Di Giorgio</surname><given-names>E</given-names></string-name>, <string-name><surname>Franforte</surname><given-names>E</given-names></string-name>, <string-name><surname>Cefalù</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>The co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressiveness</article-title>. <source>PLoS Genet</source><year>2017</year>;<volume>13</volume>:<fpage>e1006752</fpage>.<pub-id pub-id-type="pmid">28419090</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B21">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Drucker</surname><given-names>H.</given-names></string-name></person-group><article-title>Improving regressors using boosting techniques</article-title>. In: <source>ICML</source>, July 8–12, 1997; Nashville, Tennessee, USA: Morgan Kaufmann, Vol. <volume>97</volume>, <year>1997</year>, <fpage>107</fpage>–<lpage>15</lpage>.</mixed-citation>
    </ref>
    <ref id="vbae034-B22">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Durinck</surname><given-names>S</given-names></string-name>, <string-name><surname>Spellman</surname><given-names>PT</given-names></string-name>, <string-name><surname>Birney</surname><given-names>E</given-names></string-name></person-group><etal>et al</etal><article-title>Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomart</article-title>. <source>Nat Protoc</source><year>2009</year>;<volume>4</volume>:<fpage>1184</fpage>–<lpage>91</lpage>.<pub-id pub-id-type="pmid">19617889</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B23">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Feng</surname><given-names>WW</given-names></string-name>, <string-name><surname>Wilkins</surname><given-names>O</given-names></string-name>, <string-name><surname>Bang</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>CD36-Mediated metabolic rewiring of breast cancer cells promotes resistance to HER2-Targeted therapies</article-title>. <source>Cell Rep</source><year>2019</year>;<volume>29</volume>:<fpage>3405</fpage>–<lpage>20.e5</lpage>.<pub-id pub-id-type="pmid">31825825</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B24">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gao</surname><given-names>L-J</given-names></string-name>, <string-name><surname>He</surname><given-names>Z-M</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y-Y</given-names></string-name></person-group><etal>et al</etal><article-title>Role of OAS gene family in COVID-19 induced heart failure</article-title>. <source>J Transl Med</source><year>2023</year>;<volume>21</volume>:<fpage>212</fpage>.<pub-id pub-id-type="pmid">36949448</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B25">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ge</surname><given-names>SX</given-names></string-name>, <string-name><surname>Jung</surname><given-names>D</given-names></string-name>, <string-name><surname>Yao</surname><given-names>R.</given-names></string-name></person-group><article-title>ShinyGO: a graphical gene-set enrichment tool for animals and plants</article-title>. <source>Bioinformatics</source><year>2020</year>;<volume>36</volume>:<fpage>2628</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">31882993</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B26">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Giebfried</surname><given-names>J</given-names></string-name>, <string-name><surname>Lorentz</surname><given-names>A.</given-names></string-name></person-group><article-title>Relationship between the biological clock and inflammatory bowel disease</article-title>. <source>Clocks Sleep</source><year>2023</year>;<volume>5</volume>:<fpage>260</fpage>–<lpage>75</lpage>.<pub-id pub-id-type="pmid">37218867</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B27">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Goldman</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Craft</surname><given-names>B</given-names></string-name>, <string-name><surname>Hastie</surname><given-names>M</given-names></string-name></person-group><etal>et al</etal><article-title>Visualizing and interpreting cancer genomics data via the xena platform</article-title>. <source>Nat Biotechnol</source><year>2020</year>;<volume>38</volume>:<fpage>675</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">32444850</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B28">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guaita-Esteruelas</surname><given-names>S</given-names></string-name>, <string-name><surname>Bosquet</surname><given-names>A</given-names></string-name>, <string-name><surname>Saavedra</surname><given-names>P</given-names></string-name></person-group><etal>et al</etal><article-title>Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins</article-title>. <source>Mol Carcinog</source><year>2017</year>;<volume>56</volume>:<fpage>208</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="pmid">27061264</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B29">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gyamfi</surname><given-names>J</given-names></string-name>, <string-name><surname>Yeo</surname><given-names>JH</given-names></string-name>, <string-name><surname>Kwon</surname><given-names>D</given-names></string-name></person-group><etal>et al</etal><article-title>Interaction between CD36 and FABP4 modulates adipocyte-induced fatty acid import and metabolism in breast cancer</article-title>. <source>NPJ Breast Cancer</source><year>2021</year>;<volume>7</volume>:<fpage>129</fpage>.<pub-id pub-id-type="pmid">34561446</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B30">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Han</surname><given-names>YM</given-names></string-name>, <string-name><surname>Koh</surname><given-names>J</given-names></string-name>, <string-name><surname>Kim</surname><given-names>JW</given-names></string-name></person-group><etal>et al</etal><article-title>NF-kappa B activation correlates with disease phenotype in Crohn’s disease</article-title>. <source>PLoS One</source><year>2017</year>;<volume>12</volume>:<fpage>e0182071</fpage>.<pub-id pub-id-type="pmid">28753650</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B31">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hasan</surname><given-names>M</given-names></string-name>, <string-name><surname>Koch</surname><given-names>J</given-names></string-name>, <string-name><surname>Rakheja</surname><given-names>D</given-names></string-name></person-group><etal>et al</etal><article-title>Trex1 regulates lysosomal biogenesis and interferon-independent activation of antiviral genes</article-title>. <source>Nat Immunol</source><year>2013</year>;<volume>14</volume>:<fpage>61</fpage>–<lpage>71</lpage>.<pub-id pub-id-type="pmid">23160154</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B32">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>He</surname><given-names>Q</given-names></string-name>, <string-name><surname>Li</surname><given-names>Z.</given-names></string-name></person-group><article-title>The dysregulated expression and functional effect of CaMK2 in cancer</article-title>. <source>Cancer Cell Int</source><year>2021</year>;<volume>21</volume>:<fpage>326</fpage>.<pub-id pub-id-type="pmid">34193145</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B33">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hug</surname><given-names>H</given-names></string-name>, <string-name><surname>Mohajeri</surname><given-names>MH</given-names></string-name>, <string-name><surname>La Fata</surname><given-names>G.</given-names></string-name></person-group><article-title>Toll-Like receptors: regulators of the immune response in the human gut</article-title>. <source>Nutrients</source><year>2018</year>;<volume>10</volume>:<fpage>203</fpage>.<pub-id pub-id-type="pmid">29438282</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B34">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huynh-Thu</surname><given-names>VA</given-names></string-name>, <string-name><surname>Irrthum</surname><given-names>A</given-names></string-name>, <string-name><surname>Wehenkel</surname><given-names>L</given-names></string-name></person-group><etal>et al</etal><article-title>Inferring regulatory networks from expression data using tree-based methods</article-title>. <source>PLoS One</source><year>2010</year>;<volume>5</volume>:<fpage>203</fpage>.</mixed-citation>
    </ref>
    <ref id="vbae034-B35">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ideker</surname><given-names>T</given-names></string-name>, <string-name><surname>Krogan</surname><given-names>NJ.</given-names></string-name></person-group><article-title>Differential network biology</article-title>. <source>Mol Syst Biol</source><year>2012</year>;<volume>8</volume>:<fpage>565</fpage>.<pub-id pub-id-type="pmid">22252388</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B36">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ju</surname><given-names>G</given-names></string-name>, <string-name><surname>Yao</surname><given-names>Z</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>Y</given-names></string-name></person-group><etal>et al</etal><article-title>Data mining on identifying diagnosis and prognosis biomarkers in head and neck squamous carcinoma</article-title>. <source>Sci Rep</source><year>2023</year>;<volume>13</volume>:<fpage>10020</fpage>.<pub-id pub-id-type="pmid">37340028</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B37">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kang</surname><given-names>S</given-names></string-name>, <string-name><surname>Kim</surname><given-names>J</given-names></string-name>, <string-name><surname>Park</surname><given-names>A</given-names></string-name></person-group><etal>et al</etal><article-title>TRIM40 is a pathogenic driver of inflammatory bowel disease subverting intestinal barrier integrity</article-title>. <source>Nat Commun</source><year>2023</year>;<volume>14</volume>:<fpage>700</fpage>.<pub-id pub-id-type="pmid">36755029</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B38">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Karlebach</surname><given-names>G</given-names></string-name>, <string-name><surname>Shamir</surname><given-names>R.</given-names></string-name></person-group><article-title>Modelling and analysis of gene regulatory networks</article-title>. <source>Nat Rev Mol Cell Biol</source><year>2008</year>;<volume>9</volume>:<fpage>770</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">18797474</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B39">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kim</surname><given-names>S</given-names></string-name>, <string-name><surname>Lee</surname><given-names>Y</given-names></string-name>, <string-name><surname>Koo</surname><given-names>JS.</given-names></string-name></person-group><article-title>Differential expression of lipid metabolism-related proteins in different breast cancer subtypes</article-title>. <source>PLoS One</source><year>2015</year>;<volume>10</volume>:<fpage>e0119473</fpage>.<pub-id pub-id-type="pmid">25751270</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B40">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>King</surname><given-names>CR</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y</given-names></string-name>, <string-name><surname>Amato</surname><given-names>KA</given-names></string-name></person-group><etal>et al</etal><article-title>Pathogen-driven CRISPR screens identify TREX1 as a regulator of DNA self-sensing during influenza virus infection</article-title>. <source>Cell Host Microbe</source><year>2023</year>;<volume>31</volume>:<fpage>1552</fpage>–<lpage>67.e8</lpage>.<pub-id pub-id-type="pmid">37652009</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B41">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kuijjer</surname><given-names>ML</given-names></string-name>, <string-name><surname>Tung</surname><given-names>MG</given-names></string-name>, <string-name><surname>Yuan</surname><given-names>G</given-names></string-name></person-group><etal>et al</etal><article-title>Estimating Sample-Specific regulatory networks</article-title>. <source>iScience</source><year>2019</year>;<volume>14</volume>:<fpage>226</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="pmid">30981959</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B42">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kuleshov</surname><given-names>MV</given-names></string-name>, <string-name><surname>Jones</surname><given-names>MR</given-names></string-name>, <string-name><surname>Rouillard</surname><given-names>AD</given-names></string-name></person-group><etal>et al</etal><article-title>Enrichr: a comprehensive gene set enrichment analysis web server 2016 update</article-title>. <source>Nucleic Acids Res</source><year>2016</year>;<volume>44</volume>:<fpage>W90</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">27141961</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B43">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lambert</surname><given-names>SA</given-names></string-name>, <string-name><surname>Jolma</surname><given-names>A</given-names></string-name>, <string-name><surname>Campitelli</surname><given-names>LF</given-names></string-name></person-group><etal>et al</etal><article-title>The human transcription factors</article-title>. <source>Cell</source><year>2018</year>;<volume>175</volume>:<fpage>598</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">30290144</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B44">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname><given-names>J-E</given-names></string-name>, <string-name><surname>Schmidt</surname><given-names>H</given-names></string-name>, <string-name><surname>Lai</surname><given-names>B</given-names></string-name></person-group><etal>et al</etal><article-title>Transcriptional and epigenomic regulation of adipogenesis</article-title>. <source>Mol Cell Biol</source><year>2019</year>;<volume>39</volume>:<fpage>e00601-18</fpage>.<pub-id pub-id-type="pmid">30936246</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B45">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Levy</surname><given-names>G</given-names></string-name>, <string-name><surname>Guglielmelli</surname><given-names>P</given-names></string-name>, <string-name><surname>Langmuir</surname><given-names>P</given-names></string-name></person-group><etal>et al</etal><article-title>JAK inhibitors and COVID-19</article-title>. <source>J Immunother Cancer</source><year>2022</year>;<volume>10</volume>:<fpage>e002838</fpage>.<pub-id pub-id-type="pmid">35459733</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B46">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Chiu</surname><given-names>PK-F</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>Y</given-names></string-name></person-group><etal>et al</etal><article-title>Whole-exome sequencing reveals a comprehensive germline mutation landscape and identifies twelve novel predisposition genes in Chinese prostate cancer patients</article-title>. <source>PLoS Genet</source><year>2022</year>;<volume>18</volume>:<fpage>e1010373</fpage>.<pub-id pub-id-type="pmid">36095024</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B47">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lin</surname><given-names>Y</given-names></string-name>, <string-name><surname>Cai</surname><given-names>Q</given-names></string-name>, <string-name><surname>Luo</surname><given-names>Y</given-names></string-name></person-group><etal>et al</etal><article-title>Epithelial chemerin–CMKLR1 signaling restricts microbiota-driven colonic neutrophilia and tumorigenesis by up-regulating lactoperoxidase</article-title>. <source>Proc Natl Acad Sci USA</source><year>2022</year>;<volume>119</volume>:<fpage>e2205574119</fpage>.<pub-id pub-id-type="pmid">35858331</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B48">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Love</surname><given-names>MI</given-names></string-name>, <string-name><surname>Huber</surname><given-names>W</given-names></string-name>, <string-name><surname>Anders</surname><given-names>S.</given-names></string-name></person-group><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>. <source>Genome Biol</source><year>2014</year>;<volume>15</volume>:<fpage>550</fpage>.<pub-id pub-id-type="pmid">25516281</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B49">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lu</surname><given-names>Y</given-names></string-name>, <string-name><surname>Li</surname><given-names>X</given-names></string-name>, <string-name><surname>Liu</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>Toll-like receptors and inflammatory bowel disease</article-title>. <source>Front Immunol</source><year>2018</year>;<volume>9</volume>:<fpage>72</fpage>.<pub-id pub-id-type="pmid">29441063</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B50">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mandal</surname><given-names>P</given-names></string-name>, <string-name><surname>Feng</surname><given-names>Y</given-names></string-name>, <string-name><surname>Lyons</surname><given-names>JD</given-names></string-name></person-group><etal>et al</etal><article-title>Caspase-8 collaborates with caspase-11 to drive tissue damage and execution of endotoxic shock</article-title>. <source>Immunity</source><year>2018</year>;<volume>49</volume>:<fpage>42</fpage>–<lpage>55.e6</lpage>.<pub-id pub-id-type="pmid">30021146</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B51">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Marbach</surname><given-names>D</given-names></string-name>, <string-name><surname>Costello</surname><given-names>JC</given-names></string-name>, <string-name><surname>Küffner</surname><given-names>R</given-names></string-name></person-group><etal>et al</etal>; <collab>DREAM5 Consortium</collab>. <article-title>Wisdom of crowds for robust gene network inference</article-title>. <source>Nat. Methods</source><year>2012</year>;<volume>9</volume>:<fpage>796</fpage>–<lpage>804</lpage>.<pub-id pub-id-type="pmid">22796662</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B52">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Margolin</surname><given-names>AA</given-names></string-name>, <string-name><surname>Nemenman</surname><given-names>I</given-names></string-name>, <string-name><surname>Basso</surname><given-names>K</given-names></string-name></person-group><etal>et al</etal><article-title>ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context</article-title>. <source>BMC Bioinformatics</source><year>2006</year>;<volume>7</volume>:<fpage>S7</fpage>.</mixed-citation>
    </ref>
    <ref id="vbae034-B53">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Marino</surname><given-names>N</given-names></string-name>, <string-name><surname>German</surname><given-names>R</given-names></string-name>, <string-name><surname>Rao</surname><given-names>X</given-names></string-name></person-group><etal>et al</etal><article-title>Upregulation of lipid metabolism genes in the breast prior to cancer diagnosis</article-title>. <source>NPJ Breast Cancer</source><year>2020</year>;<volume>6</volume>:<fpage>50</fpage>.<pub-id pub-id-type="pmid">33083529</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B54">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Matschinske</surname><given-names>J</given-names></string-name>, <string-name><surname>Alcaraz</surname><given-names>N</given-names></string-name>, <string-name><surname>Benis</surname><given-names>A</given-names></string-name></person-group><etal>et al</etal><article-title>The AIMe registry for artificial intelligence in biomedical research</article-title>. <source>Nat Methods</source><year>2021</year>;<volume>18</volume>:<fpage>1128</fpage>–<lpage>31</lpage>.<pub-id pub-id-type="pmid">34433960</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B55">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Matulewicz</surname><given-names>N</given-names></string-name>, <string-name><surname>Stefanowicz</surname><given-names>M</given-names></string-name>, <string-name><surname>Nikolajuk</surname><given-names>A</given-names></string-name></person-group><etal>et al</etal><article-title>Markers of adipogenesis, but not inflammation, in adipose tissue are independently related to insulin sensitivity</article-title>. <source>J Clin Endocrinol Metab</source><year>2017</year>;<volume>102</volume>:<fpage>3040</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">28633482</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B56">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mears</surname><given-names>HV</given-names></string-name>, <string-name><surname>Sweeney</surname><given-names>TR.</given-names></string-name></person-group><article-title>Better together: the role of IFIT protein–protein interactions in the antiviral response</article-title>. <source>J Gen Virol</source><year>2018</year>;<volume>99</volume>:<fpage>1463</fpage>–<lpage>77</lpage>.<pub-id pub-id-type="pmid">30234477</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B57">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Meyer</surname><given-names>PE</given-names></string-name>, <string-name><surname>Lafitte</surname><given-names>F</given-names></string-name>, <string-name><surname>Bontempi</surname><given-names>G.</given-names></string-name></person-group><article-title>minet: a R/Bioconductor package for inferring large transcriptional networks using mutual information</article-title>. <source>BMC Bioinformatics</source><year>2008</year>;<volume>9</volume>:<fpage>461</fpage>.<pub-id pub-id-type="pmid">18959772</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B58">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mick</surname><given-names>E</given-names></string-name>, <string-name><surname>Kamm</surname><given-names>J</given-names></string-name>, <string-name><surname>Pisco</surname><given-names>AO</given-names></string-name></person-group><etal>et al</etal><article-title>Upper airway gene expression reveals suppressed immune responses to SARS-CoV-2 compared with other respiratory viruses</article-title>. <source>Nat Commun</source><year>2020</year>;<volume>11</volume>:<fpage>5854</fpage>.<pub-id pub-id-type="pmid">33203890</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B59">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Moerman</surname><given-names>T</given-names></string-name>, <string-name><surname>Aibar Santos</surname><given-names>S</given-names></string-name>, <string-name><surname>Bravo González-Blas</surname><given-names>C</given-names></string-name></person-group><etal>et al</etal><article-title>GRNBoost2 and arboreto: efficient and scalable inference of gene regulatory networks</article-title>. <source>Bioinformatics</source><year>2019</year>;<volume>35</volume>:<fpage>2159</fpage>–<lpage>61</lpage>.<pub-id pub-id-type="pmid">30445495</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B60">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mu</surname><given-names>J</given-names></string-name>, <string-name><surname>Fang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Yang</surname><given-names>Q</given-names></string-name></person-group><etal>et al</etal><article-title>SARS-CoV-2 N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2</article-title>. <source>Cell Discov</source><year>2020</year>;<volume>6</volume>:<fpage>65</fpage>.<pub-id pub-id-type="pmid">32953130</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B61">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nagy-Staron</surname><given-names>A</given-names></string-name>, <string-name><surname>Tomasek</surname><given-names>K</given-names></string-name>, <string-name><surname>Caruso Carter</surname><given-names>C</given-names></string-name></person-group><etal>et al</etal><article-title>Local genetic context shapes the function of a gene regulatory network</article-title>. <source>Elife</source><year>2021</year>;<volume>10</volume>:<fpage>e65993</fpage>.<pub-id pub-id-type="pmid">33683203</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B62">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nannapaneni</surname><given-names>P</given-names></string-name>, <string-name><surname>Hertwig</surname><given-names>F</given-names></string-name>, <string-name><surname>Depke</surname><given-names>M</given-names></string-name></person-group><etal>et al</etal><article-title>Defining the structure of the general stress regulon of <italic toggle="yes">Bacillus subtilis</italic> using targeted microarray analysis and random forest classification</article-title>. <source>Microbiology (Reading)</source><year>2012</year>;<volume>158</volume>:<fpage>696</fpage>–<lpage>707</lpage>.<pub-id pub-id-type="pmid">22174379</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B63">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nicolas</surname><given-names>P</given-names></string-name>, <string-name><surname>Mäder</surname><given-names>U</given-names></string-name>, <string-name><surname>Dervyn</surname><given-names>E</given-names></string-name></person-group><etal>et al</etal><article-title>Condition-dependent transcriptome reveals high-level regulatory architecture in <italic toggle="yes">Bacillus subtilis</italic></article-title>. <source>Science</source><year>2012</year>;<volume>335</volume>:<fpage>1103</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">22383849</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B64">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nielsen</surname><given-names>R</given-names></string-name>, <string-name><surname>Pedersen</surname><given-names>TA</given-names></string-name>, <string-name><surname>Hagenbeek</surname><given-names>D</given-names></string-name></person-group><etal>et al</etal><article-title>Genome-wide profiling of PPARgamma: RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis</article-title>. <source>Genes Dev</source><year>2008</year>;<volume>22</volume>:<fpage>2953</fpage>–<lpage>67</lpage>.<pub-id pub-id-type="pmid">18981474</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B65">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nieminen</surname><given-names>JK</given-names></string-name>, <string-name><surname>Niemi</surname><given-names>M</given-names></string-name>, <string-name><surname>Sipponen</surname><given-names>T</given-names></string-name></person-group><etal>et al</etal><article-title>Dendritic cells from Crohn’s disease patients show aberrant STAT1 and STAT3 signaling</article-title>. <source>PLoS One</source><year>2013</year>;<volume>8</volume>:<fpage>e70738</fpage>.<pub-id pub-id-type="pmid">23950992</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B66">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Noguchi</surname><given-names>K</given-names></string-name>, <string-name><surname>Okumura</surname><given-names>F</given-names></string-name>, <string-name><surname>Takahashi</surname><given-names>N</given-names></string-name></person-group><etal>et al</etal><article-title>TRIM40 promotes neddylation of IKK<inline-formula id="IE91"><mml:math id="IM91" display="inline" overflow="scroll"><mml:mo>γ</mml:mo></mml:math></inline-formula> and is downregulated in gastrointestinal cancers</article-title>. <source>Carcinogenesis</source><year>2011</year>;<volume>32</volume>:<fpage>995</fpage>–<lpage>1004</lpage>.<pub-id pub-id-type="pmid">21474709</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B67">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Palmer</surname><given-names>NP</given-names></string-name>, <string-name><surname>Silvester</surname><given-names>JA</given-names></string-name>, <string-name><surname>Lee</surname><given-names>JJ</given-names></string-name></person-group><etal>et al</etal><article-title>Concordance between gene expression in peripheral whole blood and colonic tissue in children with inflammatory bowel disease</article-title>. <source>PLoS One</source><year>2019</year>;<volume>14</volume>:<fpage>e0222952</fpage>.<pub-id pub-id-type="pmid">31618209</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B68">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ritchie</surname><given-names>ME</given-names></string-name>, <string-name><surname>Phipson</surname><given-names>B</given-names></string-name>, <string-name><surname>Wu</surname><given-names>D</given-names></string-name></person-group><etal>et al</etal><article-title>limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title>. <source>Nucleic Acids Res</source><year>2015</year>;<volume>43</volume>:<fpage>e47</fpage>.<pub-id pub-id-type="pmid">25605792</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B69">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rokhlin</surname><given-names>OW</given-names></string-name>, <string-name><surname>Taghiyev</surname><given-names>AF</given-names></string-name>, <string-name><surname>Bayer</surname><given-names>KU</given-names></string-name></person-group><etal>et al</etal><article-title>Calcium/calmodulin-dependent kinase II plays an important role in prostate cancer cell survival</article-title>. <source>Cancer Biol Ther</source><year>2007</year>;<volume>6</volume>:<fpage>732</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="pmid">17387273</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B70">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Saez</surname><given-names>E</given-names></string-name>, <string-name><surname>Rosenfeld</surname><given-names>J</given-names></string-name>, <string-name><surname>Livolsi</surname><given-names>A</given-names></string-name></person-group><etal>et al</etal><article-title>PPAR gamma signaling exacerbates mammary gland tumor development</article-title>. <source>Genes Dev</source><year>2004</year>;<volume>18</volume>:<fpage>528</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="pmid">15037548</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B71">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schmitt</surname><given-names>H</given-names></string-name>, <string-name><surname>Neurath</surname><given-names>MF</given-names></string-name>, <string-name><surname>Atreya</surname><given-names>R.</given-names></string-name></person-group><article-title>Role of the IL23/IL17 pathway in Crohn’s disease</article-title>. <source>Front Immunol</source><year>2021</year>;<volume>12</volume>:<fpage>622934</fpage>.<pub-id pub-id-type="pmid">33859636</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B72">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schönrock</surname><given-names>A</given-names></string-name>, <string-name><surname>Heinzelmann</surname><given-names>E</given-names></string-name>, <string-name><surname>Steffl</surname><given-names>B</given-names></string-name></person-group><etal>et al</etal><article-title>MEOX2 homeobox gene promotes growth of malignant gliomas</article-title>. <source>Neuro Oncol</source><year>2022</year>;<volume>24</volume>:<fpage>1911</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">35468210</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B73">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shojaie</surname><given-names>A.</given-names></string-name></person-group><article-title>Differential network analysis: a statistical perspective</article-title>. <source>Wiley Interdiscip Rev Comput Stat</source><year>2021</year>;<volume>13</volume>:<fpage>e1508</fpage>.<pub-id pub-id-type="pmid">37050915</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B74">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Singh</surname><given-names>DK</given-names></string-name>, <string-name><surname>Aladyeva</surname><given-names>E</given-names></string-name>, <string-name><surname>Das</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>Myeloid cell interferon responses correlate with clearance of SARS-CoV-2</article-title>. <source>Nat Commun</source><year>2022</year>;<volume>13</volume>:<fpage>679</fpage>.<pub-id pub-id-type="pmid">35115549</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B75">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stetson</surname><given-names>DB</given-names></string-name>, <string-name><surname>Ko</surname><given-names>JS</given-names></string-name>, <string-name><surname>Heidmann</surname><given-names>T</given-names></string-name></person-group><etal>et al</etal><article-title>Trex1 prevents cell-intrinsic initiation of autoimmunity</article-title>. <source>Cell</source><year>2008</year>;<volume>134</volume>:<fpage>587</fpage>–<lpage>98</lpage>.<pub-id pub-id-type="pmid">18724932</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B76">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Subramanian</surname><given-names>A</given-names></string-name>, <string-name><surname>Tamayo</surname><given-names>P</given-names></string-name>, <string-name><surname>Mootha</surname><given-names>VK</given-names></string-name></person-group><etal>et al</etal><article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title>. <source>Proc Natl Acad Sci USA</source><year>2005</year>;<volume>102</volume>:<fpage>15545</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">16199517</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B77">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sun</surname><given-names>J</given-names></string-name>, <string-name><surname>Li</surname><given-names>S</given-names></string-name>, <string-name><surname>Wang</surname><given-names>F</given-names></string-name></person-group><etal>et al</etal><article-title>Identification of key pathways and genes in PTEN mutation prostate cancer by bioinformatics analysis</article-title>. <source>BMC Med Genet</source><year>2019</year>;<volume>20</volume>:<fpage>191</fpage>.<pub-id pub-id-type="pmid">31791268</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B78">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tanaka</surname><given-names>Y</given-names></string-name>, <string-name><surname>Tamada</surname><given-names>Y</given-names></string-name>, <string-name><surname>Ikeguchi</surname><given-names>M</given-names></string-name></person-group><etal>et al</etal><article-title>System-based differential gene network analysis for characterizing a sample-specific subnetwork</article-title>. <source>Biomolecules</source><year>2020</year>;<volume>10</volume>:<fpage>306</fpage>.<pub-id pub-id-type="pmid">32075209</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B79">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tang</surname><given-names>K</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>L</given-names></string-name>, <string-name><surname>Chen</surname><given-names>J</given-names></string-name></person-group><etal>et al</etal><article-title>Hypoxia promotes breast cancer cell growth by activating a glycogen metabolic program</article-title>. <source>Cancer Res</source><year>2021</year>;<volume>81</volume>:<fpage>4949</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="pmid">34348966</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B80">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tesson</surname><given-names>BM</given-names></string-name>, <string-name><surname>Breitling</surname><given-names>R</given-names></string-name>, <string-name><surname>Jansen</surname><given-names>RC.</given-names></string-name></person-group><article-title>DiffCoEx: a simple and sensitive method to find differentially coexpressed gene modules</article-title>. <source>BMC Bioinformatics</source><year>2010</year>;<volume>11</volume>:<fpage>497</fpage>.<pub-id pub-id-type="pmid">20925918</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B81">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tu</surname><given-names>J-J</given-names></string-name>, <string-name><surname>Ou-Yang</surname><given-names>L</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>Y</given-names></string-name></person-group><etal>et al</etal><article-title>Differential network analysis by simultaneously considering changes in gene interactions and gene expression</article-title>. <source>Bioinformatics</source><year>2021</year>;<volume>37</volume>:<fpage>4414</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="pmid">34245246</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B82">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Van de Sande</surname><given-names>B</given-names></string-name>, <string-name><surname>Flerin</surname><given-names>C</given-names></string-name>, <string-name><surname>Davie</surname><given-names>K</given-names></string-name></person-group><etal>et al</etal><article-title>A scalable SCENIC workflow for single-cell gene regulatory network analysis</article-title>. <source>Nat Protoc</source><year>2020</year>;<volume>15</volume>:<fpage>2247</fpage>–<lpage>76</lpage>.<pub-id pub-id-type="pmid">32561888</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B83">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>H</given-names></string-name>, <string-name><surname>Tang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Yang</surname><given-names>X</given-names></string-name></person-group><etal>et al</etal><article-title>A crucial angiogenesis-associated gene meox2 could be a promising biomarker candidate for breast cancer</article-title>. <source>Front Oncol</source><year>2022</year>;<volume>12</volume>:<fpage>759300</fpage>.<pub-id pub-id-type="pmid">35615155</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B84">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>X</given-names></string-name>, <string-name><surname>Wang</surname><given-names>G</given-names></string-name>, <string-name><surname>Shi</surname><given-names>Y</given-names></string-name></person-group><etal>et al</etal><article-title>PPAR-Delta promotes survival of breast cancer cells in harsh metabolic conditions</article-title>. <source>Oncogenesis</source><year>2016</year>;<volume>5</volume>:<fpage>e232</fpage>.<pub-id pub-id-type="pmid">27270614</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B85">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Weintraub</surname><given-names>Y</given-names></string-name>, <string-name><surname>Cohen</surname><given-names>S</given-names></string-name>, <string-name><surname>Chapnik</surname><given-names>N</given-names></string-name></person-group><etal>et al</etal><article-title>Clock gene disruption is an initial manifestation of inflammatory bowel diseases</article-title>. <source>Clin Gastroenterol Hepatol</source><year>2020</year>;<volume>18</volume>:<fpage>115</fpage>–<lpage>22.e1</lpage>.<pub-id pub-id-type="pmid">30981000</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B86">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yamada</surname><given-names>T</given-names></string-name>, <string-name><surname>Sato</surname><given-names>S</given-names></string-name>, <string-name><surname>Sotoyama</surname><given-names>Y</given-names></string-name></person-group><etal>et al</etal><article-title>RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells</article-title>. <source>Nat Immunol</source><year>2021</year>;<volume>22</volume>:<fpage>820</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">33976430</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B87">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yu</surname><given-names>X</given-names></string-name>, <string-name><surname>Zeng</surname><given-names>T</given-names></string-name>, <string-name><surname>Wang</surname><given-names>X</given-names></string-name></person-group><etal>et al</etal><article-title>Unravelling personalized dysfunctional gene network of complex diseases based on differential network model</article-title>. <source>J Transl Med</source><year>2015</year>;<volume>13</volume>:<fpage>189</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="pmid">26070628</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B88">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zaidi</surname><given-names>D</given-names></string-name>, <string-name><surname>Wine</surname><given-names>E.</given-names></string-name></person-group><article-title>Regulation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-<inline-formula id="IE92"><mml:math id="IM92" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula><inline-formula id="IE93"><mml:math id="IM93" display="inline" overflow="scroll"><mml:mo>β</mml:mo></mml:math></inline-formula>) in inflammatory bowel diseases</article-title>. <source>Front Pediatrics</source><year>2018</year>;<volume>6</volume>:<fpage>317</fpage>.</mixed-citation>
    </ref>
    <ref id="vbae034-B89">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zeng</surname><given-names>G</given-names></string-name>, <string-name><surname>Liu</surname><given-names>X</given-names></string-name>, <string-name><surname>Su</surname><given-names>X</given-names></string-name></person-group><etal>et al</etal><article-title>The role of MEOX1 in non-neoplastic and neoplastic diseases</article-title>. <source>Biomed Pharmacother</source><year>2023</year>;<volume>158</volume>:<fpage>114068</fpage>.<pub-id pub-id-type="pmid">36495659</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B90">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>J</given-names></string-name>, <string-name><surname>Ji</surname><given-names>Y</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>L.</given-names></string-name></person-group><article-title>Extracting three-way gene interactions from microarray data</article-title>. <source>Bioinformatics</source><year>2007</year>;<volume>23</volume>:<fpage>2903</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">17921496</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B91">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>X</given-names></string-name>, <string-name><surname>Su</surname><given-names>L</given-names></string-name>, <string-name><surname>Sun</surname><given-names>K.</given-names></string-name></person-group><article-title>Expression status and prognostic value of the perilipin family of genes in breast cancer</article-title>. <source>Am J Transl Res</source><year>2021</year>;<volume>13</volume>:<fpage>4450</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="pmid">34150026</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B92">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhou</surname><given-names>Z</given-names></string-name>, <string-name><surname>Ren</surname><given-names>L</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>L</given-names></string-name></person-group><etal>et al</etal><article-title>Heightened innate immune responses in the respiratory tract of COVID-19 patients</article-title>. <source>Cell Host Microbe</source><year>2020</year>;<volume>27</volume>:<fpage>883</fpage>–<lpage>90.e2</lpage>.<pub-id pub-id-type="pmid">32407669</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinform Adv</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinform Adv</journal-id>
    <journal-id journal-id-type="publisher-id">bioadv</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics Advances</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2635-0041</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10948285</article-id>
    <article-id pub-id-type="doi">10.1093/bioadv/vbae034</article-id>
    <article-id pub-id-type="publisher-id">vbae034</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Original Article</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Gene Regulation</subject>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Inference of differential gene regulatory networks using boosted differential trees</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3980-938X</contrib-id>
        <name>
          <surname>Galindez</surname>
          <given-names>Gihanna</given-names>
        </name>
        <aff><institution>Division Data Science in Biomedicine, Peter L. Reichertz Institute for Medical Informatics of Technische Universität Braunschweig and Hannover Medical School</institution>, Braunschweig, 38106, <country country="DE">Germany</country></aff>
        <aff><institution>Braunschweig Integrated Centre of Systems Biology (BRICS), TU Braunschweig</institution>, Braunschweig, 38106, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0941-4168</contrib-id>
        <name>
          <surname>List</surname>
          <given-names>Markus</given-names>
        </name>
        <aff><institution>Experimental Bioinformatics, TUM School of Life Sciences, Technical University of Munich</institution>, Munich, 85354, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0282-0462</contrib-id>
        <name>
          <surname>Baumbach</surname>
          <given-names>Jan</given-names>
        </name>
        <aff><institution>Institute for Computational Systems Biology, University of Hamburg</institution>, Hamburg, 22607, <country country="DE">Germany</country></aff>
        <aff><institution>Computational Biomedicine Lab, Department of Mathematics and Computer Science, University of Southern Denmark</institution>, Odense, 5230, <country country="DK">Denmark</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5689-3448</contrib-id>
        <name>
          <surname>Völker</surname>
          <given-names>Uwe</given-names>
        </name>
        <aff><institution>Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald</institution>, Greifswald, 17475, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Mäder</surname>
          <given-names>Ulrike</given-names>
        </name>
        <aff><institution>Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald</institution>, Greifswald, 17475, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8651-750X</contrib-id>
        <name>
          <surname>Blumenthal</surname>
          <given-names>David B</given-names>
        </name>
        <aff><institution>Biomedical Network Science Lab, Department of Artificial Intelligence in Biomedical Engineering, Friedrich-Alexander-Universität Erlangen-Nürnberg</institution>, Erlangen, 91052, <country country="DE">Germany</country></aff>
        <xref rid="vbae034-FM1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5393-2413</contrib-id>
        <name>
          <surname>Kacprowski</surname>
          <given-names>Tim</given-names>
        </name>
        <aff><institution>Division Data Science in Biomedicine, Peter L. Reichertz Institute for Medical Informatics of Technische Universität Braunschweig and Hannover Medical School</institution>, Braunschweig, 38106, <country country="DE">Germany</country></aff>
        <aff><institution>Braunschweig Integrated Centre of Systems Biology (BRICS), TU Braunschweig</institution>, Braunschweig, 38106, <country country="DE">Germany</country></aff>
        <xref rid="vbae034-FM1" ref-type="author-notes"/>
        <xref rid="vbae034-cor1" ref-type="corresp"/>
        <!--t.kacprowski@tu-braunschweig.de-->
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Yamanishi</surname>
          <given-names>Yoshihiro</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="vbae034-cor1">Corresponding author. Division Data Science in Biomedicine, Peter L. Reichertz Institute for Medical Informatics of Technische Universität Braunschweig and Hannover Medical School, Braunschweig, 38106, Germany. E-mail: <email>t.kacprowski@tu-braunschweig.de</email></corresp>
      <fn id="vbae034-FM1">
        <p>David B Blumenthal and Tim Kacprowski Equal contribution.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="collection">
      <year>2024</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2024-02-29">
      <day>29</day>
      <month>2</month>
      <year>2024</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>29</day>
      <month>2</month>
      <year>2024</year>
    </pub-date>
    <volume>4</volume>
    <issue>1</issue>
    <elocation-id>vbae034</elocation-id>
    <history>
      <date date-type="received">
        <day>29</day>
        <month>8</month>
        <year>2023</year>
      </date>
      <date date-type="rev-recd">
        <day>24</day>
        <month>1</month>
        <year>2024</year>
      </date>
      <date date-type="editorial-decision">
        <day>19</day>
        <month>2</month>
        <year>2024</year>
      </date>
      <date date-type="accepted">
        <day>27</day>
        <month>2</month>
        <year>2024</year>
      </date>
      <date date-type="corrected-typeset">
        <day>18</day>
        <month>3</month>
        <year>2024</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2024. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2024</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="vbae034.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Summary</title>
        <p>Diseases can be caused by molecular perturbations that induce specific changes in regulatory interactions and their coordinated expression, also referred to as network rewiring. However, the detection of complex changes in regulatory connections remains a challenging task and would benefit from the development of novel nonparametric approaches. We develop a new ensemble method called BoostDiff (boosted differential regression trees) to infer a differential network discriminating between two conditions. BoostDiff builds an adaptively boosted (AdaBoost) ensemble of differential trees with respect to a target condition. To build the differential trees, we propose differential variance improvement as a novel splitting criterion. Variable importance measures derived from the resulting models are used to reflect changes in gene expression predictability and to build the output differential networks. BoostDiff outperforms existing differential network methods on simulated data evaluated in four different complexity settings. We then demonstrate the power of our approach when applied to real transcriptomics data in COVID-19, Crohn’s disease, breast cancer, prostate adenocarcinoma, and stress response in <italic toggle="yes">Bacillus subtilis</italic>. BoostDiff identifies context-specific networks that are enriched with genes of known disease-relevant pathways and complements standard differential expression analyses.</p>
      </sec>
      <sec id="s2">
        <title>Availability and implementation</title>
        <p>BoostDiff is available at <ext-link xlink:href="https://github.com/scibiome/boostdiff_inference" ext-link-type="uri">https://github.com/scibiome/boostdiff_inference</ext-link>.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>German Federal Ministry of Education and Research</institution>
          </institution-wrap>
        </funding-source>
        <award-id>031L0309A</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="20"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>Gene regulation is a fundamental biological process that underlies various cellular functions, including developmental, environmental, and disease contexts. The regulatory relationships in a biological sample can be represented by gene regulatory networks (GRNs), where two gene nodes with a regulatory relationship are connected by an edge (<xref rid="vbae034-B38" ref-type="bibr">Karlebach and Shamir 2008</xref>). GRN inference remains a challenging task because of the inherent complexity of transcriptional regulation, as well as the high dimensionality and noise in biological datasets. Furthermore, GRNs are dynamic and context-specific (<xref rid="vbae034-B35" ref-type="bibr">Ideker and Krogan 2012</xref>, <xref rid="vbae034-B61" ref-type="bibr">Nagy-Staron <italic toggle="yes">et al.</italic> 2021</xref>), i.e. some regulatory processes are active only in certain cell types, tissues, conditions, or in response to specific stimuli. Changes in these pairwise dependencies have been associated with the development of complex diseases (<xref rid="vbae034-B19" ref-type="bibr">de la Fuente 2010</xref>). Differential network analysis, which aims to detect altered connectivity between different conditions or disease states, has recently emerged as a powerful complement to standard differential expression (DE) analysis and is more suitable for detecting context-specific GRNs (<xref rid="vbae034-B19" ref-type="bibr">de la Fuente 2010</xref>, <xref rid="vbae034-B51" ref-type="bibr">Marbach <italic toggle="yes">et al.</italic> 2012</xref>). Exploring how GRN structures are rewired between two different states can reveal molecular mechanisms that drive disease development and progression and identify more relevant therapeutic targets.</p>
    <p>Various approaches for deriving differential networks have been the focus of recent studies (<xref rid="vbae034-B7" ref-type="bibr">Bhuva <italic toggle="yes">et al.</italic> 2019</xref>, <xref rid="vbae034-B4" ref-type="bibr">Basha <italic toggle="yes">et al.</italic> 2020</xref>, <xref rid="vbae034-B5" ref-type="bibr">Baur <italic toggle="yes">et al.</italic> 2020</xref>). Representative methods are shown in <xref rid="vbae034-T1" ref-type="table">Table 1</xref>. The <italic toggle="yes">z</italic>-score method performs Fisher transformation of Pearson’s correlation coefficients between two conditions. The resulting <italic toggle="yes">z</italic>-scores are modeled as a normal distribution, followed by a <italic toggle="yes">z</italic>-test to detect significant pairwise edges (<xref rid="vbae034-B90" ref-type="bibr">Zhang <italic toggle="yes">et al.</italic> 2007</xref>). Diffcoex, a framework based on weighted gene co-expression analysis (WGGNA), first builds a correlation matrix for each condition being compared and then calculates their difference. From the difference matrix, a dissimilarity matrix is calculated based on a topological overlap measure and hierarchical clustering is applied to find the differentially co-expressed gene clusters (<xref rid="vbae034-B80" ref-type="bibr">Tesson <italic toggle="yes">et al.</italic> 2010</xref>). Another approach, a Gaussian graphical model (GGM)-based method, learns the differential network from conditional associations (<xref rid="vbae034-B14" ref-type="bibr">Chu <italic toggle="yes">et al.</italic> 2011</xref>). EBcoexpress relies on empirical Bayes’ estimation to calculate the posterior probability that an edge is differentially co-expressed (<xref rid="vbae034-B16" ref-type="bibr">Dawson and Kendziorski 2012</xref>, <xref rid="vbae034-B17" ref-type="bibr">Dawson <italic toggle="yes">et al.</italic> 2012</xref>).</p>
    <table-wrap position="float" id="vbae034-T1">
      <label>Table 1.</label>
      <caption>
        <p>Overview of methods used to derive differential networks and patient-specific networks.<xref rid="tblfn1" ref-type="table-fn"><sup>a</sup></xref></p>
      </caption>
      <table frame="hsides" rules="groups">
        <colgroup span="1">
          <col valign="top" align="left" span="1"/>
          <col valign="top" align="left" span="1"/>
          <col valign="top" align="left" span="1"/>
          <col valign="top" align="left" span="1"/>
          <col valign="top" align="left" span="1"/>
          <col valign="top" align="left" span="1"/>
          <col valign="top" align="left" span="1"/>
        </colgroup>
        <thead>
          <tr>
            <th rowspan="1" colspan="1">Method</th>
            <th rowspan="1" colspan="1">Algorithmic approach</th>
            <th rowspan="1" colspan="1">Test</th>
            <th rowspan="1" colspan="1">Directionality</th>
            <th rowspan="1" colspan="1">No. of conditions</th>
            <th rowspan="1" colspan="1">Network type</th>
            <th rowspan="1" colspan="1">Reference</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td rowspan="1" colspan="1">BoostDiff</td>
            <td rowspan="1" colspan="1">Tree-based</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">Two</td>
            <td rowspan="1" colspan="1">Differential network</td>
            <td rowspan="1" colspan="1">This paper</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"><italic toggle="yes">z</italic>-score</td>
            <td rowspan="1" colspan="1">Correlation-based</td>
            <td rowspan="1" colspan="1"><italic toggle="yes">z</italic>-test</td>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1">Two</td>
            <td rowspan="1" colspan="1">Differential network</td>
            <td rowspan="1" colspan="1">
              <xref rid="vbae034-B90" ref-type="bibr">Zhang <italic toggle="yes">et al</italic>. (2007)</xref>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">EBcoexpress</td>
            <td rowspan="1" colspan="1">Empirical Bayes; correlation</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1">Multiple</td>
            <td rowspan="1" colspan="1">Differential network</td>
            <td rowspan="1" colspan="1">
              <xref rid="vbae034-B16" ref-type="bibr">Dawson and Kendziorski, (2012)</xref>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Diffcoex</td>
            <td rowspan="1" colspan="1">Correlation-based</td>
            <td rowspan="1" colspan="1">Permutation test</td>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1">Multiple</td>
            <td rowspan="1" colspan="1">Differential network</td>
            <td rowspan="1" colspan="1">
              <xref rid="vbae034-B80" ref-type="bibr">Tesson <italic toggle="yes">et al</italic>. (2010)</xref>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">GGM-based</td>
            <td rowspan="1" colspan="1">GGM; posterior odds</td>
            <td rowspan="1" colspan="1">Permutation test</td>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1">Two</td>
            <td rowspan="1" colspan="1">Differential network</td>
            <td rowspan="1" colspan="1">
              <xref rid="vbae034-B14" ref-type="bibr">Chu <italic toggle="yes">et al</italic>. (2011)</xref>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">chNet</td>
            <td rowspan="1" colspan="1">GGM; differential expression</td>
            <td rowspan="1" colspan="1">t-test</td>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1">Two</td>
            <td rowspan="1" colspan="1">Differential network</td>
            <td rowspan="1" colspan="1">
              <xref rid="vbae034-B81" ref-type="bibr">Tu <italic toggle="yes">et al</italic>. (2021)</xref>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">LIONESS</td>
            <td rowspan="1" colspan="1">Linear interpolation</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Patient-specific</td>
            <td rowspan="1" colspan="1">
              <xref rid="vbae034-B41" ref-type="bibr">Kuijjer <italic toggle="yes">et al</italic>. (2019)</xref>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <xref rid="vbae034-B78" ref-type="bibr">Tanaka <italic toggle="yes">et al.</italic> (2020)</xref>
            </td>
            <td rowspan="1" colspan="1">Nonparametric Bayesian network; <inline-formula id="IE1"><mml:math id="IM1" display="inline" overflow="scroll"><mml:mo>Δ</mml:mo></mml:math></inline-formula> Edge contribution value</td>
            <td rowspan="1" colspan="1"><italic toggle="yes">t</italic>-test</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Patient-specific</td>
            <td rowspan="1" colspan="1">
              <xref rid="vbae034-B78" ref-type="bibr">Tanaka <italic toggle="yes">et al</italic>. (2020)</xref>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">DEVC-net</td>
            <td rowspan="1" colspan="1">Differential expression variance covariance (DEVC)</td>
            <td rowspan="1" colspan="1"><italic toggle="yes">t</italic>-test; Wilcoxon rank sum test</td>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1">Two</td>
            <td rowspan="1" colspan="1">Differential network; patient-specific</td>
            <td rowspan="1" colspan="1">
              <xref rid="vbae034-B87" ref-type="bibr">Yu <italic toggle="yes">et al.</italic> (2015)</xref>
            </td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tblfn1">
          <label>a</label>
          <p>Adapted from <xref rid="vbae034-B7" ref-type="bibr">Bhuva <italic toggle="yes">et al</italic>. (2019)</xref>.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <p>The differential network methods described above measure linear relationships or rely on joint normality assumptions, which may not hold in practice (<xref rid="vbae034-B73" ref-type="bibr">Shojaie 2021</xref>). Nonlinear regulatory dependencies are common mechanisms that occur in biology (<xref rid="vbae034-B10" ref-type="bibr">Brunel <italic toggle="yes">et al.</italic> 2010</xref>, <xref rid="vbae034-B15" ref-type="bibr">Costello <italic toggle="yes">et al.</italic> 2014</xref>) and these complex relationships from real datasets may be difficult to detect using correlation- or GGM-based methods. As discussed in a recent review, new methods for differential network analysis for non-Gaussian data are needed (<xref rid="vbae034-B73" ref-type="bibr">Shojaie 2021</xref>). Some methods for inferring patient-specific networks have also been developed. To measure the sample-specific edge contributions, DEVC-net (<xref rid="vbae034-B87" ref-type="bibr">Yu <italic toggle="yes">et al.</italic> 2015</xref>) uses a method that calculates an integrated score called DEVC that considers the differential expression of a gene, differential expression variance of a gene, and covariance of gene pairs. This method uses a template network to identify differential network features from gene expression data and can be used to obtain sample-specific networks. Linear Interpolation to Obtain Network Estimates for Single Samples (LIONESS) reverse engineers sample-specific networks from an aggregate network by applying linear interpolation on the edge weights from the aggregate networks (<xref rid="vbae034-B41" ref-type="bibr">Kuijjer <italic toggle="yes">et al.</italic> 2019</xref>). This approach can be used in combination with existing network inference methods to also capture nonlinear dependencies. <xref rid="vbae034-B78" ref-type="bibr">Tanaka <italic toggle="yes">et al.</italic> (2020)</xref> infer nonparametric Bayesian networks using B-spline regression. From the model parameters, the method derives a value representing the contribution of each edge to the expression in a particular sample, called the edge contribution value (ECv). The absolute differences in ECvs (<inline-formula id="IE2"><mml:math id="IM2" display="inline" overflow="scroll"><mml:mo>Δ</mml:mo></mml:math></inline-formula>ECv) between certain samples are then used to build sample-specific networks. An alternative to the abovementioned approaches are tree-based strategies, which offer the advantage of more relaxed model assumptions. While examples such as GENIE3 and derived tools continue to be successfully applied in various biological settings (<xref rid="vbae034-B34" ref-type="bibr">Huynh-Thu <italic toggle="yes">et al.</italic> 2010</xref>, <xref rid="vbae034-B59" ref-type="bibr">Moerman <italic toggle="yes">et al.</italic> 2019</xref>, <xref rid="vbae034-B82" ref-type="bibr">Van de Sande <italic toggle="yes">et al.</italic> 2020</xref>), they cannot be used to directly compare two different biological conditions.</p>
    <p>We introduce BoostDiff, a nonparametric tree-based approach for reconstructing directed differential networks (<xref rid="vbae034-F1" ref-type="fig">Fig. 1</xref>). The main component of BoostDiff is the differential tree, a modified version of the standard regression tree that can be used to identify gene pairs exhibiting changes in regulatory dependencies between two biological conditions. To build the differential trees, we use a novel splitting criterion called the differential variance improvement (DVI), which measures the difference in predictive value of a feature on the gene expression levels between two conditions. We demonstrate that boosting the differential trees with respect to samples belonging to a specific target condition is an important step for promoting condition specificity of the output networks. Tree-based variable importance measures are then calculated to obtain a ranking of regulators and to derive the differential network. Using simulated gene expression data, we evaluate the performance of BoostDiff in comparison to baseline methods and existing differential network tools. We further apply BoostDiff to multiple transcriptomics datasets, including COVID-19, Crohn’s disease, prostate adenocarcinoma, and breast cancer data, as well as stress response data in the bacterium <italic toggle="yes">Bacillus subtilis</italic>.</p>
    <fig position="float" id="vbae034-F1">
      <label>Figure 1.</label>
      <caption>
        <p>Overview of the BoostDiff algorithm. As input, we require two gene expression matrices corresponding to a target condition (e.g. disease) and a baseline condition (e.g. control). For each of p total genes, a learning subsample (LS) is drawn from the two datasets, after which an AdaBoost ensemble of differential trees is built to identify the features that are more predictive of the gene expression levels in the target condition. By setting a target condition, BoostDiff can be used to identify regulatory relationships that are more pronounced in condition A (e.g. disease state) and condition B (e.g. control/healthy), thereby providing a differential network capturing context-specific regulatory changes. In the overall workflow, the BoostDiff algorithm is run twice, once with condition A as target condition and subsequently with B as target condition. The results are then combined to obtain the final differential network. Most notably, while existing approaches aim for the reconstruction of whole genome-scale GRNs, BoostDiff concentrates on maximizing the precision for those parts of the regulatory network that actually characterize the difference between the two phenotypes.</p>
      </caption>
      <graphic xlink:href="vbae034f1" position="float"/>
    </fig>
  </sec>
  <sec>
    <title>2 Methods</title>
    <sec>
      <title>2.1 Overview of the differential network inference approach</title>
      <p>The overall strategy of BoostDiff is inspired by the popular network inference tool GENIE3 (<xref rid="vbae034-B34" ref-type="bibr">Huynh-Thu <italic toggle="yes">et al.</italic> 2010</xref>). GENIE3 aims to reconstruct a network using as input a gene expression matrix derived from a single biological condition. For this, GENIE3 fits an ensemble of regression trees, using the expression levels of the target genes as the output variable and the expression levels of potential regulators as the features. The splitting criterion for a node in the regression tree is the reduction
<disp-formula id="E1"><mml:math id="M1" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mo>|</mml:mo><mml:mi>S</mml:mi><mml:mo>|</mml:mo><mml:mo>·</mml:mo><mml:mtext>Var</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mi>S</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo> </mml:mo><mml:mo>−</mml:mo><mml:mo> </mml:mo><mml:mo>|</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>L</mml:mi></mml:msub></mml:mrow><mml:mo>|</mml:mo><mml:mo>·</mml:mo><mml:mtext>Var</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>L</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo> </mml:mo><mml:mo>−</mml:mo><mml:mo> </mml:mo><mml:mo>|</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>R</mml:mi></mml:msub></mml:mrow><mml:mo>|</mml:mo><mml:mo>·</mml:mo><mml:mtext>Var</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>R</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula>
in variance (impurity) of the target gene’s expression caused by the split. Here, <italic toggle="yes">S</italic> denotes the set of samples that reach a node to be split, <inline-formula id="IE3"><mml:math id="IM3" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>L</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula id="IE4"><mml:math id="IM4" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>R</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> are the subsets of samples in the left and right branches of the split, respectively, and <inline-formula id="IE5"><mml:math id="IM5" display="inline" overflow="scroll"><mml:mrow><mml:mtext>Var</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> is the variance of the output variable in a set of samples <inline-formula id="IE6"><mml:math id="IM6" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>∈</mml:mo><mml:mo>{</mml:mo><mml:mi>S</mml:mi><mml:mo>,</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>L</mml:mi></mml:msub></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>R</mml:mi></mml:msub></mml:mrow><mml:mo>}</mml:mo></mml:mrow></mml:math></inline-formula>. The importance of one variable in a single regression tree is calculated by summing up the reductions in variance of all tree nodes where this variable is used as a splitting feature. The overall importance of a feature in the ensemble is then averaged across all trees. One ensemble model is learned for each target gene in the dataset. The tree-based feature importances based on variance reduction are interpreted as edge weights of candidate regulator-target gene links. A high edge weight indicates that a regulator has a large contribution in predicting the expression level of a target gene. The edges with the highest weights are returned as the inferred GRN. Biologically, the top-ranked edges inferred by GENIE3 represent the relationships that are dominant in the condition of interest.</p>
      <p>Similarly, the differential network inference problem can be decomposed into <italic toggle="yes">p</italic> independent regression subproblems, where <italic toggle="yes">p</italic> is the total number of genes in the expression data. Our strategy assumes that, in a given biological context, the expression level of a gene can be modeled as a function of the expression levels of other genes (<xref rid="vbae034-F1" ref-type="fig">Fig. 1</xref>). The crucial difference between BoostDiff and GENIE3 is that we simultaneously take into account two datasets for inferring a differential network. More precisely, our approach requires the availability of (1) gene expression data matrix
<disp-formula id="E2"><mml:math id="M2" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msub></mml:mrow><mml:mo>,</mml:mo><mml:mi>p</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula>
for <inline-formula id="IE7"><mml:math id="IM7" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> measurements from a disease condition and (2) the matrix
<disp-formula id="E3"><mml:math id="M3" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msub></mml:mrow><mml:mo>,</mml:mo><mml:mi>p</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula>
for <inline-formula id="IE8"><mml:math id="IM8" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> measurements from a control condition. Both matrices have <italic toggle="yes">p</italic> columns (total number of genes). That is, <inline-formula id="IE9"><mml:math id="IM9" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:math></inline-formula> contains the expression of gene <italic toggle="yes">g</italic> in measurement (patient) <italic toggle="yes">i</italic> from the disease condition.</p>
      <p>The inference task is modeled as a feature selection problem that aims to find features that are more predictive of expression levels in a target condition than in the baseline condition. For this, differential network analysis is performed by solving the regression problem while taking into account information from two distinct labels. We use the AdaBoost algorithm (<xref rid="vbae034-B21" ref-type="bibr">Drucker 1997</xref>) using differential trees as base learners to drive the improved prediction of expression levels in the target condition. The trained model provides a ranking of the edges by computing a feature importance weight for each regulator (see details below).</p>
      <p>For each target gene <inline-formula id="IE10"><mml:math id="IM10" display="inline" overflow="scroll"><mml:mrow><mml:mi>g</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>, we define regression problems <inline-formula id="IE11"><mml:math id="IM11" display="inline" overflow="scroll"><mml:mrow><mml:mi>L</mml:mi><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> and <inline-formula id="IE12"><mml:math id="IM12" display="inline" overflow="scroll"><mml:mrow><mml:mi>L</mml:mi><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msubsup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>. The design matrices <inline-formula id="IE13"><mml:math id="IM13" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula id="IE14"><mml:math id="IM14" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:math></inline-formula> are obtained by deleting the <italic toggle="yes">g</italic>th columns <inline-formula id="IE15"><mml:math id="IM15" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula id="IE16"><mml:math id="IM16" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:math></inline-formula> from <inline-formula id="IE17"><mml:math id="IM17" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula id="IE18"><mml:math id="IM18" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula>, respectively. The target variables are set to the deleted columns <inline-formula id="IE19"><mml:math id="IM19" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula id="IE20"><mml:math id="IM20" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:math></inline-formula>. The inference of our differential network is then performed as follows:</p>
      <list list-type="order">
        <list-item>
          <p>For each target gene <inline-formula id="IE21"><mml:math id="IM21" display="inline" overflow="scroll"><mml:mrow><mml:mi>g</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>:</p>
          <list list-type="alpha-lower">
            <list-item>
              <p>Generate the design matrices and target variable vectors for the regression problems <inline-formula id="IE22"><mml:math id="IM22" display="inline" overflow="scroll"><mml:mrow><mml:mi>L</mml:mi><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> and <inline-formula id="IE23"><mml:math id="IM23" display="inline" overflow="scroll"><mml:mrow><mml:mi>L</mml:mi><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> for gene <italic toggle="yes">g</italic> for the disease and the control conditions.</p>
            </list-item>
            <list-item>
              <p>Train an ensemble of differential regression trees with the disease selected as target condition, i.e. tree ensembles that yields a good fit for <inline-formula id="IE24"><mml:math id="IM24" display="inline" overflow="scroll"><mml:mrow><mml:mi>L</mml:mi><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> but not for <inline-formula id="IE25"><mml:math id="IM25" display="inline" overflow="scroll"><mml:mrow><mml:mi>L</mml:mi><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>.</p>
            </list-item>
            <list-item>
              <p>From the ensemble of differential trees, extract weights for all potential regulators of <italic toggle="yes">g</italic> which are large if the expression of the regulator is highly predictive of <italic toggle="yes">g</italic> in the disease condition but not in the control condition.</p>
            </list-item>
          </list>
        </list-item>
        <list-item>
          <p>Aggregate and sort the <italic toggle="yes">p</italic> gene rankings to obtain a global ranking of all differential regulatory edges.</p>
        </list-item>
        <list-item>
          <p>Repeat the steps 1 and 2 with reversed roles of <italic toggle="yes">D</italic> and <italic toggle="yes">C</italic> to identify regulatory links that are present in the control but not in the disease condition.</p>
        </list-item>
      </list>
      <p>In the following, we describe the details of the algorithm.</p>
    </sec>
    <sec>
      <title>2.2 Step 1a: Growing a differential tree</title>
      <p>We first explain how to build a single differential tree, the key ingredient of step 1a of the algorithm outlined above. We describe how to build the differential tree for the case where the disease has been selected as the target condition. The workflow with control as target condition is analogous.</p>
      <p>A differential tree is built through binary recursive partitioning. The key difference to standard regression trees is that, to determine the features (i.e. genes) used for splitting the samples at the inner nodes of our trees, we use a novel split criterion called differential variance improvement (DVI) instead of variance reduction. At each node of the differential tree, we maintain subsets <inline-formula id="IE26"><mml:math id="IM26" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo>⊆</mml:mo><mml:mo>{</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msub></mml:mrow><mml:mo>}</mml:mo></mml:mrow></mml:math></inline-formula> and <inline-formula id="IE27"><mml:math id="IM27" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo>⊆</mml:mo><mml:mo>{</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msub></mml:mrow><mml:mo>}</mml:mo></mml:mrow></mml:math></inline-formula> of the disease and control samples, respectively. Given a possible split feature (i.e. candidate predictor gene) <inline-formula id="IE28"><mml:math id="IM28" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula>, we define <inline-formula id="IE29"><mml:math id="IM29" display="inline" overflow="scroll"><mml:mrow><mml:mtext>DVI</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> as follows:
<disp-formula id="E4"><mml:math id="M4" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mtext>DVI</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mrow><mml:munder><mml:mrow><mml:mi>max</mml:mi></mml:mrow><mml:mo>τ</mml:mo></mml:munder></mml:mrow><mml:mtext>VarRed</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mo>−</mml:mo><mml:mrow><mml:munder><mml:mrow><mml:mi>max</mml:mi></mml:mrow><mml:mo>τ</mml:mo></mml:munder></mml:mrow><mml:mtext>VarRed</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p>
      <p>For a fixed <inline-formula id="IE30"><mml:math id="IM30" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> and splitting threshold <inline-formula id="IE31"><mml:math id="IM31" display="inline" overflow="scroll"><mml:mo>τ</mml:mo></mml:math></inline-formula>, the variance reduction for the disease samples is given by
<disp-formula id="E5"><mml:math id="M5" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mtext>VarRed</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mtext>MSE</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">]</mml:mo><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mo>−</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>L</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>|</mml:mo></mml:mrow><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo>|</mml:mo></mml:mrow></mml:mfrac></mml:mrow><mml:mo>·</mml:mo><mml:mtext>MSE</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>L</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">]</mml:mo><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mo>−</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>R</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>|</mml:mo></mml:mrow><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo>|</mml:mo></mml:mrow></mml:mfrac></mml:mrow><mml:mo>·</mml:mo><mml:mtext>MSE</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>R</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">]</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula>
where <inline-formula id="IE32"><mml:math id="IM32" display="inline" overflow="scroll"><mml:mrow><mml:mtext>MSE</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mo>·</mml:mo><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> is the mean squared error from the sample mean, <inline-formula id="IE33"><mml:math id="IM33" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mi>S</mml:mi><mml:mo stretchy="false">]</mml:mo><mml:mo>=</mml:mo><mml:mo>{</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>g</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo>|</mml:mo><mml:mi>i</mml:mi><mml:mo>∈</mml:mo><mml:mi>S</mml:mi><mml:mo>}</mml:mo></mml:mrow></mml:math></inline-formula> is the restriction of the target variable to the disease samples (rows) contained in a set of samples <italic toggle="yes">S</italic>, and <inline-formula id="IE34"><mml:math id="IM34" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>L</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo>{</mml:mo><mml:mi>i</mml:mi><mml:mo>∈</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo>≤</mml:mo><mml:mo>τ</mml:mo><mml:mo>}</mml:mo></mml:mrow></mml:math></inline-formula>, and <inline-formula id="IE35"><mml:math id="IM35" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>R</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo>{</mml:mo><mml:mi>i</mml:mi><mml:mo>∈</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo>&gt;</mml:mo><mml:mo>τ</mml:mo><mml:mo>}</mml:mo></mml:mrow></mml:math></inline-formula> are the subsets of disease samples <inline-formula id="IE36"><mml:math id="IM36" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> available at the current node whose split gene expression levels are, respectively, smaller or larger than the threshold <inline-formula id="IE37"><mml:math id="IM37" display="inline" overflow="scroll"><mml:mo>τ</mml:mo></mml:math></inline-formula>. Variance reduction for the control samples is defined analogously. A positive value of the <inline-formula id="IE38"><mml:math id="IM38" display="inline" overflow="scroll"><mml:mrow><mml:mtext>DVI</mml:mtext></mml:mrow></mml:math></inline-formula> hence means that the gene <inline-formula id="IE39"><mml:math id="IM39" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> is more predictive of <italic toggle="yes">g’</italic>s expression level in the disease condition than in the control condition, whereas a negative <inline-formula id="IE40"><mml:math id="IM40" display="inline" overflow="scroll"><mml:mrow><mml:mtext>DVI</mml:mtext></mml:mrow></mml:math></inline-formula> value indicates that the opposite is the case.</p>
      <p>When building our differential trees, we use genes <inline-formula id="IE41"><mml:math id="IM41" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> maximizing <inline-formula id="IE42"><mml:math id="IM42" display="inline" overflow="scroll"><mml:mrow><mml:mtext>DVI</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> as split features (see details below). If disease has been selected as the target condition, these genes correspond to regulators of <italic toggle="yes">g</italic> which are much more active in disease samples than in control samples. If control has been selected as the target condition, they correspond to regulators in healthy individuals that have lost their regulatory activity in the disease.</p>
      <p>Given the regression problems <inline-formula id="IE43"><mml:math id="IM43" display="inline" overflow="scroll"><mml:mrow><mml:mi>L</mml:mi><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> and <inline-formula id="IE44"><mml:math id="IM44" display="inline" overflow="scroll"><mml:mrow><mml:mi>L</mml:mi><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> for the disease and control conditions, respectively, we construct a differential regression tree whose nodes are 5-tuples
<disp-formula id="E6"><mml:math id="M6" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mi>v</mml:mi><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>D</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>C</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula>
where <inline-formula id="IE45"><mml:math id="IM45" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> is the split gene, <inline-formula id="IE46"><mml:math id="IM46" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>D</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow></mml:mrow></mml:math></inline-formula> is the split threshold for the disease samples, and <inline-formula id="IE47"><mml:math id="IM47" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>C</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow></mml:mrow></mml:math></inline-formula> is the split threshold for the control samples. Note that we use two different thresholds, since using a single threshold for both conditions while optimizing the <inline-formula id="IE48"><mml:math id="IM48" display="inline" overflow="scroll"><mml:mrow><mml:mtext>DVI</mml:mtext></mml:mrow></mml:math></inline-formula> leads to a skewed expression distribution in each side of the split, with one side favoring disease samples and the other side favoring control samples. The construction is done as follows:</p>
      <list list-type="order">
        <list-item>
          <p>Initialize root as
<disp-formula id="E7a"><mml:math id="M7a" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo>=</mml:mo><mml:mo>{</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msub></mml:mrow><mml:mo>}</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo>=</mml:mo><mml:mo>{</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msub></mml:mrow><mml:mo>}</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p>
          <p>where ‘<inline-formula id="IE50"><mml:math id="IM50" display="inline" overflow="scroll"><mml:mo>•</mml:mo></mml:math></inline-formula>’ is a placeholder for not yet defined split genes and thresholds.</p>
        </list-item>
        <list-item>
          <p>Starting at the root, recursively construct a differential tree via binary partitioning as follows:</p>
        </list-item>
        <list-item>
          <p>At the current node <inline-formula id="IE51"><mml:math id="IM51" display="inline" overflow="scroll"><mml:mrow><mml:mi>v</mml:mi><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> of the tree under construction, do the following:</p>
          <list list-type="alpha-lower">
            <list-item>
              <p>If a suitable termination criterion (the maximum depth of the tree has been reached or the number of target or baseline samples reaching in a node has been reached) has been satisfied or <inline-formula id="IE52"><mml:math id="IM52" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mrow><mml:mi>max</mml:mi></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:msub></mml:mrow><mml:mtext>DVI</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>≤</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></inline-formula>, label <italic toggle="yes">v</italic> as leaf and traceback.</p>
            </list-item>
            <list-item>
              <p>Otherwise, set the node <italic toggle="yes">v’</italic>s split gene to
<disp-formula id="E7"><mml:math id="M7" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msup></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:munder><mml:mrow><mml:mtext>argmax</mml:mtext></mml:mrow><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:munder></mml:mrow><mml:mtext>DVI</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p>
              <p>its disease threshold to
<disp-formula id="E8"><mml:math id="M8" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>D</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:munder><mml:mrow><mml:mtext>argmax</mml:mtext></mml:mrow><mml:mo>τ</mml:mo></mml:munder></mml:mrow><mml:mtext>VarRed</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p>
              <p>and its control threshold to
<disp-formula id="E9"><mml:math id="M9" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>C</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:munder><mml:mrow><mml:mtext>argmax</mml:mtext></mml:mrow><mml:mo>τ</mml:mo></mml:munder></mml:mrow><mml:mtext>VarRed</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mo>τ</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p>
            </list-item>
            <list-item>
              <p>Initialize <italic toggle="yes">v’</italic>s left child as
<disp-formula id="E10"><mml:math id="M10" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mi>L</mml:mi></mml:msub></mml:mrow><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>L</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>D</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>L</mml:mi><mml:mi>C</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>C</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p>
              <p>its right child as
<disp-formula id="E11"><mml:math id="M11" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mi>R</mml:mi></mml:msub></mml:mrow><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>R</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>D</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>R</mml:mi><mml:mi>C</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>∗</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>C</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p>
              <p>and continue with processing <inline-formula id="IE53"><mml:math id="IM53" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mi>L</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula id="IE54"><mml:math id="IM54" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mi>R</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>.</p>
            </list-item>
          </list>
        </list-item>
      </list>
      <p>In the regression trees described by (<xref rid="vbae034-B9" ref-type="bibr">Breiman <italic toggle="yes">et al.</italic> 1984</xref>), the prediction for a sample is determined by traversing the tree until a leaf node is reached. Here, we are more interested in predicting the expression values of the samples in the target condition; thus, prediction is performed only for target samples using the identified splitting thresholds <inline-formula id="IE55"><mml:math id="IM55" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>D</mml:mi><mml:mo>∗</mml:mo></mml:msubsup></mml:mrow></mml:mrow></mml:math></inline-formula>. The final prediction is calculated as the expected value of the expression levels of the target samples assigned to the leaf nodes after fitting the differential tree.</p>
    </sec>
    <sec>
      <title>2.3 Step 1b: Boosting the differential trees</title>
      <p>Inspired by GRNBoost2 (<xref rid="vbae034-B59" ref-type="bibr">Moerman <italic toggle="yes">et al.</italic> 2019</xref>), we implement a boosting algorithm that derives a strong prediction model by sequentially training a pool of differential trees as the weak learners. AdaBoost for regression is typically used for solving problems where the output is a continuous variable (i.e. expression levels) without explicitly considering the class of the samples. Here, we adapted the AdaBoost.R2 algorithm (<xref rid="vbae034-B21" ref-type="bibr">Drucker 1997</xref>) to handle the regression problem, given labels from two classes (i.e. conditions). Using the differential trees as base learners, the modified algorithm performs the boosting with respect to samples belonging to the specified target condition. In this way, BoostDiff attempts to find a model that is more predictive of the target condition compared to the baseline condition. In each tree, only the target samples are re-weighted in subsequent boosting iterations, while samples from the baseline condition retain uniform weight. In particular, target samples that are more difficult to predict are selected with higher weights during the bootstrapping step and will always be compared to a uniform sample from the baseline condition. To avoid overfitting, we set a low number of trees and in practice find that 50–100 differential trees in the ensemble are sufficient for real transcriptomics datasets. The algorithm is described in detail in the <xref rid="sup1" ref-type="supplementary-material">Supplementary Methods section</xref>.</p>
    </sec>
    <sec>
      <title>2.4 Step 1c: Computing variable importances to rank the candidate predictors</title>
      <p>Tree-based methods allow for the calculation of a variable importance measure that can be used to rank the features according to their relevance for predicting the output. In GENIE3, the importance of a predictor gene <inline-formula id="IE56"><mml:math id="IM56" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> is calculated as the sum of the variance reduction across all nodes where <inline-formula id="IE57"><mml:math id="IM57" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> is used as the splitting feature, averaged over all trees in the ensemble. For BoostDiff, we derive a similar measure by considering the samples belonging to the target condition (step 1c in the high-level description of BoostDiff given above). If disease is selected as target condition, the importance <inline-formula id="IE58"><mml:math id="IM58" display="inline" overflow="scroll"><mml:mrow><mml:mtext>VIM</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> attributed to a candidate predictor gene <inline-formula id="IE59"><mml:math id="IM59" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> is calculated as the weighted variance reduction for the disease samples across all <italic toggle="yes">M</italic> trees in the ensemble:
<disp-formula id="E12"><mml:math id="M12" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mtext>VIM</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mrow><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>m</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>M</mml:mi></mml:munderover></mml:mrow><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mo>α</mml:mo></mml:mrow><mml:mi>m</mml:mi></mml:msup></mml:mrow></mml:mrow><mml:mo>·</mml:mo><mml:mrow><mml:munder><mml:mo>∑</mml:mo><mml:mrow><mml:mi>v</mml:mi><mml:mo>∈</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mi>m</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:munder></mml:mrow><mml:mrow><mml:mtext>VarRed</mml:mtext></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>v</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>v</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p>
      <p>Here, <italic toggle="yes">m</italic> is the boosting iteration, <inline-formula id="IE60"><mml:math id="IM60" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mo>α</mml:mo></mml:mrow><mml:mi>m</mml:mi></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> is the weight of the differential tree returned by AdaBoost, <inline-formula id="IE61"><mml:math id="IM61" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mi>m</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> is the set of nodes in tree <italic toggle="yes">m</italic> where <inline-formula id="IE62"><mml:math id="IM62" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> was used as the split feature, and <inline-formula id="IE63"><mml:math id="IM63" display="inline" overflow="scroll"><mml:mrow><mml:mtext>VarRed</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mi>v</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>v</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> is the variance reduction for the disease samples at a node <inline-formula id="IE64"><mml:math id="IM64" display="inline" overflow="scroll"><mml:mrow><mml:mi>v</mml:mi><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mi>v</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo>,</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mo>τ</mml:mo></mml:mrow><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mrow><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mo>,</mml:mo><mml:mo>•</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>∈</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mi>m</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>. Since each node in a differential tree has two independent thresholds, interpreting the tree becomes more abstract with increasing depth. Boosting using shallow differential trees (e.g. differential tree stumps) thus favors greater interpretability of the variable importance measure.</p>
    </sec>
    <sec>
      <title>2.5 Steps 2 and 3: Edge ranking and filtering from boosted differential trees</title>
      <p>Each modified AdaBoost model yields a separate ranking of the regulators. However, simply ordering the regulatory links according to the weights leads to a bias toward highly variable target genes. To avoid this, we first scale the expression levels of each target gene to unit variance, similarly implemented in GENIE3 (<xref rid="vbae034-B34" ref-type="bibr">Huynh-Thu <italic toggle="yes">et al.</italic> 2010</xref>).</p>
      <p>Boosting with respect to a target condition does not necessarily produce a model that predicts a gene’s expression in the target condition better than its expression in the baseline condition. To illustrate, sample plots of the training progression are shown in <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S1</xref>. To restrict the results to differential edges, we recommend examining the distributions of the mean difference in prediction error. Sample distributions of these values from the simulated and real transcriptomics data are shown in <xref rid="sup1" ref-type="supplementary-material">Supplementary Figs S2 and S3</xref>, respectively. Based on these generated plots, users can filter for target genes with lower mean prediction error in the target condition than the baseline condition by applying a threshold. Alternatively, users can select the top edges with the lowest mean difference in prediction error or input a user-defined percentile. After filtering, the edges are re-ranked based on the variable importance measure used as the edge weight. The procedure is performed for each of the two sub-analyses (disease or control as target condition). The top edges (user-specified parameter) from each sub-analysis are then merged to obtain the final network.</p>
      <p>Given the ensemble nature of BoostDiff where each differential tree is constructed differently from randomly selected predictors, deriving an explanation of the model’s predictions is challenging. To obtain more mechanistic and biologically meaningful results, we can rely on the topology of the differential network and use community detection algorithms that aim to find highly connected subnetworks that could be potentially associated with the disease of interest.</p>
    </sec>
    <sec>
      <title>2.6 Compared methods</title>
      <p>We evaluate the performance of BoostDiff against baseline methods and existing differential networks methods. To verify the condition specificity of the networks output by BoostDiff, we compare its performance to those of two GRN inference methods, GENIE3 and ARACNE (<xref rid="vbae034-B52" ref-type="bibr">Margolin <italic toggle="yes">et al.</italic> 2006</xref>). GENIE3 is run using the corresponding R package. ARACNE is run using the implementation provided in the R package <italic toggle="yes">minet</italic> (<xref rid="vbae034-B57" ref-type="bibr">Meyer <italic toggle="yes">et al.</italic> 2008</xref>). For both GENIE3 and ARACNE, only the gene expression matrix from the disease condition is used as input. We also compare BoostDiff to two additional baseline methods: (i) random forests of differential trees (‘RF Difftrees’) and (ii) a ‘Differential GENIE3’ approach, where we separately infer the networks from each condition using GENIE3 and subtract the calculated edge weights derived from the control condition from the weights derived from the disease condition and vice versa. For details, an AIMe report is available at <ext-link xlink:href="https://aime.report/656I3Z/2" ext-link-type="uri">https://aime.report/656I3Z/2</ext-link> (<xref rid="vbae034-B54" ref-type="bibr">Matschinske <italic toggle="yes">et al.</italic> 2021</xref>).</p>
      <p>Next, we compare the performance of BoostDiff to other differential network methods from the benchmarking study in <xref rid="vbae034-B7" ref-type="bibr">Bhuva <italic toggle="yes">et al.</italic> (2019)</xref>. These methods include <italic toggle="yes">z</italic>-score, EBcoexpress, Diffcoex, and a GGM-based method, which are implemented in the <italic toggle="yes">dcanr</italic> package in R. Additionally, we run the chNet algorithm (<xref rid="vbae034-B81" ref-type="bibr">Tu <italic toggle="yes">et al.</italic> 2021</xref>), which considers significant changes in both partial correlations of edges and differential expression. To facilitate comparability and given that only the tree-based methods provide directionality information among the methods examined here, we convert directed edges to undirected edges (<xref rid="vbae034-B7" ref-type="bibr">Bhuva <italic toggle="yes">et al.</italic> 2019</xref>).</p>
    </sec>
    <sec>
      <title>2.7 Evaluation using simulated datasets</title>
      <p>Gene expression data for disease and control conditions are simulated by adapting the SimulatorGRN approach (<xref rid="vbae034-B7" ref-type="bibr">Bhuva <italic toggle="yes">et al.</italic> 2019</xref>), a dynamical systems modeling tool to simulate differential co-expression patterns. SimulatorGRN induces differential co-expression by perturbing a reference network via gene knockdown to reduce their expression levels and models activation/repression of a gene by a set of regulators using normalized Hill equations. Knockdown leads to complex nonlinear differences between the generated disease and control samples (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S4</xref>). By default, known regulatory interactions in <italic toggle="yes">Saccharomyces cerevisiae</italic> are used to create a reference GRN. To obtain the ‘true’ differentially co-expressed edges and allow performance evaluation, genes in the network whose abundance are affected by the knockdown perturbation and thus exhibit regulatory dependency are determined via sensitivity analysis.</p>
      <p>In the original SimulatorGRN framework, a sample can have multiple genes knocked down, even though the evaluation considers each knockdown gene separately. To explicitly eliminate the confounding effect of additional knockdown genes in our experiments, we generate the expression data in the perturbed condition such that exactly one randomly selected input gene is knocked down. We evaluate the different tools across four scenarios: (i) 50 nodes; 500 simulations, (ii) 150 nodes; 500 simulations, (iii) 300 nodes; 500 simulations, and (iv) 500 nodes; 250 simulations. In each simulation, 100 samples are generated per condition. The final disease samples are those which have the gene knockdown, whereas the control samples are ‘wild type’ (<xref rid="vbae034-B7" ref-type="bibr">Bhuva <italic toggle="yes">et al.</italic> 2019</xref>). The edges from the ‘association network’ of each simulation are used as the ground truth edges for evaluating performance. The parameters for generating the simulated data are shown in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>.</p>
      <p>In the analyses on simulated data, all genes except the target gene are considered as potential regulators. The <italic toggle="yes">z</italic>-score method, chNet, Diffcoex, and the GGM-based method are run with the default parameters. The parameters used for the RF Difftrees and BoostDiff are provided in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S2</xref>. For each simulation, we filter for the target genes belonging to the 3rd percentile based on the mean difference in prediction errors. The parameters for the EBcoexpress runs are shown in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S3</xref>.</p>
      <p>The different tools have different statistical methods and cutoffs for determining the differentially coexpressed edges depending on how the algorithm works. To facilitate comparability, we show the top <italic toggle="yes">k</italic> predicted edges output by each method (except for chNet, wherein the number of predicted differential edges depends on the tuning parameter and is variable for each simulation; thus, extracting the top <italic toggle="yes">k</italic> edges cannot be consistently applied across simulations). For visualization, we show the results based on the top 100 predicted edges output by each method for the simulated data. We report the performance using precision, recall, and F1 score as the evaluation metrics.</p>
    </sec>
    <sec>
      <title>2.8 Evaluation using real datasets</title>
      <p>For evaluation on real datasets, BoostDiff, Diffcoex, EBcoexpress, the <italic toggle="yes">z</italic>-score method, and Differential GENIE3 are run on gene expression data for four human diseases (COVID-19, Crohn’s disease, breast cancer, and prostate adenocarcinoma) and for the stress response in <italic toggle="yes">B.subtilis</italic>. For the human diseases, we extract the top 1000 edges to generate the final network. For the <italic toggle="yes">B.subtilis</italic> data, we use the top 300 edges.</p>
      <p>For the COVID-19 RNA-Seq dataset, raw gene counts are downloaded from the Gene Expression Omnibus (GEO) database under the accession number GSE156063 (<xref rid="vbae034-B58" ref-type="bibr">Mick <italic toggle="yes">et al.</italic> 2020</xref>). We use data generated from nasal swab samples from COVID-19 (<inline-formula id="IE65"><mml:math id="IM65" display="inline" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>93</mml:mn></mml:mrow></mml:math></inline-formula>) and uninfected patients (<inline-formula id="IE66"><mml:math id="IM66" display="inline" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:math></inline-formula>). Count data are normalized using the <monospace>DESeq2</monospace> package in R with the variance stabilizing transformation (<monospace>vst}</monospace>) function. Differentially expressed genes (DEGs) are obtained using <monospace>DESeq2</monospace> (<xref rid="vbae034-B48" ref-type="bibr">Love <italic toggle="yes">et al.</italic> 2014</xref>).</p>
      <p>For the Crohn’s disease (CD) dataset, normalized microarray data are downloaded from the GEO database under the accession number GSE126124 (<xref rid="vbae034-B67" ref-type="bibr">Palmer <italic toggle="yes">et al.</italic> 2019</xref>), which were generated from colon biopsies of individuals with CD (<inline-formula id="IE67"><mml:math id="IM67" display="inline" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>37</mml:mn></mml:mrow></mml:math></inline-formula>) and healthy controls (<inline-formula id="IE68"><mml:math id="IM68" display="inline" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>19</mml:mn></mml:mrow></mml:math></inline-formula>). Differential expression analysis is performed using <monospace>limma</monospace> (<xref rid="vbae034-B68" ref-type="bibr">Ritchie <italic toggle="yes">et al.</italic> 2015</xref>).</p>
      <p>To evaluate BoostDiff on data from The Cancer Genome Atlas (TCGA), preprocessed RNA-Seq gene expression data and DEGs from primary tumors and normal solid tissues are obtained from <ext-link xlink:href="https://xenabrowser.net/" ext-link-type="uri">https://xenabrowser.net/</ext-link> (<xref rid="vbae034-B27" ref-type="bibr">Goldman <italic toggle="yes">et al.</italic> 2020</xref>). We use gene expression data for two cancer types, namely, prostate adenocarcinoma (PRAD) and breast cancer (BRCA), both of which contain at least 50 samples for the normal tissues.</p>
      <p>For the human datasets, Illumina IDs are converted to HGNC symbols using the R package <monospace>biomaRt</monospace> where applicable (<xref rid="vbae034-B22" ref-type="bibr">Durinck <italic toggle="yes">et al.</italic> 2009</xref>). Expression levels corresponding to probes mapped to the same gene symbol are averaged. The top 20% of genes with the lowest variance are filtered out. To generate the final GRN and facilitate comparability with BoostDiff, we filter the outputs for edges containing a TF, using the list of human transcription factors downloaded from <ext-link xlink:href="http://humantfs.ccbr.utoronto.ca/" ext-link-type="uri">http://humantfs.ccbr.utoronto.ca/</ext-link> (<xref rid="vbae034-B43" ref-type="bibr">Lambert <italic toggle="yes">et al.</italic> 2018</xref>). These TFs are also used as the candidate regulators for BoostDiff. Genes whose mean difference in prediction error of the models are more extreme than the threshold identified from the 3rd percentiles of the distributions are retained. For the CD dataset, a more stringent filtering step is performed because of the small sample size available for inference. All the outputs from the different methods are filtered for the top 1000 edges (except for chNet). For BoostDiff, the final network is thus comprised of the combined top 500 edges from the run where the disease condition is set as the target condition and the top 500 edges from the run where the control condition is set as the target condition. To identify more specific candidate network modules and facilitate the interpretability of the resulting networks, we apply the Louvain community detection algorithm using the python-louvain package (<ext-link xlink:href="https://github.com/taynaud/python-louvain" ext-link-type="uri">https://github.com/taynaud/python-louvain</ext-link>). The enrichr module of the gseapy v. 1.1.0 package is used to identify enriched KEGG pathways in the output networks (<xref rid="vbae034-B76" ref-type="bibr">Subramanian <italic toggle="yes">et al.</italic> 2005</xref>, <xref rid="vbae034-B42" ref-type="bibr">Kuleshov <italic toggle="yes">et al.</italic> 2016</xref>). KEGG terms are considered to be significantly enriched in a network if the overlap with the gene set is at least three genes.</p>
      <p>We further test the performance of BoostDiff using transcriptome data related to the well-characterized general stress response in <italic toggle="yes">B.subtilis</italic> (<xref rid="vbae034-B63" ref-type="bibr">Nicolas <italic toggle="yes">et al.</italic> 2012</xref>). We examine three contexts, namely, response to salt stress, response to heat stress, and response to ethanol stress, all of which are known to induce the SigB regulon. Expression data for all protein-coding genes and RNA features (S1 to S1583) of <italic toggle="yes">B.subtilis</italic> from the corresponding samples were downloaded from the GEO database (accession number GSE27219). Considering that bacterial adaptation is characterized by smaller variation across samples than in animal experiments or experiments with human specimens, gene expression datasets for bacterial adaptation generally have low number of replicates. Therefore, we generate additional synthetic samples using Synthetic Minority Over-sampling TEchnique (SMOTE) (<ext-link xlink:href="https://github.com/akazs/pySMOTE/" ext-link-type="uri">https://github.com/akazs/pySMOTE/</ext-link>) to obtain 48 samples per condition to be available for inference. We note that a large sample size from experimental data still remains ideal for using BoostDiff; SMOTE is used as a workaround in order to be able to run the compared network inference methods on the <italic toggle="yes">B.subtilis</italic> datasets. Genes with low variance are filtered out using a variance cutoff of 0.4. For the BoostDiff runs, the final network is obtained by filtering the differentially predicted target genes based on the 3rd percentile and combining the top 150 edges in the differential network for each of the two sub-analyses. The results of the compared methods are filtered for the top 300 edges to obtain the differential network. Enrichment analyses for the <italic toggle="yes">B.subtilis</italic> outputs is performed using the ShinyGO v. 0.77 (<xref rid="vbae034-B25" ref-type="bibr">Ge <italic toggle="yes">et al.</italic> 2020</xref>).</p>
    </sec>
  </sec>
  <sec>
    <title>3 Results and discussion</title>
    <sec>
      <title>3.1 BoostDiff outperforms existing methods on complex simulated settings</title>
      <p>As expected, BoostDiff better identifies the differential edges than GENIE3 and ARACNE, both of which infer a static network from the disease condition alone (<xref rid="vbae034-F2" ref-type="fig">Fig. 2</xref>). The Differential GENIE3 method shows similar performance to those of the baseline methods, despite using the expression data from both disease and control conditions. These findings indicate that the feature importances calculated from the trees built using <inline-formula id="IE69"><mml:math id="IM69" display="inline" overflow="scroll"><mml:mrow><mml:mtext>DVI</mml:mtext></mml:mrow></mml:math></inline-formula> as the splitting criterion are useful for identifying the differential edges. In addition, in all but the smallest simulation scenarios, the boosting scheme performs significantly better than the random forest of differential trees (see results for BoostDiff and RF Difftrees in <xref rid="vbae034-F2" ref-type="fig">Fig. 2</xref>): While RF Difftrees outperformed all the other methods in the 50-gene setting, BoostDiff is the best performing methods in the more complex 150-, 300-, and 500-gene settings. Results are similar for varying cutoffs of the number of top edges (<inline-formula id="IE70"><mml:math id="IM70" display="inline" overflow="scroll"><mml:mrow><mml:mi>k</mml:mi><mml:mo>∈</mml:mo><mml:mo>{</mml:mo><mml:mn>50</mml:mn><mml:mo>,</mml:mo><mml:mn>100</mml:mn><mml:mo>,</mml:mo><mml:mn>150</mml:mn><mml:mo>,</mml:mo><mml:mn>200</mml:mn><mml:mo>}</mml:mo></mml:mrow></mml:math></inline-formula>) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S5</xref>).</p>
      <fig position="float" id="vbae034-F2">
        <label>Figure 2.</label>
        <caption>
          <p>Performance of differential trees and BoostDiff compared to baseline methods and other differential network tools using simulated data comprising (a) 50 genes; (b) 150 genes; (c) 300 genes; (d) 500 genes. For all methods, the top 100 edges were considered (except for chNet). The one-sided Mann–Whitney U test is used to calculate the <italic toggle="yes">P</italic>-values.</p>
        </caption>
        <graphic xlink:href="vbae034f2" position="float"/>
      </fig>
      <p>We then determine the rank of each method in terms of the F1 score across all simulations in the four simulation settings. The results show that BoostDiff is the most frequently top-ranked method in the majority of simulations, more notably in the simulation settings with larger numbers of genes (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S6</xref>). In addition, except for when a high number of base learners is used in the ensemble, the performance of BoostDiff is consistent across different hyperparameter combinations (no. of features, maximum tree depth) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S7</xref>).</p>
    </sec>
    <sec>
      <title>3.2 Results on real datasets</title>
      <sec>
        <title>3.2.1 COVID-19</title>
        <p>The network inferred by BoostDiff shows stronger enrichment of COVID-19-related pathways compared to those of Diffcoex and the <italic toggle="yes">z</italic>-score method, whereas all edges in the EBcoexpress output are assigned zero posterior probabilities (<xref rid="vbae034-F3" ref-type="fig">Fig. 3</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S4–S7</xref>). In particular, the Diffcoex and <italic toggle="yes">z</italic>-score networks are enriched in less specific terms, such as ‘Influenza A,’ ‘Measles,’ and ‘Human T-cell leukemia virus 1 infection.’ Differential GENIE3 returned ‘Coronavirus disease,’ ‘Neutrophil extracellular trap formation,’ and ‘Phagosome.’ In addition to terms related to various pathogenic infections, the BoostDiff network is significantly enriched in COVID-19-relevant pathways, such as ‘Coronavirus disease,’ ‘TNF signaling pathway,’ ‘Th17 cell differentiation pathway,’ ‘NF-<inline-formula id="IE71"><mml:math id="IM71" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>B signaling pathway,’ ‘NOD-like receptor pathway,’ ‘Toll-like receptor signaling pathway,’ and ‘Viral protein interaction with cytokine and cytokine receptor’ (<xref rid="vbae034-F3" ref-type="fig">Fig. 3</xref>). However, similar to BoostDiff, ‘Herpes simplex I infection’ is a top enriched term in the networks output by both methods, which could indicate the presence of shared genes activated in response to viral infection. For the BoostDiff network, examining the differential edges when considering the two sub-analyses separately shows generally similar results, indicating the enrichment of infection-related pathways (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S8</xref>). We also compare the BoostDiff network to the list of DEGs. While the overlap between the differential network nodes and DEGs is significant, it is quite low (<inline-formula id="IE72"><mml:math id="IM72" display="inline" overflow="scroll"><mml:mrow><mml:mtext>Jaccard similarity</mml:mtext><mml:mo>=</mml:mo><mml:mn>0.129</mml:mn></mml:mrow></mml:math></inline-formula>). Further, removing the DEGs from the genes in the differential network retains the enrichment of COVID-19-related pathways (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S9</xref>), indicating that these dysregulated genes identified by BoostDiff are missed by standard DE analysis.</p>
        <fig position="float" id="vbae034-F3">
          <label>Figure 3.</label>
          <caption>
            <p>Enriched KEGG pathways in the networks inferred by BoostDiff for the COVID-19 dataset. The resulting differential networks were strongly enriched in inflammation-related and other relevant pathways, consistent with known disease pathophysiology.</p>
          </caption>
          <graphic xlink:href="vbae034f3" position="float"/>
        </fig>
        <p>To further examine the differential networks, we apply the Louvain community detection algorithm (<xref rid="vbae034-B8" ref-type="bibr">Blondel <italic toggle="yes">et al.</italic> 2008</xref>). BoostDiff, Diffcoex, <italic toggle="yes">z</italic>-score, and Differential GENIE3, identifies modules that are enriched in viral infection terms such as ‘Influenza A,’ ‘Coronavirus disease,’ ‘Hepatitis C,’ as well as signaling pathways ‘NOD-like receptor signaling pathway,’ ‘RIG-1-like receptor signaling pathway,’ and ‘Toll-like receptor signaling pathway’ (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figs S10–S12</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S8–S11</xref>). However, the BoostDiff module is additionally enriched in the terms ‘Cytosolic DNA-sensing pathway’ and ‘Chemokine signaling pathway’ (<xref rid="vbae034-F4" ref-type="fig">Fig. 4</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S10 and S11</xref>). Notable COVID-19-related genes in the BoostDiff module include <italic toggle="yes">CXCL10, DDX58, STAT1, STAT2, EIF2AK2</italic>, and <italic toggle="yes">ISG15.</italic> Other additionally known genes involved in pathogen response include <italic toggle="yes">IFIT1, IFIT2, IFIT3, CXCL11</italic>, and <italic toggle="yes">CXCL9</italic>. Chemokines are produced in response to a range of viral infections. In COVID-19, chemokine signaling has been linked to acute respiratory distress syndrome (<xref rid="vbae034-B92" ref-type="bibr">Zhou <italic toggle="yes">et al.</italic> 2020</xref>). <italic toggle="yes">DDX58</italic> (RIG-1) is involved in the production of interferons in response to COVID-19 (<xref rid="vbae034-B86" ref-type="bibr">Yamada <italic toggle="yes">et al.</italic> 2021</xref>). Interferon signaling mediated by STAT1 and STAT2 is a key antiviral defense mechanism, and SARS-CoV-2 was demonstrated to inhibit nuclear translocation of STAT1 and STAT2 (<xref rid="vbae034-B60" ref-type="bibr">Mu <italic toggle="yes">et al.</italic> 2020</xref>). OASL, OAS2, and OAS3 are members of the oligoadenylate synthetase family of proteins, which are involved in the antiviral activity of interferons and have been reported to exacerbate cardiac effects of COVID-19 (<xref rid="vbae034-B24" ref-type="bibr">Gao <italic toggle="yes">et al.</italic> 2023</xref>). JAK inhibitors have been explored for the treatment and management of COVID-19 (<xref rid="vbae034-B45" ref-type="bibr">Levy <italic toggle="yes">et al.</italic> 2022</xref>) and is known to regulate the release of pro-inflammatory cytokines and chemokines. For instance, the chemokines <italic toggle="yes">CXCL9, CXCL10</italic> and <italic toggle="yes">CXCL11</italic> are known to be upregulated in the COVID-19 response (<xref rid="vbae034-B11" ref-type="bibr">Callahan <italic toggle="yes">et al.</italic> 2021</xref>). IFIT1, IFIT2, and IFIT3 form a functional complex and participate in interferon-induced broad viral response (<xref rid="vbae034-B56" ref-type="bibr">Mears and Sweeney 2018</xref>, <xref rid="vbae034-B74" ref-type="bibr">Singh <italic toggle="yes">et al.</italic> 2022</xref>). <italic toggle="yes">ISG15</italic> encodes a ubiquitin-like protein whose activation triggers the release of various pro-inflammatory cytokines and chemokines (<xref rid="vbae034-B12" ref-type="bibr">Cao 2021</xref>).</p>
        <fig position="float" id="vbae034-F4">
          <label>Figure 4.</label>
          <caption>
            <p>Dysregulated module identified from the COVID-19 differential network inferred by BoostDiff using the Louvain algorithm. Some notable genes in the module include <italic toggle="yes">JAK2, CXCL9, CXCL10, CXCL11, DDX58, STAT1, STAT2, IFIT1, IFIT2, IFIT3, IFITM3, OASL, OAS2, OAS3</italic>, and <italic toggle="yes">ISG15</italic>.</p>
          </caption>
          <graphic xlink:href="vbae034f4" position="float"/>
        </fig>
        <p>In addition to the enrichment of COVID-19-related genes that are consistent with literature, BoostDiff also identified edges between <italic toggle="yes">TREX1</italic> and <italic toggle="yes">IFIT1, IFIT3, IFITM3, ISG15</italic>, and <italic toggle="yes">OAS3</italic>, all of which have been implicated with COVID-19. While <italic toggle="yes">TREX1</italic> has not been directly linked to COVID-19 pathogenesis, it encodes an exonuclease that is involved in host defense and has also been implicated in autoimmune diseases (<xref rid="vbae034-B75" ref-type="bibr">Stetson <italic toggle="yes">et al.</italic> 2008</xref>). In particular, <italic toggle="yes">TREX1</italic> regulates interferon-mediated signaling in antiviral response (<xref rid="vbae034-B31" ref-type="bibr">Hasan <italic toggle="yes">et al.</italic> 2013</xref>). Interestingly, a recent genome-wide screen identified TREX1 as a pro-viral factor in viral replication during influenza infection (<xref rid="vbae034-B40" ref-type="bibr">King <italic toggle="yes">et al.</italic> 2023</xref>). Given that nucleic acid detection is a key component of the immune response, <italic toggle="yes">TREX1</italic> could be a candidate player involved in immune response to viral pathogens, including SARS-CoV-2, that can be examined in future investigations.</p>
      </sec>
      <sec>
        <title>3.2.2 Crohn’s disease</title>
        <p>Notably, the BoostDiff network shows stronger enrichment of CD-related pathways than the networks inferred by the other methods (<xref rid="vbae034-F5" ref-type="fig">Fig. 5</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S12–S15</xref>). The network returned by Differential GENIE3 does not show any significant enrichment. In addition to infection pathways, the network output by BoostDiff for the CD dataset is enriched in CD-relevant pathways, including ‘TNF signaling pathway,’ ‘NOD-like receptor signaling pathway,’ ‘Th17 cell differentiation,’ ‘IL-17 signaling pathway,’ and ‘NF-<inline-formula id="IE73"><mml:math id="IM73" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>B signaling,’ as well as ‘Inflammatory bowel disease.’ NOD-like receptors play important roles in host defense and homeostasis by acting as sensors of microbial pathogens in the intestinal mucosa. IBD has been associated with abnormal gut microbiota composition, which promotes NF-<inline-formula id="IE74"><mml:math id="IM74" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>B signaling and downstream inflammatory responses (<xref rid="vbae034-B33" ref-type="bibr">Hug <italic toggle="yes">et al.</italic> 2018</xref>). The TF NF-<inline-formula id="IE75"><mml:math id="IM75" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>B functions in maintaining intestinal homeostasis, and dysregulation of the NF-<inline-formula id="IE76"><mml:math id="IM76" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>B pathway leads to sustained inflammatory state characteristic of IBD patients (<xref rid="vbae034-B88" ref-type="bibr">Zaidi and Wine 2018</xref>). NF-<inline-formula id="IE77"><mml:math id="IM77" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>B signaling activation has been associated with more severe clinical manifestations in CD patients (<xref rid="vbae034-B30" ref-type="bibr">Han <italic toggle="yes">et al.</italic> 2017</xref>, <xref rid="vbae034-B88" ref-type="bibr">Zaidi and Wine 2018</xref>). The Th17 subset of <inline-formula id="IE78"><mml:math id="IM78" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mrow><mml:mtext>CD</mml:mtext><mml:mn>4</mml:mn></mml:mrow></mml:mrow><mml:mo>+</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> T cells have well recognized roles in IBD pathogenesis. In CD, IL-17 signaling mediates the activation of Th17 cells, which further drive pro-inflammatory cascades via the production of IL-21, IL-22, IFN-<inline-formula id="IE79"><mml:math id="IM79" display="inline" overflow="scroll"><mml:mo>γ</mml:mo></mml:math></inline-formula>, and TNF (<xref rid="vbae034-B71" ref-type="bibr">Schmitt <italic toggle="yes">et al.</italic> 2021</xref>). The differential edges obtained from the two BoostDiff sub-analyses where the disease or control states are used as the target condition also show enrichment of CD-relevant pathways (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S13</xref>). The nodes in the BoostDiff network have a small overlap with the list of DEGs (<inline-formula id="IE80"><mml:math id="IM80" display="inline" overflow="scroll"><mml:mrow><mml:mtext>Jaccard similarity</mml:mtext><mml:mo>=</mml:mo><mml:mn>0.008</mml:mn></mml:mrow></mml:math></inline-formula>). Enrichment results after removal of DEGs are similar to those of the original network (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S14</xref>). The Diffcoex network is enriched in only the term ‘Herpes simplex virus 1 infection,’ while the <italic toggle="yes">z</italic>-score network is enriched in many cancer-related terms (<xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S12 and S13</xref>). The EBcoexpress network is also enriched in CD-related terms, such as ‘IL-17 signaling pathway,’ ‘NOD-like receptor signaling pathway,’ ‘TNF signaling pathway’ and ‘NF-<inline-formula id="IE81"><mml:math id="IM81" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>B signaling pathway.’ (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S15</xref>).</p>
        <fig position="float" id="vbae034-F5">
          <label>Figure 5.</label>
          <caption>
            <p>Enriched KEGG pathways in the networks inferred by BoostDiff for the CD dataset. The resulting differential networks are strongly enriched in inflammation-related and other relevant pathways, consistent with known disease pathophysiology.</p>
          </caption>
          <graphic xlink:href="vbae034f5" position="float"/>
        </fig>
        <p>The Louvain algorithm is then applied on the differential networks to refine the results. For Diffcoex and Differential GENIE3, none of the modules show significant CD-related enrichment. For <italic toggle="yes">z</italic>-score, one module is enriched in metabolism-related genes (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S15</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S16</xref>). The EBcoexpress network contains a module that is enriched in inflammation-related terms ‘Natural killer cell mediated cytotoxicity,’ ‘NF-<inline-formula id="IE82"><mml:math id="IM82" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>B signaling pathway,’ and ‘TNF signaling pathway’ (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S16</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S17</xref>). On the other hand, the BoostDiff network contains a module enriched in the terms ‘Necroptosis,’ ‘Apoptosis,’ and ‘TNF signaling pathway’ (<xref rid="vbae034-F6" ref-type="fig">Fig. 6</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S18</xref>). CD is characterized by inflammation in the intestinal mucosa leading to necroptosis, autophagy, and apoptosis. TLRs, such as TLR3, are central players in microbial defense in the gut that trigger downstream inflammatory signaling pathways, such as NF-<inline-formula id="IE83"><mml:math id="IM83" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>B (<xref rid="vbae034-B49" ref-type="bibr">Lu <italic toggle="yes">et al.</italic> 2018</xref>). The complex roles of caspases, including CASP1, CASP8, and CASP10, are also known to drive gut inflammation and tissue damage (<xref rid="vbae034-B50" ref-type="bibr">Mandal <italic toggle="yes">et al.</italic> 2018</xref>). <italic toggle="yes">CHUCK</italic> is a member of the NF-<inline-formula id="IE84"><mml:math id="IM84" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>B signaling pathway that functions in chemokine signaling (<xref rid="vbae034-B2" ref-type="bibr">Awane <italic toggle="yes">et al.</italic> 1999</xref>). Aberrant STAT1 and STAT3 signaling in IBD pathogenesis has been previously established (<xref rid="vbae034-B65" ref-type="bibr">Nieminen <italic toggle="yes">et al.</italic> 2013</xref>). The protective role of chemokine-like receptor 1 (CMKLR1) against microbiota-driven colitis has been reported (<xref rid="vbae034-B47" ref-type="bibr">Lin <italic toggle="yes">et al.</italic> 2022</xref>). <italic toggle="yes">TRIM40</italic> drives IBD pathogenesis by targeting cell-cell junctions in the mucosal epithelial barrier and promoting inflammation in the gut (<xref rid="vbae034-B66" ref-type="bibr">Noguchi <italic toggle="yes">et al.</italic> 2011</xref>, <xref rid="vbae034-B37" ref-type="bibr">Kang <italic toggle="yes">et al.</italic> 2023</xref>). Disturbances in the circadian rhythm are also linked to IBD manifestations (<xref rid="vbae034-B26" ref-type="bibr">Giebfried and Lorentz 2023</xref>); for instance, <italic toggle="yes">CLOCK</italic> expression is disrupted in IBD patients (<xref rid="vbae034-B85" ref-type="bibr">Weintraub <italic toggle="yes">et al.</italic> 2020</xref>, <xref rid="vbae034-B26" ref-type="bibr">Giebfried and Lorentz 2023</xref>). Interestingly, BoostDiff identifies an edge between <italic toggle="yes">CLOCK</italic> and <italic toggle="yes">STAT3</italic>, which could point to a candidate regulatory mechanism where the circadian clock influences <italic toggle="yes">STAT3</italic>, a known driver of the CD phenotype. Thus, this dependency could point to further research in this direction.</p>
        <fig position="float" id="vbae034-F6">
          <label>Figure 6.</label>
          <caption>
            <p>Dysregulated module identified from the CD differential network output by BoostDiff. Notable genes include <italic toggle="yes">CLOCK, TRIM40, IL7, TLR3, CASP1, STAT3, STAT1, CASP8, CASP10, CMKLR1</italic>, and <italic toggle="yes">CHUK</italic>.</p>
          </caption>
          <graphic xlink:href="vbae034f6" position="float"/>
        </fig>
      </sec>
      <sec>
        <title>3.2.3 Stress response in <italic toggle="yes">Bacillus subtilis</italic></title>
        <p>BoostDiff also outperforms its competitors on the <italic toggle="yes">B.subtilis</italic> data (<xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S19–S28</xref>). The networks inferred by BoostDiff are found to be enriched in stress-related pathways for all three conditions (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S17</xref>). On the other hand, only the Differential GENIE3 network in the salt stress condition is enriched in stress-related pathways. For Diffcoex, only one of the networks (heat treatment) is significantly enriched in stress-related pathways.</p>
        <p>Next, we examine the networks based on the top hub genes. For the salt stress experiment, all the top ten hub genes in the differential network (<italic toggle="yes">csbD, S536, ohrB, yuzA, ywjC, S1199, S1379, yfhK, yycD, ywmE</italic>, and <italic toggle="yes">ybyB</italic>) are part of the SigB regulon (<xref rid="vbae034-F7" ref-type="fig">Fig. 7</xref>). Similarly, for the heat stress experiment, BoostDiff identifies members of the SigB regulon, namely, <italic toggle="yes">csbD, ohrB, S536, yuzA, S1199, yycD, ywjC, yfhK, ywmE</italic>, and <italic toggle="yes">nhaX</italic>, as hub genes. For the ethanol stress experiment, BoostDiff idebtifies <italic toggle="yes">yuzA, ydaD, yycD, ydaE, yocK, yjgB, yhdF, S1477</italic>, and <italic toggle="yes">ytaB</italic> as the top ten hubs. Consistent with the applied stressors, the abovementioned genes encoding response proteins are part of the SigB regulon. The general stress response is controlled by the alternative sigma factor SigB, which induces the transcription of &gt;100 genes across a wide range of stress stimuli (<xref rid="vbae034-B62" ref-type="bibr">Nannapaneni <italic toggle="yes">et al.</italic> 2012</xref>). On the other hand, the other methods identify fewer relevant hub genes or do not produce meaningful outputs. EBcoexpress assigns a total of 68 532 edges and 1 080 620 edges with a posterior probability of 1.0 for the salt stress and heat stress experiments, respectively, thereby hindering biological interpretation. For the ethanol stress experiment, EBcoexpress did not run even after stringent filtering because of strong correlations in the dataset. The <italic toggle="yes">z</italic>-score method only identifies <italic toggle="yes">ctc</italic> as the relevant hub gene in the salt stress condition and no relevant genes in the heat stress condition; for the ethanol experiment, the <italic toggle="yes">z</italic>-score method identifies the ribosomal gene <italic toggle="yes">rplJ</italic> as a hub, which is not directly involved in the stress response (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S18</xref>). For Diffcoex, only three members of the SigB regulon (<italic toggle="yes">ydbD, yqjL</italic>, and <italic toggle="yes">yvgO</italic>) are identified as hubs in the heat stress condition and one relevant hub (<italic toggle="yes">S1290</italic>) is identified in the salt stress condition; no relevant hub gene is identified in the ethanol stress condition (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S19</xref>). Differential GENIE3 identifies only <italic toggle="yes">yflD</italic> as a hub in the salt stress condition (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S20</xref>).</p>
        <fig position="float" id="vbae034-F7">
          <label>Figure 7.</label>
          <caption>
            <p>The differential networks identified by BoostDiff for the stress response experiments in <italic toggle="yes">B.subtilis</italic>. (a) The differential network inferred with the salt stress versus Spizizen’s minimal medium control comparison. (b) The differential network inferred with the heat stress versus Belitsky Minimal Medium (BMM) control comparison (c). The differential network inferred with the ethanol stress versus BMM control comparison. In all three conditions, the top ten hub genes identified by BoostDiff are members of the SigB regulon, which is induced in diverse stresses in <italic toggle="yes">B.subtilis</italic>.</p>
          </caption>
          <graphic xlink:href="vbae034f7" position="float"/>
        </fig>
      </sec>
      <sec>
        <title>3.2.4 TCGA—breast cancer</title>
        <p>Again, the network inferred by BoostDiff shows stronger enrichment of disease-related pathways (including ‘Transcriptional misregulation in cancer,’ ‘Pathways in cancer,’ ‘Proteoglycans in cancer,’ and ‘Signaling pathways regulating pluripotency of stem cells’) than networks inferred using Diffcoex, EBcoexpress, Differential GENIE3, or the <italic toggle="yes">z</italic>-score method (<xref rid="vbae034-F8" ref-type="fig">Fig. 8</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S29–S32</xref>). Only the Diffcoex network is enriched in inflammatory and cancer-related pathways. Ebcoexpress assigns a posterior probability of 1 to 375 873 edges, while the <italic toggle="yes">z</italic>-score network is enriched in one term, ‘Tight junction’ (<xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S30 and S31</xref>). The network inferred by Differential GENIE3 is enriched in terms related to olfactory transduction and metabolism (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S32</xref>). For BoostDiff, the results of enrichment analysis when considering the two sub-analyses separately shows generally similar results (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S21</xref>). The nodes in the BoostDiff network have a small overlap with the list of DEGs (<inline-formula id="IE85"><mml:math id="IM85" display="inline" overflow="scroll"><mml:mrow><mml:mtext>Jaccard similarity</mml:mtext><mml:mo>=</mml:mo><mml:mn>0.126</mml:mn></mml:mrow></mml:math></inline-formula>). Enrichment results after removal of DEGs are similar to those of the original network (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S22</xref>).</p>
        <fig position="float" id="vbae034-F8">
          <label>Figure 8.</label>
          <caption>
            <p>Enriched KEGG pathways in the networks inferred by BoostDiff for the TCGA BRCA dataset.</p>
          </caption>
          <graphic xlink:href="vbae034f8" position="float"/>
        </fig>
        <p>No BRCA-related module is found in the Differential GENIE3 network. Module analysis for Diffcoex identifies a module that is primarily enriched in generic inflammation-related pathways, such as ‘IL-17 signaling pathway,’ ‘TNF signaling pathway,’ and ‘JAK-STAT signaling pathway.’ (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S23</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S33</xref>). BoostDiff results are more specific: Here, we identify a module that is enriched in the terms ‘PPAR signaling pathway,’ ‘Insulin resistance,’ ‘AMPK signaling pathway,’ ‘Adipocytokine signaling pathway,’ ‘Pyruvate metabolism,’ and ‘Regulation of lipolysis in adipocytes’ (<xref rid="vbae034-F9" ref-type="fig">Fig. 9</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S34</xref>). Adipose tissue plays an important role in tumor progression because it provides nutrients, metabolites, and adipokines to the tumor microenvironment of breast cancer cells (<xref rid="vbae034-B18" ref-type="bibr">DeBerardinis <italic toggle="yes">et al.</italic> 2008</xref>, <xref rid="vbae034-B28" ref-type="bibr">Guaita-Esteruelas <italic toggle="yes">et al.</italic> 2017</xref>). PPAR is a ligand-activated TF that is involved in fatty acid oxidation and lipid metabolism (<xref rid="vbae034-B44" ref-type="bibr">Lee <italic toggle="yes">et al.</italic> 2019</xref>). In the context of BRCA, PPAR signaling is known to contribute to metastasis and promote survival in harsh metabolic conditions (<xref rid="vbae034-B70" ref-type="bibr">Saez <italic toggle="yes">et al.</italic> 2004</xref>, <xref rid="vbae034-B84" ref-type="bibr">Wang <italic toggle="yes">et al.</italic> 2016</xref>).</p>
        <fig position="float" id="vbae034-F9">
          <label>Figure 9.</label>
          <caption>
            <p>Dysregulated Louvain module for the TCGA BRCA dataset. Notable genes include <italic toggle="yes">PPARG, PLIN1, PLIN4, CD36, ESR2, ADIPOQ, FABP4, PCK1, CEBPA, MEOX1</italic>, and <italic toggle="yes">MEOX2</italic>.</p>
          </caption>
          <graphic xlink:href="vbae034f9" position="float"/>
        </fig>
        <p>The BoostDiff results not only make sense in light of the enriched pathways, but also when zooming-in on the individual edges and hub nodes: For instance, BoostDiff identifies a relationship between <italic toggle="yes">PPARG</italic> and <italic toggle="yes">PLIN4</italic>, which are already known to be associated in the context of adipogenesis (<xref rid="vbae034-B64" ref-type="bibr">Nielsen <italic toggle="yes">et al.</italic> 2008</xref>). Perilipins comprise lipid droplet-associated proteins that modulate lipid homeostasis. In BRCA, <italic toggle="yes">PLIN4</italic> upregulation is associated with poor prognosis (<xref rid="vbae034-B39" ref-type="bibr">Kim <italic toggle="yes">et al.</italic> 2015</xref>, <xref rid="vbae034-B91" ref-type="bibr">Zhang <italic toggle="yes">et al.</italic> 2021</xref>). BoostDiff also predicts an edge between <italic toggle="yes">PPARG</italic> and <italic toggle="yes">PCK1</italic>, which is also part of the PPAR pathway. <italic toggle="yes">PCK1</italic> encodes a protein kinase that has multiple known metabolic roles, including lipogenesis and tumorigenesis (<xref rid="vbae034-B79" ref-type="bibr">Tang <italic toggle="yes">et al.</italic> 2021</xref>). BoostDiff identifies <italic toggle="yes">CD36</italic> as a hub gene in the module. In BRCA, <italic toggle="yes">CD36</italic> has been reported to be involved in metabolic rewiring and reprogramming favoring fatty acid oxidation and has been proposed as a therapeutic target in breast cancer (<xref rid="vbae034-B23" ref-type="bibr">Feng <italic toggle="yes">et al.</italic> 2019</xref>). BoostDiff further identified an edge between <italic toggle="yes">CD36</italic> and <italic toggle="yes">FABP4</italic>. In BRCA, CD36 was shown to directly interact with FABP4 to influence transport and metabolism of fatty acids (<xref rid="vbae034-B29" ref-type="bibr">Gyamfi <italic toggle="yes">et al.</italic> 2021</xref>). Further, <italic toggle="yes">CD36</italic> is upregulated along with other lipid metabolism genes <italic toggle="yes">PLIN1</italic> and <italic toggle="yes">ADIPOQ</italic> (adiponectin) in breast cancer (<xref rid="vbae034-B53" ref-type="bibr">Marino <italic toggle="yes">et al.</italic> 2020</xref>).</p>
        <p>The correlation between <italic toggle="yes">ESR2</italic> and <italic toggle="yes">ADIPOQ</italic> in adipose tissue is also established (<xref rid="vbae034-B1" ref-type="bibr">Ahmed <italic toggle="yes">et al.</italic> 2022</xref>). While this specific relationship has not been described in breast cancer, this could be investigated in future studies, given the established role of estrogens and adiposity in breast cancer (<xref rid="vbae034-B6" ref-type="bibr">Bhardwaj and Brown 2021</xref>). Along with <italic toggle="yes">PPARG, CEBPA</italic> is a known master regulator of adipogenesis that influences lipid accumulation (<xref rid="vbae034-B44" ref-type="bibr">Lee <italic toggle="yes">et al.</italic> 2019</xref>). Here, <italic toggle="yes">CEBPA</italic> is associated with <italic toggle="yes">ADIPOQ</italic>, another adipocyte marker (<xref rid="vbae034-B55" ref-type="bibr">Matulewicz <italic toggle="yes">et al.</italic> 2017</xref>). Other identified TFs include <italic toggle="yes">MEOX1</italic> and <italic toggle="yes">MEOX2</italic>, which are involved in angiogenesis and vascular development (<xref rid="vbae034-B72" ref-type="bibr">Schönrock <italic toggle="yes">et al.</italic> 2022</xref>, <xref rid="vbae034-B83" ref-type="bibr">Wang <italic toggle="yes">et al.</italic> 2022</xref>, <xref rid="vbae034-B89" ref-type="bibr">Zeng <italic toggle="yes">et al.</italic> 2023</xref>). For instance, <italic toggle="yes">MEOX1</italic> expression was found to be associated with tumor growth triple-negative BRCA (<xref rid="vbae034-B89" ref-type="bibr">Zeng <italic toggle="yes">et al.</italic> 2023</xref>). Based on their emerging roles in neoplastic diseases, MEOX1 and MEOX2 could be candidate targets in breast cancer. Overall, our results identify genes that can be further explored and reinforce the important role of adipogenesis in breast cancer.</p>
      </sec>
      <sec>
        <title>3.2.5 TCGA—prostate adenocarcinoma</title>
        <p>For PRAD, the EBcoexpress network is too large to analyze, as 375 873 edges are assigned with posterior probability of 1, while the <italic toggle="yes">z</italic>-score network is not significantly enriched in any terms. The Diffcoex network is enriched in infection- and cancer-related terms, while the Differential GENIE3 network is enriched in terms related to metabolism. On the other hand, the BoostDiff network shows overall stronger enrichment of cancer-related terms (<xref rid="vbae034-F10" ref-type="fig">Fig. 10</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S35–S37</xref>). The nodes in the BoostDiff network have a small overlap with the list of DEGs (<inline-formula id="IE86"><mml:math id="IM86" display="inline" overflow="scroll"><mml:mrow><mml:mtext>Jaccard similarity</mml:mtext><mml:mo>=</mml:mo><mml:mn>0.114</mml:mn></mml:mrow></mml:math></inline-formula>). The results of enrichment analysis when considering the two sub-analyses separately shows generally similar results (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S24</xref>). Enrichment results after removal of DEGs are similar to those of the original network (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S25</xref>).</p>
        <fig position="float" id="vbae034-F10">
          <label>Figure 10.</label>
          <caption>
            <p>Enriched KEGG pathways in the networks inferred by BoostDiff for the TCGA PRAD dataset.</p>
          </caption>
          <graphic xlink:href="vbae034f10" position="float"/>
        </fig>
        <p>For Diffcoex, we identify a cancer-associated module enriched in terms such as ‘Cell cycle,’ ‘Cellular senescence,’ and ‘Bladder cancer’ (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S26</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S38</xref>). None of the modules in the <italic toggle="yes">z</italic>-score and Differential GENIE3 networks show significant enrichment of cancer-related terms. For BoostDiff, we identify a module enriched in the terms ‘Transcriptional misregulation in cancer,’ ‘Adrenergic signaling in cardiomyocytes,’ ‘Dilated cardiomyopathy,’ ‘Thyroid hormone signaling pathway,’ ‘Cardiac muscle contraction,’ and ‘Pathways in cancer’ (<xref rid="vbae034-F11" ref-type="fig">Fig. 11</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S39</xref>). The module contains MEF2C, a TF known to be involved in oncogenesis and tumor proliferation in many types of cancers (<xref rid="vbae034-B3" ref-type="bibr">Bai <italic toggle="yes">et al.</italic> 2015</xref>, <xref rid="vbae034-B20" ref-type="bibr">Di Giorgio <italic toggle="yes">et al.</italic> 2017</xref>). <italic toggle="yes">TEAD4</italic> was found to be an important prognostic marker in PRAD and is a known effector of oncogenic pathways (<xref rid="vbae034-B13" ref-type="bibr">Chen <italic toggle="yes">et al.</italic> 2021</xref>). The potential involvement of <italic toggle="yes">MYH7</italic> in PRAD has been recently described; in particular (<xref rid="vbae034-B46" ref-type="bibr">Liang <italic toggle="yes">et al.</italic> 2022</xref>), found a higher frequency of <italic toggle="yes">MYH7</italic> variants in prostate cancer patients. <italic toggle="yes">CAMK2A</italic> is known to promote tumor progression in prostate cancer (<xref rid="vbae034-B69" ref-type="bibr">Rokhlin <italic toggle="yes">et al.</italic> 2007</xref>, <xref rid="vbae034-B32" ref-type="bibr">He and Li 2021</xref>). In an earlier study, protein-protein interaction network-based analyses similarly identified <italic toggle="yes">ACTN2, MYL1, MYL2</italic>, and <italic toggle="yes">MYH7</italic> as hub genes associated with <italic toggle="yes">PTEN</italic>-associated prostate cancer (<xref rid="vbae034-B77" ref-type="bibr">Sun <italic toggle="yes">et al.</italic> 2019</xref>). The dysregulation of <italic toggle="yes">ACTN2</italic> and <italic toggle="yes">MYH7</italic> has been described in the context of other cancers (<xref rid="vbae034-B36" ref-type="bibr">Ju <italic toggle="yes">et al.</italic> 2023</xref>). Our results suggest that candidate genes in the identified module can be further examined in the context of prostate cancer.</p>
        <fig position="float" id="vbae034-F11">
          <label>Figure 11.</label>
          <caption>
            <p>Dysregulated Louvain module for the TCGA PRAD dataset. Notable genes include <italic toggle="yes">MEF2C, MYL1, MYH6, MYH7, MYL2, ACTN2, CAMK2A</italic>, and <italic toggle="yes">TEAD4</italic>.</p>
          </caption>
          <graphic xlink:href="vbae034f11" position="float"/>
        </fig>
      </sec>
      <sec>
        <title>3.2.6 Expression distributions of top-ranked edges identified by BoostDiff reflect shifts in correlation distributions</title>
        <p>We additionally examine the Pearson correlations of the top edges from the differential networks identified by BoostDiff using the original expression data. This procedure is performed separately for the results of the two sub-analyses, namely, when the disease condition is used as the target condition, and when the control condition is used as the target condition. For the COVID-19 and CD datasets, for the same set of edges, we observe a unimodal distribution of correlation values in the nontarget condition and a bimodal distribution in the target condition, where strong positive correlation values suggest target-condition-specific activating regulator-target relationship, while negative values indicate target-condition-specific inhibitory relationships (<xref rid="vbae034-F12" ref-type="fig">Fig. 12</xref>). Similar observations can be derived for the <italic toggle="yes">B.subtilis</italic> stress adaptation and TCGA datasets (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S27</xref>). That is, expression levels of genes incident with differential edges returned by BoostDiff tend to exhibit highly condition-specific correlation patterns, indicating that BoostDiff can indeed uncover disease-specific gene dysregulation. Importantly, this striking observation does not hold for the set of all pairwise edges whose endpoints are DEGs or for randomly selected edges. For Differential GENIE3, similar patterns were observed for the salt stress and ethanol stress networks (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S28</xref>). However, no consistent patterns are observed when the same analysis is performed on the networks inferred from the human datasets (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S29</xref>).</p>
        <fig position="float" id="vbae034-F12">
          <label>Figure 12.</label>
          <caption>
            <p>Violin plots showing that the top 500 edges in the differential network predicted by BoostDiff for each sub-analysis tend to exhibit changes in correlation distributions between the disease and control expression data, indicating dysregulation in pairwise relationships. Correlations between predicted differential edges are compared to correlations between all pairwise combinations of DEGs, as well as randomly selected edges. Results are shown for (a) COVID-19, (b) CD, (c) TCGA—BRCA, and (d) TCGA—PRAD datasets.</p>
          </caption>
          <graphic xlink:href="vbae034f12" position="float"/>
        </fig>
      </sec>
    </sec>
  </sec>
  <sec>
    <title>4 Conclusions</title>
    <p>Gene regulation is a complex process that changes under different biological contexts. Differential network biology explores the rewiring of these regulatory interaction landscapes that are fundamentally distinct from the static networks that are inferred in most standard GRN inference methods (<xref rid="vbae034-B35" ref-type="bibr">Ideker and Krogan 2012</xref>). By additionally considering the regulatory dependencies from a baseline condition, we can uncover a more refined picture underlying the molecular processes that are perturbed in a condition of interest, such as disease.</p>
    <p>Inference of networks from biological expression data is a challenging task. The novelty of BoostDiff is 2-fold: (i) We use differential variance improvement as the splitting measure in a tree-based algorithm that can explicitly compare two datasets with a continuous output variable; (ii) BoostDiff adapts the AdaBoost algorithm to use differential trees as the base learner. Boosting the differential trees with respect to samples belonging to the target condition is a crucial step that significantly improves the detection of differential edges.</p>
    <p>BoostDiff outperforms existing differential network methods on simulated data in more complex settings with higher dimensionality. BoostDiff yields biologically meaningful results when evaluated on five real-world transcriptomics datasets. We show that BoostDiff infers differential networks that are consistent with the pathophysiology of COVID-19, Crohn’s disease, and two types of cancer, namely, breast cancer and prostate adenocarcinoma, using TCGA data. We further validate BoostDiff using three different stress conditions evaluating the response of <italic toggle="yes">B.subtilis</italic> to salt, heat, and ethanol stressors, where BoostDiff correctly identifies members of the SigB regulon as hub genes in the differential networks. On the other hand, the compared methods recover few stress-related response genes. BoostDiff is also scalable and has reasonable runtime since it builds one model for each gene and can hence easily be parallelized. To facilitate biological interpretation and further refine the results, various graph-based algorithms can be used to find highly connected subnetworks. In this study, we apply the Louvain community detection algorithm, although other graph-based tools can also be used to find perturbed modules.</p>
    <p>Nevertheless, our method has several limitations. First, BoostDiff can only compare two conditions at a time. Moreover, BoostDiff is similar to GENIE3 in that it does not perform statistical testing. Instead, scores are assigned to individual edges by calculating tree-based variable importance measures; thus, only the ranking of the edge weights is considered. Further, the AdaBoost algorithm can be prone to overfitting. In our experiments, BoostDiff performance decreased when setting the number of trees to 300. Thus, to avoid overfitting, we recommend users to set a low number of base differential trees (e.g. 50 trees).</p>
    <p>The application of BoostDiff is not limited to gene expression data; the proposed feature selection approach can be generalized to other omics datasets. For instance, BoostDiff can be applied to proteomics or metabolomics studies that aim to detect changes in dependencies of proteins or metabolites. Moreover, the simple but effective strategy implemented in BoostDiff is an algorithmic advancement that can be further extended to other problems that aim to extract differentially predictive features. Adapting BoostDiff for analyzing time-series datasets is also a promising research direction.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>vbae034_Supplementary_Data</label>
      <media xlink:href="vbae034_supplementary_data.zip"/>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ack1">
    <title>Acknowledgements</title>
    <p>We are grateful to Julian Beier for technical support. We thank the anonymous reviewers for their valuable suggestions.</p>
  </ack>
  <sec>
    <title>Author contributions</title>
    <p>G.G.: Conceptualization, Formal analysis, Methodology, Software, Writing—original draft. M.L.: Conceptualization, Writing—Review &amp; Editing. J.B.: Conceptualization, Writing—Review &amp; Editing. U.V.: Validation, Writing—Review &amp; Editing. U.M.: Validation, Writing—Review &amp; Editing. D.B.B.: Conceptualization, Methodology, Supervision, Writing—Review &amp; Editing. T.K.: Conceptualization, Methodology, Supervision, Writing—Review &amp; Editing.</p>
  </sec>
  <sec>
    <title>Supplementary data</title>
    <p><xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> are available at <italic toggle="yes">Bioinformatics Advances</italic> online.</p>
  </sec>
  <sec sec-type="COI-statement">
    <title>Conflict of interest</title>
    <p>None declared.</p>
  </sec>
  <sec>
    <title>Funding</title>
    <p>This work was supported by the German Federal Ministry of Education and Research (BMBF) [031L0309A to D.B.B.]; and the Open Access Publication Funds of Technische Universität Braunschweig.</p>
  </sec>
  <sec sec-type="data-availability">
    <title>Data availability</title>
    <p>The data used in this article are publicly available. Transcriptomics data used for analyzing the COVID-19, Crohn’s disease, and <italic toggle="yes">Bacillus subtilis</italic> stress response can be downloaded from Gene Expression Omnibus under the accession numbers GSE156063, GSE126124, and GSE27219, respecively. The TCGA datasets are available at <ext-link xlink:href="https://xenabrowser.net/datapages/" ext-link-type="uri">https://xenabrowser.net/datapages/</ext-link>. The simulated gene expression data are deposited at <ext-link xlink:href="https://zenodo.org/records/10214950" ext-link-type="uri">https://zenodo.org/records/10214950</ext-link>. Our BoostDiff implementation, as well as sample scripts and tutorials are available on GitHub: <ext-link xlink:href="https://github.com/scibiome/boostdiff_inference" ext-link-type="uri">https://github.com/scibiome/boostdiff_inference</ext-link>.</p>
  </sec>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="vbae034-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ahmed</surname><given-names>F</given-names></string-name>, <string-name><surname>Hetty</surname><given-names>S</given-names></string-name>, <string-name><surname>Vranic</surname><given-names>M</given-names></string-name></person-group><etal>et al</etal><article-title>ESR2 expression in subcutaneous adipose tissue is related to body fat distribution in women, and knockdown impairs preadipocyte differentiation</article-title>. <source>Adipocyte</source><year>2022</year>;<volume>11</volume>:<fpage>434</fpage>–<lpage>47</lpage>.<pub-id pub-id-type="pmid">35856485</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Awane</surname><given-names>M</given-names></string-name>, <string-name><surname>Andres</surname><given-names>PG</given-names></string-name>, <string-name><surname>Li</surname><given-names>DJ</given-names></string-name></person-group><etal>et al</etal><article-title>Nf-<inline-formula id="IE87"><mml:math id="IM87" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula>b-inducing kinase is a common mediator of il-17-, tnf-<inline-formula id="IE88"><mml:math id="IM88" display="inline" overflow="scroll"><mml:mo>α</mml:mo></mml:math></inline-formula>-, and il-1<inline-formula id="IE89"><mml:math id="IM89" display="inline" overflow="scroll"><mml:mo>β</mml:mo></mml:math></inline-formula>-induced chemokine promoter activation in intestinal epithelial cells</article-title>. <source>J Immunol</source><year>1999</year>;<volume>162</volume>:<fpage>5337</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="pmid">10228009</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bai</surname><given-names>XL</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Q</given-names></string-name>, <string-name><surname>Ye</surname><given-names>LY</given-names></string-name></person-group><etal>et al</etal><article-title>Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth factor and Wnt/<inline-formula id="IE90"><mml:math id="IM90" display="inline" overflow="scroll"><mml:mo>β</mml:mo></mml:math></inline-formula>-catenin signaling</article-title>. <source>Oncogene</source><year>2015</year>;<volume>34</volume>:<fpage>4089</fpage>–<lpage>97</lpage>.<pub-id pub-id-type="pmid">25328135</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Basha</surname><given-names>O</given-names></string-name>, <string-name><surname>Argov</surname><given-names>CM</given-names></string-name>, <string-name><surname>Artzy</surname><given-names>R</given-names></string-name></person-group><etal>et al</etal><article-title>Differential network analysis of multiple human tissue interactomes highlights tissue-selective processes and genetic disorder genes</article-title>. <source>Bioinformatics</source><year>2020</year>;<volume>36</volume>:<fpage>2821</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">31960892</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Baur</surname><given-names>B</given-names></string-name>, <string-name><surname>Shin</surname><given-names>J</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>Data integration for inferring context-specific gene regulatory networks</article-title>. <source>Curr Opin Syst Biol</source><year>2020</year>;<volume>23</volume>:<fpage>38</fpage>–<lpage>46</lpage>.<pub-id pub-id-type="pmid">33225112</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bhardwaj</surname><given-names>P</given-names></string-name>, <string-name><surname>Brown</surname><given-names>KA.</given-names></string-name></person-group><article-title>Obese adipose tissue as a driver of breast cancer growth and development: update and emerging evidence</article-title>. <source>Front Oncol</source><year>2021</year>;<volume>11</volume>:<fpage>638918</fpage>.<pub-id pub-id-type="pmid">33859943</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bhuva</surname><given-names>DD</given-names></string-name>, <string-name><surname>Cursons</surname><given-names>J</given-names></string-name>, <string-name><surname>Smyth</surname><given-names>GK</given-names></string-name></person-group><etal>et al</etal><article-title>Differential co-expression-based detection of conditional relationships in transcriptional data: comparative analysis and application to breast cancer</article-title>. <source>Genome Biol</source><year>2019</year>;<volume>20</volume>:<fpage>236</fpage>.<pub-id pub-id-type="pmid">31727119</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Blondel</surname><given-names>VD</given-names></string-name>, <string-name><surname>Guillaume</surname><given-names>J-L</given-names></string-name>, <string-name><surname>Lambiotte</surname><given-names>R</given-names></string-name></person-group><etal>et al</etal> Fast unfolding of communities in large networks. <italic toggle="yes">J Stat Mech</italic><year>2008</year>;<volume>2008</volume>:P10008.</mixed-citation>
    </ref>
    <ref id="vbae034-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Breiman</surname><given-names>L</given-names></string-name>, <string-name><surname>Friedman</surname><given-names>J</given-names></string-name>, <string-name><surname>Olshen</surname><given-names>R</given-names></string-name></person-group><etal>et al</etal><article-title>Classification and regression trees</article-title>. <source>Wadsworth Int Group</source><year>1984</year>;<volume>37</volume>:<fpage>237</fpage>–<lpage>51</lpage>.</mixed-citation>
    </ref>
    <ref id="vbae034-B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brunel</surname><given-names>H</given-names></string-name>, <string-name><surname>Gallardo-Chacón</surname><given-names>J-J</given-names></string-name>, <string-name><surname>Buil</surname><given-names>A</given-names></string-name></person-group><etal>et al</etal><article-title>MISS: a non-linear methodology based on mutual information for genetic association studies in both population and sib-pairs analysis</article-title>. <source>Bioinformatics</source><year>2010</year>;<volume>26</volume>:<fpage>1811</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">20562420</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Callahan</surname><given-names>V</given-names></string-name>, <string-name><surname>Hawks</surname><given-names>S</given-names></string-name>, <string-name><surname>Crawford</surname><given-names>MA</given-names></string-name></person-group><etal>et al</etal> The pro-inflammatory chemokines CXCL9, CXCL10 and CXCL11 are upregulated following SARS-CoV-2 infection in an AKT-dependent manner. Viruses <year>2021</year>;<volume>13</volume>:<fpage>1062</fpage>.</mixed-citation>
    </ref>
    <ref id="vbae034-B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cao</surname><given-names>X.</given-names></string-name></person-group><article-title>ISG15 secretion exacerbates inflammation in SARS-CoV-2 infection</article-title>. <source>Nat Immunol</source><year>2021</year>;<volume>22</volume>:<fpage>1360</fpage>–<lpage>2</lpage>.<pub-id pub-id-type="pmid">34671145</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B13">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>C-L</given-names></string-name>, <string-name><surname>Hsu</surname><given-names>S-C</given-names></string-name>, <string-name><surname>Chung</surname><given-names>T-Y</given-names></string-name></person-group><etal>et al</etal><article-title>Arginine is an epigenetic regulator targeting tead4 to modulate oxphos in prostate cancer cells</article-title>. <source>Nat Commun</source><year>2021</year>;<volume>12</volume>:<fpage>2398</fpage>.<pub-id pub-id-type="pmid">33893278</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B14">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chu</surname><given-names>J-H</given-names></string-name>, <string-name><surname>Lazarus</surname><given-names>R</given-names></string-name>, <string-name><surname>Carey</surname><given-names>VJ</given-names></string-name></person-group><etal>et al</etal><article-title>Quantifying differential gene connectivity between disease states for objective identification of disease-relevant genes</article-title>. <source>BMC Syst Biol</source><year>2011</year>;<volume>5</volume>:<fpage>89</fpage>.<pub-id pub-id-type="pmid">21627793</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B15">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Costello</surname><given-names>JC</given-names></string-name>, <string-name><surname>Heiser</surname><given-names>LM</given-names></string-name>, <string-name><surname>Georgii</surname><given-names>E</given-names></string-name></person-group><etal>et al</etal>; <collab>NCI DREAM Community</collab>. <article-title>A community effort to assess and improve drug sensitivity prediction algorithms</article-title>. <source>Nat. Biotechnol</source><year>2014</year>;<volume>32</volume>:<fpage>1202</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="pmid">24880487</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B16">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dawson</surname><given-names>JA</given-names></string-name>, <string-name><surname>Kendziorski</surname><given-names>C.</given-names></string-name></person-group><article-title>An empirical Bayesian approach for identifying differential coexpression in high-throughput experiments</article-title>. <source>Biometrics</source><year>2012</year>;<volume>68</volume>:<fpage>455</fpage>–<lpage>65</lpage>.<pub-id pub-id-type="pmid">22004327</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B17">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dawson</surname><given-names>JA</given-names></string-name>, <string-name><surname>Ye</surname><given-names>S</given-names></string-name>, <string-name><surname>Kendziorski</surname><given-names>C.</given-names></string-name></person-group><article-title>R/EBcoexpress: an empirical Bayesian framework for discovering differential co-expression</article-title>. <source>Bioinformatics</source><year>2012</year>;<volume>28</volume>:<fpage>1939</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="pmid">22595207</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B18">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>DeBerardinis</surname><given-names>RJ</given-names></string-name>, <string-name><surname>Lum</surname><given-names>JJ</given-names></string-name>, <string-name><surname>Hatzivassiliou</surname><given-names>G</given-names></string-name></person-group><etal>et al</etal><article-title>The biology of cancer: metabolic reprogramming fuels cell growth and proliferation</article-title>. <source>Cell Metab</source><year>2008</year>;<volume>7</volume>:<fpage>11</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="pmid">18177721</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B19">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>de la Fuente</surname><given-names>A.</given-names></string-name></person-group><article-title>From ‘differential expression’ to ‘differential networking’ – identification of dysfunctional regulatory networks in diseases</article-title>. <source>Trends Genet</source><year>2010</year>;<volume>26</volume>:<fpage>326</fpage>–<lpage>33</lpage>.<pub-id pub-id-type="pmid">20570387</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B20">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Di Giorgio</surname><given-names>E</given-names></string-name>, <string-name><surname>Franforte</surname><given-names>E</given-names></string-name>, <string-name><surname>Cefalù</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>The co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressiveness</article-title>. <source>PLoS Genet</source><year>2017</year>;<volume>13</volume>:<fpage>e1006752</fpage>.<pub-id pub-id-type="pmid">28419090</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B21">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Drucker</surname><given-names>H.</given-names></string-name></person-group><article-title>Improving regressors using boosting techniques</article-title>. In: <source>ICML</source>, July 8–12, 1997; Nashville, Tennessee, USA: Morgan Kaufmann, Vol. <volume>97</volume>, <year>1997</year>, <fpage>107</fpage>–<lpage>15</lpage>.</mixed-citation>
    </ref>
    <ref id="vbae034-B22">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Durinck</surname><given-names>S</given-names></string-name>, <string-name><surname>Spellman</surname><given-names>PT</given-names></string-name>, <string-name><surname>Birney</surname><given-names>E</given-names></string-name></person-group><etal>et al</etal><article-title>Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomart</article-title>. <source>Nat Protoc</source><year>2009</year>;<volume>4</volume>:<fpage>1184</fpage>–<lpage>91</lpage>.<pub-id pub-id-type="pmid">19617889</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B23">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Feng</surname><given-names>WW</given-names></string-name>, <string-name><surname>Wilkins</surname><given-names>O</given-names></string-name>, <string-name><surname>Bang</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>CD36-Mediated metabolic rewiring of breast cancer cells promotes resistance to HER2-Targeted therapies</article-title>. <source>Cell Rep</source><year>2019</year>;<volume>29</volume>:<fpage>3405</fpage>–<lpage>20.e5</lpage>.<pub-id pub-id-type="pmid">31825825</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B24">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gao</surname><given-names>L-J</given-names></string-name>, <string-name><surname>He</surname><given-names>Z-M</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y-Y</given-names></string-name></person-group><etal>et al</etal><article-title>Role of OAS gene family in COVID-19 induced heart failure</article-title>. <source>J Transl Med</source><year>2023</year>;<volume>21</volume>:<fpage>212</fpage>.<pub-id pub-id-type="pmid">36949448</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B25">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ge</surname><given-names>SX</given-names></string-name>, <string-name><surname>Jung</surname><given-names>D</given-names></string-name>, <string-name><surname>Yao</surname><given-names>R.</given-names></string-name></person-group><article-title>ShinyGO: a graphical gene-set enrichment tool for animals and plants</article-title>. <source>Bioinformatics</source><year>2020</year>;<volume>36</volume>:<fpage>2628</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">31882993</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B26">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Giebfried</surname><given-names>J</given-names></string-name>, <string-name><surname>Lorentz</surname><given-names>A.</given-names></string-name></person-group><article-title>Relationship between the biological clock and inflammatory bowel disease</article-title>. <source>Clocks Sleep</source><year>2023</year>;<volume>5</volume>:<fpage>260</fpage>–<lpage>75</lpage>.<pub-id pub-id-type="pmid">37218867</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B27">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Goldman</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Craft</surname><given-names>B</given-names></string-name>, <string-name><surname>Hastie</surname><given-names>M</given-names></string-name></person-group><etal>et al</etal><article-title>Visualizing and interpreting cancer genomics data via the xena platform</article-title>. <source>Nat Biotechnol</source><year>2020</year>;<volume>38</volume>:<fpage>675</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">32444850</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B28">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guaita-Esteruelas</surname><given-names>S</given-names></string-name>, <string-name><surname>Bosquet</surname><given-names>A</given-names></string-name>, <string-name><surname>Saavedra</surname><given-names>P</given-names></string-name></person-group><etal>et al</etal><article-title>Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins</article-title>. <source>Mol Carcinog</source><year>2017</year>;<volume>56</volume>:<fpage>208</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="pmid">27061264</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B29">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gyamfi</surname><given-names>J</given-names></string-name>, <string-name><surname>Yeo</surname><given-names>JH</given-names></string-name>, <string-name><surname>Kwon</surname><given-names>D</given-names></string-name></person-group><etal>et al</etal><article-title>Interaction between CD36 and FABP4 modulates adipocyte-induced fatty acid import and metabolism in breast cancer</article-title>. <source>NPJ Breast Cancer</source><year>2021</year>;<volume>7</volume>:<fpage>129</fpage>.<pub-id pub-id-type="pmid">34561446</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B30">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Han</surname><given-names>YM</given-names></string-name>, <string-name><surname>Koh</surname><given-names>J</given-names></string-name>, <string-name><surname>Kim</surname><given-names>JW</given-names></string-name></person-group><etal>et al</etal><article-title>NF-kappa B activation correlates with disease phenotype in Crohn’s disease</article-title>. <source>PLoS One</source><year>2017</year>;<volume>12</volume>:<fpage>e0182071</fpage>.<pub-id pub-id-type="pmid">28753650</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B31">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hasan</surname><given-names>M</given-names></string-name>, <string-name><surname>Koch</surname><given-names>J</given-names></string-name>, <string-name><surname>Rakheja</surname><given-names>D</given-names></string-name></person-group><etal>et al</etal><article-title>Trex1 regulates lysosomal biogenesis and interferon-independent activation of antiviral genes</article-title>. <source>Nat Immunol</source><year>2013</year>;<volume>14</volume>:<fpage>61</fpage>–<lpage>71</lpage>.<pub-id pub-id-type="pmid">23160154</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B32">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>He</surname><given-names>Q</given-names></string-name>, <string-name><surname>Li</surname><given-names>Z.</given-names></string-name></person-group><article-title>The dysregulated expression and functional effect of CaMK2 in cancer</article-title>. <source>Cancer Cell Int</source><year>2021</year>;<volume>21</volume>:<fpage>326</fpage>.<pub-id pub-id-type="pmid">34193145</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B33">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hug</surname><given-names>H</given-names></string-name>, <string-name><surname>Mohajeri</surname><given-names>MH</given-names></string-name>, <string-name><surname>La Fata</surname><given-names>G.</given-names></string-name></person-group><article-title>Toll-Like receptors: regulators of the immune response in the human gut</article-title>. <source>Nutrients</source><year>2018</year>;<volume>10</volume>:<fpage>203</fpage>.<pub-id pub-id-type="pmid">29438282</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B34">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huynh-Thu</surname><given-names>VA</given-names></string-name>, <string-name><surname>Irrthum</surname><given-names>A</given-names></string-name>, <string-name><surname>Wehenkel</surname><given-names>L</given-names></string-name></person-group><etal>et al</etal><article-title>Inferring regulatory networks from expression data using tree-based methods</article-title>. <source>PLoS One</source><year>2010</year>;<volume>5</volume>:<fpage>203</fpage>.</mixed-citation>
    </ref>
    <ref id="vbae034-B35">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ideker</surname><given-names>T</given-names></string-name>, <string-name><surname>Krogan</surname><given-names>NJ.</given-names></string-name></person-group><article-title>Differential network biology</article-title>. <source>Mol Syst Biol</source><year>2012</year>;<volume>8</volume>:<fpage>565</fpage>.<pub-id pub-id-type="pmid">22252388</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B36">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ju</surname><given-names>G</given-names></string-name>, <string-name><surname>Yao</surname><given-names>Z</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>Y</given-names></string-name></person-group><etal>et al</etal><article-title>Data mining on identifying diagnosis and prognosis biomarkers in head and neck squamous carcinoma</article-title>. <source>Sci Rep</source><year>2023</year>;<volume>13</volume>:<fpage>10020</fpage>.<pub-id pub-id-type="pmid">37340028</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B37">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kang</surname><given-names>S</given-names></string-name>, <string-name><surname>Kim</surname><given-names>J</given-names></string-name>, <string-name><surname>Park</surname><given-names>A</given-names></string-name></person-group><etal>et al</etal><article-title>TRIM40 is a pathogenic driver of inflammatory bowel disease subverting intestinal barrier integrity</article-title>. <source>Nat Commun</source><year>2023</year>;<volume>14</volume>:<fpage>700</fpage>.<pub-id pub-id-type="pmid">36755029</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B38">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Karlebach</surname><given-names>G</given-names></string-name>, <string-name><surname>Shamir</surname><given-names>R.</given-names></string-name></person-group><article-title>Modelling and analysis of gene regulatory networks</article-title>. <source>Nat Rev Mol Cell Biol</source><year>2008</year>;<volume>9</volume>:<fpage>770</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">18797474</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B39">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kim</surname><given-names>S</given-names></string-name>, <string-name><surname>Lee</surname><given-names>Y</given-names></string-name>, <string-name><surname>Koo</surname><given-names>JS.</given-names></string-name></person-group><article-title>Differential expression of lipid metabolism-related proteins in different breast cancer subtypes</article-title>. <source>PLoS One</source><year>2015</year>;<volume>10</volume>:<fpage>e0119473</fpage>.<pub-id pub-id-type="pmid">25751270</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B40">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>King</surname><given-names>CR</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y</given-names></string-name>, <string-name><surname>Amato</surname><given-names>KA</given-names></string-name></person-group><etal>et al</etal><article-title>Pathogen-driven CRISPR screens identify TREX1 as a regulator of DNA self-sensing during influenza virus infection</article-title>. <source>Cell Host Microbe</source><year>2023</year>;<volume>31</volume>:<fpage>1552</fpage>–<lpage>67.e8</lpage>.<pub-id pub-id-type="pmid">37652009</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B41">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kuijjer</surname><given-names>ML</given-names></string-name>, <string-name><surname>Tung</surname><given-names>MG</given-names></string-name>, <string-name><surname>Yuan</surname><given-names>G</given-names></string-name></person-group><etal>et al</etal><article-title>Estimating Sample-Specific regulatory networks</article-title>. <source>iScience</source><year>2019</year>;<volume>14</volume>:<fpage>226</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="pmid">30981959</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B42">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kuleshov</surname><given-names>MV</given-names></string-name>, <string-name><surname>Jones</surname><given-names>MR</given-names></string-name>, <string-name><surname>Rouillard</surname><given-names>AD</given-names></string-name></person-group><etal>et al</etal><article-title>Enrichr: a comprehensive gene set enrichment analysis web server 2016 update</article-title>. <source>Nucleic Acids Res</source><year>2016</year>;<volume>44</volume>:<fpage>W90</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">27141961</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B43">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lambert</surname><given-names>SA</given-names></string-name>, <string-name><surname>Jolma</surname><given-names>A</given-names></string-name>, <string-name><surname>Campitelli</surname><given-names>LF</given-names></string-name></person-group><etal>et al</etal><article-title>The human transcription factors</article-title>. <source>Cell</source><year>2018</year>;<volume>175</volume>:<fpage>598</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">30290144</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B44">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname><given-names>J-E</given-names></string-name>, <string-name><surname>Schmidt</surname><given-names>H</given-names></string-name>, <string-name><surname>Lai</surname><given-names>B</given-names></string-name></person-group><etal>et al</etal><article-title>Transcriptional and epigenomic regulation of adipogenesis</article-title>. <source>Mol Cell Biol</source><year>2019</year>;<volume>39</volume>:<fpage>e00601-18</fpage>.<pub-id pub-id-type="pmid">30936246</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B45">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Levy</surname><given-names>G</given-names></string-name>, <string-name><surname>Guglielmelli</surname><given-names>P</given-names></string-name>, <string-name><surname>Langmuir</surname><given-names>P</given-names></string-name></person-group><etal>et al</etal><article-title>JAK inhibitors and COVID-19</article-title>. <source>J Immunother Cancer</source><year>2022</year>;<volume>10</volume>:<fpage>e002838</fpage>.<pub-id pub-id-type="pmid">35459733</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B46">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Chiu</surname><given-names>PK-F</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>Y</given-names></string-name></person-group><etal>et al</etal><article-title>Whole-exome sequencing reveals a comprehensive germline mutation landscape and identifies twelve novel predisposition genes in Chinese prostate cancer patients</article-title>. <source>PLoS Genet</source><year>2022</year>;<volume>18</volume>:<fpage>e1010373</fpage>.<pub-id pub-id-type="pmid">36095024</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B47">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lin</surname><given-names>Y</given-names></string-name>, <string-name><surname>Cai</surname><given-names>Q</given-names></string-name>, <string-name><surname>Luo</surname><given-names>Y</given-names></string-name></person-group><etal>et al</etal><article-title>Epithelial chemerin–CMKLR1 signaling restricts microbiota-driven colonic neutrophilia and tumorigenesis by up-regulating lactoperoxidase</article-title>. <source>Proc Natl Acad Sci USA</source><year>2022</year>;<volume>119</volume>:<fpage>e2205574119</fpage>.<pub-id pub-id-type="pmid">35858331</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B48">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Love</surname><given-names>MI</given-names></string-name>, <string-name><surname>Huber</surname><given-names>W</given-names></string-name>, <string-name><surname>Anders</surname><given-names>S.</given-names></string-name></person-group><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>. <source>Genome Biol</source><year>2014</year>;<volume>15</volume>:<fpage>550</fpage>.<pub-id pub-id-type="pmid">25516281</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B49">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lu</surname><given-names>Y</given-names></string-name>, <string-name><surname>Li</surname><given-names>X</given-names></string-name>, <string-name><surname>Liu</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>Toll-like receptors and inflammatory bowel disease</article-title>. <source>Front Immunol</source><year>2018</year>;<volume>9</volume>:<fpage>72</fpage>.<pub-id pub-id-type="pmid">29441063</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B50">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mandal</surname><given-names>P</given-names></string-name>, <string-name><surname>Feng</surname><given-names>Y</given-names></string-name>, <string-name><surname>Lyons</surname><given-names>JD</given-names></string-name></person-group><etal>et al</etal><article-title>Caspase-8 collaborates with caspase-11 to drive tissue damage and execution of endotoxic shock</article-title>. <source>Immunity</source><year>2018</year>;<volume>49</volume>:<fpage>42</fpage>–<lpage>55.e6</lpage>.<pub-id pub-id-type="pmid">30021146</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B51">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Marbach</surname><given-names>D</given-names></string-name>, <string-name><surname>Costello</surname><given-names>JC</given-names></string-name>, <string-name><surname>Küffner</surname><given-names>R</given-names></string-name></person-group><etal>et al</etal>; <collab>DREAM5 Consortium</collab>. <article-title>Wisdom of crowds for robust gene network inference</article-title>. <source>Nat. Methods</source><year>2012</year>;<volume>9</volume>:<fpage>796</fpage>–<lpage>804</lpage>.<pub-id pub-id-type="pmid">22796662</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B52">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Margolin</surname><given-names>AA</given-names></string-name>, <string-name><surname>Nemenman</surname><given-names>I</given-names></string-name>, <string-name><surname>Basso</surname><given-names>K</given-names></string-name></person-group><etal>et al</etal><article-title>ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context</article-title>. <source>BMC Bioinformatics</source><year>2006</year>;<volume>7</volume>:<fpage>S7</fpage>.</mixed-citation>
    </ref>
    <ref id="vbae034-B53">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Marino</surname><given-names>N</given-names></string-name>, <string-name><surname>German</surname><given-names>R</given-names></string-name>, <string-name><surname>Rao</surname><given-names>X</given-names></string-name></person-group><etal>et al</etal><article-title>Upregulation of lipid metabolism genes in the breast prior to cancer diagnosis</article-title>. <source>NPJ Breast Cancer</source><year>2020</year>;<volume>6</volume>:<fpage>50</fpage>.<pub-id pub-id-type="pmid">33083529</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B54">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Matschinske</surname><given-names>J</given-names></string-name>, <string-name><surname>Alcaraz</surname><given-names>N</given-names></string-name>, <string-name><surname>Benis</surname><given-names>A</given-names></string-name></person-group><etal>et al</etal><article-title>The AIMe registry for artificial intelligence in biomedical research</article-title>. <source>Nat Methods</source><year>2021</year>;<volume>18</volume>:<fpage>1128</fpage>–<lpage>31</lpage>.<pub-id pub-id-type="pmid">34433960</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B55">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Matulewicz</surname><given-names>N</given-names></string-name>, <string-name><surname>Stefanowicz</surname><given-names>M</given-names></string-name>, <string-name><surname>Nikolajuk</surname><given-names>A</given-names></string-name></person-group><etal>et al</etal><article-title>Markers of adipogenesis, but not inflammation, in adipose tissue are independently related to insulin sensitivity</article-title>. <source>J Clin Endocrinol Metab</source><year>2017</year>;<volume>102</volume>:<fpage>3040</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">28633482</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B56">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mears</surname><given-names>HV</given-names></string-name>, <string-name><surname>Sweeney</surname><given-names>TR.</given-names></string-name></person-group><article-title>Better together: the role of IFIT protein–protein interactions in the antiviral response</article-title>. <source>J Gen Virol</source><year>2018</year>;<volume>99</volume>:<fpage>1463</fpage>–<lpage>77</lpage>.<pub-id pub-id-type="pmid">30234477</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B57">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Meyer</surname><given-names>PE</given-names></string-name>, <string-name><surname>Lafitte</surname><given-names>F</given-names></string-name>, <string-name><surname>Bontempi</surname><given-names>G.</given-names></string-name></person-group><article-title>minet: a R/Bioconductor package for inferring large transcriptional networks using mutual information</article-title>. <source>BMC Bioinformatics</source><year>2008</year>;<volume>9</volume>:<fpage>461</fpage>.<pub-id pub-id-type="pmid">18959772</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B58">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mick</surname><given-names>E</given-names></string-name>, <string-name><surname>Kamm</surname><given-names>J</given-names></string-name>, <string-name><surname>Pisco</surname><given-names>AO</given-names></string-name></person-group><etal>et al</etal><article-title>Upper airway gene expression reveals suppressed immune responses to SARS-CoV-2 compared with other respiratory viruses</article-title>. <source>Nat Commun</source><year>2020</year>;<volume>11</volume>:<fpage>5854</fpage>.<pub-id pub-id-type="pmid">33203890</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B59">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Moerman</surname><given-names>T</given-names></string-name>, <string-name><surname>Aibar Santos</surname><given-names>S</given-names></string-name>, <string-name><surname>Bravo González-Blas</surname><given-names>C</given-names></string-name></person-group><etal>et al</etal><article-title>GRNBoost2 and arboreto: efficient and scalable inference of gene regulatory networks</article-title>. <source>Bioinformatics</source><year>2019</year>;<volume>35</volume>:<fpage>2159</fpage>–<lpage>61</lpage>.<pub-id pub-id-type="pmid">30445495</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B60">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mu</surname><given-names>J</given-names></string-name>, <string-name><surname>Fang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Yang</surname><given-names>Q</given-names></string-name></person-group><etal>et al</etal><article-title>SARS-CoV-2 N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2</article-title>. <source>Cell Discov</source><year>2020</year>;<volume>6</volume>:<fpage>65</fpage>.<pub-id pub-id-type="pmid">32953130</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B61">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nagy-Staron</surname><given-names>A</given-names></string-name>, <string-name><surname>Tomasek</surname><given-names>K</given-names></string-name>, <string-name><surname>Caruso Carter</surname><given-names>C</given-names></string-name></person-group><etal>et al</etal><article-title>Local genetic context shapes the function of a gene regulatory network</article-title>. <source>Elife</source><year>2021</year>;<volume>10</volume>:<fpage>e65993</fpage>.<pub-id pub-id-type="pmid">33683203</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B62">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nannapaneni</surname><given-names>P</given-names></string-name>, <string-name><surname>Hertwig</surname><given-names>F</given-names></string-name>, <string-name><surname>Depke</surname><given-names>M</given-names></string-name></person-group><etal>et al</etal><article-title>Defining the structure of the general stress regulon of <italic toggle="yes">Bacillus subtilis</italic> using targeted microarray analysis and random forest classification</article-title>. <source>Microbiology (Reading)</source><year>2012</year>;<volume>158</volume>:<fpage>696</fpage>–<lpage>707</lpage>.<pub-id pub-id-type="pmid">22174379</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B63">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nicolas</surname><given-names>P</given-names></string-name>, <string-name><surname>Mäder</surname><given-names>U</given-names></string-name>, <string-name><surname>Dervyn</surname><given-names>E</given-names></string-name></person-group><etal>et al</etal><article-title>Condition-dependent transcriptome reveals high-level regulatory architecture in <italic toggle="yes">Bacillus subtilis</italic></article-title>. <source>Science</source><year>2012</year>;<volume>335</volume>:<fpage>1103</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">22383849</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B64">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nielsen</surname><given-names>R</given-names></string-name>, <string-name><surname>Pedersen</surname><given-names>TA</given-names></string-name>, <string-name><surname>Hagenbeek</surname><given-names>D</given-names></string-name></person-group><etal>et al</etal><article-title>Genome-wide profiling of PPARgamma: RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis</article-title>. <source>Genes Dev</source><year>2008</year>;<volume>22</volume>:<fpage>2953</fpage>–<lpage>67</lpage>.<pub-id pub-id-type="pmid">18981474</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B65">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nieminen</surname><given-names>JK</given-names></string-name>, <string-name><surname>Niemi</surname><given-names>M</given-names></string-name>, <string-name><surname>Sipponen</surname><given-names>T</given-names></string-name></person-group><etal>et al</etal><article-title>Dendritic cells from Crohn’s disease patients show aberrant STAT1 and STAT3 signaling</article-title>. <source>PLoS One</source><year>2013</year>;<volume>8</volume>:<fpage>e70738</fpage>.<pub-id pub-id-type="pmid">23950992</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B66">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Noguchi</surname><given-names>K</given-names></string-name>, <string-name><surname>Okumura</surname><given-names>F</given-names></string-name>, <string-name><surname>Takahashi</surname><given-names>N</given-names></string-name></person-group><etal>et al</etal><article-title>TRIM40 promotes neddylation of IKK<inline-formula id="IE91"><mml:math id="IM91" display="inline" overflow="scroll"><mml:mo>γ</mml:mo></mml:math></inline-formula> and is downregulated in gastrointestinal cancers</article-title>. <source>Carcinogenesis</source><year>2011</year>;<volume>32</volume>:<fpage>995</fpage>–<lpage>1004</lpage>.<pub-id pub-id-type="pmid">21474709</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B67">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Palmer</surname><given-names>NP</given-names></string-name>, <string-name><surname>Silvester</surname><given-names>JA</given-names></string-name>, <string-name><surname>Lee</surname><given-names>JJ</given-names></string-name></person-group><etal>et al</etal><article-title>Concordance between gene expression in peripheral whole blood and colonic tissue in children with inflammatory bowel disease</article-title>. <source>PLoS One</source><year>2019</year>;<volume>14</volume>:<fpage>e0222952</fpage>.<pub-id pub-id-type="pmid">31618209</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B68">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ritchie</surname><given-names>ME</given-names></string-name>, <string-name><surname>Phipson</surname><given-names>B</given-names></string-name>, <string-name><surname>Wu</surname><given-names>D</given-names></string-name></person-group><etal>et al</etal><article-title>limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title>. <source>Nucleic Acids Res</source><year>2015</year>;<volume>43</volume>:<fpage>e47</fpage>.<pub-id pub-id-type="pmid">25605792</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B69">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rokhlin</surname><given-names>OW</given-names></string-name>, <string-name><surname>Taghiyev</surname><given-names>AF</given-names></string-name>, <string-name><surname>Bayer</surname><given-names>KU</given-names></string-name></person-group><etal>et al</etal><article-title>Calcium/calmodulin-dependent kinase II plays an important role in prostate cancer cell survival</article-title>. <source>Cancer Biol Ther</source><year>2007</year>;<volume>6</volume>:<fpage>732</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="pmid">17387273</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B70">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Saez</surname><given-names>E</given-names></string-name>, <string-name><surname>Rosenfeld</surname><given-names>J</given-names></string-name>, <string-name><surname>Livolsi</surname><given-names>A</given-names></string-name></person-group><etal>et al</etal><article-title>PPAR gamma signaling exacerbates mammary gland tumor development</article-title>. <source>Genes Dev</source><year>2004</year>;<volume>18</volume>:<fpage>528</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="pmid">15037548</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B71">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schmitt</surname><given-names>H</given-names></string-name>, <string-name><surname>Neurath</surname><given-names>MF</given-names></string-name>, <string-name><surname>Atreya</surname><given-names>R.</given-names></string-name></person-group><article-title>Role of the IL23/IL17 pathway in Crohn’s disease</article-title>. <source>Front Immunol</source><year>2021</year>;<volume>12</volume>:<fpage>622934</fpage>.<pub-id pub-id-type="pmid">33859636</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B72">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schönrock</surname><given-names>A</given-names></string-name>, <string-name><surname>Heinzelmann</surname><given-names>E</given-names></string-name>, <string-name><surname>Steffl</surname><given-names>B</given-names></string-name></person-group><etal>et al</etal><article-title>MEOX2 homeobox gene promotes growth of malignant gliomas</article-title>. <source>Neuro Oncol</source><year>2022</year>;<volume>24</volume>:<fpage>1911</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">35468210</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B73">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shojaie</surname><given-names>A.</given-names></string-name></person-group><article-title>Differential network analysis: a statistical perspective</article-title>. <source>Wiley Interdiscip Rev Comput Stat</source><year>2021</year>;<volume>13</volume>:<fpage>e1508</fpage>.<pub-id pub-id-type="pmid">37050915</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B74">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Singh</surname><given-names>DK</given-names></string-name>, <string-name><surname>Aladyeva</surname><given-names>E</given-names></string-name>, <string-name><surname>Das</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>Myeloid cell interferon responses correlate with clearance of SARS-CoV-2</article-title>. <source>Nat Commun</source><year>2022</year>;<volume>13</volume>:<fpage>679</fpage>.<pub-id pub-id-type="pmid">35115549</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B75">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stetson</surname><given-names>DB</given-names></string-name>, <string-name><surname>Ko</surname><given-names>JS</given-names></string-name>, <string-name><surname>Heidmann</surname><given-names>T</given-names></string-name></person-group><etal>et al</etal><article-title>Trex1 prevents cell-intrinsic initiation of autoimmunity</article-title>. <source>Cell</source><year>2008</year>;<volume>134</volume>:<fpage>587</fpage>–<lpage>98</lpage>.<pub-id pub-id-type="pmid">18724932</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B76">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Subramanian</surname><given-names>A</given-names></string-name>, <string-name><surname>Tamayo</surname><given-names>P</given-names></string-name>, <string-name><surname>Mootha</surname><given-names>VK</given-names></string-name></person-group><etal>et al</etal><article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title>. <source>Proc Natl Acad Sci USA</source><year>2005</year>;<volume>102</volume>:<fpage>15545</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">16199517</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B77">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sun</surname><given-names>J</given-names></string-name>, <string-name><surname>Li</surname><given-names>S</given-names></string-name>, <string-name><surname>Wang</surname><given-names>F</given-names></string-name></person-group><etal>et al</etal><article-title>Identification of key pathways and genes in PTEN mutation prostate cancer by bioinformatics analysis</article-title>. <source>BMC Med Genet</source><year>2019</year>;<volume>20</volume>:<fpage>191</fpage>.<pub-id pub-id-type="pmid">31791268</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B78">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tanaka</surname><given-names>Y</given-names></string-name>, <string-name><surname>Tamada</surname><given-names>Y</given-names></string-name>, <string-name><surname>Ikeguchi</surname><given-names>M</given-names></string-name></person-group><etal>et al</etal><article-title>System-based differential gene network analysis for characterizing a sample-specific subnetwork</article-title>. <source>Biomolecules</source><year>2020</year>;<volume>10</volume>:<fpage>306</fpage>.<pub-id pub-id-type="pmid">32075209</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B79">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tang</surname><given-names>K</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>L</given-names></string-name>, <string-name><surname>Chen</surname><given-names>J</given-names></string-name></person-group><etal>et al</etal><article-title>Hypoxia promotes breast cancer cell growth by activating a glycogen metabolic program</article-title>. <source>Cancer Res</source><year>2021</year>;<volume>81</volume>:<fpage>4949</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="pmid">34348966</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B80">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tesson</surname><given-names>BM</given-names></string-name>, <string-name><surname>Breitling</surname><given-names>R</given-names></string-name>, <string-name><surname>Jansen</surname><given-names>RC.</given-names></string-name></person-group><article-title>DiffCoEx: a simple and sensitive method to find differentially coexpressed gene modules</article-title>. <source>BMC Bioinformatics</source><year>2010</year>;<volume>11</volume>:<fpage>497</fpage>.<pub-id pub-id-type="pmid">20925918</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B81">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tu</surname><given-names>J-J</given-names></string-name>, <string-name><surname>Ou-Yang</surname><given-names>L</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>Y</given-names></string-name></person-group><etal>et al</etal><article-title>Differential network analysis by simultaneously considering changes in gene interactions and gene expression</article-title>. <source>Bioinformatics</source><year>2021</year>;<volume>37</volume>:<fpage>4414</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="pmid">34245246</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B82">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Van de Sande</surname><given-names>B</given-names></string-name>, <string-name><surname>Flerin</surname><given-names>C</given-names></string-name>, <string-name><surname>Davie</surname><given-names>K</given-names></string-name></person-group><etal>et al</etal><article-title>A scalable SCENIC workflow for single-cell gene regulatory network analysis</article-title>. <source>Nat Protoc</source><year>2020</year>;<volume>15</volume>:<fpage>2247</fpage>–<lpage>76</lpage>.<pub-id pub-id-type="pmid">32561888</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B83">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>H</given-names></string-name>, <string-name><surname>Tang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Yang</surname><given-names>X</given-names></string-name></person-group><etal>et al</etal><article-title>A crucial angiogenesis-associated gene meox2 could be a promising biomarker candidate for breast cancer</article-title>. <source>Front Oncol</source><year>2022</year>;<volume>12</volume>:<fpage>759300</fpage>.<pub-id pub-id-type="pmid">35615155</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B84">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>X</given-names></string-name>, <string-name><surname>Wang</surname><given-names>G</given-names></string-name>, <string-name><surname>Shi</surname><given-names>Y</given-names></string-name></person-group><etal>et al</etal><article-title>PPAR-Delta promotes survival of breast cancer cells in harsh metabolic conditions</article-title>. <source>Oncogenesis</source><year>2016</year>;<volume>5</volume>:<fpage>e232</fpage>.<pub-id pub-id-type="pmid">27270614</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B85">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Weintraub</surname><given-names>Y</given-names></string-name>, <string-name><surname>Cohen</surname><given-names>S</given-names></string-name>, <string-name><surname>Chapnik</surname><given-names>N</given-names></string-name></person-group><etal>et al</etal><article-title>Clock gene disruption is an initial manifestation of inflammatory bowel diseases</article-title>. <source>Clin Gastroenterol Hepatol</source><year>2020</year>;<volume>18</volume>:<fpage>115</fpage>–<lpage>22.e1</lpage>.<pub-id pub-id-type="pmid">30981000</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B86">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yamada</surname><given-names>T</given-names></string-name>, <string-name><surname>Sato</surname><given-names>S</given-names></string-name>, <string-name><surname>Sotoyama</surname><given-names>Y</given-names></string-name></person-group><etal>et al</etal><article-title>RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells</article-title>. <source>Nat Immunol</source><year>2021</year>;<volume>22</volume>:<fpage>820</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">33976430</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B87">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yu</surname><given-names>X</given-names></string-name>, <string-name><surname>Zeng</surname><given-names>T</given-names></string-name>, <string-name><surname>Wang</surname><given-names>X</given-names></string-name></person-group><etal>et al</etal><article-title>Unravelling personalized dysfunctional gene network of complex diseases based on differential network model</article-title>. <source>J Transl Med</source><year>2015</year>;<volume>13</volume>:<fpage>189</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="pmid">26070628</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B88">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zaidi</surname><given-names>D</given-names></string-name>, <string-name><surname>Wine</surname><given-names>E.</given-names></string-name></person-group><article-title>Regulation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-<inline-formula id="IE92"><mml:math id="IM92" display="inline" overflow="scroll"><mml:mo>κ</mml:mo></mml:math></inline-formula><inline-formula id="IE93"><mml:math id="IM93" display="inline" overflow="scroll"><mml:mo>β</mml:mo></mml:math></inline-formula>) in inflammatory bowel diseases</article-title>. <source>Front Pediatrics</source><year>2018</year>;<volume>6</volume>:<fpage>317</fpage>.</mixed-citation>
    </ref>
    <ref id="vbae034-B89">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zeng</surname><given-names>G</given-names></string-name>, <string-name><surname>Liu</surname><given-names>X</given-names></string-name>, <string-name><surname>Su</surname><given-names>X</given-names></string-name></person-group><etal>et al</etal><article-title>The role of MEOX1 in non-neoplastic and neoplastic diseases</article-title>. <source>Biomed Pharmacother</source><year>2023</year>;<volume>158</volume>:<fpage>114068</fpage>.<pub-id pub-id-type="pmid">36495659</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B90">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>J</given-names></string-name>, <string-name><surname>Ji</surname><given-names>Y</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>L.</given-names></string-name></person-group><article-title>Extracting three-way gene interactions from microarray data</article-title>. <source>Bioinformatics</source><year>2007</year>;<volume>23</volume>:<fpage>2903</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">17921496</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B91">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>X</given-names></string-name>, <string-name><surname>Su</surname><given-names>L</given-names></string-name>, <string-name><surname>Sun</surname><given-names>K.</given-names></string-name></person-group><article-title>Expression status and prognostic value of the perilipin family of genes in breast cancer</article-title>. <source>Am J Transl Res</source><year>2021</year>;<volume>13</volume>:<fpage>4450</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="pmid">34150026</pub-id></mixed-citation>
    </ref>
    <ref id="vbae034-B92">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhou</surname><given-names>Z</given-names></string-name>, <string-name><surname>Ren</surname><given-names>L</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>L</given-names></string-name></person-group><etal>et al</etal><article-title>Heightened innate immune responses in the respiratory tract of COVID-19 patients</article-title>. <source>Cell Host Microbe</source><year>2020</year>;<volume>27</volume>:<fpage>883</fpage>–<lpage>90.e2</lpage>.<pub-id pub-id-type="pmid">32407669</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
